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Abstract 
 
SWI/SNF chromatin remodelling complexes are one of the well-characterized cellular 
machineries capable of regulation of gene expression. Numerous lines of evidence indicate 
that SWI/SNF complexes are involved in a wide range of cellular processes and the 
maintenance of homeostasis whereas aberrant expression of those proteins contributes 
towards cancer development. Colorectal cancer remains one of the most clinically significant 
cancers due to its high incidence in developed countries and previous studies have 
demonstrated that SWI/SNF complexes are aberrantly regulated in a significant proportion of 
patients with this disease. However, whilst the sequence of molecular events leading to CRC 
has been well-established, the role of SWI/SNF chromatin remodelling complex ATPase 
subunits Brm and its paralogue Brg1 in the colorectal tumorigenesis remains elusive.  
The chromatin remodelling catalytic subunit Brm has been found to interact with the Notch 
pathway effectors ICD-22 and CBF-1 and also to be necessary for expression of the Wnt 
target gene CD44 and for Rb-mediated cell cycle arrest. In this PhD thesis, the potential of 
Brm to modulate Wnt-driven intestinal tumorigenesis was  addressed. Initially, a murine 
model carrying constitutively deleted Brm was used to assess the consequences of this loss on 
homeostasis of the small intestinal and colonic epithelia. The effects of Brm deficiency were 
also examined in the context of Wnt-activated epithelium via conditional loss of Apc. 
Additionally, the effect of concomitant loss of Brm and Brg1 was addressed in the contexts of 
both normal homeostasis and aberrant Wnt signalling.  
The results presented here demonstrate that Brm plays an important role in the small intestine 
by regulating the distribution of proliferating cells and cell fate decisions mediated through 
Notch pathway effectors. Furthermore, Brm deficiency was found to modulate intestinal 
phenotype of Wnt activation through the attenuation of the Wnt transcriptional programme 
and the suppressed expression of the intestinal stem cell marker Olfm4. Thus while Brg1 has 
been widely characterized as a bone fide tumour suppressor, the function of Brm continues to 
remain elusive especially in the light of contrasting effects co-mediated by Brm on 
proliferation, differentiation and gene expression.  
Taken together, these results elucidate the tissue-specific role of Brm, the catalytic subunit of 
SWI/SNF chromatin remodelling complex, on both normal intestinal homeostasis and acute 
activation of Wnt pathway while the extent of these Brm-dependent effects depend upon the 
gradient of Wnt signalling throughout the epithelium of small and large intestine. 
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Chapter 1  
General introduction 
 
1.1 The Mammalian intestines  
 
1.1.1 Anatomy and functions of gastrointestinal tract  
The human digestive tract is a central part of the digestive system where different elements of 
this tract have some distinct functions assigned. The main function of the digestive tract is to 
convert the consumed food into the basic nutrients as it passes through its different parts, gets 
digested and absorbed in the form of elementary molecules. Gastrointestinal tract is the 
largest part of the digestive tract and consists of the stomach and the intestines (Figure 1.1).  
Stomach primarily functions as storage and mixing chamber as the body of the stomach 
consists of series of ridges called rugae which are produced by numerous folds that can 
stretch in and therefore allow the expansion of the stomach volume upon the entry of the 
food.  Once the food enters this compartment of the digestive tract, it is mixed with stomach 
secretions to form chyme which also undergoes some initial and very limited digestion and 
absorption. The gastric glands of stomach epithelium secrete hydrochloric acid, digestive 
enzymes such as pepsinogen and mucus that provides the lubrication and protects the 
stomach mucosa from damage by acidic chyme and digestive enzymes. Three muscular 
layers within the stomach enable the mixing of its contents and help with the movement of 
those partially digested gastric contents into the intestine where the majority of digestion and 
absorption occurs (Seeley et al., 2002). The intestine is divided into two major parts: the 
small intestine and the large intestine, each organised into smaller compartments. The small 
intestine consists of the duodenum, the jejum, and the ileum. All three parts of small intestine 
can be characterized by similar organization (Figure 1.2) with some exceptions to duodenum 
where Brunner glands are present in the submucosa and two papillae through which the 
duodenal lumen receives the secretions from bile duct and pancreatic duct.  
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Figure 1.1 The basic anatomy of gastrointestinal tract consisting of small and large intestine supported in their 
function by multiple glands. Both small and large intestine can be further subdivided into three sections that 
bear some structural differences as well as minor changes in pH. 
Those four histologically different layers are serosa, muscularis, submucosa and mucosa and 
they are present within the length of gastrointestinal tract from the esophagus to the anus. The 
outermost layer, serosa consists of a connective tissue and simple squamous epithelium that is 
lining the abdominal cavity. The next underlying layer is muscularis which is represented by 
longitudinal smooth muscle and circular smooth muscle. The myenteric plexus, a network of 
nerve cells lays between those two muscle layers and it is responsible for controlling the 
motility of the gastrointestinal tract. A layer of connective tissue containing blood and 
lymphatic vessels and nerves, the submucosa, provides the support for the innermost layer of 
mucosa as well as connection between mucosa and muscularis due to the presence of the 
submucosal plexus. The submucosal plexus and myenteric plexus together form the enteric 
nervous system which plays a crucial role in the secretion and movement control within 
gastrointestinal tract. The mucosa surrounding the lumen of the gut is composed of three 
distinct layers: a thin layer of smooth muscle - muscularis mucosae, loose connective tissue 
called lamina propria and mucous epithelium. This epithelium differs from that of the 
esophagus which is stratified, squamous epithelium as in the intestine it is represented by 
simple columnar epithelium specialized for absorption. The lymphatic nodules in the mucosa 
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and submucosa of ileum called Payer’s patches protect the intestine as they trigger the 
immune responses against microorganisms.  
The surface of the small intestine can be greatly enhanced about 600-fold by the presence of 
specific histological structures that allow for the most efficient digestion and absorption of 
the passing chyme. First of those are plicae ciculares, a series of folds formed within the 
mucosa and submucosa that run perpendicularly to the intestinal axis. Furthermore, the 
mucosa forms long finger-like projections covered by simple columnar epithelium that are 
protruding into the lumen called villi. As the small intestine is traced towards the ileum, the 
number of those circular folds, the density and the length of the villi decrease gradually. At 
the base of the villi, the epithelium produces the pocket-like tubular invaginations into the 
lamina propria termed crypts of Lieberkuhn. Lastly, the majority of the cells that cover the 
surface of the villus possess numerous cytoplasmic extensions termed microvilli that enhance 
the surface for digestion and absorption even further. 
 
Figure 1.2 Histology of small and large intestinal epithelium including the underlying layers of tissue. The small 
intestine consists of finger-like projections into the lumen called villi and invaginations called crypts. The large 
intestine is made up of single layer of epithelial cells similarly to small intestine, however those cells form a flat 
surface of epithelium with no villi.   
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The small intestine possesses a variety of functions the most important of which include the 
digestion and absorption. As the acidic chyme is entering the duodenum from the stomach, it 
is neutralized by bicarbonate ions from pancreas and bile from the liver. This produces the 
pH conditions suitable for further digestion of passing chyme by pancreatic and intestinal 
enzymes. Those final stages of the breakdown of the food molecules are achieved mostly by 
the enzymes entering the small intestine from pancreas with the aid of intestinal enzymes 
bound to the membranes of the microvilli. Although the latter are exclusively associated with 
epithelium surface, it is indeed due to the extremely large surface area of the intestinal 
epithelium that they are able to perform their digestive function so efficiently. Once the 
digestion of food is completed, the absorption of the majority of the nutrients, water and 
electrolytes occurs through the microvilli in the duodenum and jejum of the small intestine, 
whereas the remainder is absorbed in the large intestine.  
The large intestine can be subdivided into caecum, colon, rectum and anal canal where the 
colon constitutes the major part of the large intestine. The absorption of the remaining water 
and salts from the chyme occurs in the proximal part of the colon as the chyme is converted 
further into faeces.  
The mucosa in the colon bears some crucial differences from that of small intestine as it lacks 
plicae ciculares and villi in the epithelium (Figure 1.2). The crypts similar to those found in 
the small intestinal mucosa are also present in the colon however the most apparent is the 
change in major populations of cell types present in the epithelium. The predominant cell 
population in the colon are mucus secreting cells whereas in the small intestine the majority 
of the cells are absorptive cells. This shift in the cell type abundance correlates closely with 
the main functions conducted by small and large intestine. 
1.1.2 Micro-architecture of small intestinal epithelium 
As mentioned in the previous section, gastrointestinal tract is comprised of different parts and 
each of those possesses specific functions including digestion, absorption or protection which 
are supported and accomplished by cells of multiple lineages localised within the epithelium. 
In the intestinal epithelium those cells are arranged in crypt-villus structures that run along 
the vertical axis of the gut lumen. The intestinal crypts are compartments at the base of which 
intestinal stem cells are localised, whereas above we can find originating from those stem 
cells highly proliferative cell progenitors. Progenitor cells create a transit-amplifying zone 
within the crypt where cells undergo few rounds of cell division as well as initial stages of the 
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differentiation that determine their cell fate. As those incompletely differentiated progenitor 
cells migrate towards the crypt-villus junction they steadily begin to lose their proliferative 
capacities and differentiate towards one of two differentiated cell lineages that populate the 
villi. Fully differentiated cells are continuing to migrate upwards towards the tip of the villi, 
once there they undergo the apoptosis and are shed into the gut lumen (Gregorieff et al., 
2005). This migration pattern is followed by all mature cells of intestinal epithelium with 
exception of Paneth cells that in contrast upon differentiation migrate towards the base of the 
intestinal crypt. The progenitor cells are actively dividing producing on the daily basis around 
200 cells per crypt and upon the differentiation they continue to migrate towards the tip of the 
villus, fundamentally all fully differentiated cells of intestinal epithelium are renewed every 5 
days in humans (Figure 1.3) (Marshman et al., 2002).  
 
 
Figure 1.3 The epithelial cell lining of small intestine forms invaginations into the mucosa and finger-like 
projections into the gut lumen and consists of numerous cell populations. Intestinal stem cell and Paneth cells 
are located at the bottom of the crypt escaping the general trend of upward migration. Other differentiated cell 
types reside along the length of villus migrating upward and eventually being shed off the villus tip. 
We can distinguish between four major epithelial cells types that can be divided into two 
distinct lineages: absorptive or secretory lineage. Absorptive lineage consists of enterocytes 
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while Paneth, goblet and enteroendocrine cells belong to secretory lineage. Whereas the 
epithelium of small intestine comprises of all four main differentiated cells (notably, 
enterocytes, goblet, Paneth and enteroendocrine cells), the colonic epithelium consists of 
mostly the absorptive enterocytes and goblet cells. 
The vast majority of the differentiated cells within intestinal epithelium are enterocytes. 
Enterocytes represents more than 80% of all intestinal epithelial cells and they are present in 
the top part of the crypt compartment and all along the length of the villus. The main 
characteristic of enterocytes is the presence of the microvilli on their surface whereas the 
combined microvilli of all epithelial surfaces form a brush border. In contrast to secretory 
lineage cells, absorptive enterocytes do not contain secretory granules. Instead the brush 
border membrane vesicles contain multiple hydrolases that function to aid the final 
breakdown of complex molecules such as peptides and disaccharides into simple compounds 
that can be absorbed. The transporter proteins within apical and basolateral membranes 
actively transport various ions and nutrients from the lumen to the blood capillaries (Smith 
1985). Furthermore enterocytes can be distinguished from other three mature cell types of 
intestinal epithelium by the expression of intestinal alkaline phosphatase which functions as a 
marker for fully differentiated enterocytes. Alkaline phosphatase (AP) activity is not present 
in the stomach with the highest levels detected within brush border membrane of the 
duodenum and substantially decreasing towards the large intestine (Hinnebusch et al., 2003).  
Amongst the mature cell types of secretory lineage, goblet cells are the most abundant cells 
of epithelium with the numbers of cells varying between different parts of the gastrointestinal 
tract. Goblet cells are localized in between enterocytes from top half of the crypt all the way 
upwards to the tip of the villus and similarly to enterocytes they are renewed every 3 days. 
Those cells contain of large granules that are filled with mucin and large endoplasmic 
reticulum. Goblet cells produce a protective mucous lining that lubricates the intestinal wall 
in order to facilitate the passing of food, prevents the injury from the acidic chyme as well as 
autodigestion by digestive enzymes.  
Another secretory lineage cell type is represented by enteroendocrine cells.  Although these 
cells are very rare within the small intestinal epithelium accounting for less than 1% of all 
differentiated cells amongst themselves they can be subdivided into 15 distinct cell types 
according to the morphology of their granules, the type of secretory product, the expression 
of the specific marker molecule and their capacity for expressing particular transgenes. This 
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highly heterogeneous population of cells shares one common function which is the 
expression and secretion of hormones including serotonin, secretin, substance P, 
cholecystokinin, gastric inhibitory polypeptide, neuropeptide Y and many others (Hocker and 
Wiedenmann 1998).  
As mentioned before, the last cell type belonging to the secretory lineage as well as the only 
where instead of migrating up towards the tip of villus cells are migrating towards the crypt 
base is Paneth cells. Within the secretory lineage, they are the second most abundant cell type 
after goblet cells in the intestinal epithelium and in comparison to other 3 cell types they have 
much longer lifespan. The Paneth cell turnover has been extensively investigated in the past 
by injection of [
3
H]-thymidine labelling agent that is allowed to be incorporated into the 
nuclei of cells actively synthesizing DNA showing that Paneth cells whose nuclei contain the 
label are present at 18-22 days post-injection (Cheng 1969) and at 29 days post injection 
(Troughton and Trier 1969). Nevertheless both groups have confirmed that Paneth cells do 
not possess proliferative capacities. Most recently, a new method exploiting a distinct ability 
of progenitor cells but not Paneth cells to express inducible AhCre transgene and furthermore 
to express Cre-activated the enhanced yellow fluorescent protein (EYFP) was applied to 
determine the life span of Paneth cells. Ireland et al. (2005) found that contrary to previous 
data published, Paneth cells are capable of surviving up to 57 days meaning their turnover is 
19 times longer than that of any other differentiated cell type of the intestinal epithelium. As 
other cells of secretory lineage, one of the crucial features of Paneth cells is the presence in 
abundance of well-pronounced secretory granules in the apical cytoplasm (Troughton and 
Trier 1969). The protective function of Paneth cells against the bacteria is indeed achieved 
through the presence of various antimicrobial substances in their granules. Fully 
differentiated Paneth cells secrete antimicrobial peptides (AMP) α-defensins (cryptdins in 
mice) and enzymes such as lysozyme and phospholipase A2 type IIA that are specifically 
targeting the bacterial cell walls (Keshav et al., 2006, Ouellette et al., 2005). Other 
components of granules, notably immunoglobulin IgA, secretory leukocyte inhibitor and 
pancreatitis-associated protein may be involved in supporting AMPs in fighting the intestinal 
inflammation (Porter et al., 2002). Consequently, Paneth cells play a central role in the 
intestinal immunity and may as well contribute towards the immunopathology. The recent 
data also suggests that Paneth cells are necessary in maintaining the intestinal stem cell niche 
(Sato et al., 2010) with this particular aspect discussed in more detail in later sections of this 
PhD thesis.   
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With the exception of the above mentioned four main differentiated cell types, two small 
populations of cells can be found in the small intestinal epithelium. M (microfold) cells are 
very distinct epithelial cells present in the follicle-associated epithelium, adjacent to Peyer’s 
patches. In contrast to enterocytes, M cells do not possess microvilli but instead they can be 
characterized by the presence of the microfolds on their apical surface. They are capable of 
the uptake and transporting of microorganisms and foreign antigens from the lumen of the 
gut, across the epithelium by transcytosis (endo- or phagocytosis). Upon the delivery to the 
basolateral memebrane, those antigens are presented to dendritic cells and B and T 
lymphocytes within the lymphoid tissues. The mechanism of functioning of M cells is 
believed to act as an antigen sampling system and therefore very important in inducing an 
immune response within the intestinal epithelium (Kraehenbuhl et al., 2000, Kucharzik et al., 
2000). Tuft cells (also known as brush, caveolated or fibrillovesicular cells) are present 
throughout the organs of digestive and respiratory tract and comprise up to 0.4% of the 
epithelial cells in ileum (Gerbe et al., 2012). They can be characterized by goblet-like shape, 
shorter than enterocytes and blunt brush border associated with much weaker alkaline 
phosphatase activity and multiple vesicles in the apical cytoplasm (Sato 2007).  Since their 
discovery in 1956 in both trachea and glandular stomach (Järvi and Keyrilainen 1956) the 
origin, differentiation and functions of tuft cells have not been unveiled yet. Some of existing 
data suggests they may be playing role in secretion or absorption or function as 
chemoreceptors and until the determination of their differentiation and specification their 
principal function and the relationship with other cells of intestinal epithelium remain 
undefined (Gerbe et al., 2012, Sato et al., 2007).  
1.1.2.1 Stem cell niche and identity 
Considering that the rate of renewal of cells within the intestinal epithelium where nearly all 
differentiated cell types (with exception to Paneth cells) are replaced every few days, the 
maintenance of renewal rate requires tightly regulated stem cell activity. In the context of 
adult organism, stem cells are defined as undifferentiated cells that maintained their capacity 
for long-term self-renewal as well as multipotency to generate several particular cell types 
(Siminovitch and Axelrad, 1963).   
In the absence of discreet set of intestinal stem cell markers, the identification of stem cells 
within the intestinal crypts has been a subject of large debate in the field.  
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Nearly four decades ago Potten et al. (1974) performed tritated thymidine- 
3
HTdR-labelling 
of intestinal epithelium incorporates into DNA during S phase of cell cycle and identified a 
population of slowly cycling cells located at the +4 cell position in regards to the crypt base. 
Interestingly, these cells were found directly above Paneth cells and further experiments 
utilizing irradiation as means to stem cell expansion revealed that 
3
HTdR label was 
incorporated into the DNA of +4 stem cells that underwent regeneration and the label was 
retained for more than one week (Potten 1974, 1978). The most recent data from the same 
group further confirms previous results showing that labelling of intestinal epithelium post-
irradiation using both 
3
HTdR and BrdU detected a population of cells that were double-
labelled with one template DNA stand carrying 
3
HTdR label whereas the daughter stand 
incorporated BrdU (Potten et al. 2002). The localisation of intestinal stem cells at the +4 
position in the epithelium resulted in the identification of numerous potential stem cell 
markers expressed specifically in that area of crypt including Musashi-1 however further 
studies indicated that Musashi-1 is not limited to +4 cells but also to CBC and early 
progenitor cells negating its use as stem cell marker (Potten et al. 2003). Bmi-1 (polycomb 
ring finger oncogene) was amongst other potential stem cell markers found to be expressed in 
the +4 cells. Linage tracing with inducible Bmi1-CreER in the small intestinal epithelium 
found that Bmi1
+
 cells were located predominantly at +4 position. This notion together with a 
finding that a single Bmi1
+
 cell can generate 3D organoid structures in vitro highlight the “+4 
position” cells as intestinal stem cell niche (Sangiorgi and Capecchi, 2008). DCAMKL-1 
(doublecortin and calcium/calmodulin-dependent protein kinase-like-1) was another stem cell 
marker that showed expression around +4 position however it was also found expressed in 
some differentiated cells of villus as well as being co-expressed with tuft cells markers (May 
et al. 2008, Gerbe et al. 2009). A well-known hematopoietic stem cell marker CD133 
(Prominin 1 in mice) was also proposed as intestinal stem cell marker as Prom1 was found to 
be expressed exclusively within CBC cells (Zhu et al., 2009) in contrast to data from Snippert 
et al. (2009) suggesting that Prom1 expression is not restricted to CBC cells only and 
furthermore showing that reporter-labelled cells were removed from the intestinal epithelium 
in a short period of time suggesting Prom1 as a marker for progenitor cells as well as stem 
cells (Snippert et al. 2009).  Throughout the decades of experiments investigating stem cells 
of intestinal epithelium, numerous novel markers specifically expressed at +4 position were 
identified such as Hopx homeobox protein (Takeda et al., 2011), mTert (mouse telomerase 
reverse transcriptase) (Montgomery et al., 2011) and Lrig1 (pan-ErbB inhibitor) (Powell et 
al., 2012) marking long-lived, slow-cycling and label-retaining cells at +4 position.  
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In the context of the downward migration of Paneth cells towards the crypt base which 
generates two differential migration gradients that originate directly above Paneth cells, it is 
plausible that intestinal stem cells niche can be found at the crypt base neighbouring with 
Paneth cells (Cairnie et al., 1965). As alternative to +4 stem cell theory, crypt-base columnar 
cells (CBC) cells found between Paneth cells at the crypt base were proposed as intestinal 
stem cells. They have been characterized as being undifferentiated cell type that is 
multipotent and capable of generating all differentiated cell types of epithelium and sensitive 
to irradiation as 
3
HTdR labelling prior to irradiation showed that some CBC cells became 
phagocytosed by neighbouring CBC cells and those 
3
HTdR-labelled phagosomes were 
detected later in mature epithelial cell types suggesting they are the progeny of phagocytosed 
CBC cells (Cheng and Leblond 1974). This notion indicating CBC cells as potential intestinal 
stem cells have been overlooked for decades at the cost of “+4 stem cell” model however 
most recent studies have provided the field with new evidence in support of this notion.   
Lineage tracing in murine intestinal epithelium found that CBC cell expressing leucine-rich 
repeat-containing G-protein coupled receptor 5 (Lgr5) were actively cycling and displayed a 
multipotency potential in a long-term study (Barker et al., 2007). Moreover the isolation of 
Lgr5-positive cells and their culture in vitro in 3D matrix revealed they were capable of 
generating organoid structures (Sato et al., 2009). Further characterization of Lgr5
+
 cells have 
implicated Ascl2 (Achaete scute-like 2) and Olfm4 (Olfactomedin-4) as additional stem cell 
markers that are exclusively co-expressed with Lgr5 in CBC cells (van der Flier et al., 2009). 
Taken together, extensive data from +4 position and CBC cell stem cell studies implicate the 
existence of two different pools of intestinal stem cells: quiescent stem cells located at the +4 
position characterised by the presence of Bmi1
 
expression and actively cycling Lgr5
+
 CBC 
cells. Accordingly, each of those two populations of intestinal stem cells possess very 
particular but at the same time collaborative functions contributing towards a reciprocal back-
up system that is capable of the maintenance of intestinal epithelium and its regeneration in 
case of the damage (Li and Clevers, 2010). Bmi1+ cells were previously shown to proliferate 
at a slower rate than Lgr5-expressing CBC cells which divide approximately once a day 
providing further evidence for the presence of two separate populations of intestinal stem 
cells (Baker et al. 2007, Sangiorgi and Capecci, 2008).  
Despite this indications, the identification and nature of quiescent intestinal stem cells 
remains elusive as many studies failed to recapitulate the above findings using “+4 position”-
specific stem cell markers. Recent study by Muñoz et al. (2012) showed that in Lgr5
+
 cells 
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Bmi1, Hopx, Tert and Lrig1 are found to be expressed at high levels in contrast to Lgr5
-
 cells 
in which no such enrichment was detected using transcriptome and proteomic analysis. These 
results are contrary to previous data obtained by Bmi1 lineage tracing experiments (Muñoz et 
al., 2012).  
 
In summary, the existence of population of quiescent stem cell pool cannot be excluded 
however the use of mentioned “+4 position” stem cell markers does not guarantee the correct 
identification of those cells. Furthermore, an alternative hypothesis exists suggesting that the 
transit-amplifying cells in close proximity to the stem cell niche might display plasticity and 
subsequently be capable of reverting to intestinal stem cell phenotype in order to support the 
regeneration process in case of damage (Cheng and Leblond 1974, Potten et al. 1974). 
 
1.1.3 The homeostasis in the intestinal epithelium  
As a majority of functions performed by the intestinal epithelium of gastrointestinal tract 
relies on the continuous renewal of the intestinal epithelium it requires very strict and 
coordinated regulation to maintain the balance between proliferation and differentiation of 
epithelial stem cells and immature progenitor cells in order to preserve this unique 
multicellular tissue architecture. The maintenance of the homeostasis is based on three 
principal mechanisms, first of which involves the active proliferation dictated by the small 
population of the stem cells at the crypt base which safeguards the renewal of all epithelial 
surface. Secondly, the differentiation of newly produced cells along secretory or absorptive 
lineage ensures the right balance between cell numbers and enables them to perform their 
functions. Thirdly, the continuous migration of cells up the crypt-villus axis provides the 
means for the complete replenishment of epithelial cell layer as the cells are shed of the tip of 
the villus to accommodate newly produced cells within the crypt.  
Therefore the maintenance of small intestinal homeostasis which involves numerous 
processes that control the structure as well as functions within intestinal epithelium is tightly 
coordinated  by a network of signalling pathways including Wnt, Notch, Hedgehog, BMP, 
PDGF and TGFβ (Andrae et al., 2008, Büller et al., 2012, Clevers 2006, He et al., 2004, 
Katoh and Katoh 2006, Karlsson et al., 2000, Shi and Massague 2003). This section will 
briefly describe each of those pathways and its role in maintaining homeostasis in the small 
intestine.  
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1.1.3.1 Hedgehog and Platelet-derived growth factor pathways  
The mesenchyme-to-epithelium signalling is governed by the Hedgehog and PDGF pathways 
whereas the other side of this interaction from mesenchyme to epithelium is dictated by TGF-
β/BMP pathway (Sancho 2004). Within Hh pathway we can distinguish between three 
different transmembrane receptors: Smootherned (Smo), Patched (Ptch) and Hedgehog-
interacting protein (HIP) present on the surface of hedgehog-responsive cells as well as three 
ligands that are paralogues: Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert 
hedgehog (Dhh). Sonic Hh and Indian Hh are both expressed in the epithelium and play 
crucial role in formation of intestinal structures of crypts and villi.  
In the absence of secreted Hh ligands, Ptch is believed to inhibit the Smo activity. The 
inactive form of Smo functions as an assembly core of a complex comprising of Costal-2 
(Cos-2) and Fused (Fu) whereas Cos-2 binds several other molecules such as glycogen 
synthase kinase-3β (GSK3β), casein kinase 1α (CK1α) and protein kinase (PKA). This 
complex impounds Glioblastoma (Gli) transcription factors and targets them for proteasomal 
degradation.  GLI family of zinc-finger transcription factors consists of Gli1, Gli2 and Gli3. 
Resulted from the proteasomal degradation truncated Gli2 and Gli3 proteins are not capable 
of transducing the Hh signal and therefore act as Hh suppressors. Upon the Hh ligand binding 
to the PTCH, its inhibitory action upon Smo is lifted and downstream signalling cascade 
blocks the formation of GLI destruction complex (Figure 1.4). The stabilisation and 
translocation of GLI transcription factors from cytoplasm into the nucleus triggers the 
transcription and expression of Hh target genes (reviewed in Sancho 2004, Katoh and Katoh 
2006).  
In the intestinal epithelium Gli2 and Gli3 are the major transducers of Hh signalling. In early 
development of mouse, the Hh ligands Shh and Ihh are both produced in the endodermal 
epithelium and play crucial role in controlling the cell fate specification processes. With time 
as the villi develop their expression becomes confined to proliferative crypt compartment 
whereas the expression of Hh receptors and effector molecules is strictly restricted to stromal 
cells. Inactivation of Ihh or Shh leads to the death of animals soon after birth restricting the 
possibilities to investigate the role of Hh signalling in stem cell renewal and normal intestinal 
homeostasis in adult mice. Moreover Ihh deficient mice display greatly reduced numbers of 
proliferating progenitor cells, decline in enteroendocrine cell differentiation and short villi. In 
contrast, Shh
-/-
 animals can be characterized by the enlarged villi structures advocating for the 
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opposite phenotype and in turn, increased proliferation levels (Ramalho-Santos 2000). These 
results suggest that Ihh and Shh each possess a specific role within the intestinal epithelium 
although they are expressed in the same compartments. Inhibition of Hh signalling using 
Hhip hedgehog interacting protein is capable of blocking both Hh ligands and was conducted 
in tissue-specific manner being restricted to the intestine. The high expression of Hhip leads 
to significantly increased rates of proliferation and complete abrogation of villi structures. 
However the lower expression levels of Hhip are capable of inducing a milder phenotype that 
includes the formation of abnormal villi containing crypt-like structures near their tips as well 
as presence of ectopic sites of Wnt activation through Tcf4/β-catenin target gene 
enhancement and increased proliferation. These results have led Madison and his lab to 
hypothesis that Shh and Ihh are both released in the crypt compartment of intestinal 
epithelium and Hh signalling is paracrine from the epithelium surface to myofibroblasts and 
smooth muscle cells successively controls the patterning along crypt-villus axis safeguarding 
the correct size and localization of newly arising crypt compartments (Madison et al., 2005).  
Platelet-derived growth factor (PDGF) pathway is another signalling pathway that governs 
the epithelium-to-mesenchyme interactions. This signalling network consists of four ligands: 
PDGF-A, PDGF-B, PDGF-C and PDGF-D that are capable of binding receptor tyrosine 
kinases, PDGFR-α and PDGFR-β. Upon the activation of PDGF signalling, these receptors 
form dimers and undergo phosphorylation which enables the signal transduction through 
numerous pathways such as phosphatidylinositol 3-kinase (PI3K/Akt), signal transducer and 
activator of transcription (STAT) and Mitogen-activated protein kinase (MAPK) (reviewed in 
Andrae et al,. 2008).  
Mice deficient of PDGF-A or PDGFR-α develop villi that are aberrant in their shape and 
present at much lower density within the epithelium as well as loss of pericryptal 
mesenchyme (Karlsson et al., 2000). The theory explaining the abnormal villus patterning 
suggested that PDGF-A expression from epithelial cells maintains the self-renewal and 
proliferation of PDGFR-α positive mesenchymal cells thus preventing their premature 
differentiation and depletion (Karlsson et al., 2000). Those PDGFR-α positive cells are 
clustering into “villus clusters” supporting the morphogenesis of villi therefore the inability to 
form those clusters results in decrease in villi numbers.  
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Figure 1.4 Hedgehog is one of the major pathway playing role in the maintenance of intestinal homeostasis and 
represents epithelium-to-mesenchyme signalling with Ptch playing a dual role in the signal transduction. 
 
1.1.3.2  TGF-β and BMP pathways 
TGF-β signalling pathway regulates the abundance of the processes such as embryonic 
development, angiogenesis, proliferation and differentiation (Shi and Massague 2003) and 
mediates the mesenchyme-to-epithelium signalling. TGF-β family of cytokines comprises of 
TGF-β, bone morphogenetic protein (BMP) and activins molecules which are all ligands for 
type I and type II serine-threonine kinase receptors. TGF-β signalling also possesses a wide 
range of SMAD intracellular messengers that can be subdivided into three different classes of 
molecules: receptor-regulated SMADs (R-Smads: Smad1, 2, 3, 5 and 8), co-mediator SMAD 
(Smad 4) and inhibitory SMADs (I-Smads: Smad6 and 7).  
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The binding of ligands to type I and type II kinase receptors leads to colocalisation of those 
two types of receptors allowing type II receptor of phosphorylating the type I receptor and 
therefore activating the signalling cascade. Further phosphorylation of R-Smads through the 
action of activated type I receptor results in the formation of heterodimeric complex 
consisting of R-Smads and Co-Smad, Smad4 which together translocate to the nucleus. Once 
within the nucleus, Smad complex regulates the expression of TGF-β target genes. Although 
this mechanism of pathway activation is common for all cytokines members of TGF-β 
family, some preferential binding exists between the ligands and particular Smads where 
TGF-β ligands signal through Smad2 and 3 however BMP ligands through Smad3, 5 and 8. 
The inhibition of TGF-β pathway occurs via the association of I-Smads with kinase receptors 
as they are competing for receptor binding with R-Smads (Figure 1.5).  
The majority of the TGF-β family members are expressed non-epithelial parts of the gut 
notably lamina propria and muscularis with some restricted expression of some of the Smads 
in villi of small intestine. No expression of TGF-β molecules is detected in the crypt 
compartments of either small or large intestine (Winesett et al., 1996). In particular, BMP2 
and BMP4 ligands are found to be expressed in the intravillus mesenchyme being positively 
regulated by the Hh pathway (Madison et al., 2005). Other BMPs such as BMP receptor 
Bmpr1a and Smads: Smad1, 5 and 8 are expressed in the epithelial cells of villi (Karlsson et 
al., 2000). Loss of Bmpr1a in the intestinal epithelium disturbs the intestinal homeostasis 
causing an expansion of the stem and progenitor cell populations leading to the intestinal 
phenotype including development of multiple polyps resembling that of human juvenile 
polyposis syndrome (He et al., 2004). Noggin is an inhibitor of BMP pathway expressed in 
the submucosa surrounding the crypt compartment (Figure 1.8) abrogating the signalling 
from mesenchyme (He et al., 2004). Overexpression of Noggin results in development of 
ectopic crypts on the sides of villi (Haramis et al., 2004) suggesting that both loss of Bmpr1a 
and overexpression of Noggin lead to similar phenotype consisting of  excessive formation of 
abnormal structures closely resembling intestinal crypts and development of polyps with 
enlarged proliferative compartment. 
These results indicate the importance of BMP signalling in controlling the proliferation of 
continuously self-renewing intestinal epithelium. The proliferation of stem and progenitor 
cells is restricted to the crypt compartment by the presence of Noggin in the inter-villus zone. 
Moreover the BMP signals from stroma underlying the epithelial cell layer of villi are 
inhibiting proliferation in that region halting the ectopic formation of crypt-like structures. 
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The mismanagement of crypt fission and excessive formation of intestinal crypts is repressed 
by active BMP signalling.   
In all the expression patterns of different elements of BMP and Hh signalling contribute 
towards explaining crypt-villus organisation of intestinal epithelium. From the epithelial layer 
Hh signals are released influence underlying mesenchyme layer which consecutively releases 
BMP ligands.    
 
Figure 1.5 TGF-β and BMP pathways together with Hedgehog pathway regulate activation of Wnt signalling 
and intestinal homeostasis acting through their common co-effector SMAD4. 
 
1.1.3.3 Wnt pathway 
One of the most important pathways that conveys the maintenance of the intestines is Wnt 
signalling (Figure 1.6). This pathway has been implicated in a wide spectrum of cellular 
processes being one of the fundamental signalling pathways in development and disease and 
has been extensively investigated over the last 30 years (Nusse and Varmus 2012, Reya and 
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Clevers 2005). Wnt ligands and its downstream effectors were first discovered in Drosophila 
and Wnt ligands and downstream effectors of the Wnt pathway are conserved within the 
animal kingdom (Rijsewijk et al., 1987). Wnt signaling is playing a central role in embryonic 
development especially in body patterning and formation of anterior-posterior axis. It is also 
involved in the maintenance of homeostasis and self-renewal processes in various adult 
tissues and therefore in many pathological events that result from disturbance of this state 
(reviewed in Clevers 2006). In normal circumstances within intestinal epithelium Wnt 
signalling regulates proliferation within the intestinal crypt (Muncan et al., 2006, Pinto 2003), 
differentiation of progenitor cells towards secretory lineage (Andreu et al., 2005, Pinto 2003) 
as well as controls spatial segregation of cell populations via Eph/ephrin receptor-ligand 
system (Batlle 2002). Equally Wnt signalling is also a major pathway involved in intestinal 
tumorigenesis and colorectal cancer. 
 
The family of Wnt genes consists of 19 cysteine-rich glycoprotein members in humans and 
mice. In order to render those Wnts biologically active the palmitoylation of a conserved 
cysteine residue is required during their production and secretion (Willert et al., 2003).  
Upon their release into the intracellular space, Wnts activate responding cells by interacting 
with Frizzled (Fz) receptor transmembrane proteins and single-span LRP5/6 receptor protein. 
The binding of Wnts to Frizzled and LRP5/6 proteins is an initial step in canonical Wnt 
pathway and involves a cascade of events that changes the amount of β-catenin present in 
nucleus.   
The phosphorylation of the cytoplasmic domain of LPR5/6 upon the binding between Wnt, 
Fz and LPR5/6, aided by Fz-bound Dishevelled (Dsh) leads to the recruitment of Axin to the 
plasma membrane. Subsequently Axin becomes degraded and dissociated from β-catenin 
“destruction complex” which disturbs the integrity of the complex and non-phosphorylated β-
catenin accumulates in the cytoplasm. This stabilized form of β-catenin then further 
translocated into the nucleus. Once in the nucleus, β-catenin binds to TCF/ LEF transcription 
factors which converts TCF/LEF factors from repressors into activators, thus activating the 
transcription of downstream Wnt target genes.  
In the absence of Wnt ligand, cytoplasmic pool of β-catenin is sequestered by the 
“destruction complex”. This “destruction complex” comprises of two scaffolding proteins 
APC and Axin that bind synthesized β-catenin. CK1 phosphorylates the N-terminus of β-
catenin at the Ser45 residue and further action of GSK3β kinase drives the phosphorylation of 
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serine and threonine residues at N terminus of β-catenin. This pattern of phosphorylation of 
β-catenin recruits β-TrCP ligase and β-catenin is ubiquitinated. Once ubiquitinated, β-catenin 
is targeted for degradation by proteasome machinery (Figure 1.6) (Reya and Clevers 2005, 
Ricci-Vitiani et al., 2009).  
In case of cells that are not responding to Wnt signals, Tcf proteins associate with general 
transcription repressors like Groucho and this binding result in the repression of Tcf-
responsive genes. This form of silencing is achieved by recruitment of histone deacetylases 
(HDACs) that transform the chromatin structure into form that is inaccessible for 
transcription machinery. Upon the activation of Wnt signalling and binding of β-catenin to 
Tcf proteins, it displaces the Groucho and recruits numerous nuclear factors that are capable 
of transactivating Tcf target genes such as chromatin remodelling factors.  
 
Wnt signalling is crucial for the maintenance of proliferation within crypt compartment  
The extensive studies of Wnt signalling over the last decade have gathered strong line of 
evidence suggesting that Wnt signalling and β-catenin are necessary for the survival of the 
crypt proliferative population therefore aberrant Wnt signalling by its ablation inhibits the 
proliferation and by its activation expands the proliferative compartment of intestinal 
epithelium. The importance of particular elements of the Wnt pathway in the crypt 
homeostasis is emphasized by the severity of phenotype resulting from their abnormal 
expression.  
Tissue-specific ablation of β-catenin in the small intestine leads to quickly progressing loss of 
cells of epithelium layer, including loss of crypt compartment and inhibition of proliferation. 
Moreover the loss of β-catenin disrupts the maintenance of homeostasis within the stem cell 
niche inducing stem cells to terminally differentiate and rendering them incapable of self-
renewal and therefore disturbing normal functioning of small intestinal epithelium (Fevr et 
al., 2007). Corresponding phenotype of loss of crypt compartment and increase in apoptosis 
was observed upon the conditional deletion of β-catenin under the expression of inducible 
AhCre promoter (Ireland 2005). 
Disruption of both alleles of TCF-4 gene in the germline resulted in death of those animals 
shortly after birth due to their inability to maintain a proliferative stem cell compartment in 
the small intestinal epithelium (Korinek et al., 1998). Similarly the inhibition of canonical 
Wnt pathway through the expression of Wnt inhibitor Dickkopf-1 (Dkk1) results in the levels 
of proliferation being significantly repressed together with disruption of normal intestinal 
architecture involving loss of crypt and villus structures (Kuhnert et al., 2004). 
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Deletion of one of main Wnt target genes, c-myc in the small intestinal epithelium under the 
expression of the same transgene as Ireland et al (2005) resulted in reduction of the crypt 
length, significant decline in the proliferation rates and cell cycle progression in the 
progenitor cells. This triggers the response in the crypts that escaped the c-myc ablation that 
consequently repopulate the c-myc deficient crypts leading to their complete elimination 
from the epithelium of small intestine (Muncan et al., 2006).   
 
Wnt signalling directs progenitor cells towards the secretory lineage  
Wnt signalling has been showed to be involved not only in the maintenance of proliferation 
in the crypt compartment of intestinal epithelium but also in regulation of cell fate decision of 
early progenitor cells. Specifically the Paneth cell differentiation is affected due to the fact 
that unlike other differentiated cell types of intestinal epithelium that migrate towards the tip 
of the villus, Paneth cells migrate down towards the crypt base where they remain throughout 
their lifespan. Moreover similarly to crypt proliferating cells they are characterized by the 
presence of active Wnt signalling and express high levels of nuclear β-catenin. Wnt signalling 
has been shown to drive the expression of Paneth-specific genes (van Es et al., 2005) and 
ablation of β-catenin significantly reduced the numbers of Paneth cells as well as caused their 
mislocalisation. Dkk1 overexpression driving the inhibition of Wnt signalling results in the 
loss of cells belonging to all three secretory lineages however not affecting the enterocytes 
(Pinto 2003). Different studies found that the loss of β-catenin increases the differentiation of 
enterocytes (Fevr 2007). 
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Figure 1.6 Wnt signalling pathway is responsible for the maintenance of intestinal homeostasis by regulating 
stem cell renewal and progenitor cell differentiation. In a normal cell, β-catenin degradation complex prevents 
the accumulation of β-catenin in the cytoplasm and active transcription of Wnt target genes. 
 
1.1.3.4  Notch pathway 
Notch pathway mediates cell-to-cell signal transduction due to the interactions between 
Notch receptors and ligands between the adjacent cells. Multiple biological functions are 
regulated by Notch including cell proliferation, apoptosis, spatial patterning and cell fate 
determination.   
Mammalian Notch includes 4 receptors: Notch1, Notch2, Notch3 and Notch4 and 5 ligands: 
Delta-like 1, Delta-like 2, Delta-like 3, Jagged 1 and Jagged 2 and the association between 
each ligand and each receptor command different Notch response. Notch signalling receptors 
are evolutionary conserved large transmembrane glycoproteins that consist of two domains: 
extracellular domain (ECD) and intracellular domain (ICD). Initially, Notch receptor is 
synthesised as an inactive form that upon the cleavage by Furin protease at first cleavage site 
(S1) in the trans-Golgi produces Notch ICD and Notch ECD heterodimer at the cell surface. 
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Prior to the full integration into the cell membrane, both domains undergo O-glycosylation by 
Fringe and O-fucosylation by O-fucosyl transferase.  
The binding between Notch ligands and Notch receptor triggers the activation of the Notch 
signalling as the two cleavage events of the receptor occur. The second cleavage site (S2) 
becomes exposed as a result of endocytosis action of E3 ligases and then cleaved by tumour 
necrosis factor-α-converting-enzyme (TACE) to release NECD. Consecutively, the final third 
cleavage (S3) is triggered and achieved by γ-secretase leading to release of NICD and its 
translocation into the nucleus. Within the nucleus, NICD forms a transcriptional complex 
with Notch mediator CSL (CBF-1/RBP-jκ) and Mastermind-like co-activator proteins that 
triggers the transcription of Notch target genes. In the absence of the Notch signalling, CSL 
acts as the repressor of the transcription (Figure 1.7).  
 
Figure 1.7 Notch signalling pathway represents cell-to-cell signalling within small intestinal epithelium and 
regulates cell fate decision of progenitor cells as they exit the crypt compartment.  
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In the intestinal epithelium Notch receptors and ligands are expressed in the crypt 
compartment of small intestine and colon (Sander et al., 2004). Canonical Notch signalling to 
CSL-NICD-Mastermind complex inhibits the differentiation of stem cells and progenitor 
cells however in case of unnatural Notch ligands to the Notch receptor triggers non-canonical 
Notch signalling acting via CSL-NICD-Deltex complex. This non-canonical signalling unlike 
canonical Notch promotes the differentiation of progenitor cells by activation of the 
transcription of genes such as MAG that induce terminal differentiation of cells.  
The best characterized Notch target is a large family of hairy enhancer of split (Hes) 
transcriptional repressors which in turn regulate the expression of many downstream Notch 
genes. Upon the activation of Notch signalling, Hes together with Hey family becomes 
upregulated and consequently inhibits the transcription of other downstream tissue-specific 
transcription factors such as Math1 leading to repression of differentiation and maintenance 
of stem and progenitor cells. Hes1 is normally promoting the differentiation towards the 
absorptive enterocyte lineage whereas loss of Hes1 shifts the cell fate determination leading 
to increase in goblet and enteroendocrine cell numbers (van Es et al., 2005). Removal of CSL 
or similarly inhibition of Notch signalling via introduction of γ-secretase in the small 
intestinal epithelium results in the loss of proliferating crypts and concurrently immense 
changes in cell fate decisions as all proliferating cells turn into post-mitotic goblet cells (van 
Es et al., 2005). Therefore it seems like the differentiation of cells towards secretory lineages 
in particular goblet cells is a default choice in the absence or Notch signalling deficiencies.    
Mimicking the effects of the activation of Notch signalling is possible by gain-of-function 
studies involving Notch receptors. The activation of Notch receptor (Notch1 IC) under the 
expression of Villin promoter revealed the inhibition of cell differentiation into either 
absorptive or secretory lineage and most importantly in the expansion of immature intestinal 
progenitor cells (Fre et al., 2005). As the upregulation of Notch signalling results in high 
Hes1 and thus Math1 inhibition the phenotype of Math1 deficient mice was investigated. 
Math
-/-
 animals displayed normal intestinal architecture with a depletion of all differentiated 
cell types of secretory lineage but not affecting the differentiation of enterocytes.  This is due 
to the fact that absorptive lineage enterocytes arise from a Math1-independent progenitor as 
opposed to secretory lineage cells (Yang et al., 2001).  
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Accordingly Notch together with Wnt signalling is suggested as one of the main gatekeepers 
of intestinal progenitor compartment as both pathways are required for the maintenance of 
proliferating and non-differentiating cell in the intestinal crypts.  
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To summarize, the maintenance of intestinal homeostasis requires a firmly controlled 
interplay between numerous signalling pathways transducing signals between different layers 
of epithelium. Presence of high Wnt and Notch signals in the crypts safeguards the 
undifferentiated state of stem cells and progenitors within that niche whereas as those signal 
levels decline as cells migrate up towards the crypt-villus junction progenitor cells lose their 
proliferating capacities and differentiate into mature epithelial cell types. The expression of 
Hh ligands by the epithelial cells of crypt compartment consequently induces Hh signalling in 
the surrounding stroma leading to BMP ligand activation. BMP signalling suppresses Wnt 
pathway activation in the villus area restricting the proliferation whereas BMP antagonist 
Noggin protects the crypts from BMP signalling ensuring controlled self-renewal of stem cell 
strictly within that intestinal niche (Figure 1.8). 
  
Figure 1.8 In order to maintain the intestinal homeostasis the interplay between different signalling pathways: 
Wnt, Notch, BMP/TGF-β and Hedgehog is necessary to control all processes regulating cell renewal, 
proliferation, differentiation, migration and cell death. While BMP/TGF-β and Hedgehog pathways are crucial 
for regulating Wnt signalling, the Wnt pathway is crucial for proliferation and self-renewal within a stem cell 
niche. Notch signalling directs the differentiation of intestinal progenitor cells safeguards the immature state in 
the crypt in particular within stem cell niche through high levels of Notch in those compartments.  
1.2 Colorectal cancer 
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1.2.1 Incidence of colorectal cancer and environmental risk factors 
Colorectal cancer (CRC) is the third most common cancer in UK accounting for 12.5% of all 
new cancer cases. In 2010 over 40,000 new cases of CRC have been diagnosed with male to 
female ratio of 13:10 and this incidence has persisted at the similar levels since last decade. 
There is a geographical variation in incidence of CRC across the world which can be 
associated with environmental and dietary factors previously implied in increased risk of 
developing CRC. High consumption of red and processed meat (Norat et al., 2000), diet 
deficient in natural fibres (Park et al., 2005) as well as other lifestyle factors including lack of 
physical activity (Wolin et al., 2011), obesity (Moghaddam et al., 2007), smoking (Liang et 
al., 2009) and alcohol consumption (Fedirko et al., 2011) have been reported to predispose 
and therefore rapidly increase the risk for CRC.  
As with vast majority of cancers, relative survival for CRC has been improving with 1-, 5- 
and 10-year survival rates increasing two-fold since 1970’s. Nevertheless CRC remains the 
second most common cause of cancer death in UK accounting for over 600,000 deaths 
worldwide in 2008 (Cancer Research UK). 
1.2.2 Genetic predisposition to colorectal cancer 
Colorectal cancer can be subdivided into sporadic and familial cases and it is estimated that 
around 20-25% of all CRC cases is considered to have a hereditary origin whereas another 5-
10% of all cases are inherited according to the Mendelian laws implying that the causing 
mutation is inherited in the autosomal dominant manner (Lynch and de la Chapelle, 2003, de 
la Chapelle 2004).  
Therefore, except the environmental and dietary, genetics factors play a major role in 
predisposing towards CRC. For that reason hereditary syndromes conferring susceptibility to 
CRC development have been of a great value in identification and understanding of roles of 
genes important for colorectal carcinogenesis to occur as well as in the design of novel 
diagnostic and therapeutic strategies.    
Hereditary CRC syndromes can be organised into two main categories on the ground of 
presence or absence of intestinal polyps. Furthermore polyposis syndromes can be classified 
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into two separate groups of adenomatous and hamartomatous polyposis depending on the 
type of tissue present predominantly within those polyps.     
1.2.2.1 Familial adenomatous polyposis  
Familial adenomatous polyposis can be characterized by the emergence of hundreds to 
thousands of adenomas in the colon in the late childhood or adolescence primarily composed 
of epithelial cells. From an average age of 40 years old the malignant degeneration occurs 
where due to the extremely high numbers of proliferating adenomas present, one or few of 
those develop into adenocarcinoma. One of the common features of tumours from FAP 
patients is the presence of chromosomal instability and aneuploidy as well as more aggressive 
phenotype. Mutations in several key oncogenes and tumour suppressor genes such as APC, 
P53, KRAS have been identified in those tumours (reviewed in Lynch and de la Chapelle 
2003).  
Years of cohort studies have led to the discovery that APC gene mutations are responsible for 
the development of FAP by Groden et al. in 1991 and that the vast majority of germ-line 
APC mutations involve truncating or nonsense mutations often leading to the alteration of the 
reading frame. The location of those germ-line mutations seems to be correlated with the 
number of polyps present in the colorectum of FAP patients: truncating mutations in the 5’ 
region of APC gene upstream of codon 157 result in the “attenuated” FAP phenotype which 
involves delayed adenoma formation (reviewed in Sancho et al., 2004) and in general fewer 
adenomas predominantly located at the proximal end of colon (Nagase and Nakamura, 1993) 
whereas mutations in the other parts of the gene lead to “classical” FAP. Furthermore, the 
mutations in APC gene have been identified in around 80% of early adenomas in sporadic 
cases of colorectal cancer (Nagase and Nakamura, 1993).  
 
1.2.2.2 Hamartomatous polyposis syndromes 
Hamartomatous polyposis syndromes are a heterogenous group of inherited non neoplastic 
conditions that encompasses Peutz-Jeghers syndrome, Cowden syndrome, Bannayan-Riley-
Ruvalcaba syndrome and familial juvenile polyposis (Eng and Ji 1998). All of those disorders 
can be characterized by the overgrowth of normal tissue within the colon with a marked 
expansion of cells derived predominantly from stroma. Although all of those syndromes are 
rare and comprise a very small proportion of familial CRC, in particular two of them, notably 
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Peutz-Jeghers Syndrome and juvenile polyposis are associated with a significantly increased 
risk of gastrointestinal and other malignancies (de la Chapelle 2004).  
Mutations in PTEN gene have been identified in both Cowden syndrome and Bannayan-
Riley-Ruvalcaba syndrome and with only some subtle distinctions between the two and 
considerable overlap in symptoms the argument exists that they both represent same 
syndrome (Lachlan and Lucassen 2007, Eng and Li 1998). Furthermore as both lead to 
development of benign non-neoplastic lesions which only in rare cases result in malignant 
adenocarcinoma, the thorough involvement of Cowden syndrome and Bannayan-Riley-
Ruvalcaba syndrome in development of colorectal malignancies remains to be explored.  
The main clinical criteria of Peutz-Jeghers syndrome in patients are multiple hamartomatous 
polyps throughout the gastrointestinal tract as well as the presence of mucocutaneous melanin 
deposition. Those polyps are frequently present in the jejunum and ileum, they are large and 
pedunculated with entrapped glands containing mucus-producing goblet cells (Tomlinson and 
Houlston, 1997). Germline mutations in tumour suppressor gene, LKB1 are responsible for 
50% of Peutz-Jeghers cases (Lim et al., 2003).  
Juvenile polyposis syndrome involves the development from few to few hundred polyps in 
the colorectum. These juvenile polyps possess a distinct histology from that of adenomatous 
polyps present in FAP patients where mucous cysts are surrounded by cells derived from 
lamina propria. Several genes are known to be associated with JPS with approximately 20% 
of affected individuals carrying mutations in SMAD4 (Howe et al., 1998), another 20% - in 
BMPR1A (Howe et al., 2001). Both of those belong to the superfamily of transforming 
growth factor-beta (TGF-β) indicating the involvement of this signalling pathway in the 
development of colorectal cancer.  
 
1.2.2.3 Hereditary nonpolyposis colorectal cancer syndrome  
Hereditary nonpolyposis colorectal cancer syndrome is also commonly known as Lynch 
syndrome due to the fact that it predisposes not only to CRC, but also several other cancers 
such as endometrial cancer, ovarian and brain cancer. Depending upon the clinical definition 
of this syndrome, it is responsible for 2.5-5% of all CRC cases (de la Chapelle 2004). Patients 
with Lynch syndrome occasionally develop colon polyps that at the accelerated rate progress 
toward CRC characterized by poorly differentiated tumours (Lynch and de la Chapelle, 2003) 
and relatively late onset in comparison to other hereditary CRC syndromes (Hampel et al., 
2005). Lynch syndrome is caused by mutations in the mismatch repair (MMR) genes MLH1, 
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MSH2, MSH6 and PMS2 where mutations in MLH1 and MSH2 account for approximately 
90% of all patient cases (Lynch and de la Chapelle 2003) with different levels of penetrance 
of those disease alleles for various cancers ranging from 80% for CRC, 60% for endometrial 
cancer and less than 20% for all other cancer types. Whereas the mutations in MLH1 and 
MSH2 display no apparent differences in expressivity, MSH6 mutations result in an 
“attenuated” form of Lynch syndrome distinguished by lower penetrance and higher age of 
onset however the mechanism behind this phenotype needs to be further explored due to very 
low numbers of MSH6 mutations identified so far (de la Chapelle 2004). The deficiency in 
the MMR mechanism leads to microsatellite instability which is known as the hallmark of 
Lynch syndrome (Thibodeau et al. 1996, 1998) and therefore an excellent diagnostic marker.  
 
 
 
 
Each of syndromes governing the inherited susceptibility to CRC described above involves a 
separate class of genes that when mutated, contributes towards tumorigenesis. According to 
Kinzler and Vogelstein (1998), there are 3 main groups of “gatekeeper”, “landscaper” and 
“caretaker” genes. Inactivation of gatekeeper genes such as APC which normally act as 
tumour suppressors leads to formation of benign neoplastic polyps. The penetrance is 
approximately 100% due to the abundance of those polyps throughout the colon as eventually 
few of those growths will progress towards malignant degeneration. In case of defects in the 
caretaker genes i.e. MMR pathway genes, the rate of polyp development is similar to that of 
observed in the general population as in comparison to gatekeeper genes, those genes 
suppress neoplasia indirectly. However those mutations lead to the mutator phenotype where 
increases rate of mutagenesis eventually results in development of CRC. The last class of 
genes is represented by landscaper genes that lead to hamartomatous polyps in which the 
abnormal microenvironment of bulk of stromal cells increases the risk of associated epithelial 
cells to undergo neoplastic transformation and therefore becoming malignant. 
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1.2.3 Major signalling pathways involved in the development, progression 
and metastasis of CRC 
 
As mentioned previously, hereditary cancer syndromes account for approximately 20% of all 
CRC cases with the remainder of cases having a sporadic origin. However the genes and the 
pathways found to be causative of those conditions are often found mutated in the sporadic 
cases too.   
Hereditary CRC syndromes and analysis of mutations occurs in sporadic CRC provide us 
with a valuable insight into the signalling pathways involved in the complex nature of 
colorectal tumours, their development and progression (reviewed in Sancho 2004).  
1.2.3.1 Wnt signalling  
1.2.3.1.1 Human mutations in the Wnt pathway 
The discovery that APC mutations are implicated in the development of FAP by Groden et al 
(1991) provided one of the first hints towards the association between Wnt pathway and 
CRC.  
As previously described in (Chapter 1.1.3 The homeostasis in the intestinal epithelium), APC 
is a one of the crucial components of the β-catenin destruction complex where together with 
GSK3β and Axin it is responsible for β-catenin phosphorylation, subsequent ubiquitination 
and degradation (Figure from pathways). Therefore any mutations leading to the loss of APC 
and its function within the destruction β-catenin complex result in the failure to regulate β-
catenin levels in the cytoplasm as well as the failure to inhibit transcriptional activation of 
downstream Wnt target genes (reviewed in Giles et al. 2003, Fodde et al, 2001).  
Although APC mutations detected in FAP patients account for a very limited proportion of all 
CRC cases, approximately 80% of CRC patients possess mutations in APC gene (Nagase and 
Nakamura, 1993). Mutations in CTNNB1 gene encoding β-catenin are found in 10% of CRC 
cases. In those patients, alteration of several important phosphorylation sites leads to inability 
to target β-catenin for proteasomal degradation and eventually β-catenin stabilization (Morin 
et al., 1997). Therefore activating mutations of the Wnt pathway are found in over 90% of all 
CRC cases, interestingly mutations in APC and CTNNB1 genes are suggested to be mutually 
exclusive insinuating that both of them have similar effect on the β-catenin stabilization and 
activation of downstream elements of Wnt signalling pathway. Nonetheless, some differences 
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in tumour phenotype have been observed as the vast majority of β-catenin mutations have 
been identified in small adenomas in comparison with a small proportion in invasive 
colorectal tumours. This observation suggested that small adenomas containing β-catenin 
mutations are less likely to progress to large adenomas and invasive cancer raising the notion 
that despite APC and CTNNB1 genes performing similar function in regards to β-catenin 
destruction, APC can possibly possess some other tumour suppressor functions yet to be 
explored (Samowitz et al., 1999). 
Remarkably, mutations of the Wnt pathway components have been found in other cancers 
types such as gastric, melanoma and ovarian. Mutations in Axin and aberrant expression of 
several Wnt ligands have been identified amongst many others genetic alterations, however 
their role in colorectal tumorigenesis appears to be minimal (reviewed in Giles et al., 2003). 
Activating mutations of the Wnt pathway have been identified as the only known genetic 
modifications present in the early premalignant lesions in the intestine, such as aberrant crypt 
foci and small polyps. In particular, the maintenance of the frequency of mutations in APC 
gene throughout the sequential progression from benign to malignant cancer further provides 
evidence suggesting that aberrant activation of Wnt signalling is one of the initial stages in 
the development of colorectal tumours.   
Years of studies of FAP syndrome revealed that the nature and position of germ-line APC 
mutation account for a great clinical variability amongst the individuals with FAP. The most 
common human APC mutations are located between codon 450 and 1578 resulting in stable 
truncated proteins.  This genotype-phenotype correlation gives even further insight into APC-
related tumorigenesis where majority of CRC cases with APC mutations do not result in the 
complete ablation of APC protein. As indicated by a “just right” hypothesis the function of 
APC must be impaired in a very particular manner - at the level sufficient for the 
accumulation of β-catenin but at the same time below the threshold triggering the apoptosis. 
In those CRC cases, one allele of APC is lost due to truncating mutations whereas the other 
one acquires another truncating mutation or undergoes a loss of heterozygosity. This 
hypothesis suggests the interdependence of different mutations which allow for the 
successive accumulation of β-catenin sufficient for tumour progression however limited to a 
certain level in order to avoid programmed cell death (Lamlum et al., 1999, Albuquerque et 
al., 2002, Crabtree et al., 2003). 
1.2.3.1.2 Mouse models of alterations in the Wnt pathway 
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As the molecular processes involved in development of hereditary cancer syndromes and thus 
CRC have been of a great interest for many years numerous animal models comprising 
mutations in Wnt pathway components have been generated. The first model of intestinal 
tumorigenesis, named Multiple Intestinal Neoplasia was stably expressing a truncated APC 
protein as a result of a nonsense mutation at codon 850. Mice heterozygous for Apc
Min
 show 
changes which are characteristic for early preneoplastic tissue such as increased β-catenin and 
expansion of proliferative compartment, developing a large number of adenomas in the 
gastrointestinal tract which eventually leads to shortened lifespan (Su et al., 1992). Mice 
carrying one allele with a truncating mutation in the codon 716 of Apc gene (Apc
Δ716
) are one 
of the most extensively used mouse models to study FAP and CRC. Similarly to Apc
Min
 
animals, they develop up to 100 adenomas with a vast majority of tumours arising in the 
small intestine (Oshima et al., 1995). In contrast to the two models of Apc mutations 
described above, mice heterozygous for Apc mutation at the codon 1638 (Apc
1638N
) develop 
only few intestinal tumours however they display a large spectrum of extra-intestinal 
phenotypes characteristic for FAP patients (Fodde et al., 1994). Another CRC model 
characterised by a conditional deletion of exon 14 of Apc gene using a colon-specific Cre 
recombinase (Apc
580S
) results in the adenoma formation within 4 weeks post-induction 
(Shibata et al., 1997). Intestinal adenomas also develop in animals expressing oncogenic 
forms of β-catenin as the activation of Wnt signalling is a dominant driver of intestinal 
neoplasia. Conditional deletion of exon 3 of β-catenin resulted in a phenotype similar to that 
one observed in Apc
Δ716
 animals (Harada et al., 1999). Studies of Apc
Min
 have allowed 
identifying two modifier loci of tumour development called Mom 1 (Modifier of Min 1) and 
Mom2 (Modifier of Min 2) that can modify the number as well as the size of colon tumours 
(Gould et al., 1996, Silverman et al., 2002).  
1.2.3.2 TGF-β and BMP pathways 
1.2.3.2.1 Human mutations in the TGF-β and BMP pathway 
As previously described, TGF-β cytokines family comprises of TGF-β, bone morphogenetic 
protein (BMP) and activins molecules which are all ligands for type I and type II serine-
threonine kinase receptors and share SMAD4 as the common signal mediator. Therefore, 
both TGF-β and BMP pathway have similar effect on the target tissue favouring apoptosis 
and differentiation and opposing proliferation. Two specific mutations - in a co-mediator 
SMAD4 and a BMP receptor BMPR1 have been identified in families with Juvenile 
polyposis syndrome (Chow et al. 2005). A 4 base deletion in exon 9 of Smad4 gene is a 
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mutational hotspot and resulting loss of growth inhibition and neoplasia. Mutation in the 
BMPR1 results in a receptor missing its intracellular serine-threonine kinase domain halting 
the signal transduction through SMAD4 eventually. These two mutations account for 
approximately 50% of JPS cases with the remaining cases of JPS possibly carrying mutations 
in different components of BMP pathway (reviewed in Sancho 2004). Mutations in SMAD-2 
and SMAD-4 generating truncated proteins are frequent in colorectal cancer (Eppert et al., 
1996). The most common mutation in TGF-β pathway is inactivation of receptor type II 
(TGFβR2) present in the vast majority of microsatellite instable (MSI) tumours as well as in 
more than 50% of microsatellite stable (MSS) tumours. MSI tumours can be characterized by 
the accumulation of mutations in a 10 bp coding polyadenine tract (Grady et al., 1999). 
According to the current hypotheses about the general tumour suppressor roles of TGF-β and 
BMP pathways in tumorigenesis, those two pathways are critical for the maintenance of 
homeostasis by regulating the growth of non-neoplastic cells as well as cells that are already 
progressing through early stages of tumorigenesis (Roberts and Orkin 2004). 
1.2.3.2.2 Mouse models of alterations in the TGF-β and BMP pathway 
Over the years numerous mouse models targeting TGF-β superfamily were generated. 
Animals with heterozygous mutations inactivating the components of this family of cytokines 
such as TGF-β ligands, TGF-β1, -2 and -3 or SMAD2 have failed to recapitulate the increase 
in tumorigenesis in the colon with the homozygous mutations being embryonic lethal. The 
exception to this rule seemed to be SMAD3-deficient animals which survive until adulthood 
and later develop metastatic colorectal carcinomas (Zhu et al., 1998) however this finding 
was not confirmed by other studies on SMAD3 loss. Heterozygous mutation in SMAD4 
results in the development of polyps in the stomach and duodenum of SMAD4-deficient 
animals with intestinal polyps being similar to those observed in JPS patients (Takaku et al., 
1999). Moreover heterozygous loss of SMAD4 leads to acceleration of progression of benign 
adenomas carrying Apc
Δ716 
mutation to more aggressive carcinomas (Takaku et al., 1998). In 
similar manner, homozygous loss of TGF-β1 in immunocompromised animals results in the 
more rapid progression of lesions towards CRC (Engle 1999). Overexpression of the BMP 
inhibitor, Noggin results in development of crypt-resembling structures on the sides of villi 
and development of adenomatous polyps with enlarged proliferative compartment which is 
identical to the phenotype observed in JPS patients (Haramis et al., 2004). While results from 
in vivo animal studies may not be able to fully recapitulate the effects of TGF-β signalling 
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deficiency on intestinal tissue it has been reported that the loss of TGF-β and BMP signalling 
is a frequent occurrence in the advance stages of CRC cancer (Markowitz et al., 1995) 
suggesting that the loss of signalling is a necessary step in the process of progression of pre-
neoplastic lesions towards CRC.     
1.2.3.3 Ras-Raf-MAPK pathway  
1.2.3.3.1 Human mutations in the Ras-Raf-MAPK pathway 
In many cases of CRC, except genetic alterations in Wnt and TGF-β pathway, mutations in 
Ras-Raf-MAPK pathway are very common. Human Rat Sarcoma viral oncogene homology 
(Ras) family consists of three genes: Kirsten (K-Ras), Harvey (H-Ras) and neuroblastoma 
(N-Ras) with all of them encoding GTP-binding proteins that are involved in the signal 
transduction from various receptor tyrosine kinases (RTK). Depending whether those Ras 
proteins are bound by GDP or GTP, they can become activated or inactive. Upon the binding 
of an EGF ligand to the extracellular portion of receptor tyrosine kinase, the dimerization of 
RTK subunits occurs which in turn catalyses the phosphorylation of both RTK subunits. The 
growth factor receptor-bound protein 2 (GRB2) binds to the phosphorylated RTK while SOS 
proteins can be activated by GRB2 and bind membrane-bound Ras. Inactive Ras is GDT-
bound however SOS catalyses the dissociation of GDP and binding of GTP to Ras leading to 
the activation of Ras. Once activated, Ras can bind and phosphorylate many downstream 
effectors of this transduction pathway such as Raf serine/threonine kinases which 
consequently phosphorylate and activate mitogen activated protein (MAP) kinase cascade 
including Mek1 and 2, and ERK1 and 2. This kinase cascade translocates to the nucleus and 
activates transcriptional factors such as c-jun and fos resulting in the expression of many 
genes that control cell cycle. In the normal cell the active Ras is inactivated immediately after 
its activation by the GTPase activating protein (GAP) which binds to the Ras-GTP complex 
and assists in the hydrolysis of GTP to GDP. With Ras-GDT complex being inactive, the 
MAP signalling pathway is switched off.  
The Ras oncogenes are often activated by point mutations that prevent the activation of GAP 
with those mutations being very frequent in CRC with around 50% of colorectal carcinomas 
and adenomas containing some kind of Ras mutation. More than 30% of CRCs display 
activating mutations in the K-Ras gene (Bos et al. 1987) whereas another 20% of cases with 
functional K-Ras have activating mutations in B-Raf gene (Rajagopalan et al. 2002). The vast 
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majority of all mutations in Ras is found in the more advanced stages of CRC tumorigenesis 
being very rare in the pre-neoplastic lesions (Vogelstein et al. 1988).   
1.2.3.3.2 Mouse models of alterations in the Ras-Raf-MAPK pathway 
The role of Ras genes in the progression of CRC have been explored using several mouse 
models. Transgenic animals that carry activating mutations of K-Ras display no or very few 
gastrointestinal tumours suggesting that Ras does not play role in the initiation of CRC 
(Coopersmith et al., 1997; Kim et al., 1993). However Janssen et al. (2002) observed that 
over 80% of experimental animals that express K-Ras (V12G) mutation under the control of 
Villin Cre recombinase have developed few intestinal lesions. Detected lesions included a 
wide spectrum of neoplastic structures ranging from aberrant crypt foci (ACF) to invasive 
adenocarcinomas all characterized by the deregulated proliferation (Janssen et al., 2002). 
What is specific for this particular murine model is that expression of K-Ras from the Villin 
promoter leads to constitutive activation as well as over-expression of Ras oncogenes. 
Another study investigating the effects of K-Ras activation from the endogenous promoter 
failed to detect any alterations such as misregulation of proliferation in the intestinal 
epithelium (Guerra et al. 2003). Whereas the expression of K-Ras (V12) on its own have not 
been associated with abrogation of intestinal homeostasis or intestinal tumorigenesis, when 
combined with heterozygous loss of Apc in a long-term study it leads to acceleration of 
tumorigenesis as well as more invasive properties in comparison to animals with a functional 
K-ras oncogene (Sansom et al., 2006). 
Although many mouse models with activating mutations in Ras genes have been generated 
over the years, these results suggest that K-ras plays a minor role in the maintenance of 
intestinal homeostasis and tumour initiation however together with other elements of Ras-
Raf-MAP pathway it plays a crucial role in the progression of pre-existing lesions.    
1.2.3.4 PI3K pathway  
1.2.3.4.1 Human mutations in the PI3K pathway 
Phosphoinositide-3-kinase (PI3K) pathway is one of the most frequently mutated pathways in 
CRC however due to the number of different signalling transducers involved as well as 
various feedback loops it is still far from being understood. Similarly to MAP pathway 
activation, PI3K signalling may be activated by binding of EGF to RTKs or it may also 
become activated indirectly by K-Ras. In first instance, the binding results in the dimerization 
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and subsequent phosphorylation of both monomers. The type of proteins that may bind 
depends upon the different receptors such as insulin receptor substrate 1 (IRS1) may bind to 
the activated IGF1 receptor with receptor-bound IRS1 functioning as a binding and activation 
site for PI3K. Additionally in some cases, PI3K may bind directly to the phosphorylated 
RTK.  A different mechanism of PI3K activation is accomplished by Ras where PI3K binds 
to the activated Ras-GTP complex. Migration of the active PI3K and its binding to the 
phosphatidylinositol 4,5-bisphosphate (PI[4,5]P2 (PIP2) leads to the phosphorylation of PIP2 
to phosphatidylinositol 3,4,5-triphosphate (PI[3,4,5]P3 (PIP3). Once PIP3 is formed, it can 
activate serine/threonine kinase AKT which upon further phosphorylation and full activation 
is subsequently capable of activating mammalian target of Rapamycin (mTOR). Downstream 
effects of activated AKT involve many different substrates and processes such as inhibition 
of apoptosis by binding and preventing the activity of BAX, activation of protein synthesis 
via mTOR and translation factor S6K or regulating proliferation by maintenance of low 
concentrations of FOXO protein. 
In normal PI3K signalling, the antagonist of the PI3K, the phosphatase and tensin homologue 
(PTEN) dephosphorylates PIP3 terminating PI3K signalling. However in many cases of 
cancer, PTEN is mutated or lost leading to the accumulation of PIP3. Mutations in PTEN 
gene have been previously identified in both Cowden syndrome and Bannayan-Riley-
Ruvalcaba syndrome belonging to the hamartomatous polyposis syndromes (Blumenthal and 
Dennis, 2008). Sporadic mutations in PTEN gene are associated with many different types of 
cancer such as skin, prostate, breast cancer as well as CRC (Salmena et al., 2008). With 
exception to PTEN, mutations in AKT gene were found in 6% of CRCs (Carpten et al., 2007).  
1.2.3.4.2 Mouse models of alterations in the PI3K pathway 
The germ-line mutations in PTEN tumour suppressor gene of PI3K signalling have been 
previously reported in Cowden syndrome which predisposes affected individuals towards 
colorectal tumorigenesis. Early studies on PTEN function showed that Pten is required during 
murine embryogenesis whereas a small proportion of Pten heterozygous animals revealed the 
presence of colonic carcinomas (Di Cristofano et al., 1998, Suzuki et al., 1998). The etiology 
of juvenile polyps developed by CS patients remained elusive for many years implicating the 
loss of PTEN in the stromal compartment as a contributing factor. Transgenic mouse model 
of PTEN loss recapitulating the juvenile polyposis in the colonic epithelium reported that the 
absence of requirement for stromal PTEN deletion for the formation of juvenile polyps 
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further implicating that polyps found in the colorectum of CS patients are early precursor 
lesions of  neoplastic transformation (Marsh et al., 2014). Furthermore the same group 
previously showed that in the context of intestinal homeostasis loss of PTEN does not lead to 
abrogation of normal crypt-villus architecture however in the context of Apc loss and 
aberrant Wnt signalling it accelerates the formation of adenocarcinoma through increased 
activation of Akt levels (Marsh et al., 2008).  
1.2.4 Genetic model of CRC progression 
 
Considering the numerous molecules and signalling pathways involved in the maintenance of 
intestinal homeostasis, indication by Foulds (1958) that cancer is a multistep process where 
several irreversible changes “in one or more characters of its cells” occur appears to be 
perfectly thought. The identification of molecular events determinant of the initiation as well 
as progression of tumorigenesis required years of extensive research nowadays it not only 
provides us with an insight into basics governing tumorigenesis but also is critical for the 
development of novel therapies to treat cancer. Over 30 years after Foulds, Fearon and 
Vogelstein proposed their genetic model of colorectal cancer progression based on the 
extensive study of genetic and histopathological data which remains the most comprehensive 
model until today (Fearon and Vogelstein 1990). At the core of this model lies the notion that 
in regards to tumorigenesis seen as continuum, the accumulation of mutations in multiple 
tumour suppressor genes and proto-oncogenes results in the transformation and progression 
of tumorigenesis from early neoplastic lesions into advanced and invasive forms of tumour. 
Importantly, although genetic alterations in particular genes frequently occur along the 
preferred sequence, in regards to tumour progression it is the gradual accumulation rather 
than chronological order of genetic changes that is responsible for biological features of CRC 
tumours (Figure 1.9) (Fearon and Vogelstein 1990). Consistent with the proposed order of 
genetic alterations, mutations in the Wnt pathway such as stabilizing mutations in β-catenin 
or most frequently loss of Apc tumour suppressor gene leading to the aberrant activation of 
signalling lay are critical event for CRC initiation. As adenomas progress towards more 
advanced stages of adenoma, they acquire activating mutations in KRAS oncogene and 
allelic loss of chromosome 18q. Detailed mapping of this region identified Deleted in 
colorectal cancer (DCC) as potential candidate with tumour suppressor capacities however 
transgenic studies later revealed that DCC does not predispose or accelerates the progression 
of tumours in Apc
Min
 mice (Fazeli et al. 1997). In the absence of phenotype of DCC loss, 
other genes such as SMAD2 and SMAD4 effectors of TGF-β/BMP pathway mapped to the 
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same region on the chromosome 18q have been suggested as tumour suppressors (Eppert et 
al. 1996). Lastly, the loss of chromosome 17 short arm containing TP53 locus encoding p53 
tumour suppressor was one of the final steps of CRC tumorigenesis involving the progression 
to malignant disease (Fearon and Vogelstein 1989). The mutations in p53 were reported in 
over 50% of carcinomas and often coincided with the allelic loss of 17p leading to its 
association with the progression of tumours from adenoma to carcinoma (Nigro et al. 1989, 
reviewed in Iacopetta 2003).  
Presented genetic model of CRC progression suggests that formation of carcinoma would 
require more than five genetics events with adenoma arising as a result of fewer alterations 
(Fearon and Volgelstein 1990) however taking into the account the mutation rate in normal 
human tissue such a number of independent genetic changes is implausible to be achieved 
(Kinzel and Vogelstein 1996). In regards to this, two other pathways of CRC tumorigenesis 
exist allowing for cancer progression (reviewed in Dunican et al., 2002). Microsatellite 
instability (MIN) pathway involves alterations in the mismatch repair system such as those 
reported in HNPCC leading to a marked increase in mutation rate and eventually 
microsatellite instability. In contrast, chromosomal instability (CIN) pathway is characterized 
by chromosomal lesions due to the escalation in the chromosomal rearrangements where CIN 
is frequently associated with loss of Apc function (Fodde et al., 2001). The predominant form 
of genetic instability in CRC is CIN accounting for 85% and MIN respectively for 15% of 
sporadic CRC cases. Moreover, mutations found in CIN colorectal cancer frequently involve 
Wnt, Ras-Raf-MAPK, TGF-β/BMP and p53 pathways further accentuating the role of those 
signalling cascades in the CRC (reviewed in Dunican et al., 2002).  
 
 
38 
 
Figure 1.9. Genetic model of CRC progression from adenoma to carcinoma. The initial step in the CRC 
tumorigenesis involving the transformation of normal intestinal epithelium into adenoma is associated with loss 
of APC. As the tumour progresses towards more advanced stages it accumulates additional mutations - large 
adenomas and early carcinomas acquire mutations in the KRAS, followed by loss of chromosome 18q with 
SMAD4 and mutations in TP53. The original source of diagram: Walther et al. 2009 
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1.2.5 Colorectal cancer stem cell 
The concept of colorectal cancer stem cells as the means by which tumours are propagated 
has become of a great interest in the last few decades. Unveiling of such a mechanism would 
in turn have major implications on the detection of cancer, therapeutic compound discovery 
as well as metastasis amongst all (Wicha et al. 2006). Early observations of tumours revealed 
the heterogeneity amongst them leading to the formulation of the stochastic model. 
According to this model, all cell types ranging from stem cells to early differentiated cells 
had equal capacity to become cancer cell of origin whereas the genomic instability of those 
cells and microenvironment accounted for the differential phenotypical characteristics (Lobo 
et al. 2007).  An alternative model, notably cancer stem cell model suggested that the 
existence of a specific subpopulation of cancer cells characterized by the self-renewal 
capacity and pluripotency that drive tumour progression and heterogeneity (Vries et al. 
2010). Consistent with this notion, targeting of the cancer stem cells clinically would result in 
the eradication of tumour in contrast to targeting other cancer cells (He et al. 2009).  
The requirement for accurate markers of those cancer stem cells exist in order to pursue the 
idea of developing the therapy specifically targeting this subpopulation of cancer cells. One 
of the first colorectal cancer stem cells markers identified was CD133 (Prominin-1). A study 
using renal capsule transplantation into non-obese diabetic/severe combined immune 
deficiency (NOD/SCID) mice found that only a CD133
+
 cells were capable of initiation of 
tumour growth showing over 200 fold enrichment for cancer initiating cells in comparison to 
CD133- cells (O'Brien et al., 2007). The identification of other colorectal cancer stem cell 
markers including CD24, CD29, CD166 and Lgr5 was based on their expression in the 
CD133
+
-derived cultures (Vermeulen et al., 2008). In contrast to reports by O’Brien et al. 
(2007), Shmekov and his colleagues showed that CD133 is widely expressed in the human 
and mouse metastatic colon cancers undermining its potential as colorectal cancer stem cell 
marker (Shmelkov et al. 2008) Another study by Dalerba et al. (2007) found that highly 
proliferative cells capable of forming tumour morphologically resembling the original lesion 
were characterised by the high expression levels of epithelial cell adhesion molecule 
(EpCAM) and the presence of the cell surface marker CD44 suggesting they act as potential 
cancer stem cell markers (Dalerba et al., 2007). Whereas the identification of numerous 
cancer stem cells markers would facilitate the targeting of this subset of cancer cells, the 
question of which of those cell surface markers are required for cancer cell survival remained 
unresolved. Recent study by Barker et al. (2009) has provided strong evidence in support of 
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the notion that the intestinal cancer stem cell is a cell of origin of CRC. The activation of 
aberrant Wnt signalling through conditional loss of Apc in the Lgr5
+
 intestinal stem cells but 
not in progenitor or early differentiated cells resulted in the rapid adenoma formation (Barker 
et al. 2009). Lineage tracing using multicolor Cre-reporter R26R-Confetti by Schepers et al. 
(2012) identified Lgr5 intestinal stem cell marker as a marker of adenoma cells that are fuel 
the growth of established intestinal adenomas (Schepers et al., 2012). This notion indicating 
that intestinal stem cell markers can equally be expressed in a subset of colorectal cancer 
stem cells was confirmed by an analysis of gene expression signatures by Merlos-Suarez et 
al. (2011). EphB2-enriched intestinal stem cells were shown to be capable of tumour 
initiation in immunodeficient animals together with the enrichment of cells characterised by 
this gene expression signature in recurrent and metastatic CRC cases (Merlos-Suarez et al., 
2011).  
In summary, whereas these observations support the cancer stem cell hypothesis, several 
important questions including the nature of tumour relapse and the role of tumour 
microenvironment will have to be addressed prior to the development of cancer stem cell 
targeted therapies. 
 
1.2.6 Mouse models as a tool for recapitulating human colorectal 
tumorigenesis and translational research 
Due to the nature of CRC tumorigenesis comprising of an array of molecular changes in 
different signalling pathways involved it requires appropriate models to recapitulate all 
aspects of the disease which would enable discovery and validation of novel compounds and 
therapies in future.  Use of human cancer cell lines for validation of potential candidates and 
drug testing was one of the first platforms allowing for examination of some crucial cellular 
features of cancer cells such as proliferation and apoptosis levels, clonal survival, 
invasiveness capacities and in particular their ability to generate tumours in 
immunocompromised mice. Whereas human cancer cell lines provide relatively cheap means 
of assessment of drug validation there are several shortcoming worth considering. 
Importantly, many of human cancer cell lines have been isolated many decades ago and since 
then they have been continuously propagated implicating that due to the native mutation rate 
as well as some genomic instability they might no longer recapitulate the phenotype of their 
tumours of origin. Another issue is the setting of the in vitro experiments as those cancer cells 
are taken out of the context of their natural microenvironment and factors in vivo. The 
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mentioned limitations are overcome partially by the use of method of transplantation of 
cancer cells into immunodeficient animals however injections of cells into the skin flank do 
not mimic their normal setting. In the light of the importance and dependence of those cancer 
cells upon the factors and interactions with microenvironment such as with surrounding 
stroma or immune system, the absence of full recapitulation of tumour microenvironment by 
xenotransplant procedure provides an avenue for cancer cells to become more susceptible to 
anti-cancer therapies. Consequently this leads to significantly reduced pool of potential anti-
cancer compounds after validation in appropriate murine models that are successfully applied 
in human studies (Olive et al. 2009). Therefore the recapitulation of molecular events and 
cancer phenotype of such a complex disease like colorectal cancer requires the development 
of murine models of human cancers capable of mimicking both natural tumour environment 
as well as being easily reproducible. Despite of some genetic differences between humans 
and mice, these animals are a great animal cancer model characterised by short reproductive 
period, the presence of well-established transgenic techniques and similar gene expression 
regulation. The use genetically modified mouse models (GEMMs) in CRC studies carries 
some limitations revealed by early transgenic experiments showing that often the control of 
transgene expression levels is somehow limited with  expression levels of many proteins 
surpassing those found in human counterparts. The localisation of intestinal neoplasia in the 
murine models of CRC differs significantly from that found in humans with a vast majority 
of lesions found in the small intestinal epithelium. Moreover the progression of CRC towards 
more malignant phenotype according to the model proposed by Fearon and Vogelstein (1990) 
has not been successfully recapitulated in mice.  
In summary, whereas the process of the CRC initiation have been well-described appropriate 
advanced murine models are required in order to overcome all limitations imposed by in vitro 
studies or xenotransplantation approach. Considering the intercalating roles of different 
signalling pathways in CRC tumorigenesis, more “humanised” models of cancers in mice 
would provide the better learning platform for understanding of cancer progression as well as 
a validation platform for novel compounds.        
1.2.6.1 Constitutive transgenesis 
The generation of GEMMs recapitulating the phenotype of human cancers requires the use of 
transgenic techniques in order to mimic the mutations that comprise of that particular 
phenotype. The generation of first targeted deletion of hypoxanthine-guanosine 
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phosphoribosyl transferase (HPRT) by Kuehn et al. (1987) set the stepping stone for the 
decades of studies in generating mouse models of gene deletion in vivo. Numerous murine 
models of constitutive gene deletion have been generated since then providing a great deal of 
insight into the redundancy and function of many genes in the embryogenesis. However this 
technique carries some restrictions due to the nature of the gene deletions.  
Most importantly, physiological functions of many genes have not been uncovered as they 
have been found to be necessary for normal embryonic development whereas constitutive 
loss of those genes resulted in the pre-implantational or embryonic lethality. This have 
subsequently led to situations where the role of particular gene could not been investigated in 
the context of adult tissue homeostasis and tumorigenesis due to its role in the early 
development of the embryo such as in case of Pten tumour suppressor loss (Di Cristofano et 
al., 1998). Another limitation is the use of constitutive knock-down is that the expression of 
targeted gene is lost in the whole organism. Tissue-specific effects of gene deletion cannot be 
investigated and accounted for as complications in other systems may lead to severe 
phenotype besides tissue of interest. Moreover constitutive deletion of a particular gene in all 
cells of the organism might mask the extend of tissue-specific consequences through the 
changes in other systems and tissue microenvironment.          
 
1.2.6.2 Conditional transgenesis  
Considering the limitations imposed by the constitutive transgenesis together with the fact 
that in many cases heterozygous deletion of a gene is insufficient for tumour development, an 
alternative approaches were required for the investigation of  tissue-specific effects of gene 
targeting. Conditional transgenesis systems such as site–specific recombination using LoxP 
sites or Tet-on and Tet-off system ensures more stringent control over gene manipulation.  
Cre-loxP (Causes recombination (Cre) - Locus of crossover of bacteriophage P1 (loxP)) 
involves the Cre, a DNA recombinase driven under the expression of a particular promoter 
and LoxP sites that are 34 base pair sequences from bacteriophage P1(Sauer and Henderson, 
1988). Upon the induction of Cre activity, the recombination between LoxP sites occurs 
leading to the excision or inversion of flanked sequence. Recombination may lead to loss of 
tumour suppressor gene when LoxP sites flank the sequence necessary for its activity. The 
excision of transcription stop cassette results in the constitutive activation of an oncogene. 
Cre-LoxP system is most frequently used to exploit inducible promoter that are normally 
transcriptionally silenced however upon the induction with xenobiotic they become 
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expressed. One of the most commonly used inducible Cre recombinases is AhCre 
recombinase consisting of a rat cytochrome P4501A1 gene (Cyp1A1) which is 
transcriptionally silent in normal conditions whereas the administration of xenobiotic such as 
β-naphthoflavone results in the interaction with aryl hydrocarbon receptor, translocation to 
the nucleus where it binds to the Cyp1A1 promoter and initiates transcription (Ireland et al. 
2004). The control of transgenesis at the translational level is achieved by tissue-specific 
promoters. An example of such a promoter is CreER transgene encoding Cre recombinase-
estrogen receptor fusion protein which is activated in the presence of the estrogen antagonist 
Tamoxifen.  The binding of Tamoxifen to the ER domain of the protein allows for 
translocation of Cre into the nucleus subsequently leading to the catalysis of recombination 
between loxP sites. Dual control at both transcriptional and post-translational level ensures 
stringent control over expression of transgene which is illustrated by AhCreER transgene.  
FLP/FRT is similar to Cre-LoxP system of control of expression of genes. FLP recombinase 
is extracted from Saccharomyces cerevisiae (Dymecki, 1996) and together with FLP 
recognition target (FRT) sites are inserted into the genome. One of the crucial limitations of 
this mechanism is a substantial thermolability and limited activity. 
 
Overcoming of the main disavantages of both Cre-LoxP and FLP/FRP systems which is the 
irreversibility of the genetic alterations driven by the excision or inversion of targeted 
sequence was generation of Tet-on and Tet-off gene expression system controlled by the 
tetracycline. Tet repressor protein utilized in this system originates from Escherichia coli 
(Gossen and Bujard, 1992) and it can induce or suppress expression of target gene in 
response to administration of the tetracycline derivative doxycycline (Gossen and Bujard, 
1992, Gossen et al., 1995). 
 
1.3 Brm as a potential therapeutic target for Wnt-driven 
tumorigenesis  
 
1.3.1 Chromatin structure and chromatin remodelling 
DNA is tightly packaged into chromatin which importantly serves as a very important 
mechanism of controlling the expression of genes within that sequence. The core unit of 
chromatin structure is nucleosome consisting of 147 base pairs of DNA that are wrapped 
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around an octameric core of histone proteins: H2A, H2B, H3 and H4. These repeating 
nucleosome structures are bundled together in order to form a higher-order organized, 
condensed chromatin. Such a condense assembly of DNA prevents the interactions of some 
DNA sequences with elements of transcription machinery, consequently regulating the gene 
expression. However as the chromatin is a very dynamic structure capable of responding to 
the external signals the process termed chromatin remodelling may later the level of DNA 
packaging. The chromatin remodelling may be achieved by three different mechanisms: DNA 
methylation, histone modifications or ATP-dependent chromatin remodelling. DNA 
methylation is one of the major means for epigenetic signalling and it involves the addition of 
methyl groups to cytosine residues by DNA methyltransfereses converting them from 
cytosines into 5-methylcytosines. Usually those methylated cytosine residues are adjacent to 
guanine residues forming methylated CpG sequences dispersed across the whole length of the 
genome with exception of CpG islands comprising of large clusters of CpG sites that remain 
unmethylated. The methylation of those CpG islands results in inappropriate gene silencing 
such as silencing of the tumour suppressor gene sequences and it is therefore widely 
recognized as an important component of cancer development. Histone-modifying enzymes 
catalyze the changes at N-terminal tails of histone proteins such as methylation, acetylation, 
phosphorylation, ubiquitination, sumoylation and ADP-ribosylation. Those modifications 
affect interactions between the negatively charged backbone of DNA and the positively 
charged residues within histones and hence tighten or loosen the chromatin structure. Finally, 
ATP-dependent chromatin remodelling complexes are regulating the gene expression by 
being capable of moving, ejecting and stabilizing nucleosomes. Each complex comprises of 
an ATPase subunit which together with the energy from ATP hydrolysis enables them to 
perform their function. 
1.3.2 Mammalian SWI/SNF and its subunits 
SWI/SNF chromatin remodelling complex was initially identified in Saccharomyces 
cerevisiae and subsequent purification of complexes containing homologous ATP-dependent 
nucleosome remodelling activity identified related complexes in Drosophila melanogaster 
and mammalians (Wang et al., 1996). SWI/SNF chromatin remodelling complex is one of 
four families of SWI-like, ATP-dependent chromatin remodelling complexes which share an 
evolutionarily conserved SWI-like ATPase catalytic domain with other functional domains 
being unique to particular family. The main function of SWI/SNF complexes is coordinated 
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regulation of gene expression playing a crucial role in development and stem cell 
pluripotency.  
 
The main components of mammalian SWI/SNF complexes are catalytic ATPase subunits: 
brahma (BRM; SMARCA2) or brahma-related gene 1 (BRG1; SMARCA4) which are 
mutually exclusive. These complexes also consist of a minimum 8 highly conserved subunits 
referred as Brm or Brg1-associated factors (BAFs) such as BAF47, BAF155, BAF170, 
BAF53, BAF57, BAF60A, BAF250 or BAF180 and other variant subunits that are 
contributing towards targeting, assembly and regulation of those complexes (Muchardt 1999). 
Whereas 13 BAFs have been identifies so far, no SWI/SNF complex containing all of those 
subunits exists. The number of mammalian SWI/SNF components greatly exceeds those 
found in Drosophila and Saccharomyces suggesting exceeding structural and possibly 
functional diversity (Wang et al., 1996).  
 
Recently SWI/SNF complexes have become a novel link between chromatin remodelling and 
cancer development as alterations in chromatin structure can lead to changes in gene 
expression leading to tumorigenesis in some cases. Mutations in subunits of these complexes 
have been found to be present in different types of cancers and suggest having an effect on 
the tumour suppression (Cohet et al., 2010, Glaros et al., 2008, Sevenet et al., 1999, Sun et 
al., 2007, Wilson et al., 2011). One of the core members of SWI/SNF, SNF5 (BAF47, INI1) 
has been identified as bona fide tumour suppressor gene that is lost (one allele of BAF47 
being deleted whereas the other allele is mutated or silenced by methylation) in nearly all 
cases of paediatric malignant rhabdoid tumours (Biegel et al., 1999, Versteege et al., 1998) 
and currently is used as a marker gene for those tumours in the field of diagnostics. Mice 
heterozygous for SNF5 gene develop rhabdoid tumours histologically resembling those found 
in humans characterized by high aggressiveness and invasiveness and frequent metastasis to 
lungs and lymph nodes (DelBove et al., 2011, Guidi et al., 2001, Klochendler et al., 2000, 
Roberts 2000). Heterozygous deletion of BAF47 subunit has been detected in many cases of 
chronic myeloid leukemia (CML) (Grand et al., 1999) and conditional inactivation of one 
allele in mice results in lymphomas or rhabdoid tumours with 100% penetrance (Roberts 
2002). BAF60A has been found to bind p53 and has been linked to lung cancer risk (Hsiao et 
al., 2003, Gorlov et al., 2005). Furthermore BRG1 heterozygosity confers mice being more 
prone (10%) to develop mammary tumours indicating that its haplosufficiency of that gene 
can drive tumorigenesis (Bultman et al., 2007). Furthermore, approximately 10% of human 
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primary lung tumours are deficient in both Brg1 and Brm indicating a poorer prognosis than 
patients whose tumours express either of ATPases (Reisman et al., 2003, Fukuoka et al., 
2004).  
Strong evidence exists supporting the role of SWI/SNF complexes in a number of processes 
that are critical for self-renewal and proliferation, cell cycle control, and cell differentiation 
whose abrogation is essential for tumour development and growth suggesting SWI/SNF 
complexes to function as potential tumour suppressors.  
1.3.3 Comparison between paralogues Brm and Brg1 
Human Brm catalytic subunit is highly homologous with Brg1 (75% in humans) in its amino 
acid sequence and possesses highly conserved structures. At the BRG1-N terminus between 
residues 1-282 we find a region with high sequence divergence from corresponding region of 
Brm. Within that particular region between the residues 216-254 Brm contains a polyQ 
domain encoding about 33 glutamines which is absent from Brg1 (Reisman et al., 2009). The 
role of this polyQ repeat has not yet been explored however the data from C33 and SW13 cell 
lines revealed the presence of the variable length polyQ repeats among those cell lines. Brg1 
contains 99 base pair exon located between 1235-1334 bp that is unique to this protein and 
not present in Brm (Kadam and Emerson 2003, Reyes 1998).    
The other six conserved domains in Brm and Brg1 include: QLQ domain, a proline-rich 
domain, a helicase/SANT-associated domain, an ATPase domain, an Rb-binding domain and 
a Bromo domain. At the N-terminus QLQ domain (Brm 168-208, Brg1 170-200aa) contains 
conserved glutamine-leucine-glutamine motif and is believed to mediate the protein-protein 
interactions. A proline-rich domain is distal to the polyQ domain of Brm and proximal to 
HSA domain of both Brm and Brg1 (Brm 255-375, Brg1 210-345aa). The ATPase domain of 
Brm and Brg1 consists of helicase and DEAD box domains which are the main elements of 
ATP-dependent DNA unwinding mechanism. The free energy released from the ATP 
hydrolysis stimulates the translocation of those helicases along the length of DNA which in 
turn unwind the duplex DNA. helicase/SANT-associated domain (Brm 450-500, Brg1 475-
525aa) is often associated with helicase activity and DNA binding. Rb domain comprises of 
LxCxE motif (Brm 1356, Brg1 1292aa) which is essential for binding to members of the Rb 
tumour suppressor family. At the C-terminal, a bromo domain is present (Brm 1380-1500, 
Brg1 1455-1575aa) functioning as a binding element for acetylated histones and it is an 
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important element securing the association between SWI/SNF remodelling complexes and 
chromatin (Figure 1.10).   
 
 
Figure 1.10 Structural domains of Brg1 and Brm ATPase subunits include six common domains that are 
evolutionarily conserved: QLQ, proline-rich, HSA, ATPase, RB and bromodomain. Proximal to QLQ domain, 
polyQ domain is present exclusively in Brm whereas a 99bp exon located before the LxCxE Rb binding 
sequence is unique for Brg1.  
 
Taken together, Brm and Brg1 subunits are sharing multiple domains within their structure 
most of which are evolutionarily conserved however non-homologous region near N-
terminus and 99bp unique exon which may account for some differences in functions of those 
two ATPases. 
Biochemical activity of Brm and Brg1 differs significantly as deletion of Brg1 but not Brm 
results in aberrant chromatin organisation involving redistribution of histone modifications 
and dissolution of pericentromeric heterochromatin domains (Bourgo et al., 2009). These 
differences in biochemical properties may account for difference in severance of the 
phenotype of murine knockout of Brm and Brg1 as those ATPases are likely to possess 
distinctive roles in chromatin remodelling as well as regulating different downstream genes 
(Bultman et al., 2000). Homozygous deletion of BRG1 is embryonic lethal whereas mice that 
lost both copies of Brm are still viable but interestingly they express very little or no CD44 
(Banine et al., 2005, Reyes et al., 1998). The lack of strong phonotype in the Brm mutant 
may be due to the ability of Brg1 to compensate for Brm deficiency (Reyes et al., 1998).  
Previous studies of SWI/SNF chromatin remodelling complexes during male meiosis suggest 
that Brm and Brg1 may have complementary, non-redundant roles (Kim et al., 2012). 
Contrary to this observation, Brm is unable to compensate for loss of conditionally deleted 
Brg1 allele in developing hematopoietic and endothelial cells questioning the functional 
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redundancy between Brm and Brg1 ATPases in vitro (Griffin et al., 2008). Similarly, in vivo 
study of a retinoblastoma-induced growth arrest of human melanocytic nevi supports that 
notion. Cell culture studies of osteoblasts have also suggested the distinctive roles of those 
two ATPases as Brm negatively regulates osteoblast differentiation and in contrast Brg1 
promotes this process (Flowers et al., 2009).  
It has been shown that both ATPase subunits of SWI/SNF complex Brm and Brg1 can have 
distinct roles in regulating transcription as they associate with different promoters as well as 
preferentially bind distinctive classes of transcription factors in response to signalling 
pathways. BRG1 binds zinc finger proteins via domain that is not present in BRM but BRM 
can uniquely interact with ankyrin repeats which results in differential promoter targeting 
(Kadam and Emerson 2003). Those two proteins that belong to the ankyrin family, ICD22 
and CBF-1 play a crucial role in as regulators of Notch signalling pathway and therefore can 
inhibit differentiation, and thus alter fate of the proliferating cells. 
Both, Brm and Brg1 proteins are involved in the regulation of cell cycle. In SW13 cell line 
expression of either of proteins induces growth arrest (Dunaief et al., 1994, Shanahan et al., 
1999, Strober et al., 1996) which has been indicated as an effect of the interaction between 
those ATPases and tumour suppressor and cell cycle control Rb (retinoblastoma) protein 
(Asp et al., 2002). Functional Brm protein is necessary for formation of Rb/HP1β complex 
and binding of Rb protein to chromatin during cellular senescence in vivo.  
Brm and Brg1 are also capable of inducing the changes in DNA methylation at the promoter 
sites of CD44 and E-cadherin genes in order to promote transcriptional activation. 
Hypermethylation of those two promoters is observed in cells that have lost Brm or Brg1 but 
restoration of ATPase activity by transfection with either Brm or Brg1 induces loss of 
methylation, activation of transcription and CD44 and E-cadherin expression in those cells. 
Proposed mechanism by which Brm and Brg1 could influence the methylation of the 
promoters may involve recruitment of demethylase to those promoter sequences or by 
blocking the methyltransferases (Banine et al., 2005). Previous studies have shown that Brm 
and Brg1 proteins possess the ability to enhance transcription mediated by the glucocorticoid 
receptor (Muchardt et al., 1993, Wang et al., 1996), the estrogen receptor (Chiba 1994) and 
retinoic acid receptor (Chiba 1994).  
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1.3.4 Physiological functions of Brm  
Murine studies of spermatogenesis and oogenesis demonstrated that a decrease in the 
methylation of CpG islands within Brm promoter correlates with an increase in expression of 
Brm (Nagrani et al., 2011) which facilitates its transcription. Brm is actively recruited to 
cyclin A promoter by cyclin A bipartite repressor sequence and consequently maintains the 
state in which cyclin A promoter is tightly wrapped around nucleosomes repressing cyclin A 
expression. Moreover quiescent cells that are deficient for Brm fail to repress this promoter 
suggesting that Brm is necessary for repression of cyclin A during early phases of cell cycle 
(Coisy et al. 2004).  
In NB4 resistant cell line (retinoid-maturation-resistant NB4-LR1 subclone), CD44 
expression is silence due to the methylation of CpG islands and underacetylation of H3 at 
CD44 promoter. The reversing CD44 gene silencing and therefore re-expression of functional 
CD44 signalling pathway is facilitated by cAMP which recruits Brm and c-jun to the sites at 
the CD44 proximal promoter where Brm is shown to be involved in the crosstalk between 
transcription and RNA polymerase II processing and also the binding of phosphorylated RNA 
Pol II to the proximal promoter region of CD44 (Abercassis et al., 2008). In the same cell 
line, UV-irradiation induced apoptosis leads to the cleavage at carboxyl terminus of Brm by 
cathepsin G. The subsequent removal of bromodomain of Brm leads to the disruption of its 
association with nuclear matrix and inactivation of Brm protein as it cannot perform its 
functions in a same manner as full-length Brm. This rapid inactivation of Brm resulting 
indicates possible mechanism by which cells are becoming apoptotic is response to DNA 
damage (Biggs et al. 2001).    
Brm has been reported to be contributing towards the crosstalk between transcription and 
RNA polymerase II processing of numerous genes such as CD44, E-cadherin and cyclin D1. 
Furthermore it is also found to be associated with elements of spliceosome and ERK-
activated enhancer of variant exon inclusion Sam68 facilitating the recruitment of the splicing 
machinery and eventually inclusion of their variable exons of those genes (Abercassis et al. 
2008, Batsche et al. 2006).  
It has been found that formation of the complex between cEBP-α and Brm inhibits E2F-
driven gene expression and therefore proliferation of hepatic progenitor cells leading to 
decline in regenerative capacity of aging liver (Conboy et al., 2005). Similar interaction 
between cEBP-α and Brm has been observed in MCF-7 breast cancer cell line where the 
stimulation of hVDR transcription by binding between cEBP-α and Brm is inhibited by 
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mutation in Brm ATPase domain (Dhawan et al., 2009). Brm has been also shown to form 
complex with MeCP2 in methylation-mediated gene silencing of gene promoters ABCB1 and 
THBS1 in cancer cell lines suggesting its ATPase activity is playing important role in co-
repression mechanism. (Harikrishan et al., 2005) 
 
1.2.4.1 Brm interaction with Notch signalling  
 
As previously mentioned in section 1.2.3 ChIP analysis of both ATPase subunits of SWI/SNF 
chromatin remodelling have detected an exclusive interaction of Brm but never Brg1 with 
ankyrin repeats domains which results in differential promoter targeting (Kadam and 
Emerson 2003). The two proteins identified belong to the ankyrin family, ICD22 and CBF-1 
play a crucial role in as regulators of Notch signalling pathway and therefore can inhibit 
differentiation, and thus alter fate of the proliferating cells. This data suggest that 
manipulations of Brm levels may have an effect on Notch signalling which regulates multiple 
processes in the intestinal epithelium. 
 
1.3.5 The role of Brm in mammalian development 
Brg1 null animals similarly to SNF5-deficient mice are embryonic lethal whereas Brm null 
mice are viable suggesting a differential role of Brm and Brg1 in mouse development. In 
early development of murine embryo Brg1 is expressed during the pre-implantation 
development and Brm expression levels are detectable from blastocyst stage onward which 
also marks the first cell fate decision event. During this first differentiation event, cells within 
blastocyst so-called inner cell mass are destined to become a proper embryo and external 
cells give rise to the trophectoderm that forms the embryonic part of placenta. Brm is 
uniquely restricted to inner cell mass however it becomes expressed in cell-type specific 
manner after the differentiation of embryonic stem cells (LeGouy 1998).   
In adult animals, Brm is preferentially expressed in cell types such as brain or liver which do 
not undergo continuous self-renewal and proliferation. Brm is dispensable for thymic 
development, does not contributes towards the phenotype as well as being unable to 
compensate for loss of Brg1 in T cells (Chi et al., 2003, Gebuhr et al., 2003). Enzymes of 
SWI/SNF chromatin remodelling complex are necessary for activation of transcription of 
muscle-specific genes but are redundant for cell cycle arrest (de la Serna 2006). Previous data 
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on embryos deficient for both Brm and Brg1 showed no exacerbation of vascular phenotype 
over that seen in single Brg1 mutant (Griffin et al., 2011). 
 
1.3.6 The role of Brm as tumour suppressor  
Consistent with the roles of both Brm and Brg1 in regulating transcription of numerous genes 
contributing towards processes involved in cell cycle, it implicates the importance of the 
presence as well as functioning of those ATPases on cancer development in in vivo and in 
vitro studies.  
Furthermore, common point mutation in Brm has been detected in basal squamous carcinoma 
and basal cell carcinoma (de Zwaan et al., 2010). Brm deficiency is shown to potentiate 
tumour development induced by lung-specific carcinogen ethyl carbamate leading to an 
increase in numbers of adenomas (Glaros et al., 2007). Additionally, Brm expression is 
absent in approximately 15% of human tumours such as bladder, ovarian, esophageal, breast 
and lung (Glaros et al., 2007). Further analysis of primary lung carcinoma cases revealed that 
independently of Brg1 status Brm low expression or loss correlates with poor prognosis 
suggesting that Brm loss may accelerate poorer cell differentiation and epithelial-
mesenchymal transition (EMT) eventually leading to even more malignant phenotype 
(Matsubara et al., 2013). Similarly Brm loss in mammary epithelial cells promotes the 
malignant phenotype by the induction of C/EBPβ-dependent transcription of α5 integrin 
(Damiano 2013). Expression levels of Brm but not Brg1 were significantly lower in primary 
hepatocellular carcinoma (HCC) and alike in lung carcinoma cases correlated with overall 
poor prognosis. 
Previous studies conducted in our laboratory looking at Brg1 loss showed that upon the 
activation of Wnt pathway due to Apc loss, multiple adenomas form within small intestinal 
epithelium however Brg1-deficient cells are selected against leading to suppression of Wnt-
driven tumorigenesis. In comparison, in Wnt-activated large intestine, Brg1 deficiency is 
tolerated in adenomas and Brm is overexpressed in Brg1 deficient tumour lesions.  
Consistent with the data, similarly to Brg1 and BAF47 (SNF5), Brm is believed to function 
as tumour suppressor. Whereas many tumour suppressor genes are inactivated in cancer by 
mutations, Brm deficiency is caused by silencing and therefore its expression could be 
restored (Glaros et al., 2007). Taken together, Brm re-expression may therefore be a valuable 
clinical target in many solid tumour types but regrettably interactions of Brm subunit with 
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signalling pathways such as Wnt, Notch or BMP pathway responsible for maintaining tissue 
homeostasis remain as yet unknown.   
 
53 
 
1.4 Aims and objectives  
 
The main objective of this thesis is to explore the role of an active SWI/SNF chromatin 
remodelling complex containing Brm catalytic subunit in the small and large intestinal 
epithelium. The enzymatic activities of Brm towards nucleosome remodelling and therefore 
the role of Brm in the control of transcription of genes involved in cell cycle and 
differentiation implicates its function in the maintenance of normal homeostasis as well as 
during the cellular transformation during cancer development and progression. Strong 
evidence exists supporting the notion that aberrant activation of Wnt signalling is a key 
initiation step in intestinal tumorigenesis however no direct links between Brm and Wnt 
signalling have been identified in contrast to interactions between Brm and the Notch 
pathway (Kadam and Emerson 2003). This project aimed to further explore the possibility of 
modulation of phenotype observed in the small and large epithelium in the context of acutely 
activated Wnt signalling in context of Brm loss which might be possibly mediated by Brm 
effect on Notch pathway components or changes in the expression of Brm paralogue Brg1. 
Upregulation of Brm expression has been reported in Brg1-deficient human cancers, 
implying that a level of SWI/SNF chromatin remodelling is maintained, possibly through 
compensation mechanism between the Brm and Brg1 ATPases. 
Initially, Brm null mouse model will be used to investigate the role of Brm ATPase subunit in 
the small and large intestine by assessment of effects of Brm deficiency on the maintenance 
of homeostasis within normal, non-neoplastic intestinal epithelium. This part of the project is 
outlined in Chapter 3. Furthermore, I will assess the consequences of Brm deficiency in the 
context of aberrant Wnt signalling on the epithelium of small and large intestine which are 
described in Chapter 4. Lastly, the consequences of combined deficiency in both Brm and 
Brg1 catalytic subunits will be analysed, with respect to normal homeostasis and acute Wnt 
signalling activation in small and large intestinal epithelial allowing for the differentiation 
between dependency on Brm-containing complexes, Brg1- containing complexes or 
synergistic effect of active SWI/SNF including both Brm and Brg1 on the intestinal 
phenotype in the epithelium. This part of the project is being addressed in Chapter 5 of this 
PhD thesis.  
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Chapter 2  
Materials and Methods 
 
2.1 Experimental animals 
All the animal work conducted during this PhD studies have been carried out in accordance 
with UK Animal Scientific Procedures Act 1986  and UK Home Office regulations under 
valid personal (Joanna Krzystyniak 30/9673) and project licenses (Prof Alan R Clarke, years 
2010-2015, 30/2737).  
2.1.1 Transgenic constructs and animal models used in the project  
A number of different transgenic mouse lines have been used for the needs of this project 
with all mice being maintained on the mixed background. Some of mice have not been 
carrying a Cre recombinase due to the Brm allele being constitutively knocked-out with no 
need for such a transgene. Mice carrying the Tg(Cyp1a1-cre/ESR1)1Dwi transgene 
(abbreviated in the text as AhCreER) are induced by combined injection of Tamoxifen and β-
napthoflavone which drives the recombination in small intestine, esophagus, stomach, liver, 
gall bladder and bladder. Tg(Cyp1a1-cre/ESR1)1Dwi created by Douglas J Winton is a 
trangene insertion 1 of cytochrome 450 (Cyp1a1) rat promoter that drives the expression of 
cre recombinase fused with Estrogen receptor 1. The control over the Cre activity is greatly 
improved in comparison to Tg(Cyp1a1-cre)1Dwi transgene (abbreviated as AhCre) as it is 
regulated at two levels – by the transcriptional control of AhCre promoter and by the 
requirement for Tamoxifen binding to the fusion protein containing mutated oestrogen-
binding domain. This type of dual control at the transcriptional and protein level ensures 
tightly regulated tissue-specific recombination (Kemp 2004). Animals used for the ex vivo 
studies were bearing Tg(Vil-cre/ESR1)23Syr transgene (abbreviated VillinCre) where fusion 
protein consisting of Cre recombinase and oestrogen receptor is transcriptionally controlled 
by Villin1 promoter and requires a binding of synthetic ligand of Tamoxifen (el Marjou 
2004). Animals carrying targeted disruption of Brm allele where the exon a has been replaced 
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by neomycin resistance cassette together with targeted Brg1 allele with lox P sites are 
flanking exons 2 and 3 were provided by Christian Muchardt (Reyes 1998) (Figure 2.1a, 2.1 
b). The targeted Apc allele bearing the lox P sites present in the intronic sequences on both 
sides of exon 14 was maintained in our laboratory (Shibata 1997) (Figure 2.1c).  
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Figure 2.1 Schematic representation of the targeted disruption of Brm gene and loxP targeted Brg1 and Apc 
alleles and their primer positions. (A) exon a of the endogenous Brm locus has been replaced by the targeting 
vector containing neomycin phosphotransferase (PGK-neo) gene and thymidine kinase (PGK-tk) gene both 
linked to the phosphoglycerate kinase (PGK) promoter  placed in a reverse orientation relative to Brm 
transcription. Primers specific to the regions on the either side of exon a and within Neo gene are indicated as 1, 
2 and 3 as the oligos used for genotyping of animals by PCR (B) Two loxP sites are placed in Brg1 gene in 
order to flank exons 2 and 3. Primers specific to regions either side of the second loxP site (GenFw-GenRev) are 
the oligos used for genotyping of animals by PCR. (Sumi-Ichinose et al., 1997). (C) Two loxP sites are placed in 
a way to flank either side of exon 14 of Apc gene. Primers specific to regions either side of the first loxP site 
(GenFw-GenRev) are the oligos used for genotyping of animals (Shibata et al.,1997). 
  
A 
B 
C 
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2.1.2 Animal husbandry 
 
2.1.2.1 Colony maintenance 
All animals were housed in the semi-barriered facility and have been fed the Harlan standard 
diet (Scientific Diet Services, RM3(E)) and water.  
2.1.2.2 Breeding  
All animals were maintained as outbred. Adult animals (6-8 weeks old) of a known genotype 
were bred mainly as pairs (one male and one female), rarely in trios (one male and two 
females). Pups were left with their mother until they were capable of feeding independently. 
Those pups were usually weaned at 4 weeks of age unless they were too small which meant 
the risk of post-weaning mortality was high.    
2.1.2.3 Identification by ear biopsy  
At the time that pups were weaned, the male and female littermates were sexed and separated 
accordingly. The method of animal identification involved ear clipping and the tissue sample 
obtained through this procedure was used for DNA extraction and genotyping.  
2.1.3 Experimental procedures 
All experimental animals were aged until 70 days of age (10 weeks) before being subjected to 
any procedures. Intraperitoneal injections were performed using 1 ml syringe (BD Plastipak) 
and 26G needle (BD Microlance). 
2.1.3.1 Injection of Tamoxifen  
Animals carrying the VillinCre transgene were induced by administration of Tamoxifen 
(Sigma) in corn oil according to the high dose protocol of four daily IP injections of 80 
mg/kg. Tamoxifen in the powder form was measured out and added to amber glass bottle 
containing corn oil to the final concentration of 10 mg/ml. The solution was then heated up to 
80 °C with continuous stirring of the in order to aid the Tamoxifen to dissolve and finally 
aliquoted appropriately and stored at -20 °C. At the time of the procedure, the solution was 
briefly defrosted and heated up to 80 °C in the water bath and kept at that temperature until 
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immediately prior to the injection. At the end of the procedure, the remaining solution of 
Tamoxifen was re-frozen and was further defrosted and used up to 3 times to minimize the 
risk of Tamoxifen degradation. 
2.1.3.2 Injection of Tamoxifen and β-napthoflavone 
Animals expressing the AhCreER transgene were inducted by administration of Tamoxifen 
and β-napthoflavone solution. Cre recombinase activity and expression was achieved by five 
bi-daily IP injections of 80 mg/kg β-napthoflavone combined with 80 mg/kg Tamoxifen at 
the interval of 12 hours between each injection. Both, powdered β-napthoflavone and 
Tamoxifen were dissolved in corn oil to obtain final concentrations of 10 mg/ml. The 
solution was then heated up to 80 °C in the water bath and further stirred on the heated 
magnetic stirrer until complete dissolution of both components.  Obtained solution was stored 
at -20 °C and a single batch was used during the bi-daily induction protocol which included 
repeated cycles of defrosting and re-freezing.   
2.1.3.3 Injection of 5’-bromo-2-deoxyuridine 
Selected experimental animals were administered with a single IP injection of 0.25 ml of 5’-
bromo-2-deoxyuridine at the concentration of 10 mg/ml (BrdU, Amersham Biosciences). 
This procedure was conducted 2 hours or 24 hours prior to the dissection of the animal in 
order as a means to labelling all of the cells in the S-phase of the cell cycle at that discrete 
point of time.   
2.1.4 PCR genotyping 
All animals were genotyped by PCR using DNA extracted from the ear biopsies at the 
weaning age of four weeks and furthermore all experimental animals were genotyped again 
upon their death to confirm the genotype. Majority of the primers were provided by previous 
publications however if this was not the case they were designed using primer3 software at 
http://fokker.wi.mit.edu/primer3/input.htm, checked for specificity using BLAST engine 
against Ensembl database (http://www.ensembl.-org/Multi/blastview) and synthesised by 
Sigma Genosys.  
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2.1.4.1 DNA purification 
At the time of the ear biopsy, the tissue sample taken was placed in a 1.5 ml eppendorf tube 
and stored at -20 °C until analysis. DNA isolation was performed using 250 μl of Cell Lysis 
Solution (Gentra) and 5 μl of 20mg/ml Proteinase K (Roche) which were both added to the 
tissue and incubated with agitation at 37 °C overnight. The following day the tube contests 
were cooled to room temperature, then mixed with 100 μl of Protein Precipitation Solution 
(Gentra) and centrifuged at 13000 RPM for 10 min in a microcentrifuge. The supernatant was 
collected and placed in a fresh 1.5 ml eppendorf, then mixed with 250 μl of isopropanol and 
centrifuged at 13000 RPM for 15 min. Resulting supernatant was carefully removed and 
discarded leaving the tubes to air-dry for 1 hour. Purified DNA was dissolved in 250 μl of 
PCR-grade water (Sigma) and 2.5 μl of the solution obtained was used to perform PCR 
reactions.  
2.1.4.2 Generic protocol for PCR genotyping 
PCR reactions were performed in a thin-wall 0.2 ml strip tubes (Greiner Bio-One) or thin-
wall 96-well plate and run using GS1 (G-Storm) thermal cycler. All the pipetting of the 
reagents and DNA samples was carried out using filtered pipette tips to avoid aerosol 
contamination.  
2.5 μl of genomic DNA extracted from ear biopsy was loaded into wells using a multi-
channel pipette followed by the addition of 47.5 μl of prepared master-mix (Table 2.1) 
containing all the remaining components of the reaction (distilled water, GOTaq 5X PCR 
buffer (Promega), 25 mM Magnesium Chloride (Promega), 25 mM dNTPs (Bioline), Primers 
(Sigma-Genosys) and either GOTaq (Promega) or Dream-Taq (Fermentas) DNA 
Polymerase). Strip-tubes were closed using caps (Greiner Bio-One) whereas 96-well plates 
were sealed with aluminium foil tape ensuring that no air bubbles were present in the 
mixture. 
Reactions were run using cycle conditions outlined in Table 2.1. 
The primer sequences used for genotyping of the particular transgenes and the size of 
respective products are provided in Table 2.2. 
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2.1.4.3 Visualization of PCR products 
After the completion of PCR reactions the products were visualised using agarose gel elecrophoresis.  
The reactions using colourless 5X PCR buffer (Promega) were mixed with 5 μl of DNA 
loading dye (50% Glycerol (Sigma), 50% distilled water, 0.1% (w/v) Bromophenol Blue 
(Sigma)) while the reactions using 5X Green PCR buffer (Promega) were loaded without the 
addition of loading dye. All samples along with an appropriate marker (e.g. 100 bp ladder 
(Promega)) were loaded onto 2% agarose gel (4 g agarose (Eurogentech), 200 ml 1X Tris-
Borate-EDTA (TBE) buffer (Sigma), 10 μl of 10 mg/ml ethidium bromide (Sigma) or 10 μl 
Safeview (NBS Biologicals)). Gels were run in 1X TBE buffer at 120 V for 30 min. Products 
were visualised in UV light using ChemiDoc MP apparatus (BioRad).  
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Table 2.1 Genotyping PCR reaction components and cyclin conditions  
 
 Cre/LacZ Responder ApcLoxP Brg1LoxP Brm null 
PCR Reaction Components:      
DNA extract (See section 2.1.4.1) 2.5 μl 2.5 μl 2.5 μl 2.5 μl 2.5 μl 
Master Mix:      
PCR-grade H2o (Sigma) 31.5 μl 31.7 μl 31.7 μl 31.7 μl 31.6 μl 
GOTaq PCR Buffer (5X, Promega) 10 μl 10 μl 10 μl 10 μl 10 μl 
Magnesium Cloride (25 mM, Promega) 5 μl 5 μl 5 μl 5 μl 5 μl 
dNTPs (25 mM, Bioline) 0.4 μl 0.4 μl 0.4 μl 0.4 μl 0.4 μl 
Forward Primer (100 mM, Sigma Genosys) 2 x 0.1 μl 0.1 μl 0.1 μl 0.1 μl 0.1 μl 
Reverse Primer (100 mM, Sigma Genosys) 2 x 0.1 μl 0.1 μl 0.1 μl 0.1 μl 2 x 0.1 μl 
Taq Polymerase 0.2 μl 0.2 μl 0.2 μl 0.2 μl 0.2 μl 
Taq Polymerase Brand GOTaq DreamTaq DreamTaq GOTaq DreamTaq 
Total Reaction Volume: 50 μl 50 μl 50 μl 50 μl 50 μl 
 
 
Cycling conditions (Time; Temperature) Cre/LacZ Responder ApcLoxP Brg1LoxP Brm null 
Initial denaturation 3 min; 94 °C 5 min; 94 °C 2.5 min; 95 °C 2.5 min; 95 °C 2.5 min; 95 °C 
Cycle number 30 30 30 35 35 
Step 1 (Denaturation) 30 sec; 95 °C 20 sec; 94 °C 30 sec; 95 °C 30 sec; 94 °C 30 sec; 94 °C 
Step 2 (Annealing) 30 sec; 55 °C 20 sec; 57 °C 30 sec; 60 °C 30 sec; 60 °C 30 sec; 61°C 
Step 3 (Elongation) 1 min; 72 °C 30 sec; 72 °C 1 min; 72 °C 1 min; 72 °C 1 min; 72 °C 
Final Extension 5 min; 72 °C 5 min; 72 °C 5 min; 72 °C 5 min; 72 °C 5 min; 72 °C 
Hold 1; 15 °C 1; 15 °C 1; 15 °C 1; 15 °C 1; 15 °C 
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Table 2.2 Primer sequences and size of products of genotyping PCR reaction  
 
Name Forward primer Reverse primer Product size 
Cre specific TGACCGTACACCAAAATTTG ATTGCCCCTGTTTCACTATC 1000 bp 
ROSA26:LacZ CTGGCGTTACCCAACTTAAT ATAACTGCCGTCACTCCAAC 500 bp 
ApcLoxP GTTCTGTATCATGGAAAGATAGGTGGTC CACTCAAAACGCTTTTGAGGGTTGATTC WT at 226 bp; Targeted at 314 bp 
Brg1LoxP CCAAGGTAGCGTGTCCTCAT CACTGCTCAGCTTCACTTGC WT at 407 bp; Targeted at 500 bp 
Brm
- CCTGAGTCATTTGCTATAGCCTGTG CTGGACTGCCAGCTGCAGAG;  
CATCGCCTTCTATCGCCTTC 
WT at 310 bp; Targeted at 700 bp 
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2.2 Tissue harvesting and processing 
 
2.2.1 Tissue harvesting 
All experimental animals were culled by cervical dislocation which was chosen amongst 
schedule 1 approved methods of culling mice. The animals were dissected in the designated 
surgery room using a student micro-dissection kit. The fur along the ventral axis of the 
animal was sprayed using 70% ethanol and incisions were made along the mid-line of the 
abdomen, initially through the skin, then through peritoneal wall followed by two horizontal 
incisions on both sides of the mid-line in order to expose all contents of abdominal cavity.  
The standard protocol of intestinal tissue harvesting was applied to all animals in exception to 
animals harvested for ex vivo studies. Stomach together with about 0.5 cm of esophagus was 
separated from the remainder of gastrointestinal tract. It was cut open in the middle with its 
contents flushed away with running cold tap water. Once empty, the forestomach was folded 
over the glandular stomach along the ridge separating respective parts and together with 
esophagus they were fixed using surgical microtape. The small intestine from the pylorus 
junction to the caecum was separated and it contents flushed away using syringe filled up 
with ice cold 1X PBS (Invitrogen). The first 9 cm of the small intestine were assembled as a 
“swiss roll” where the all 9 cm were cut open longitudinally, spread on the flat surface with 
the intestinal epithelium side-up, rolled from the pylorus junction down using the forceps and 
securing this conformation by piercing it through with 23G syringe needle (BD Microlance). 
Following 8 cm of the small intestine were cut into 4 equal-size pieces and bundled together 
with surgical microtape. The tissue for RNA and protein extraction was taken from the next 5 
cm of the intestinal epithelium which were cut into 2-3 mm pieces, placed in an eppendorf 
and snap frozen in liquid nitrogen. Following 6 cm of the small intestine were cut into 3 equal 
pieces and bundled using microtape. The remainder of the small intestine down to caecum 
was “swiss rolled”.  The entire length of the large intestine was “swiss rolled” expect from 
the first 5 mm of the caecum and last 5 mm of rectum that were cut into half, the tissue 
placed in an eppendorf and snap frozen in liquid nitrogen for RNA and protein extraction.  
The samples from other abdominal cavity tissues such as liver, pancreas, spleen, kidney and 
bladder were taken for histological analysis as well as snap frozen in liquid nitrogen.  
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2.2.2 Tissue fixation 
All the tissue samples collected for histological analysis were immersed in the ice cold 
formalin (4% neutral buffered formaldehyde in saline, Sigma) and quick fixed for 24 hours at 
4 °C. In case of samples that could not be processed straight away after fixation, the tissues 
were transferred into 70% ethanol and stored at 4 °C until processed.  
2.2.3 Tissue processing for light microscopy 
 
2.2.3.1 Tissue dehydration 
All the tissue samples collected during dissection were appropriately arranged in the 
histocassettes and processed by automatic processor (Leica TP1050).  The dehydration of the 
samples occurred as a sequential process involving increasing concentrations of ethanol (70% 
for 1 hour, 95% for 1 hour, 100% 2 x 1 hour 30 min, 100% for 2 hours), xylene 2 x 1 hour 
and eventually paraffin 1 x 1 hour and 2 x 2 hours. Once the dehydration process was 
completed, tissue samples were embedded in paraffin wax.   
2.2.3.2 Tissue sectioning 
5 μm thick sections were cut from paraffin blocks using microtome (Leica RM2135). Those 
pre-cut section were then floated on slides coated with poly-L-lysine (PLL) and baked at 58 
°C for 24 hours.  
2.2.4 Tissue preservation for DNA, RNA and protein 
 
2.2.4.1 Tissue collected for DNA extraction 
The tissues collected for DNA extraction were placed in 1.5 ml eppendorf, transported on ice 
into laboratory and stored at -20 °C until required for DNA extraction. 
2.2.4.2 Tissue collected for RNA and protein extraction 
As previously briefly explained in section 2.2.1 tissue samples collected for RNA and protein 
extraction were removed, cut into small pieces and transferred into a clean 1.5 ml eppendorf. 
The tissue was arranged around the walls of an eppendorf in a way to avoid the single pieces 
touching one another. This method was implied in order to enable the transfer of single pieces 
of tissue once required for extraction without the need of defrosting whole block of tissue 
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collected. The eppendorf was immersed in the liquid nitrogen as quickly as possible, later on 
transferred onto the dry ice to be transported between semi-barriered animal facility and 
laboratory and eventually stored at -80 °C until needed.    
2.3 Histological analysis 
 
2.3.1 Haematoxylin and Eosin staining (H&E) 
Tissue sections have undergone the dewaxing and rehydration step as described in section 
2.4.1 and were immersed in Mayer’s Haemalum (R.A. Lamb) for 5 min. Stained slides were 
then washed under the running tap water for 5 min followed by staining in 1% aqueous Eosin 
solution (R.A. Lamb). The excess of Eosin stain was briefly washed off using water by 15 
second washes. Stained sections were subsequently dehydrated and mounted as described in 
section 2.4.9. 
2.3.2 Quantitative histological analysis of H&E sections 
Histological quantification of stained sections of tissue was carried out using an Olympus 
BX43. The images representing histological traits analysed were taken using Moticam 5000 
(5 megapixel, Motic Instruments) aided with Motic Images Advanced software (version 3.2 
Motic China Group).  
2.3.2.1 Scoring of crypt length 
The crypt length was scored by counting the number of cells from the base of the intestinal 
crypt up to the crypt-villus junction where the bottom-most cell was indicated as #1. Crypt 
length was counted per half crypt-villus and minimum of 50 crypts were scored per animal. 
In order to maintain the consistency of the epithelium scored, the proximal ends of both small 
and large intestine were chosen for the analysis. 
 
2.3.2.2 Scoring of villus length 
The villus length was determined by counting the number of cells from the crypt-villus 
junction all the way up to the tip of the villus. Similarly to crypt scoring, villus scoring was 
conducted on half crypt-villus axis and minimum of 50 villi were scored per animal. Parallel 
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to crypt length scoring mentioned above, villus length was scored for the epithelium at the 
proximal end of small intestine. 
2.3.3 Quantitative of histological traits using specific stains and 
markers 
 
2.3.3.1 Alkaline phosphatase staining 
The combined microvilli on the entire epithelial surface form the brush border. Alkaline 
phosphatase is a brush border-specific stain used as a differentiation marker to measure the 
abundance of mature enterocytes. Slides with tissue were dewaxed and rehydrated as 
described in section 2.4.1 and placed in the humidified chamber. Tissue sections were then 
covered with Liquid Permanent Red solution (DAKO) (1 drop of Liquid Permanent Red 
Chromogen in 3 ml of Liquid Permanent Red Substrate Buffer) and incubated for 20 min at 
the room temperature. The excess of staining solution was removed and tissue sections were 
washed in dH2O for 5 min. The slides were counterstained in Mayer’s Haemalum for 30 
seconds, washed for 5 min under running tap water and mounted using glycerol (Sigma).  
The localisation and intensity of staining as well as the thickness of the brush border were 
visually assessed using light microscopy and representative photograph of appropriate 
structures were taken.    
2.3.3.2 Lysozyme staining 
Lysozyme is one of Paneth cells-specific secretions therefore anti-lysozyme 
immunohistochemistry (section 2.4) was used to detect those cells. Cell numbers as well as 
cell position were scored within the small intestinal epithelium. The Paneth cell 
quantification was assessed as number of cells displaying positive lysozyme staining scored 
in 50 half crypt-villi per tissue section. Furthermore the average number of Paneth cells 
across those 50 crypt-villi was calculated for each animal in that cohort and analysed as 
described in section 2.7. Paneth cell position was counted from the base of the intestinal crypt 
up all the way up to the villus tip where the bottom-most cell was indicated as #1. Paneth 
cells positions from all animals belonging to the same experimental cohort were pooled 
together and analysed as described in section 2.7.  
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2.3.3.3 Alcian Blue staining 
Mucin-secreting goblet cells have been identified using Alcian Blue staining. Slides with 
tissue were dewaxed and rehydrated as described in section 2.4.1 and immersed in Alcian 
Blue solution (1% (w/v) Alcian Blue (Sigma) in 3% (v/v) Acetic acid (Fisher Scientific)) for 
30 seconds. Stained slides were washed under running tap water for 5 min and counterstained 
with 0.1% Nuclear fast red (Sigma) for 5 min. The excess of counterstain was washed off 
under running tap water for 5 min and sections were subsequently dehydrated and mounted as 
described in section 2.4.9. 
Tissue sections were assessed for the presence of positive staining and the number of goblet 
cells was scored in 50 crypt-villi for each animal. The average number of goblet cells per half 
crypt-villus axis was calculated for each animal and further analysed as described in section 
2.7.  
2.3.3.4 Grimelius staining 
Enteroendocrine cells have been identified within the intestinal epithelium using Grimelius 
staining which detects argyrophilic cells. Prior to the beginning of staining, all glassware to 
be used was carefully rinsed 3 times in ultrapure double-distilled (dd) H2O. Slides with tissue 
were dewaxed and rehydrated as described in section 2.4.1. The silver solution was prepared 
by dissolving 1% (w/v) silver nitrate (Sigma) in Acetate buffer pH5.6 (0.02M Acetic acid 
(Fisher Scientific), 0.02M sodium acetate (Sigma) in ddH2O) and heated to 65°C in a Coplin 
jar in the water bath. Tissue sections were subsequently inserted, Coplin jar was sealed and 
wrapped in tin foil to avoid any exposure to light, water or steam. Slides were incubated at 65 
°C for 3 hours and then transferred into freshly prepared reducing solution (0.04M sodium 
sulphite (Fisher Scientific), 0.1g hydroquinone (Sigma) in ddH2O) preheated to 45 °C in the 
water bath. Sections were incubated for 5 min or until the tissue developed intensive yellow 
colour. Tissue sections were subsequently dehydrated and mounted as described in section 
2.4.9. 
Grimelius stained tissue sections were examined to identify enteroendocrine cells and the 
number of those cells was scored in 50 half crypt-villi for each animal. The average number 
of enteroendocrine cells per half crypt-villus axis was calculated for each animal and further 
analysed as described in section 2.7. 
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2.3.3.5 Ki67 staining 
Proliferating cells within the tissue have been identified using anti-Ki67 
immunohistochemistry (section 2.4). The numbers as well as position of Ki67 positive cells 
were scored within the intestinal epithelium where the cell position of those cells was 
indicative of the localization and size of proliferative compartment within this tissue. The 
number of proliferating cells was assessed and scored in 50 half crypt-villi per tissue section. 
Furthermore the average number of Ki67 positive cells across those 50 crypt-villi was 
calculated for each animal in that cohort and analysed as described in section 2.7. Position of 
those proliferating cells was counted from the base of the intestinal crypt up all the way up to 
the villus tip where the bottom-most cell was indicated as #1. Ki67 positive cell positions 
from all animals belonging to the same experimental cohort were pooled together and 
analysed as described in section 2.7. 
2.3.3.6 BrdU staining 
5-bromo-2'-deoxyuridine (BrdU) can be incorporated into the newly synthesized DNA of 
replicating cells during the S phase of the cell cycle, substituting for thymidine. By 
performing anti-BrdU immunohistochemistry we are capable of detecting all cells that have 
been actively replicating their DNA. Therefore BrdU as well as Ki67 is a marker of 
proliferating cells however due to being limited to S phase, it is more specific.   
Experimental mice were injected with BrdU at 2 or 24 hours prior to dissection and tissue 
harvest. Staining with anti-BrdU antibody was conducted according to generic protocol 
described in section 2.4. The numbers as well as position of BrdU positive cells at both 2 
hour and 24 hour time point were scored within the intestinal epithelium. This quantification 
allowed for evaluation of overall proliferation activity as well as cell migration within the 
tissue. The number of proliferating cells was assessed and scored in 50 half crypt-villi per 
tissue section. The average number of BrdU positive cells per 50 crypt-villi was calculated 
for each animal in that cohort and analysed as described in section 2.7.  Position of those 
proliferating cells was counted from the base of the intestinal crypt up all the way up to the 
villus tip where the bottom-most cell was indicated as #1. BrdU positive cell positions from 
all animals belonging to the same experimental cohort were pooled together and analysed as 
described in section 2.7. 
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2.3.3.7 Cleaved-Caspase-3 staining 
Immunohistochemistry against cleaved caspase 3 was used to identify apoptotic cells in 
which caspase 3 is activated. Staining with anti-cleaved caspase 3 antibody was conducted 
according to generic protocol described in section 2.4. The number of cells in which positive 
staining was detected was scored in 50 half crypt-villi per tissue slide. The average number of 
apoptotic cells per half crypt-villus axis was calculated for each animal and further analysed 
as described in section 2.7.   
2.4 Immunochistochemical staining (IHC) 
 
2.4.1  Dewaxing and rehydrating of tissue sections 
The tissue sections were dewaxed by the immersion 2 x 5 min in the xylene (Fisher 
Scientific) followed by the series of rehydration steps in decreasing concentration of ethanol 
(Fisher Scientific): two 3 min immersions in 100%, one 3 min immersion in 95% and one 3 
min immersion in 70% ethanol. After the slides have reached 70% ethanol they were 
transferred into dH2O prior to antigen retrieval step. 
2.4.2 Antigen retrieval 
Depending upon the primary antibody used as well as how long time ago the sections were 
cut, different methods of antigen retrieval were applied. All of those have involved using 
citrate buffer: either 1X Citrate Buffer (LabVision) or custom-made citrate buffer (10 mM 
sodium Citrate (Sigma) at pH 6.0). Most commonly applied method of antigen retrieval 
involved boiling water bath where the Coplin jar (R.A. Lamb) filled up with citrate buffer 
was placed in cold water bath and then gradually heated up to 100 °C. Once this temperature 
was reached the dewaxed and rehydrated sections were immersed in the pre-heated buffer 
and incubated at this temperature for a time specified in the protocol (Table 2.3). Another 
method involved using microwave either using a plastic box or pressure cooker to pre-heat 
the citrate buffer for 5 min at 900 W. Once pre-heated the slides were submerged in the 
buffer and incubated for 3 cycles of 5 min at 300 W with occasional shaking of the rack 
containing sections. For the pressure cooker, after the slides were immersed in the heated 
buffer, the pressure cooker lid was firmly closed and short cycle of 2 min at 900 W was 
applied until we have observed the rise in pressure in the pressure cooker, followed by 
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decrease in the power to 300 W for the remaining 15 min of the antigen retrieval cycle. After 
the antigen retrieval process was complete, the slides were left in the citrate buffer to cool 
down for minimum 30 min. Slides were briefly washed in dH2O followed by 3 x 5 min 
washes in wash buffer: either 1X TBS (Sigma) or 1X PBS (Invitrogen) in dH2O with 0.1% 
(v/v) TWEEN-20 (Sigma) according to the protocol (Table 2.3).  
2.4.3 Endogenous peroxidise activity block 
The activity of endogenous peroxidises was blocked by incubating tissue sections with 
hydrogen peroxide. Depending upon the particular primary antibody used, different 
concentrations and incubation times have been used indicated in Table 2.3. Either 
commercial peroxidise block solution (Envision+Kit, DAKO) or 30% hydrogen peroxide 
(Sigma) diluted to an appropriate concentration in distilled water. In cases when ready-made 
peroxidise block was used, the excess of wash buffer was removed by tapping dry, tissue area 
is circled with water-resistant pen and placed in the humidified slide chamber and tissue was 
overlaid with enough solution. Otherwise when using hydrogen peroxide made up from 30% 
stock solution, slides were placed in the Coplin jars containing enough solution to fully cover 
the tissue. After slides were incubated for required amount of time with blocking solution, the 
solution was removed and washed 3 x 5 min in wash buffer.  
2.4.4 Non-specific antibody binding block 
In order to reduce the non-specific antibody binding, tissue sections were incubated with 
normal serum (DAKO) or BSA (Sigma) which was diluted to a correct concentration in wash 
buffer.  The specific blocking agent, its concentration and incubation time in regards to 
particular primary antibody is detailed in Table 2.3.  
Generally, the serum from the species that secondary antibody was raised is used prior to 
primary antibody incubation (i.e. if a secondary antibody was raised in goat, normal goat 
serum is used as block against non-specific binding). In cases when peroxidise block was 
performed using 30% stock solution, the tissue sections were circled with water-resistant pen 
prior to covering the slide surface with 200 μl of blocking solution and incubating for time 
indicated in Table 2.3.  
2.4.5 Primary antibody 
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Subsequent step after incubation is the removal of blocking serum and 200 μl of primary 
antibody diluted in the blocking serum solution was directly overlaid without washing 
sections in wash buffer. The dilution and incubation time and temperature for particular 
antibodies are outlined in Table 2.3. After the incubation, the tissue sections were washed 3 x 
5 min in wash buffer.  
 
2.4.6 Secondary antibody 
The slides were removed from Coplin jars and placed in the humidified chamber and 200μl 
of an appropriate secondary was applied.  
Depending whether the signal amplification was necessary for the specific protocol, different 
types of secondary antibodies were used. When signal amplification was needed, an 
appropriate biotinylated secondary antibody (DAKO) was diluted 1:200 in blocking serum 
solution.  Otherwise, an appropriate Horseradish peroxidase (HRP) conjugated secondary 
antibody (Envision+Kit, DAKO) was applied directly onto the slides. 
Detailed information about secondary antibodies applied and their incubation times is 
provided in Table 2.3. After the incubation, slides were washed 3 x 5 min in wash buffer.  
 
2.4.7 Signal amplification 
For those primary antibodies where Envision+Kit (DAKO) could not be used additional step 
including signal amplification was introduced into the protocol. The Avidin-Biotin Complex 
reagent (Vectastain ABC kit, Vector labs) was prepared as indicated by the manufacturer’s 
instructions 30 min prior to application and stored at room temperature. Tissue was then 
covered with 200 μl of ABC reagent and left for 30 min incubation at room temperature, 
followed by 3 x 5 min washes in wash buffer. 
 
2.4.8 Signal visualisation using DAB  
Primary antibody binding was visualised by colourimetric detection with 3,3'-
diaminobenzidine (DAB). Tissue sections were removed from humidified chamber and 
placed on the blue tissue roll and then covered with 200 μl of DAB solution (2 drops of DAB 
chromogen in 1 ml of DAB substrate (Envision+ Kit, DAKO)). Slides were incubated for 5-
10 min until a sufficient level of staining was obtained followed by a 5 min wash in dH2O. 
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2.4.9 Counterstaining, dehydration and tissue mounting 
Tissue sections were placed in the slide wrack and counterstained in Mayers Haemalum 
(R.A. Lamb) for 1 min and subsequently washed under running tap water for 5 min. Slides 
were then transferred into 70% ethanol and dehydrated by consecutive washes in increasing 
concentrations of ethanol (1 x 3 min 70%, 1 x 3 min 95%, 2 x 3 min 100%) and 2 x 5 min 
washes in xylene until the tissue was mounted using DPX (R.A. Lamb). 
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Table 2.3 Antibody-specific conditions for immunohistochemical staining 
Primary 
antibody 
Manufacturer Antigen retrieval Non-specific 
staining block 
Wash 
Buffer 
Primary antibody 
incubation 
Secondary antibody Signal 
amplification 
Anti-β-
catenin 
BD Transduction Labs 
#610154 
20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
Peroxidase block 
(DAKO) 5 min, RT; 
10% NRS, 30 min, 
RT 
3 x 5 min 
TBS/T 
1:300 in 10% NRS o/n, 
4°C 
Envision + HRP-
conjugated anti-mouse 
(DAKO), 30 min, RT 
N/A 
Anti-BrdU BD Biosciences #347580 20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
Peroxidase block 
(DAKO) 5 min, RT; 
1% BSA, 30 min, RT 
3 x 5 min 
PBS/T 
1:150 in 1% BSA, 1h, RT Envision + HRP-
conjugated anti-mouse 
(DAKO), 30 min, RT 
N/A 
Anti-Brg1 Santa Cruz (G-7): sc-
17796 
20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
Peroxidase block 
(DAKO) 5 min, RT; 
10% NRS, 30 min, 
RT 
3 x 5 min 
TBS/T 
1:200 in 10% NRS o/n, 
4°C 
Envision + HRP-
conjugated anti-mouse 
(DAKO), 30 min, RT 
N/A 
Anti-Brm Santa Cruz (N-19): sc-
6450 
20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
Peroxidase block 
(DAKO) 5 min, RT; 
5% NRS, 30 min, RT 
3 x 5 min 
TBS/T 
1:200 in 10% NRS o/n, 
4°C 
Biotinylated anti-goat 
(DAKO), 1:200 in 10% 
NRS, 30 min, RT 
ABC Kit 
(Vector Labs) 
Anti-CD44 BD Pharmigen #550538 20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
1.5% H2O2, 15 min, 
RT; 10% NRS, 30 
min, RT 
3 x 5 min 
TBS/T 
1:50 in 10% NRS, 1h, RT Biotinylated anti-rat 
(DAKO), 1:200 in 10% 
NRS, 30 min, RT 
ABC Kit 
(Vector Labs) 
Anti-
Cleaved 
Caspase 3 
Cell Signalling 
Technology #9661 
Boil in PC, 15 
min under 
pressure, citrate 
buffer (Thermo) 
3% H2O2, 10 min, 
RT; 5% NGS, 1h, RT 
3 x 5 min 
TBS/T 
1:200 in 5% NGS, 2 days, 
4°C 
Biotinylated anti-rabbit 
(DAKO), 
1:200 in 5% NGS, 30 
min, RT 
ABC Kit 
(Vector Labs) 
Anti-Hes5 Millipore: AB5708 20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
Peroxidase Block 
(DAKO) 5 min, RT; 
5% NGS, 30 min, RT 
3 x 5 min 
TBS/T 
1:200 in 5% NGS, o/n, 
4°C 
Envision + HRP-
conjugated anti-rabbit 
(DAKO), 1h, RT 
N/A 
Anti-Ki67 Vector Labs #VPK452 20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
0.5% H2O2, 20 min, 
RT; 20% NGS, 30 
min, RT 
3 x 5 min 
TBS/T 
1:20 in 20% NRS o/n, 4°C Biotinylated anti-
mouse (DAKO), 
1:200 in 20% NGS, 30 
min, RT 
ABC Kit 
(Vector Labs) 
Anti-
Lysozyme 
Neomarkers #RB-372-A 20 min, 100°C, 
WB, citrate buffer 
(Thermo) 
1.5% H2O2, 15 min, 
RT; 10% NGS, 30 
min, RT 
3 x 5 min 
TBS/T 
1:100 in 10% NGS, 1 
hour, 4°C 
Envision + HRP-
conjugated anti-rabbit 
(DAKO), 30 min, RT 
N/A 
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2.5 Gene expression analysis 
During all procedures involving RNA handling and processing additional care was taken to 
ensure that all plasticware and glassware was RNA free. All solutions used within the 
protocol were prepared using RNAse free water (Sigma) and sterile filter-tips were used 
throughout.    
2.5.1 RNA extraction from tissue  
 
2.5.1.1 Homogenisation of tissue 
Frozen at -80 °C tissue samples were removed and adequate amount was placed in screw-cap 
tubes containing 1.4 mm ceramic beads (Lysing matrix D tubes, MP Biomedical) overlaid 
with 1 ml Trizol (Invitrogen). Prepared samples were homogenised in the Precellys24 
homogeniser (Bertin Technologies) at 6500 RPM for 2 x 45 second cycles followed by the 
centrifuging of tubes at 11000 x g for 10 min at 4 °C. The centrifugation step is necessary in 
order to pellet the ceramic beads and tissue debris created during homogenisation.    
 
2.5.1.2 RNA extraction 
The supernatant created after centrifugation was carefully transferred without disturbing 
ceramic beads into a fresh 1.5 ml eppendorf tubes and 200 μl of pre-cooled on ice chloroform 
(Fisher Scientific) was added. The contents of tubes were shaken vigorously for 30 seconds 
and allowed to stand at room temperature for 3 min. All eppendorf tubes were centrifuged at 
11000 x g for 15 min at 4 °C. The top, aqueous phase (approximately 500 μl) containing 
RNA was transferred into fresh eppendorf tubes containing 500 μl of isopropanol. Tubes 
were gently inverted until all contents mixed well and incubated at 4 °C over night. The 
following day tubes were centrifuged at the maximum speed for 15 min at room temperature. 
The supernatant was carefully discarded and the pellet was washed with 500 μl pre-cooled 
70% ethanol. The tube contents were centrifuged at the maximum speed for 5 min at room 
temperature and the resulting supernatant was removed leaving the pellet to air dry for 5-10 
min. The pellet was then dissolved in 20 μl of RNAse free H2O (Sigma), placed on the heat 
block at 65 °C for 10 min followed by quenching on ice. While sample were on the ice, the 
purity and concentration of extracted RNA was determined using NanoVue Plus (GE 
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Healthcare). RNA samples were stored at -80 °C with exception of 10 μg of RNA which 
underwent further DNase treatment.  
 
2.5.1.3 DNase treatment of RNA samples 
DNase treatment of extracted RNA was performed using RQ1 RNase-Free DNase (Promega) 
according to the protocol described at: 
http://www.promega.co.uk/~/media/Files/Resources/Protocols/Product%20Information%20S
heets/G/RQ1%20RNase-Free%20DNase%20Protocol.pdf.  
For each digestion reaction 10 μg of extracted RNA was used and mixed with 10 μl of RQ1 
RNase-Free DNase, 5 μl of RQ1 RNase-Free DNase 10X Reaction Buffer and made up to 50 
μl with RNAse free H2O (Sigma). The contents of tubes were placed on the heating block at 
37 °C for 30 min followed by addition of 5 μl of RQ1 DNase STOP Solution to terminate the 
DNAse digestion reaction. Tubes were incubated on the heating block at 65 °C for 10 min in 
order to inactivate the DNase. All samples were quenched on ice and the purity and 
concentration of DNAse-treated RNA was determined using NanoVue Plus (GE Healthcare). 
RNA samples were stored at -80 °C until needed.  
 
2.5.1.4 Determining of RNA quality  
The quality of total RNA extracted – its integrity and some initial information about the yield 
was assessed by elecrophoresis on a denaturing agarose gel as described in Qiagen Bench 
Guide (Qiagen). The aliquot of RNA samples containing 2 μg of RNA were mixed with an 
appropriate amount of RNA 5X buffer (0.25% Bromophenol blue (Sigma), 4 mM EDTA 
(Sigma), 0.9 M formaldehyde (Sigma), 20% glycerol (Sigma), 30.1 % formamide (Sigma), 
4X FA gel buffer (instructions bellow)). Samples were incubated at 65 °C for 3-5 min, 
quenched on ice, followed by loading onto a denaturing agarose gel (1% agarose 
(Eurogentech), in 1X FA gel buffer (20 mM 3-(N-Morpholino) propanesulfonic acid (MOPS, 
Sigma), 5 mM sodium acetate (Sigma), 1 mM EDTA (Sigma), 0.22 M formaldehyde 
(Sigma), 0.1 μg/ml Ethidium bromide (Sigma) in dH2O)). Prepared gel was run in FA gel 
running buffer (20 mM 3-(N-Morpholino)propanesulfonic acid (MOPS, Sigma), 5 mM 
sodium acetate (Sigma), 1 mM EDTA (Sigma), 0.25 M formaldehyde (Sigma) in dH2O) at 50 
V for 1 hour. RNA products were visualised in UV light using ChemiDoc MP apparatus 
(BioRad). Intact total RNA run on a denaturing gel should result in clear and sharp 28S and 
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18S ribosomal RNA bands therefore the gel was carefully assessed for the presence of 
appropriate ratio between 28S rRNA band and 18S rRNA band intensiveness and lack of any 
smeared RNA bands. 
 
2.5.2 Preparation of cDNA   
cDNA synthesis was performed using Superscript III Reverse Transcriptase (Invitrogen) 
according to the protocol described at 
http://tools.lifetechnologies.com/content/sfs/manuals/superscriptIII_man.pdf 
 
First-strand cDNA synthesis was done in strip tubes where 2 μg of total RNA was mixed with 
0.5 μl of 500 ng/μl random primers (Promega), 1 μl of 10 mM dNTPs (Bioline) and made up 
to 13 μl with DNAse free H2O (Sigma). Prepared reaction volume was incubated at 65 °C for 
5 min and then quenched on ice for at least 1 min. The contents of tubes were briefly 
centrifuged to collect all the volume to which 7 μl enzyme mix was added (4 μl 5X First 
Strand Buffer, 1 μl 0.1 M DTT, 1 μl RNAse-free H2O (Sigma), 1 μl SuperScript III RT (200 
units/μl) per each reaction strip tube. All contents of tubes were gently mixed by pipetting 
and incubated at 25 °C for 10 min, 50 °C for 1 hour, 70 °C for 15 min and held at 4 °C. At 
the end of the incubation 20 μl of DNAse free dH2O was added to 20 μl volume of reaction 
and 1 μl of the resulting cDNA was used per reaction in quantitative RT-PCR. Negative 
control cDNA samples were synthesised in the same manner as mentioned above however no 
Superscript III enzyme was added to the enzyme mix. 
 
2.5.3 Quantitative real-time PCR analysis  
 
2.5.3.1 Primer design 
Primers used for qRT-PCR analysis that have not been previously published were designed 
using Primer3 software (http://fokker.wi.mit.edu/primer3/input.htm). Moreover BLAST 
engine (http://www.ensembl.org/Multi/blastview) was used to check for any mispriming of 
those primers followed by primer synthesis by Sigma Genosys. Therefore while designing 
and selecting for sets of primers some general guidelines were followed. The primers have to 
be specific to the target gene with no amplification of pseudogenes or other related genes. 
The primer should span one or more introns to avoid amplification of sequences in genomic 
DNA. In order to obtain the most efficient and the most consistent results amplicons were 
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designed to yield PCR products of 100 – 200 bp. The annealing temperature should be 
between 58–60°C. 
All primers designed should be tested to select the ones that have the highest signal-to-noise 
ratio. The primer and probe sequences used for qRT-PCR are listed in Table 2.4.  
 
 
Table 2.4 Primer and probe sequences for qRT-PCR analysis 
Name Forward primer Reverse primer 
Brm CGGGATGTGGACTACAGTGA AGCCGTACCTCCTCTTCCAT 
Brg1 Probe pre-designed cat n: 4331182 Probe pre-designed cat n: 4331182 
β-catenin AGTCCTTTATGAATGGGAGCAA TCTGAGCCCTAGTCATTGCATA 
c-Myc CTAGTGCTGCATGAGGAGACAC GTAGTTGTGCTGGTGAGTGGAG 
CD44 ATCGCGGTCAATAGTAGGAGAA AAATGCACCATTTCCTGAGACT 
Cyclin D1 ACGATTTCATCGAACACTTCCT GGTCACACTTGATGACTCTGGA 
E-cadherin CAGATGATGATACCCGGGACAA GGAGCCACATCATTTCGAGTCA 
Hes1 TCATGGAGAAGAGGCGAAGG GGTTCCGGAGGTGCTTCAC 
Hes5 TCAGCTACCTGAAACACAGCA TAGTCCTGGTGCAGGCTCTT 
Math1 ATGCACGGGCTGAACCA TCGTTGTTGAAGGACGGGATA 
 
 
2.5.3.2 Setting up of qRT-PCR reaction 
Reactions set up in the 96-well plate were run on StepOnePlus real-time PCR system 
supplemented with StepOne software version 2.2.2 (Applied Biosystems) whereas reactions 
loaded onto 384-well plate were run on QuantStudio 7 Flex aided with QuantStudio 6 and 7 
Flex Real-Time PCR System Software version 1.0. All reactions were run as triplicates and 
minimum of four biological replicates were run per each qRT-PCR. Samples lacking cDNA 
were set up as negative controls in order to be able to detect possible contamination or non-
specific amplicon in the reaction. β-actin housekeeping gene was used as a reference gene for 
each qRT-PCR run.  
All qRT-PCR reactions were run using either Fast SYBR Green Master Mix (Applied 
Biosystems) or TaqMan Universal PCR Master Mix (Applied Biosystems) according to the 
manufacturer’s instructions in the 384-well PCR plate (Applied Biosystems). TaqMan assay 
was specifically used for intestinal stem cell markers such as Ascl2, Lgr5 and Olfm4 where 
instead of primers, custom designed TaqMan probes for those stem cell markers were used. 
Each TaqMan probe comprises oligonucleotide with a reporter dye at its 5’ end and a 
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quencher dye at its 3’ end. During the reaction, TaqMan probe undergoes cleavage by 
AmpliTaq Gold DNA Polymerase which results in separation of dyes at their respective ends 
of the probe and consequently increases the fluorescence of the reporter. This increase in 
reporter florescence is recorded as it is a direct indication of the amount of PCR product that 
becomes accumulated (Figure 2.2). In contrast, the SYBR Green assay takes advantage of the 
chemistry of SYBR Green I dye as a way of detecting the PCR product due to the binding of 
this dye to the newly generated double-stranded DNA (Figure 2.2).  The primer sequences 
and probes used for qRT-PCR reactions using SYBR Green and TaqMan assay are indicated 
in Table 2.4. For all reactions using SYBR Green assay, appropriate forward and reverse 
primers (100 mM) were mixed in equal quantities and further diluted to concentration of 10 
mM with 0.5 μl of this primer mix used for each reaction within the assay.  
Master mix containing 5 μl of either SYBR Green Mix or TaqMan Mix, 4 μl of RNAse-free 
H2O and 0.5 μl of appropriate primer mix (10 mM) or TaqMan probes(10 mM) was prepared 
and each reaction well on the 384-well PCR plate was loaded with 9 μl of this mix. 
Subsequently 1 μl of cDNA was loaded to individual wells and plate was sealed with 
optically clear sealing film (Applied Biosystems). Plate was centrifuged at 8000 RPM for 1 
min.  
All reactions using SYBR Green were run under following thermocycler conditions: 95 °C 
for 10 min followed by 40 cycles (95 °C for 15 seconds, 60 °C for 30 seconds, 72 °C for 30 
seconds). In case of running TaqMan reactions, the cycling conditions were following: 50 °C 
for 2 min, 95 °C for 10 min followed by 40 cycles (95 °C for 15 seconds, 60 °C for 1 min). 
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Figure 2.2 The differences between SYBR Green-based and TaqMan-based qRT-PCR reactions. The diagram 
was taken from  
http://www.lifetechnologies.com/uk/en/home/life-science/pcr/real-time-pcr/qpcr-education/taqman-assays-vs-
sybr-green-dye-for-qpcr.html 
 
  
 
 
2.5.3.3 Analysis of qRT-PCR data 
The data collected automatically by StepOne Software from samples with reproducible cycle 
time (Ct) values were analysed. 
For the data analysis, all Ct values were examined manually from raw data to ensure all 
replicates of the reaction can be used. The difference in the cycle time ΔCt values were 
calculated between cohorts of experimental animals by normalising each reaction to β-actin 
Ct values for that reaction. β-actin was used as a reference gene for all reactions performed 
using either SYBR Green or TaqMan assay. The average ΔCt values were calculated for each 
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cohort of experimental animals and those ΔCt values were tested for significant differences 
using Mann-Whitney U test. In order to compare Ct values of a target gene to β-actin 
reference gene as a fold difference ΔΔCt data for each biological group was further analysed 
using the formula: 2
ΔΔCT
(Livak and Schmittgen, 2001). The data showing fold changes values 
were graphically represented as bar graphs using Microsoft Office Excel.   
 
2.5.4 In situ hybridization 
In situ hybridization method was used as a means of examining the expression of Wnt-
independent intestinal stem cell marker Olfm4 using anti-sense RNA probes for Olfm4 which 
are complementary to the its mRNA sequence and labelled with digoxigenin (DIG). The 
binding of the probe visualised the presence of purple staining within the tissue was detected 
using anti-digoxigenin antibody conjugated to alkaline phosphatase. The probe for Olfm4 was 
a gift from Hans Clevers’s group (Hubrecht Institute, Netherlands). Due to the sensitivity of 
riboprobe all the glassware used in this protocol was treated at 200°C overnight in baking 
oven whereas dH2O was treated with DEPC (Sigma).     
2.5.4.1 Probe synthesis 
The Olfm4 ribeprobe was synthesised through the process of linearisation of plasmid DNA, 
RNA polymerase reaction from the T7 promoter and DIG labelling of probes. 30 μg of 
plasmid DNA was linearised using NotI restriction enzyme (NEB) according to the 
manufacturer’s protocol. Linear DNA required was then extracted using phenol-chloroform 
method (as described in section 2.5.1.2), the concentration was determined using NanoVue 
Plus (GE Healthcare) and dissolved at concentration of 1μg/μl in 10 Mm Tris (pH 8.0). 
Prepared linear plasmid DNA was as a template for probe transcription using T7 RNA 
polymerase (Roche) followed by the DIG labelling of riboprobes. 
The labelling of riboprobes was performed for 2 hours at 37°C using components enlisted in 
Table 2.5. DNA template was DNase treated by incubation with 20 units of DNase I 
(Ambion) for 15 minutes at 37°C followed by the addition of 1μl of 0.5 M EDTA (ph 8.0). 
Ethanol precipitation was performed to purify riboprobes and 10 μl aliquots of those probes 
were stored at -80°C until needed.  
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Table 2.5 Components of probe-labelling reaction 
Compound Volume 
RNase-free H2O 12 μl 
Transcription buffer 10X (Roche) 2 μl 
DIG RNA labelling mix (Roche) 2 μl 
RNA polymerase T7 (Roche) 2 μl 
RNase inhibitor (Promega) 1 μl 
DNA at 1 μg/μl 1 μl 
 
2.5.4.2 Probe hybridization 
Tissue slides were dewaxed in 2 x 10 min xylene followed by the rehydration step involving 
immersion in the decreasing concentrations of ethanol: 2 x 100% for 1 min, 95%, 85%, 75% 
50% and 30% - all for 30 sec. The slides were transferred to 1X saline for 5 min and then 
washed in 1X PBS for 5 min. Endogenous alkaline phosphatase activity was blocked by the 
immersion of slides in 6% hydrogen peroxide solution in 1X PBS for 30 min followed by 
rinsing off in 1X PBS for 5 min. Ice-cold 4% RNase-free PFA (paraformaldehyde (Sigma), 
DEPC H2O, 1 M NaOH in 1X PBS) was used for fixation followed by two washes in 1X PBS 
for 5 min. Next step involved incubation for 5 min in Proteinase K (Roche) (1 M Tris pH 8.0, 
0.5 M EDTA, 20 μg/ml Proteinase K in DEPC H2O) and subsequent two 5 min washes in 1X 
PBS. The disintegration of tissues on the glass slides was prevented by postfixing in ice-cold 
4% PFA for 5 min. The slides were rinsed in DEPC dH2O for 2 min and immersed into TEA 
HCl/acetic anhydrite solution (0.01 M acetic anhydrite (Sigma) in 0.1 M triethanolamine 
hydrochloride (Sigma)) for 10 min. Slides were then washed in 1X PBS for 5 min and 1X 
saline for 5 min followed by the dehydration in preparation for probing in increasing 
concentrations of ethanol: 30%, 50% for 30 sec, 75% for 5 min, 85%, 95% for 30 sec and 
finally twice in 100% for 30 sec. Slides were air-dried for 30-60 min and transferred to dark 
boxes in which overnight incubation of probe was performed. Those boxes were lines with 3 
mm paper saturated with moisture buffer (5X saline sodium citrate buffer (SSC) (Sigma), 
50% v/v formamide (Sigma) in dH2O). The probe preparation included heating of probe at 
80°C for 3 min followed by quenching on ice. Hybridization buffer (5X SCC, 50% 
formamide, 1% SDS, 0.05 mg/ml heparin (Sigma), 0.05 mg/ml calf liver tRNA (Merck) in 
dH2O) was heated to 80°C and then mixed with probe at concentration of 1 μl of probe in 99 
μl of hybridization buffer. Prepared mixture was then added to each slide and parafilm-
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covered to avoid the evaporation. Dark boxes were then sealed with electrical tape and 
incubated at 65°C overnight in the water bath.   
2.5.4.3 Post-hybridization treatment 
Following overnight incubation with probe, tissue slides were incubated in the pre-warmed to 
65°C 5X SSC buffer for 15 min and then immersed twice in pre-warmed solution I (50% 
formamide, 5X SSC, 1% (v/v) SDS(Sigma)) at 65°C for 15 min. Next step involved 3 washes 
at room temperature in solution II (0.5 M NaCl (Sigma), 0.01 Tris pH 7.5 (Sigma), 0.1% 
TWEEN-20 (Sigma)) and subsequent digestion of unhybridized probe by incubation with 
RNaseH (Roche) for 45 min at 37°C. A series of washes: two 5 min washes in warm solution 
II at 65 °C followed by another 2 x 30 min in solution III (50% formamide, 5X SSC) at 65°C 
and two 10 min washes in 1X PBS preceded application of DIG-labelled antibody. Slides 
were blocked using 10% heat-inactivated sheep serum (DAKO) in PBS/T for 3 hours. Anti-
DIG antibody (Roche) was pre-absorbed in 1% sheep serum containing 3 mg/ml small 
intestinal powder for 3 hours at 4°C mixed using rotor. The antibody was then diluted to 
1:2000 concentration in 1% sheep serum in PBS/T whereas slides were washed in PBS/T for 
5 min followed by adding of 100 μl of prepared antibody on the top of tissue and overnight 
incubation at 4°C.  
2.5.4.4 Signal detection 
After probe binding and series of post-hybridization washes, the next step involved signal 
detection using BM Purple (Roche). Slides were washed 3 times in PBS/T for 5 min and then 
again washed in PBS/T twice for 30 min. Preconditioning of slides in NTMT (0.1 M sodium 
chloride, 0.1 M Tris pH 9.5, 0.05 M magnesium chloride (Sigma), 0.1% v/v TWEEN-20, 2 M 
Levamisole (Sigma)) by three 5 min washes proceeded applying of BM purple substrate 
(Roche) and incubation in the dark boxes for a required amount of time. Once the desired 
level of signal was detected, slides were washed in PBS/T for 10 min followed by wash in 
dH2O for 30 min. Counterstaining using Eosin Y Solution (Sigma) for 5 seconds was 
followed by rinsing in dH2O for 5 min, air-drying of slides for 30 min, immersion in xylene 
for 10 seconds and finally mounting using DPX mounting media (R.A. Lamb)   
 
  
83 
 
2.6 Protein analysis 
 
2.6.1 Protein extraction from collected tissues  
The samples of selected tissues: small intestine, large intestine and liver were removed from -
80 °C storage and kept on dry ice until ready to be used to avoid defrosting and degradation 
of the tissue. Fresh cell lysis buffer consisting of 1 M Tris-HCl, pH 8.0, 0.5 M EDTA pH 8.0, 
10% NP-40 (Sigma), ddH2O with addition of protease inhibitors (cOmplete Mini Protease 
Inhibitor Cocktail Tablets, Roche) and phosphatase inhibitors (500 mM sodium β-
glycerophosphate (Calbiochem), 0.5 M sodium fluoride (Sigma), 200 mM sodium 
pyrophosphate (Sigma), 20 μM Calyculin A from Discodermia calyx (Sigma)) was prepared 
prior to the extraction of the protein. 200 μl of ice cold lysis buffer were aliquoted into 
SpinLyse tubes placed on ice, tissue samples were briefly removed from dry ice and small 
pieces of frozen tissue were dropped into prepared tubes. All tubes were placed in Precellys 
homogeniser and span at maximum setting (2 cycles of 45 sec at 6500 RPM). Once the froth 
was settled out, the cell lysate was transferred into fresh eppendorf using 1 ml syringe and 
23G needle and passed through needle 5-8 times. The tubes were briefly placed on ice prior 
to being centrifuged in the pre-cooled centrifuge at 13.3 x g for 10 min at 4 °C. The obtained 
supernatant was transferred into a fresh eppendorf and centrifuged at the same settings again 
in order to remove any insolubles. The collected supernatant was aliquoted into three separate 
0.5 ml tubes: 10 μl for protein assay, 100 μl and all remaining volume of cell lysate which 
were snap frozen in liquid nitrogen and stored at -80 °C.  
2.6.2 Quantification of protein concentration   
To determine the protein concentration in the extracted tissue sample I have used Pierce BCA 
assay (Thermo Scientific). BSA was provided as a stock solution at 2 mg/ml and was further 
diluted to the concentration of 100 μg/ml in the cell lysis buffer. The serial dilutions of BSA 
(from 5 μg/ml to 35 μg/ml) in 1X PBS along with blank solutions containing 100 μl of 1X 
PBS were loaded in 96-well microtitre plate. 10 μl aliquot of the cell lysate was defrosted on 
ice and serial dilutions (1:100, 1:200, 1:400 in 1X PBS) of the protein were also prepared on 
the plate. All of the solutions: BSA, blanks and protein extracts were loaded in duplicates.  
BCA kit reagents A and B were mixed at the ratio 50:1 and 100 μl of obtained solution was 
added to each well and mixed well by pipetting. The plate was sealed and wrapped in 
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aluminium foil and incubated for 1 hour at 37 °C prior to the plate being read at 590 nm on a 
microplate reader (BioTek). All data were entered in Excel (Microsoft Office 2007) and 
standard curve was plotted on the basis of BSA serial dilutions. In respect to the standard 
curve, the protein concentrations of the extracted tissue samples were calculated together 
with respective volumes of the lysate to contain 30 μg of protein. 
2.6.3 Analysis of protein levels by Western blotting  
 
2.6.3.1 Preparation of protein samples 
Previously frozen and stored at -80 °C protein extracts were placed on ice to defrost. The 
calculated volume of the protein extract to contain 30 μg of protein was removed and 
transferred into fresh 1.5 ml eppendorf. Appropriate amount of cell lysis buffer was added to 
the protein extract to the total volume of 15μl and further 15 μl of 2X Laemmli buffer 
(Sigma) were added. The samples together with molecular weight rainbow marker were 
heated to 95 °C on the heat block for 10 min and then quenched on ice prior to the loading.  
 
2.6.3.2 Casting of SDS-PAGE gels 
SDS-PAGE gels were casted in Mini-Protean III (BioRad) gel casting apparatus using 1.5 
mm spacers. Prior to the gel casting, all casting plates were well washed to remove any 
remaining gel, wiped with 70% ethanol and left to air dry. Depending upon the expected 
molecular weight of the target protein, solutions for resolving gels at different concentrations 
were prepared along with solution for 5% stacking gels according to the Table 2.6.  Once the 
gel casting apparatus was clean and assembles, the required amount of TEMED was added to 
resolving solution and the mixture was immediately poured using stripette in between the 
casting plates up to about 1.5 cm from the top of the short plate. The resolving gel solution 
was overlaid with 1 ml of ddH2O to prevent the gel from drying. The gel was allowed to set 
and then the water was drained off onto a tissue paper. TEMED was added and mixed with 
stacking gel solution which was again immediately poured into the gel cast until it was 
overflowing the edge between two plates. The 1.5 mm 10-well comb was carefully inserted to 
avoid any bubbles to be formed and the gel was left to set. Once completely set, the plates 
containing gels were removed from the gel casting apparatus and kept wrapped in cling film 
to avoid drying and shrinking of gel.  
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Table 2.6 Gels and solutions used for quantitative protein analysis by Western blotting  
10% resolving polyacrylamide gel (2 gels) 5% stacking polyacrylamide gel (2 gels) 
6.8 ml dH2O 6.9 ml dH2O 
8.4 ml 30% acrylamide/bisacrylamide (Sigma) 1.7 ml 30% acrylamide/bisacrylamide (Sigma) 
9.4 ml 1 M Tris-HCl pH 8.8 1.3 ml 1 M Tris-HCl pH 6.8 
250 μl 10% (w/v) SDS (Sigma)  100 μl 10% (w/v) SDS (Sigma)  
72 μl 25% (w/v) Ammonium persulphate (Sigma) 66 μl 25% (w/v) Ammonium persulphate (Sigma) 
13.2 μl N, N, N, N-tetramethylethylenediamine 
(TEMED, Sigma) 
13.2 μl N, N, N, N-tetramethylethylenediamine 
(TEMED, Sigma) 
 
5X Running Buffer 1X Transfer Buffer 
950 ml dH2O 800 ml dH2O 
15.1 g Tris base  2.9 g Tris base  
94 g Glycine  14.5 g Glycine  
50 ml 10% (w/v) SDS (Sigma)  100 ml Methanol (Fischer)  
 
2.6.3.3 Protein separation using SDS-PAGE gels 
The pre-casted gels were assembled onto the Mini-Protean III (BioRad) electrophoresis tank 
which was filled with 400 ml of 1X running buffer (Table 2.6). The combs were carefully 
removed from the gels and each well was rinsed with running buffer by repeated pipetting up 
and down to remove any unwanted pieces of the gel. Full-range Rainbow molecular weight 
marker (Amersham), cell lysate control and prepared protein samples were loaded into the 
appropriate wells. Gels containing 7% or 10% resolving gel were run at 130V and 15% gels – 
at 200V until the dye run out of the end of the gel. 
2.6.3.4 Protein transfer onto nitrocellulose membrane 
As soon as the protein elecrophoresis was completed the gels were released from the plates 
and submerged in the transfer buffer (Table 2.6). The wet electroblotting system (Flowgen 
Biosciences) was placed in the polystyrene box filled up with ice ready for the assembly. The 
blots were set up by placing a pre-soaked in transfer buffer elements on the top of plastic blot 
holder in the following order: sponge, 2 sheets of 3 MM blotting paper (Whatman) and the 
gel. The Amersham Hybond-ECL nitrocellulose membrane (GE Healthcare) was carefully 
placed on the top of the gel to avoid any air bubbles followed by another 2 sheets of blotting 
paper, sponge and plastic blot holder.  All assembled blots were placed into the 
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electroblotting tank in a correct orientation and filled up with transfer buffer. The transfer 
was run at 100V for 1 hour for all target proteins with exception to Brg1 run for 18 hours at 
65 mA.  
2.6.3.5 Generic protocol for membrane probing 
Once the transfer was completed, the membrane was removed from the sandwiched elements 
of blots and placed in the vessel to be blocked in 5% milk powder in TBS/T for a minimum 
of 1 hour at RT with agitation. Primary antibodies were diluted according to the manufacturer 
recommendations in 5% blocking buffer or 1-5% BSA in TBS/T and the membrane was 
incubated with the antibody with agitation in the conditions specified in the Table 2.7. At the 
end of incubation with primary antibody, the membrane was removed and washed 3 x 15 min 
in TBS/T. Remaining primary antibody was placed in the Falcon tube and frozen at -20°C to 
be re-used in future experiments. Secondary HRP-conjugated antibody was diluted in the 
blocking buffer (Table 2.7), applied on to the membrane and incubated with agitation. The 
secondary antibody was poured off and the membrane was washed 3 x 15 min in TBS/T. The 
membrane was drained off the excess TBS/T and appropriate ECL detection reagent kit 
(Amersham) was used according to manufacturer’s instructions to develop the membrane 
depending on the abundance of the target protein and the specificity of primary antibody 
used. After the incubation with ECL reagents, the membrane was briefly drained and placed 
in the plastic pocket inside of the cassette ensuring no air bubbles formed between the 
membrane and the pocket. 
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Table 2.7 Outline of antibody-specific conditions for Western blotting 
Primary 
antibody 
Manufacturer Primary Ab 
conditions 
Secondary Ab conditions 
Anti-active-β-
catenin  
Millipore clone 
8E7; #05-665 
1:2000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-mouse (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-total-β-
catenin 
Cell Signalling; 
#9562 
1:3000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-rabbit (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-Brg1 Santa Cruz (G-7); 
#sc-17796 
1:200 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-mouse (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-Hes1 Millipore; #ab5702 1:1000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-rabbit (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-Hes5 Millipore; #ab5708 1:2000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-rabbit (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-Math1 Abcam; C-terminal 
#ab137534 
1:1000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-rabbit (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-Notch1 ICD Abcam; # ab8925 1:500 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-rabbit (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
Anti-β-actin Sigma; A5316 1:5000 in 5% milk in 
TBS/T; o/n at 4°C 
HRP-conjugated anti-mouse (GE Healthcare) 
1:2000 in 5% milk in TBS/T, 1h at RT 
 
2.6.3.6 Signal detection  
Enhanced chemiluminescent (ECL) signal produced by the secondary antibody-bound HRP 
enzyme was detected by radiograph exposure. The piece of X-ray film (FujiFilm Super RX 
blue background) was exposed to the blots in the dark room for various amounts of time until 
we obtained good quality images. The exposed film was fed into and processed by an 
automatic X-ray film processor (Xograph Compact X4). Processed films were placed back in 
the cassette containing the original blot as the identification of target protein is possible after 
correct labelling of the position of molecular weight markers on the film and comparing it to 
expected molecular weight described by the primary antibody manufacturer. The membrane 
was washed 3 x 15 min in TBS/T, placed in 50 ml Falcon tube of TBS/T and stored at 4 °C 
until needed again. 
2.6.3.7 Evaluation of protein levels and densitometry analysis  
Each membrane probed with specific target antibody was then re-probed with β-Actin 
antibody, a house keeping gene to ensure the equal loading of the extracted proteins. The 
processed film were scanned using GelDoc and assess by densitometry using ImageJ. The 
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amount of the target protein was normalized to the levels of β-Actin which ensures that any 
errors can be corrected for. The quantity of protein was represented as a percentage relative to 
control.  
2.7 Statistical and quantitative analysis of data 
 
2.7.1 Quantitative analysis of histological traits 
Histological quantification of stained tissue sections was carried out using an Olympus BX43 
light microscope. Initially the tissue of interest was assessed for sectioning artefacts and 
regions of epithelium to be scored were carefully selected as means to maintain consistency 
of quantification where proximal ends of both small and large intestine were chosen for the 
analysis. All histological traits that were quantifiable such as crypt length, villus length, 
number of proliferating and apoptotic cells, number of differentiated cells were scored on the 
appropriately stained tissue slides. Minimum of 50 crypts or 50 crypt-villi were assessed per 
mouse and at least 4 experimental animals of the same genotype were analysed. Individual 
scores for crypt or crypt-villus were totalled and averaged out to generate the values per 
mouse. Furthermore the scores from all animals of the same genotype were used to generate 
the score per experimental cohort and standard deviation for that experimental group. This 
data were represented as histograms where the average score for experimental cohort was 
plotted together with error bars representing standard deviation for that group. The values per 
mouse have been used to test the significance difference between the averages for particular 
experimental groups. Microsoft Office Excel 2007 was primary program used to graphically 
present the data.  
 
2.7.2 Comparison of means 
Initially all quantifiable data were tested for normal distribution using the R statistical 
software. Normally distributed data was then tested for significant difference between 
averages of experimental groups using One-Way ANOVA in SPSS software (IBM SPSS 
Statistics 20). In cases where more than two experimental cohorts were compared, in addition 
to One-Way ANOVA, Post-Hoc Tukey’s test was used to make pair-wise comparisons 
between those cohorts.   
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Data that have been initially found not to be normally distributed were tested for significant 
difference using Mann-Whitney U test.  
All mentioned above statistical tests were performed using SPSS software and a significant 
difference between the means was accepted if p value was equal or less than 0.05. Statistical 
significance of the data was indicated on the histograms representing that data by “*” symbol 
where p value was equal or less than 0.05. 
2.7.3 Kolmogorov-Smirnov Z Test 
Differences in the distribution between two data sets were tested using Kolmogorov-Smirnov 
Z test. Datasets tested included cell types such as distribution of Paneth cells as well as some 
histological traits like proliferation markers such as BrdU positive and Ki67 positive cells. 
Positions of the above mentioned cells were recorded in a specific manner in a Microsoft 
Office Excel spreadsheet where each half crypt-villus structure was represented as a single 
column of ascending numbers. Cells were counted from the base of the intestinal crypt with 
the bottom-most cell was indicated as #1, all the way up to the villus tip where each particular 
row meant cell position within half crypt-villus counted. Positive cells were recorded as 1 
whereas negative cells were recorded as 0 for 50 half crypt-villi per experimental animal. For 
each row corresponding to cell position, the sum was calculated per mouse and then all those 
sums from animals belonging to the same experimental cohort were pooled together. The 
pooled data were used in SPSS (IBM SPSS Statistics 20) to construct graph of cumulative 
frequency of positive cells. 
 
In order to be able to test for the difference in a distribution between different cohorts of 
experimental animals, data recorded and pooled in the Excel spreadsheet were transformed 
using KST (Kolmogorov-Smirnov Transformation) custom-designed program written by 
Aliaksei Holik (http://bio.bsu.by/t/temp/holik/KST/). The number of instances of positive 
cells at a position was transformed into a sequence of numbers corresponding to this 
particular position which in turn was tested using two-tailed Kolmogorov-Smirnov Z test. A 
significant difference between distributions was accepted if p value was equal or less than 
0.05.  
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2.7.4 Kaplan-Meier survival analysis 
 
Kaplan-Meier method was used for analysis of survival as well as generation of survival 
curves and was performed using SPPS software (IBM SPSS Statistics 20). Cohorts of 
experimental animals were tested for a statistical significance of survival time between 
groups of those animals using Log-Rank test. A significant difference in the survival 
possibility was accepted if p value was equal or less than 0.05.
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Chapter 3 
Investigating the effects of Brm loss in the 
epithelium of small and large intestine 
 
3.1 Introduction 
Subunits of the SWI/SNF chromatin remodelling complex have been implicated in regulating 
transcriptional activation and repression of genes controlling a variety of processes from 
embryonic development to cell apoptosis. Due to the very high sequence homology between 
Brm and Brg1 ATPases (~75%), it was speculated that those subunits might be redundant due 
to sharing of many cellular functions. However numerous studies conducted on both ATPases 
revealed that the catalytic subunits interact with different classes of transcription factors and 
bind different promoters, indicating they are recruited in response to specific signalling 
pathways by unique interactions with different protein domains (Kadam and Emerson 2003). 
As previously mentioned, Brg1 is involved in direct interaction with the Wnt pathway 
through its capacity of regulating Wnt target genes such as Cyclin D1 and CD44, whereas 
Brm exclusively interacts with the ICD22 and CBF-1 elements of Notch pathway (Baker et 
al. 2001, Kadam and Emerson 2002, 2003). This transcriptional specificity discriminating 
between Brm-containing SWI/SNF complexes and Brg1-containing SWI/SNF complexes in 
performing cellular functions has additionally been shown to be tissue-specific. Moreover, 
mouse model studies of loss of either ATPase revealed further differences with Brg1 
emerging as a bona fide tumour suppressor gene whereas Brm loss not being capable of 
inducing tumorigenesis but rather potentiating tumour development when combined with a 
known carcinogen (Bultman et al. 2000, Bultman et al. 2008, Glaros et al. 2008). Specificity 
and often exclusivity of interactions between Brm and Brg1 together with an observation that 
Brg1 is ubiquitously expressed throughout development whereas Brm is expressed at high 
levels in differentiating cells may indicate the possibility that remodelling complexes 
containing a particular ATPase are preferentially recruited to a specific subpopulation of cells 
(Muchardt et al. 1998).  
Considered as putative tumour suppressor genes, both Brm and Brg1 catalytic subunits of the 
SWI/SNF chromatin remodelling complex have been detected to frequently be lost in cancers 
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of the lung, esophagus, pancreas, skin, ovaries and breast (Reisman et al. 2009). However in 
contrast to Brg1, in many types of cancer Brm was found to be epigenetically silenced rather 
than mutated suggesting Brm as a potential therapeutic target (Glaros et al. 2007, Kahali et 
al. 2013). Moreover Brm loss has been correlated to poor prognosis in majority of those 
cancers suggesting that Brm expression may play an important role in modulation of cancer 
phenotypes.  
The intestinal epithelium, due to its complex architecture and dynamic self-renewal, has been 
known to require a complex interplay between signalling pathways such as Wnt, Notch, 
Hedgehog and TGF β/BMP to maintain homeostasis (reviewed in Sancho 2004). More 
importantly, the maintenance of the stem cell niche is highly dependent upon the active 
signalling of Wnt and Notch pathways (Reya and Clevers 2005, Kühl and Kühl 2013) with 
Notch signalling in particular playing an important role in the regulation of cell fate and 
differentiation of intestinal epithelial cells (van Es et al. 2005). Moreover, mouse intestinal 
epithelium is the most commonly used model tissue to study human colorectal cancer.   
In contrast to Brg1, due to the lack of evidence supporting interactions of Brm with the Wnt 
pathway, targeting Brm may have less adverse effects on those of tissues that in a great 
degree are dependent on the active Wnt signalling. To evaluate the capacity of Brm as a 
potential therapeutic target for cancer including colorectal cancer, it appears appropriate to 
investigate the consequences of Brm loss in the normal intestinal epithelium and therefore a 
possible role of Brm in maintenance of its homeostasis. 
This chapter will aim to characterise the effects of Brm deficiency on the small and large 
intestinal epithelium. 
 
3.2 Results 
 
3.2.1 Brm null mice are viable and not prone to tumorigenesis 
Mating of heterozygous mice yielded pups at the expected Mendelian ratio of wild-type, 
heterozygous and homozygous. Further crosses using Brm null mice have resulted in litters of 
normal size with no lethality – pre or post-weaning observed. The viability of Brm null mice 
contrasts to the respective knock-out mouse model of its paralogue, Brg1, as Brg1 null is 
embryonically lethal. However, some fertility issues have been encountered in Brm null mice 
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but this was only in the case of Brm null homozygous breeding couples. Moreover the 
sterility seems to affect males only as approximately 15% of those failed to produce a litter 
over a period of 3 months whereas the coupled Brm null females were successfully producing 
offspring once mated with other homozygous males. The genetic background does not seem 
to affect this partial sterility as all mice used in these studies are of the mixed background.  
Similarly to Reyes et al. we have not observed any differences in the weight of homozygote 
animals in comparison to their wild-type littermates. Brm null mice have been also monitored 
for signs of illness or tumour formation, twice a week for a period of a year but no 
abnormalities were observed.   
3.2.2 The complete loss of Brm in Brm null mice 
Conversely to Brg1 which is expressed in tissues undergoing high cell turnover, Brm is 
actively expressed in low proliferating organs such as brain, liver, fibromuscular and 
endothelial cell. Additionally, in the cell line study by Muchardt et al. (1998) it has been 
observed that non-differentiated cells contain predominantly Brg1 whereas Brm accumulated 
upon in vitro differentiation. Furthermore as mentioned previously the loss of Brm in Brm 
null mice occurred without the need of induction of Cre recombinase as the Brm gene was 
constitutively inactivated (refer to Methods section 2.1.1). A LoxP flanked allele would have 
been preferable for this study, as combined with a Cre recombinase specific for the 
epithelium of the gastrointestinal tract, it would have alleviated any possible effects of Brm 
deficiency in other tissues and systems. However, such a strain does not exist. In order to 
overcome the issues resulting from the very low expression levels of Brm in the small 
intestinal epithelium, liver and spleen were chosen as internal controls of Brm loss in further 
investigation of the expression of Brm in the gastrointestinal tract.  
Firstly, in order to investigate the pattern of expression of Brm in murine tissues, control 
(Brm
+/+
) and Brm null (Brm
-/-
) animals at 70 days of age were sacrificed and a number of 
different organs from the abdominal cavity were taken including stomach, small and large 
intestine, liver, spleen, kidney and bladder. The immunohistochemical analysis of Brm 
expression in various tissues confirmed its complete loss of expression in investigated tissues 
of Brm null animals (Figure 3.1). The presence of a minor population of cells characterized 
by a positive Brm staining in Brm null tissues is due to the cross-reactivity of anti-Brm 
antibody with Brg1. The same experiment showed different patterns of expression of Brm in 
individual organs with no detectable staining within the intestinal epithelium in control mice 
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cohort. The only Brm-positive cells in the small intestine of control animals were present in 
the lamina propria except from some non-specific staining of Goblet cells in both Brm null 
and controls (Figure 3.1d). The nuclear staining of cells of lamina propria was absent from 
tissue sections of Brm null animals. Co-immunofluorescence for Brm and its paralogue Brg1 
in both control and Brm deficient animals further allowed the identification of Brm-
expressing cells as well as the examination of co-distribution of those proteins in the same 
tissue slice (Figure 3.2). Due to the previously detected non-specific staining of some 
differentiated cell types within the epithelium of the small intestine, spleen samples present 
on the same tissue section were treated as internal controls for staining. The staining of spleen 
sections confirmed the presence of nuclear Brm expression in the lymphoid germinal centres 
and sinusoidal cells in red pulp in control animals; a staining pattern which was lost in Brm 
null (Figure 3.2b). As previously observed Brg1 was found to be ubiquitously expressed in all 
epithelial cells of small intestine in both control and Brm null animals (Holik A. unpublished 
observations) (Figure 3.2a). In comparison to Brg1, we have been able to detect Brm 
expression in the small intestinal epithelium of controls for the first time and found it to be 
expressed at very low levels. Brm expression appears to be stronger in stromal cells of the 
lamina propria than in epithelial cells however this positive staining disappeared in the Brm 
null animals with only some non-specific Goblet cell staining still present within the tissue 
samples (Figure 3.2a). Furthermore, no Brm-positive cells were found in the crypts of 
Lieberkühn with the expression being limited to low number of early differentiated or mature 
epithelial cell types.  
Immunohistochemical staining of subsequent tissue sections with Brg1 confirmed the mosaic 
expression of both catalytic subunits of SWI/SNF in control animals (Figure 3.3). In the liver 
of control animals (Figure 3.3a) small neighbouring clusters of Brm and Brg1 positive cells 
were detected. Further immunofluorescence analysis detected very weak immunofluorescent 
signal for both Brm and Brg1 incapacitating the analysis of co-distribution of those proteins 
in the liver cells.  
Brm null animals have an overall higher proportion of Brg1 positive cells than controls 
(Figure 3.3b) which is consistent with previous data (Reyes et al., 1998) showing the 
upregulation of Brg1 in case of Brm loss. However not all of the liver cells are expressing 
Brg1 in case of Brm loss (Figure 3.3a) meaning there are some that are expressing neither of 
the ATPase catalytic subunits. 
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Figure 3.1 The complete loss of Brm in Brm null knock-out mice. Brm null animals along with Brm 
+/+
 controls 
were dissected at 70 days of age. Immunohistochemical analysis of Brm expression revealed 100% loss of Brm 
in all tissues investigated: (A) kidney, (B) liver, (C) spleen and (D) small intestine in comparison to normal 
expression levels of Brm in control cohort. White arrows mark non-specific positive staining of cells whereas 
black arrows positive Brm-specific-stained cells. Some positive non-specific staining was detected in cells of 
secretory lineage in small intestinal sections of both Brm null and control animals. No Brm-stained cells were 
detected in control animals. Scale bar represents 100μm except zoomed sections (x40 mag) (black and red box) 
where scale bar represents 50 μm. 
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Figure 3.2 The expression pattern of Brm in the small intestinal epithelium. Brm null animals along with Brm 
+/+
 
controls were dissected at 70 days of age and immunofluorescent staining was conducted on harvested tissue. 
Blue channel corresponds to DAPI nuclear staining, green channel to Brm staining and red channel to Brg1. (A) 
Immuflourescent analysis of Brm expression revealed 100% loss of Brm in control organ of spleen. However in 
contrast to the small intestinal epithelium, high levels of cross-reactivity between Brm and Brg1 have been 
detected in red pulp of spleen resulting in Brm-positive staining in Brm null tissue (B) Small intestine staining 
revealed lower levels of Brm expression in comparison to spleen. Brm expression levels were low in control 
cohort, limited to few cells and located outside of the crypt compartment. Some positive non-specific staining 
was detected in cells of secretory lineage in small intestinal sections of both Brm null and control animals. Scale 
bar represents 100μm. 
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Figure 3.3 The mosaic expression of Brm and Brg1 in liver. (A) Immunohistochemical analysis of expression 
patterns of Brm and Brg1 on the sequential sections in Brm 
+/+
 animals at day 70 of age revealed a non-
overlapping pattern of nuclear localisation of Brm and Brg1 subunits. White arrows mark individual cells 
stained with anti-Brm antibody whereas black arrows indicate the same cells stained with anti-Brg1 antibody 
present on the serial section of the same tissue (B) Immunohistochemical analysis of Brg1 and Brm in liver 
sections from Brm 
+/+
 control cohort and Brm null cohort shows a higher proportion of Brg1-positive cells in 
Brm null animals in comparison to controls. The scale bar represents 100 μm. 
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On the basis of the immunohistochemical data, I assessed whether the Brm loss affected the 
levels of Brg1 protein in the liver by a western blotting. Previously obtained tissue from the 
livers of control and Brm null mice (n=4) were used for protein extraction and Western 
blotting analysis (Figure 3.4a). Quantitative analysis of those protein samples further 
confirmed the higher levels of Brg1 in Brm null animals in comparison to controls (p=0.03, 
n=8, Figure 3.4b).  
 
 
        wt             wt wt    wt       null           null             null             null 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Brm loss affects the expression levels of Brg1. (A) Western blotting analysis for Brg1 confirmed the 
presence of upregulated levels of Brg1 in Brm null animals in comparison to controls (B) Densitometry was 
carried out to quantify the differences observed. The results were normalised to β-actin loading control and 
represented as a value relative to controls (p=0.03, n=4, Mann Whitney U Test)  
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3.2.3 Brm loss has mild effects on the small intestinal homeostasis 
Although Brm null intestinal epithelium did not show any obvious morphological 
abnormalities that could be assessed on H&E sections, quantitative analysis of histological 
and some basic functional parameters detected some subtle differences between Brm null and 
control animals. The results of quantitative analysis of those histological parameters are 
summarized in Table 3.1. 
Crypt and villus lengths have been assessed on H&E stained sections as the average number 
of cells (± standard deviation) from the bottom of the crypt of Lieberkühn till the crypt-villus 
junction and from the crypt-villus junction till the very top of the villus where the cell 
shedding occurs respectively. Both, crypt and villus size are found to be altered in the Brm 
null small intestinal epithelium with a small increase in crypt length in experimental animals 
versus control (22.56±0.16 and 21.62±0.92, p=0.008, n=8, Figure 3.5a). Conversely, the 
quantification of the villus length showed a small decrease in the villus size (71.67±1.48 and 
73.40±1.48, p=0.03, n=8, Figure 3.5b).  
Both apoptosis and mitosis were scored on the basis of immunohistochemical staining using 
specific markers: Cleaved Caspase-3 for sequential caspase activation cascade in cell 
apoptosis and Ki67 protein expressed in all active phases of the cell cycle except G0. Scoring 
of apoptosis detected a trend of lower apoptosis levels in Brm null mice in comparison to 
control animals. However, the trend was not significant (0.866±0.06 and 0.744±0.33, p=0.17, 
n=8, Figure 3.5c). Quantification of the cells scored as positive for Ki67 marker revealed no 
difference in the levels of proliferation between control and Brm null animals (13.51±0.70 
and 13.40±0.76, p=0.74, n=8, Figure 3.5d). 
A further marker of cell proliferation was used to quantify the number of cells in S-phase of 
the cell cycle. Brm null and control mice were injected with BrdU labelling reagent 2 hours 
and 24 hours prior to dissection and the obtained tissue sections were stained using an anti-
BrdU antibody. In parallel to the previous levels of proliferation detected by Ki67, there was 
no difference between the numbers of BrdU-labelled cells in the half crypt-villus between 
controls and experimental animals at the 2 hour time point (5.07±1.61 and 6.06±0.95, p=0.40, 
n=4, Figure 3.5e). Further, scoring at the 24 hour time point showed the expected, 
approximate doubling of the number of cells in S-phase in comparison to 2 hour time point 
and detected a significant increase in the number of BrdU-positive cells in Brm null animals 
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in comparison to controls (10.15±1.82 and 14.31±2.13, p=0.026, n=4, Figure 3.5e) however 
this result should be considered with a great care due to the significant effect of Brm on the 
crypt length.  
Therefore in the context of complete Brm loss, the quantitative analysis of basic functional 
and morphological factors detected some very mild effects including a small increase in crypt 
length, a decrease in villus length and subtle changes in the shape of the proliferative 
compartment within small intestinal epithelium. However, the intestinal homeostasis appears 
to be maintained and not affected by these small changes.    
 
 
Parameter  Cohort  Mean  SD  p-value  
Crypt length  Control 
Brm null  
21.617 
22.564  
0.92 
0.156  
0.008  
Villus length  Control 
Brm null 
73.402 
71.669  
1.478 
1.476  
0.029  
Caspase 
positive cells  
Control 
Brm null 
0.866 
0.744  
0.061 
0.338  
0.170  
Ki67 positive 
cells  
Control 
Brm null 
13.395 
13.513  
0.762 
0.702  
0.744  
BrdU positive 
cells  
2 hours 
 
24 hours 
 
 
Control 
Brm null 
Control 
Brm null 
 
 
5.070 
6.064 
10.157 
14.305 
 
 
1.605 
0.950 
1.822 
2.131 
 
 
0.400 
 
0.026 
 
Table 3.1 Quantitative analysis of the effects of Brm loss on the small intestinal histology. Epithelium from 
small intestine from Cre
-
 Brm 
+/+
 (marked as Control) and Cre
-
 Brm null (marked as Brm null) was harvested 
from animals at 70 days of age. Histological parameters including crypt and villus length, apoptosis, 
proliferation and BrdU incorporation were quantified and comparison between those two cohorts was conducted 
using statistical software. 
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Figure 3.5 Histological analysis of the effects of constitutive Brm loss in the small intestinal epithelium. Control 
and experimental Brm null animals were harvested at day 70 of age. A-F histological parameters such as (A) 
crypt length (B) villus length were counted on H&E sections for control and Brm deficient animals. The average 
number of (C) Cleaved Caspase 3 (D) Ki67 (E) BrdU 2h and 24h -positive cells was scored on the 
corresponding immunostained sections. Error bars represent standard deviation and asterisk symbol indicates 
those histological parameters that showed a statistically significant difference (p value < 0.05) between cohorts 
of mice. Exact values, standard deviations, p values are provided in Table 3.1 
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3.2.4 Brm loss changes the shape of proliferative compartment in the epithelium of 
small intestine 
The distribution of Ki67 positive cells was analysed to assess any possible changes in the 
shape of the proliferative compartment within epithelium of small intestine. Analysis of the 
cumulative frequency of Ki67 positive cells detected a significant change in the position of 
proliferating cells along the length of the intestinal crypt with a small but significant change 
in Ki67-labelled cells towards the top of the crypt suggesting an increase in activity within 
that region of the epithelium (Kolmogorov-Smirnov Z test, p=0.03, n=8, Figure 3.6).  
  
 
 
Figure 3.6 Immunohistochemical analysis of Ki67 staining of control and experimental animals at day 70 of age 
detected no gross differences in distribution of Ki67-positive cells within the epithelium. Cumulative frequency 
analysis of Ki67 positive cells revealed changes in the shape of proliferative compartment (Kolmogorov-
Smirnov Z test p=0.03, n=8) with an expansion towards the top of the intestinal crypt. Scale car represents 100 
μm.  
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3.2.5 Brm loss does not affect the cell migration in the small intestinal epithelium  
BrdU labelling reagent is used not only as a cell cycle phase-specific proliferation marker in 
addition to Ki67, but also to visualise the migration of the cells within the crypt-villus axis of 
the small intestine. All Brm null and control animals at day 70 of age were administered with 
BrdU by intraperitoneal injection at either 2 hour or 24 hour prior to being sacrificed.  
Immunohistochemistry against BrdU was carried out and the position of all BrdU positive 
cells along a half crypt-villus axis was scored on the small intestinal sections in order to 
assess the effects of Brm loss on the migration capacity of epithelial cells of the small 
intestine. 
The cumulative frequency of BrdU positive cell position at 2 hours prior to dissection showed 
that all of the BrdU labelled cells were confined within the intestinal crypt which is in 
agreement with the existence of proliferation zone. Although there is a trend of BrdU positive 
cells being present in the lower cell positions along the crypt-villus axis in small intestinal 
epithelium of Brm null mice this trend is not significant in comparison to control animals 
(Kolmogorov-Smirnov Z test, p=0.619, n=4, Figure 3.7a).  
BrdU injection 24 hours prior to dissection showed an expansion of the migration area of 
labelled cells within crypt-villus axis outside of the intestinal crypt. Similarly to 2 hours 
experiment, the cumulative frequency of BrdU positive cells at 24 hours revealed a trend of 
BrdU labelled cells being positioned lower within the crypt-villus axis in Brm experimental 
mice compared to controls yet again this trend is not significant (Kolmogorov-Smirnov Z 
test, p=0.281, n=4, Figure 3.7b).   
Although the cumulative frequency curve for both 2 hours and 24 hours appears to be shifted 
suggesting that the migration of the cells along crypt-villus axis is slower in the Brm null, this 
effect is not significant in comparison to control animals.  
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Figure 3.7 Brm deficiency does not affect the population of BrdU positive cells and the migration pattern of 
those cells remains unchanged. Cumulative frequency analysis of BrdU immunostaining 2 hours (A) and 24 
hours  (B) post labelling revealed no significant changes between Brm null and control animals (Kolmogorov-
Smirnov Z test, p=0.619, n=4 and p=0.281, n=4, respectively). 
 
 
3.2.6 Brm loss affects the differentiation of the certain intestinal epithelial cell types 
The network of signalling pathways maintaining the homeostasis in the intestinal epithelium 
is also responsible for regulating cell proliferation and differentiation processes. As 
evidenced before, Brm loss has some effects on the crypt and villus length as well as the 
proliferative compartment in the epithelium. Accordingly, quantitative analysis of the four 
main differentiated cell types found in the small intestinal epithelium was conducted in Brm 
null and control mice at day 70 of age in order to further characterise the effects of Brm loss 
on the maintenance of small intestinal homeostasis.  
Enterocytes are the only differentiated cell type of absorptive lineage nevertheless accounting 
for the majority of the cells present in the villus. To assess the abundance and the distribution 
of enterocytes in the Brm null epithelium, alkaline phosphatase staining was performed, 
which marks brush border of the enterocytes. No difference in the intensity or thickness of 
the staining was observed within the epithelium of Brm null and control animals (Figure 3.8) 
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The most abundant cell type of the secretory lineage in the small intestinal epithelium is a 
goblet cell. Alcian Blue staining was carried out to assess the frequency of goblet cells in the 
small intestine in Brm null and control animals (Figure 3.9). Scoring of the Alcian Blue 
stained cells showed the increase in the number of goblet cells in the experimental animals 
per half crypt-villus in comparison to controls (7.40±0.30 and 6.37±0.19, p<0.0001). 
Another member of the secretory lineage, Paneth cells, are present only in the crypts of 
Lieberkühn. To quantify the numbers of this cell type, lysozyme staining was carried out on 
the sections of small intestinal epithelium (Figure 3.10). The quantification of the Paneth 
cells showed no difference in the number of cells present in the half-crypt between control 
and Brm null animals (1.84±0.26 and 1.73±0.15, p=0.31, n=8). 
Enteroendocrine cells are the final differentiated cell type belonging to the secretory lineage. 
Those cells are identified within the small intestinal epithelium by Grimelius staining as 
enteroendocrine cells take up the silver ions present in the staining solution. Scoring of the 
enteroendocrine cells have detected an increase in the number of cells positively stained with 
Grimelius in Brm null mice compared to controls (2.24±0.05, 2.14±0.08, p=0.009, n=8) 
(Figure 3.11).    
The quantification of differentiated cell types in the small intestinal epithelium revealed that 
Brm loss affects differentiation of two secretory lineages leading to an increase in the number 
of both goblet and enteroendocrine cells.  
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Figure 3.8 Alkaline phosphatase staining detected the normal brush border pattern corresponding to the 
membrane of differentiated enterocytes. The small intestinal sections of control and Brm null mice dissected at 
day 70 of age were stained with chromogen for alkaline phosphatase. Staining revealed no changes in the 
alkaline phosphatase expression in the small intestinal epithelium of control and Brm experimental animals. The 
localisation of differentiated enterocytes and therefore polarisation of the epithelium remains normal in control 
and Brm null cohort. The scale bar represents 100μm.  
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Figure 3.9 Alcian Blue staining was used in order to mark goblet cells within small intestinal epithelium. The 
small intestinal sections of control and Brm null mice dissected at day 70 of age and stained using cell specific 
stain detecting mucin secreting cells. Black arrows indicate individual goblet cells. Staining revealed no changes 
in the localisation of Alcian Blue stained cells in the small intestinal epithelium of control and Brm experimental 
animals. The number of Alcian Blue positive cells increased in Brm null animals in comparison with controls. 
The scale bar represents 100μm.  
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Figure 3.10 Immunohistochemistry against lysozyme was carried out in order to mark Paneth cells within small 
intestinal epithelium. The small intestinal sections of control and Brm null mice dissected at day 70 of age and 
stained using cell specific stain to reveal the number and localisation of Paneth cells. Black arrows indicate 
individual Paneth cells. Staining revealed no changes in the localisation of lysozyme positive cells in the small 
intestinal epithelium of control and Brm experimental animals. Subsequent scoring of Paneth cells showed no 
change in the number of lysozyme positive cells between Brm null and control animals. The scale bar represents 
100μm. 
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Figure 3.11 Grimelius staining of small intestinal sections was carried out to visualize the number of 
enteroendocrine cells on small intestinal sections of control and Brm null mice dissected at day 70 of age. Black 
arrows indicate individual enteroendocrine cells within the epithelium. Staining reveal normal localisation of 
enteroendocrine cells in Brm deficient animals in comparison with controls. The scoring of numbers of cells 
detected significant increase in numbers of enteroendocrine cells in Brm null in comparison to control animals. 
The scale bar represents 100μm. 
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3.2.7 Brm loss does not affect CD44 expression 
Although complete loss of Brm does not have a tumorigenic effect on the small intestinal 
epithelium, immunohistochemical analysis of the Wnt target gene CD44 was conducted on 
the tissue sections from Brm null and control mice harvested when they were 70 days of age. 
Analysis of the CD44 staining in the small and large intestine detected no perceptible 
differences between Brm null and control animals (Figure 3.12a). In contrast, previous data 
from Reisman et al. (2002) showed that Brm loss leads to loss of expression of CD44 in 
multiple organs such as gut epithelium, lungs, brain and liver. The expression levels of CD44 
were assessed by qRT-PCR. mRNA was extracted from small intestinal tissue samples of 
Brm null and control animals at day 70. qRT-PCR analysis of mRNA levels revealed no 
significant changes between Brm deficient and control mice (p=0.29, n=8, Figure 3.12b). 
Given our data contrasted with published report, a collaboration was initiated with Prof 
Bernard E Weissman (Lineberger Comprehensive Cancer Center, University of North 
Carolina, Chapel Hill, North Carolina), co-author of Reisman et al. (2002), which resulted in 
immunofluorescent staining for CD44 of control and Brm null tissue sections sent by myself. 
The staining again showed no difference in CD44 expression in the small intestinal 
epithelium of control and Brm deficient cohorts confirming previously obtained data from 
immunohistochemical staining (Figure 3.13a). Similarly, no substantial differences in the 
expression of CD44 have been observed in the epithelium of stomach and lung tissue (Figure 
3.13b, 3.13c). A decrease in the CD44 expression was detected in the liver of Brm null 
animals compared to control animals, however CD44-positive signal distribution was not 
even across the tissue sample with some areas characterized by high expression and other 
areas low or negative (Figure 3.13d).  
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Figure 3.12 Analysis of the expression of CD44. Immunohistochemical staining against CD44 revealed no 
differences in expression of CD44 in the intestinal epithelium in Brm null in comparison to control animals. 
Scale bar represents 50 μm. (B) The transcriptional level of CD44 was quantified by quantitative real-time-PCR 
(qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised with β-actin (n=8). Analysis of 
levels of CD44 mRNA further confirmed the lack of differences between control and experimental animals. The 
data is presented as a fold change (initial Ct values were plotted with error bars) 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
Brm wt Brm null
R
e
la
ti
ve
 q
u
an
ti
ty
 o
f 
C
D
4
4
Control Brm null 
115 
 
A 
B 
C 
D 
 
                                                                 
Figure 3.13 Immunofluorescent staining for CD44 for (A) small intestinal epithelium (B) stomach (C) lung (D) 
liver. The analysis of the CD44 expression revealed no differences in the small intestine, stomach or lung tissue 
between Brm null and controls harvested at 70 days of age. A decrease in the expression of CD44 was detected 
in the liver however the staining of whole tissue lacks the consistency of positive signal. Staining and CD44 
expression analysis conducted by Prof B. E. Weissman (LCCC, Chapel Hill, USA). Scale bar represents 100 
μm. 
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3.2.8 Brm loss does not directly interact with Wnt signalling  
Brm null experimental animals did not show any signs of illness or tumour formation which 
confirms previously published data (Reyes et al., 1998) but as its paralogue ATPase Brg1 is 
widely considered a tumour suppressor. Therefore I assessed levels of β-catenin in the 
epithelium to look for any evidence of a direct interaction between Brm and Wnt signalling.  
Immunohistochemical analysis of β-catenin in 70 days old control and Brm null animals 
detected a significant difference in the expression levels of β-catenin in the small intestinal 
epithelium (Figure 3.14a). In both Brm deficient and control cohorts, β-catenin is observed at 
the cell membrane of intestinal epithelial cells, which is consistent with the role of β-catenin 
in cell-to-cell adhesion as adherens junction component however the staining was 
significantly stronger in control animals. Some nuclear β-catenin was detected within the 
bottom third of the crypts suggesting that some cells within the stem cell niche express 
nuclear β-catenin.  
The observation of elevated levels of stabilized β-catenin in the cytoplasm and nucleus in 
following disruption of the β-catenin destruction complex is one of the first hallmarks of 
activated Wnt signalling. The validation of differences observed in β-catenin 
immunohistochemical staining between control and Brm null animals and therefore nuclear 
accumulation of β-catenin was investigated quantifiably by Western blotting in Brm null and 
control animals at day 70 (n=4) (Figure 3.14b). This analysis of levels of active 
(dephosphorylated) β-catenin detected no difference between control and experimental 
animals (p=0.355, n=4, Figure 3.14c). At the same time, I have also assessed the total levels 
of β-catenin including its endogenous expression. Once again, the levels of the total β-catenin 
showed no difference between control and Brm null animals (p=0.343, n=4, Figure 3.14c).  
The data above show that complete Brm loss does not lead to changes in the downstream 
effector of Wnt signalling, β-catenin, further suggesting that any possible effects of Brm on 
Wnt signalling are not mediated at the level of β-catenin stabilization and accumulation but 
may occur somewhere downstream the pathway. 
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Figure 3.14 The analysis of expression of β-catenin in small intestinal epithelium in Brm null and Brm wild-type 
animals harvested at 70 days of age. (A) Immunohistochemical analysis of β-catenin revealed presence of 
staining within the membrane and decreased expression in Brm null in comparison to control animals. Nuclear 
β-catenin staining was detected in the certain cells within crypt compartment (B) Western blot for β-catenin 
forms: total endogenous β-catenin and dephoshorylated β-catenin. Previous immunohistochemical analysis does 
not allow for quantification of levels of β-catenin, protein levels of β-catenin were measured by Western 
blotting. (C) The analysis of blotting by densitometry revealed no differences in protein levels between Brm null 
and control animals indicating no effects of Brm loss on protein levels of main Wnt pathway effector, β-catenin. 
The results were normalised to the β-actin loading control and represented as a value relative to controls (p= 
0.355, n=4 and p=0.343, n=4, Mann Whitney U Test). The scale bar represents 50μm.  
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3.2.9 Brm loss leads to changes in Notch signalling 
Both Wnt and Notch signalling are responsible for controlling crypt cell proliferation, 
directing the differentiation of progenitor cells towards secretory or absorptive lineages and 
maintaining the intestinal stem cell niche. The immunohistochemical analysis reported 
changes in the number of identified differentiated cell types observed in Brm null animals 
suggest that the homeostasis between different signalling pathways maintaining the 
proliferation and migration of the cells within the small intestinal epithelium is somehow 
disturbed. The Notch pathway and its effectors belonging to the bHLH (basic helix-loop-
helix) family of transcription factors play a crucial role in the progenitor cell fate 
determination. NICD (Notch intracellular domain) which is released upon the Notch ligand 
binding translocates into the nucleus to form an active complex with Rbp-j Notch mediator in 
order to stimulate the expression of Notch target genes. Hes1 is one of those target genes and 
it acts as a major effector of Notch signalling. During normal intestinal homeostasis Hes1 
promotes the progression of progenitor cells into enterocytes whereas Hes1 loss shifts the 
differentiation and specification of progenitors from absorptive lineage cell type into a 
secretory Goblet cell fate. Other two hairy and enhancer of split (Hes) family members, Hes3 
and Hes5, have been shown to act cooperatively with Hes1 in regulating the cell fate of 
intestinal progenitor cells and repressing the expression of epithelial cell fate determination 
genes such as Math1 (Ueo et al 2012, van Es et al 2005). Math1 is another member of the 
family of bHLH transcription factors which is essential for intestinal cell differentiation into 
secretory lineage (van Es 2010). Because of the crucial role of Notch signalling on the 
maintenance of intestinal homeostasis, the levels of “canonical” Notch signalling pathway 
elements such including Hes1, Hes5, Notch 1 ICD and Math1 were closely investigated by 
Western blotting. The target proteins have been specifically chosen as they are present in 
different parts within the signalling cascade to enable the step-wise analysis in determining 
whether any and which particular parts of the Notch signalling pathway are affected by Brm 
loss.   
The analysis of Notch1 ICD protein levels which is a receptor for membrane-bound Notch 
ligands Jagged1, Jagged 2 and Delta1 showed no significant changes (p=0.686, n=4, Figure 
3.15b). Similarly, the levels of main Notch signalling effector downstream of NICD binding, 
Hes1 did not detect any changes (p=0.114, n=8, Figure 3.15b).   
119 
 
Immunohistochemical analysis of Hes5 expression in the small intestinal epithelium of Brm 
null and control animals detected Hes5-positve cells to be localised predominantly at the 
crypt base neighbouring with Paneth cells with some rare positive cells present within the 
bottom two thirds of the crypt (Figure 3.16a). Therefore there is no difference in the 
localisation of the Hes5-positive cells between Brm deficient and control animals. Despite no 
changes detected in the pattern of expression of Hes5 within the small intestinal epithelium, 
notable changes in the level of expression of Hes5 were observed. In the control tissue, Hes5-
positive cells were present in each crypt whereas in Brm null only a small percentage of small 
intestinal crypts contained Hes5-positive cells. Assessment of Hes5 protein levels conducted 
by Western blotting detected a significant reduction of Hes5 protein levels in Brm null tissue 
samples compared to controls (p<0.05, n=8, Figure 3.16b, 3.16c).   
Finally, the levels of Math1 were investigated by Western blotting and revealed a slight 
increase in Math1 protein in Brm null samples in comparison to control tissue (p<0.05, n=4, 
Figure 3.15b). 
In order to assess whether the observed changes are occurring at the transcriptional, protein 
level or both, the expression levels of Hes1 and Math1 were assessed by qRT-PCR. mRNA 
was extracted from small intestinal tissue samples of Brm null and control animals at day 70. 
qRT-PCR analysis of Hes5 mRNA levels revealed no significant changes between Brm 
deficient and control mice (p=0.287, n=6, Figure 3.17a).  An increase in mRNA of Hes1 in 
Brm null animals was observed however this trend was not significant (Figure 3.17b, 
p=0.054, n=6). This was in contrast to Math1 mRNA, where we found a marked increase in 
Brm null in comparison to control cohort (Figure 3.17b, p=0.031, n=6). 
Although Brm loss does not affect either the receptor Notch1 or the best-characterized 
effector of Notch signalling cascade Hes1, significant changes in Hes5 at the protein level 
and in Math1 at both transcriptional and protein level have been detected.  
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Figure 3.15 (A) Western blots for numerous elements of Notch signalling such as Hes1, Math1, Notch1 ICD. 
(B) Analysis of protein levels of Hes1 and Notch1 ICD revealed no changes due to Brm loss comparing Brm 
null and Brm wild-type animals (p=0.114, n=8 and p=0.686, n=4, respectively). However the increased protein 
levels of Math1 were found in Brm null animals in comparison to controls (p<0.05, n=4).  
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Figure 3.16 Analysis of Hes5 expression in the small intestinal epithelium. (A) Immunohistochemistry against 
Hes5 showed that Hes5 is expressed with intestinal crypt compartment and detected a decline in number of Hes5 
positive cells in Brm null animals in comparison with controls (B) Western blot analysis was perform in order to 
confirm the observation from immunohistochemical staining of intestinal sections. (C) Analysis of protein levels 
of Hes5 by densitometry showed loss of Hes5 in Brm null animals in comparison to normal levels expressed in 
Brm wild-type animals (p<0.05, n=8, Mann Whitney U Test). Scale bar represents 50μm.   
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Figure 3.17 The transcriptional levels of Hes5, Hes1 and Math1 were quantified by quantitative real-time-PCR 
(qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised with β-actin and presented as a 
mean ± S.D. (n=6). (A) Analysis of levels of Hes5 mRNA showed no differences between control and 
experimental animals (p=0.287, n=6). (B) Analysis of levels of Hes1 mRNA showed a trend of an increase in 
Brm null animals compared to controls (p=0.054, n=6) whereas a marked increase in Math1mRNA was detected 
(p=0.031, p=6)  
 
 
 
 
0
2
4
6
8
10
12
14
Control Brm null
R
e
la
ti
ve
 q
u
an
ti
ty
 o
f 
H
e
s5
123 
 
3.2.10 Brm loss does not affect the stem cell compartment  
To analyse potential changes in the stem cell compartment in situ hybridisation using a probe 
against Olfm4, a Wnt-independent gene and a marker of intestinal stem cells which revealed 
positive staining within the bottom third of the intestinal crypt of control animals whereas in 
Brm null animals the area where Olfm4 probe has bound extended approximately half way up 
the length of the crypt with some of Paneth cells showing positive staining with Olfm4 ribo-
probe. The intensity of staining also appeared to be higher in the Brm deficient cohort (Figure 
3.18a). In order to further confirm the results obtained from in situ hybridization, we assessed 
the effects of Brm deficiency on the expression of stem cell marker Olfm4 at the 
transcriptional level. mRNA was extracted from the small intestinal tissue samples of Brm 
null and control animals at day 70 and used for qRT-PR. Expression analysis of the Olfm4 
stem cell marker revealed a trend of decreased Olfm4 expression in Brm null animals 
however this result was not significant (p=0.572, n=6, Figure 3.18b).  
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Figure 3.18 Analysis of intestinal stem cell niche in Brm null animals. (A) In situ hybridization against Olfm4 
detected some differences in the amount of probe bound in the small intestinal epithelium of Brm null in 
comparison to control animals. The stained area is extended and the intensity of staining is higher in Brm null 
cohort. Scale bar represents 50 μm. (B) The transcriptional level of Olfm4 was quantified by quantitative real-
time-PCR (qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised with β-actin and 
presented as a mean (n=4). Analysis of levels of Olfm4 mRNA revealed a trend of decrease in Brm 
experimental animals in comparison to controls which was not significant (p=0.572, n=6).  
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3.2.11 The pattern of Brm expression in large intestinal epithelium  
 
The expression of both Brm and Brg1 ATPase in normal human tissues have been described 
by Reisman et al., (2005) indicating tissue-specific patterns of expression depending on 
whether particular cell types are engaged in constant proliferation and self-renewal. Brm was 
found to be expressed in the muscularis propria of small and large intestine however in the 
intestinal epithelium only Brg1 expression was detected. Contrary to this study, Yamamichi 
and his colleagues (2007) detected Brm-positive cells with a nuclear staining in human 
colonic mucosa. To investigate the pattern of expression of Brm in the colonic epithelium of 
our murine model, immunofluorescence staining against Brm was conducted (Figure 3.19). 
Staining of colonic epithelium revealed the presence of nuclear Brm-positive cells along the 
length of the colonic crypt. The vast majority of the cells within the epithelium were 
expressing Brm in contrast to results obtained in the small intestinal epithelium.   
  
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19 The expression pattern of Brm in the colonic epithelium. Brm null animals along with Brm 
+/+
 
controls were dissected at 70 days of age and immunofluorescent staining was conducted on harvested tissue. 
Blue channel corresponds to DAPI nuclear staining and green channel to Brm staining. Immuflourescent 
analysis of Brm expression revealed Brm expression along the length of colonic crypt in control cohort. Some 
positive non-specific staining was detected in cells of secretory lineage of both Brm null and control animals. 
Scale bar represents 100μm. 
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3.2.12 Brm loss has a mild effects on the homeostasis of large intestinal epithelium 
 
In the small intestinal epithelium no morphological abnormalities or tumorigenesis were 
observed in the cohort of Brm deficient animals. However a detailed quantitative analysis 
revealed significant changes in crypt and villus length as well as a shift in the differentiation 
of cells towards the secretory lineage in Brm null mice compared to controls. As a 
consequence of those observations and the fact that cells of the secretory lineages are the 
predominant cell population present in the colonic epithelium, the effects of Brm loss on the 
large intestinal epithelium were investigated in Brm null and control animals dissected at 70 
days of age. A quantitative analysis performed on these tissue sections is summarized in 
Table 3.2. 
Similarly to the results obtained from small intestinal epithelium, macroscopic analysis of 
colonic epithelium during tissue harvesting revealed no tissue abnormalities or tumorigenesis.    
Crypt length was assessed on H&E stained sections as the average number of cells (± 
standard deviation) from the bottom of the crypt of Lieberkühn till the flat surface of the 
epithelium. Crypt size was found to be unaltered in Brm null colonic epithelium in 
comparison with control animals (24.50±0.43 and 24.31±0.32, p=0.476, n=8, Figure 3.20a).  
Apoptosis within the epithelium was detected and scored by cleaved Caspase-3 
immunohistochemical staining. The quantification of cleaved Caspase-3-positive cells 
showed a trend of increase in levels of apoptosis in Brm null mice versus control animals, 
however this increase was not significant (0.064±0.022 and 0.060±0.016, p=0.763, n=8, 
Figure 3.19b). The size and the shape of proliferative compartment in the colonic epithelium 
was assessed using immunohististochemical staining against proliferation marker, Ki67. 
Scoring of Ki67-positive cells revealed a trend of an increase in the average number of 
proliferating cells per crypt in Brm deficient cohort in comparison to controls, however this 
result was not significant (7.92±2.55 and 6.61±1.04, p=0.34, n=8, Figure 3.20c) similarly to 
the quantification of apoptosis by cleaved Caspase-3.  The analysis of the cumulative 
frequency of Ki67-positive cells showed no difference between control and Brm null animals 
(Kolmogorov-Smirnov Z test p=0.978, n=8, Figure 3.20d). The distribution of proliferating 
cells and therefore the shape of proliferative compartment remained unaltered in the 
experimental mice in comparison with controls.  
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As in case of small intestine, BrdU incorporation was used as another marker for cell 
proliferation to specifically quantify number of cells in the S-phase of the cell cycle. Brm null 
and control mice were injected with BrdU labelling reagent 2 hours and 24 hours prior to 
dissection and the obtained tissue sections were stained using anti-BrdU antibody. However 
due to the low numbers of BrdU-positive cells detected the quantification and analysis of 
those cells would not prove beneficial towards histological analysis. 
Therefore in the context of Brm deficiency within the colonic epithelium, the quantitative 
analysis of functional and morphological parameters detected no effect on the length of crypt 
and a trend in an increase in both apoptosis and proliferation but no changes in the shape of 
proliferative compartment. Thus homeostasis in the large intestinal epithelium appears to not 
be affected by constitutive loss of Brm.    
 
Parameter  Cohort  Mean  SD  p-value  
Crypt length  Control 
Brm null  
24.31 
24.50  
0.32 
0.43  
0.476  
Caspase3  
positive cells 
Control 
Brm null 
0.064 
0.060  
0.022 
0.016  
0.763  
Ki67 positive 
cells  
Control 
Brm null 
7.92 
6.61  
2.55 
1.04  
0.34 
 
Table 3.2 Quantitative analysis of the effects of Brm loss on the histology of colonic epithelium. Epithelium 
from large intestine from Cre
-
 Brm 
+/+
 (marked as Control) and Cre
-
 Brm null (marked as Brm null) was 
harvested from animals at 70 days of age. Histological parameters including crypt length, apoptosis and 
proliferation were quantified and comparison between those two cohorts was conducted using statistical 
software. 
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Figure 3.20 Histological analysis of the effects of constitutive Brm loss in the colonic epithelium. Control and 
experimental Brm null animals were harvested at day 70 of age. A-D histological parameters such as (A) crypt 
length was counted on H&E sections for control and Brm deficient animals. The average number of (B) Cleaved 
Caspase3 and (C) Ki67-positive cells was scored on the corresponding immunostained sections. (D) Cumulative 
frequency analysis detected no changes in the proliferation compartment between Brm null and control animals. 
Error bars represent standard deviation and asterisk symbol indicates those histological parameters that showed 
a statistically significant difference (p value <0.05) between cohorts of mice. Exact values, standard deviations, 
p values are provided in Table 3.2 
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3.2.13 Brm deficiency results in a shift in the differentiation pattern towards the 
secretory lineages 
 
Although homeostasis of colonic epithelium appears to be maintained with no significant 
effects upon cell number or crypt size (as discussed in the previous section), quantification of 
the differentiated cell types within the colonic epithelium was carried out.  
The most abundant cell type in the epithelium of the colon is the goblet cell. Alcian Blue 
staining was carried out to score the numbers of those secretory lineage cells in the colonic 
epithelium of Brm null and control animals (Figure 3.21). Quantification of the Alcian Blue 
stained cells showed a significant increase in the number of goblet cells per half crypt in the 
Brm deficient epithelium in comparison to controls (7.63±0.40 and 6.50±0.07, p<0.0001). 
Enteroendocrine cells are another of secretory lineage present in the colonic crypts. Grimelius 
staining was used to identify these cells within the large intestinal epithelium. The scoring of 
cells per half crypt that have taken up the silver stain revealed a marked decrease in the 
numbers of enteroendocrine cells in the Brm null animals compared to control animals 
(1.47±0.07 and 1.61±0.05, p=0.02, n=8, Figure 3.22).    
The quantification of the major differentiated cell types in the epithelium of the colon 
revealed a shift in the differentiation of secretory lineage with an increase in numbers of 
mucin-secreting cells and a decrease in enteroendocrine cells in the Brm deficient epithelium. 
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Figure 3.21 Alcian Blue staining was used in order to mark goblet cells within colonic epithelium. The colon 
sections of control and Brm null mice dissected at day 70 of age and stained using cell specific stain detecting 
mucin secreting cells. Black arrows indicate individual goblet cells. Staining revealed no changes in the 
localisation of Alcian Blue stained cells in the epithelium of control and Brm experimental animals. The number 
of Alcian Blue positive cells increased in Brm null animals in comparison with controls. The scale bar 
represents 50μm.  
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Figure 3.22 Grimelius staining of colonic sections was carried out to visualize the number of enteroendocrine 
cells on colonic epithelium sections of control and Brm null mice dissected at day 70 of age. Black arrows 
indicate individual enteroendocrine cells. Staining reveal normal localisation of enteroendocrine cells in Brm 
deficient animals in comparison with controls. The scoring of numbers of cells detected significant decrease in 
numbers of enteroendocrine cells in Brm null in comparison to control animals. The scale bar represents 50μm. 
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3.3 Discussion 
The generation of constitutive knock-out through the replacement of the exon a by a 
Neomycin resistance cassette (Reyes et al.,1998) was the first and crucial step in providing 
important insights into the role of Brm as Brm null animals are viable and fertile, unlike its 
paralogue Brg1. This murine model has already provided some crucial insights into the 
physiological role of Brm with to date no spontaneous tumour formation being reported 
(Reyes et al., 1998).  
3.3.1 Mosaic pattern of expression of Brm in different tissues 
Previous data on the pattern of Brm expression in normal tissues (non-dysplastic) have 
indicated that higher levels have been found in several slowly proliferating tissues such as 
brain, liver and spleen further suggesting that the levels of Brm within fast proliferating and 
high-turnover tissues like the intestine might be not discernible. I aimed to investigate the 
expression of Brm in a range of tissues from abdominal cavity: small and large intestine, 
liver, spleen and kidney collected from Brm null and control animals at day 70 days of age. 
Immunohistochemical analysis revealed nuclear localisation of Brm in liver, spleen and 
kidney whereas small and large intestine displayed very little or no nuclear Brm staining. The 
immunofluorescent analysis of Brm revealed a low level of Brm expression in the small 
intestinal epithelium in contrast to colon where nearly all epithelial cells were positive for 
Brm. Previous observations by Muchardt and Reyes (1998) indicated that non-differentiated 
cells contain predominantly Brg1 and Brm is accumulated upon in vitro differentiation. This 
could explain why the expression levels of Brm in intestinal and colonic crypts are lower than 
in other organs such as spleen. Nonetheless, in the small intestine Brm is limited to rare 
populations of early differentiating and mature epithelial cells whereas in the colon Brm is 
present in the crypt compartment. The expression levels of Brm could possibly be tissue-
specific and depend upon the levels of Brg1 in a particular type of epithelium. 
Similar to the data published by Reisman et al., (2005), very specific cell types were 
observed to express nuclear Brm such as lymphoid germinal centers, sinusoidal cells in the 
red pulp and central artery of the spleen as well as in Bowman’s capsule epithelium and 
mesangial cells of the kidney. In the liver of control animals only Brm expression was 
detected with no Brg1 expression in hepatocytes. However, in the liver of Brm deficient 
animals Brg1-positive cells with nuclear staining were present and some of those Brg1-
expressing cells were hepatocytes.   
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Therefore we can conclude that although the level of Brm expression varies across numerous 
organs the presence of Brm is often limited to a particular subpopulation of cells.   
 
3.3.2 Complete Brm loss has very mild effects on intestinal homeostasis 
Due to the fact that Brm constitutive knockouts are viable, this model was the most suitable 
way of investigating the effects of Brm deficiency on homeostasis of the small intestinal and 
colonic epithelium.  
General histological inspection of H&E sections of the intestinal epithelium of animals 
dissected at day 70 revealed no abnormal structures within the epithelium and the 
maintenance of general crypt-villus architecture in Brm null animals suggesting that complete 
loss of Brm expression does not lead to abrogation of intestinal organisation. Nevertheless, 
further quantitative analysis of the epithelium showed some subtle changes in the 
homeostasis.  
In the small intestine, a slight increase in crypt length was detected together with a decrease 
in villus length which could implicate an expansion of the proliferative compartment of the 
epithelium. However as no differences in proliferation or apoptosis were observed this data 
suggests that rather than detecting an increasing pool of stem and progenitor cells we are 
detecting an increased pool cells that have already begun to differentiate towards the 
absorptive or secretory lineages. In contrast to the small intestine, there were no changes in 
the crypt length of the colonic epithelium and a trend of decrease in number of proliferating 
cells suggesting that small intestinal and colonic epithelium respond in a different manner to 
Brm deficiency.  
Previous study by Reyes et al. (1998) detected a four-fold increase in proliferation in the liver 
of Brm null animals which was expressed as the increase in the number of BrdU-positive 
cells compared to control animals. In this study we have not quantified histological 
parameters such as proliferation in the liver, however our results from the small intestine 
revealed a marked increase in the number of BrdU-positive cells scored 24 hours after BrdU 
exposure additionally confirming the previously detected trend of an increase in the number 
of Ki67-positive cells in Brm null animals. As a result of the low numbers or indeed absence 
of BrdU-positive cells in the crypts of the colonic epithelium, quantification of BrdU 
incorporation did not reveal any differences yet the quantification of proliferation by Ki67 
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marker showed an opposite trend to the one observed in small intestine with a decrease in 
numbers of proliferating cells in the colon of Brm null mice.  
The differences in effects and trends observed between small and large intestinal epithelium 
of Brm null animals indicates a tissue-specific role of Brm. 
 
3.3.3 Complete Brm loss affects Notch signalling 
Intestinal homeostasis is a finely controlled process of maintaining the balance between 
diverse cellular processes including proliferation, differentiation and apoptosis in order to 
ensure the continuous renewal of the intestinal epithelium. It involves different cell 
populations the most important of which are stem cells and immature progenitor cells both 
localised within the intestinal crypts. The Wnt pathway, specifically the canonical Wnt 
pathway is well known for playing a crucial role in regulating intestinal homeostasis. 
Recently, the Notch signalling pathway which comprises of a large family of bHLH (basic 
helix-loop-helix) transcription factors emerged as another of the central regulators of 
intestinal homeostasis and in particular regulation of the stem cells and progenitor 
compartments.  
Hes1 is one of the best characterized target genes of Notch signalling and it is involved in the 
maintenance of hematopoietic and neural stem cells. In the intestinal epithelium, it is 
expressed by proliferating cells of the crypt and it represses the expression of Math1 and 
Ngn3. Math1 regulates the differentiation into all mature cell types of secretory lineage whilst 
Ngn3 specifically directs the differentiation into enteroendocrine cell type. Hes1 knock-out 
animals display a phenotype characterised by overproduction of secretory cells and fewer 
enterocytes, which is consistent with the role of Notch-Hes1 signalling in regulating the 
proliferation within intestinal crypts and inhibiting Math1 and Ngn3 expression (Jensen et al., 
2000). Concurrently with the loss of Hes1 expression, two other members of the hairy and 
enhancer of split family, Hes3 and Hes5 are upregulated in the intestinal epithelium (Jensen 
et al., 2000).  The precise mechanism of action of the Hes genes and most of all the hierarchy 
of different members of this family of genes remains largely unclear. Hes1 phenotype is 
characterized by the increase in numbers of cleaved Caspase-3 positive cells, goblet and 
enteroendocrine cells at 2.5 days postnatal however none of these effects were observed in 
adult mice at 8 weeks. Furthermore, Hes1 was found to be expressed in the proliferating cells 
of the intestinal epithelium but not present in the Paneth cells in control animals and Hes5 is 
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expressed by Paneth cells (van Es 2005). In double of Hes3/5 knock-out mice, Hes1 was 
found to be expressed in the Paneth cells suggesting it compensates for Hes3 and Hes5 
deficiency. The triple knock-out of Hes1/Hes3/Hes5 genes displayed a phenotype similar to 
that one found in Hes1 deficient mice at day 2.5 together with a premature Paneth cell 
differentiation and mislocalisation (Ueo et al., 2012). No changes in Wnt or BMP pathways 
were reported in mutant Hes1/Hes3/Hes5 mice.  
Previous studies investigating the role of the Notch signalling in the gut have found that all 
three Hes genes: Hes1, Hes3 and Hes5 negatively regulate the development of all types of 
secretory cells. Although the Hes genes are required for proliferation of intestinal progenitor 
cells they are not essential for the maintenance of the stem cells. This suggests that there are 
other Notch effectors that might be compensating for Hes genes in the maintenance of stem 
cells. Hes genes are essential for proliferation of transit-amplifying or progenitor cells and for 
the secretory versus absorptive cell fate decision ensuring normal intestinal development and 
homeostasis (Ueo et al., 2012). The conditional removal of the Rbp-j transcription factor 
revealed undetectable levels of Hes1 and marked de-repression of Math1. The phenotype 
observed included a significant increase in goblet cell numbers and the arrest of all epithelial 
proliferation labelled by BrdU  in both the small and large intestine of Rbp-j deficient mice. 
The marked differences in the phonotype observed in Rbp-j knock-out and Hes1 knock-out 
animals were accounted for by the presence of other genes belonging to the hairy and 
enhancer of split family, notably Hes5 and Hes6 (van Es et al., 2005). 
Western blot analysis performed on small intestinal tissue from Brm null mice revealed 
diminished protein levels of Hes5 expression in comparison to control animals. Further 
immunohistochemical analysis and scoring of Hes5-stained intestinal epithelium detected 
Hes5 positive cells localized exclusively within the crypt compartment however visibly 
reduced numbers of Hes5-posistive cells were observed suggesting that Hes5 expression is in 
some extent abrogated in the intestinal epithelium of Brm null animals. In contrast, no Hes5 
expression was detected in the large intestinal epithelium. Further quantification of mRNA 
levels of Hes1, Hes5 and Math1 revealed no significant changes for Hes1 and Hes5. 
However, a significant decrease in Math1 mRNA was observed suggesting that Math1 is 
regulated at both transcriptional and protein levels in Brm deficient animals. 
Chip analysis showed that CBF-1 recruits SWI/SNF Brm-containing complexes to Hes1 and 
Hes5 promoters through preferential interaction with Brm rather than Brg1. Promoter regions 
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of those two Notch target genes appear to be already remodelled prior to Notch signalling 
activation via Notch2, and therefore Hes1 and Hes5 promoters appear poised for transcription 
by CBF-1 binding, Brm recruitment and histone acetylation. 
Taken together, previous data supports our results that in case of Brm loss and subsequent 
loss of Hes5 expression, Hes1 protein levels remain unchanged due to a compensatory 
mechanism between Hes family members as well as other elements of Notch signalling nota 
bene which have not been investigated by our study. Similarly as no changes in other 
signalling pathways have been observed in the Hes1/Hes3/Hes5 deficient mouse we can 
extrapolate that Hes5 deficiency induced by loss of Brm is likely to have little effect on other 
signalling pathways involved in the maintenance of intestinal homeostasis. This would 
explain the lack of change in β-catenin protein levels and would account for the very mild 
Brm phenotype we observe. As a result of morphological differences between small intestinal 
and colonic epithelium such as the absence of enterocytes, the balance between Hes1 and 
Math1 expression in the large intestine as well as the need for Hes5 expression appears to be 
different.  
Furthermore, changes in cell numbers of goblet and enteroendocrine cells in both the small 
and large intestine seems to be driven by upregulation of Math1. Similarly to Rpbj deficient 
animals, in Brm null animals Math1 might become de-repressed as a result of Hes5 loss in 
small intestinal epithelium which however may be compensated for. 
 
3.3.4 Brm loss does not compromise the expression levels of CD44 
Previous data investigating the concomitant loss of Brm and Brg1 revealed that Brm null 
animals lack CD44 expression even in the presence of functional Brg1 regardless of 
upregulation of Brg1 expression.  No positive CD44 staining was detected in tissues such as 
the liver, gut epithelium, brain and lungs suggesting that Brm loss alone results in the 
ablation of CD44 expression (Reisman et al., 2002). In contrast to this data Strobeck et al. 
(2001) found that reintroduction of Brg1 only in the C33A cervical carcinoma cell line is 
capable of restoring CD44 expression. 
The complete loss of CD44 expression was not confirmed for Brm null animals dissected at 
70 days of age. The subtle trend of CD44 increase was observed but was not confirmed to be 
significant for the cohort of Brm null mice analysed during this PhD.  
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Analysis of Brm and Brg1 deficiency in a subset of human cancer cell lines has shown that 
combined lack of SWI/SNF results in loss of CD44 expression. Furthermore, in depth 
analysis of SW13 human adrenal carcinoma cell line revealed the existence of two subtypes 
of SWI/SNF complexes in the same cells: one that expresses both Brm and Brg1 and a 
second that expresses neither of two ATPases. No change in transcription activities between 
the subtypes was detected indicating the capacity of SW13 cell line to spontaneously 
transition between Brm Brg1 negative and Brm Brg1 positive subtype (Yamamichi et al., 
2003).  
Taken together, as Brm loss does not compromise the expression levels of CD44 in the small 
intestinal epithelium at 70 day of age I hypothesise that the effect of Brm on CD44 observed 
by Reisman et al. was due to sampling at a different time point (timepoint not specified by 
Reisman et al. 2003). These observations correlate well with the mechanism of spontaneous 
transition suggested by Yamamichi et al. (2003) and therefore in case of re-expression of 
Brg1 restoring CD44 expression similarly to observations by Strobeck et al. (2001) providing 
us one possible explanation for the lack of change in CD44 expression in our experimental 
cohort.   
 
 
Given  the  observation that  Brm is not expressed in the  stem cell compartment, but rather in 
the differentiating or mature epithelial cell types and further that the differentiation promoting 
genes Hes1, Hes5 and  cyclin A are well-known  Brm-specific target  genes, we can conclude 
that  Brm,  in contrast to  Brg1,  has  less  severe effect  on the  epithelium of  small and  large 
intestine  and is  predominantly involved in the  differentiation of progenitor cells into mature 
cell types.  
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Chapter 4  
Investigating the effects of Brm loss in the 
Wnt activated epithelium of small and large 
intestine 
 
4.1 Introduction 
Subunits of SWI/SNF chromatin remodelling complex have been implicated in regulating 
numerous genes controlling a variety of processes from embryonic development to cell 
apoptosis. Some subunits have been detected to frequently be silenced in cancers of lungs, 
esophagus, ovaries and breast (Reisman et al. 2009). Similarly Brm loss has been correlated 
to poor prognosis in the majority of those cancers suggesting that Brm expression may play 
an important role in the modulation of cancer phenotype.  
Over 80% of CRCs are caused by the aberrant activation of the Wnt pathway which has been 
proven to play a crucial role in normal homeostasis of intestinal epithelium (Korinek et al. 
1998, Pinto et al. 2003, Kuhnert et al. 2004) as well as in colorectal tumorigenesis (Korinek 
et al. 1997, Morin et al. 1997, Polakis et al. 1999). The interplay between Wnt and Notch 
pathway is the most dominant force driving the stem cell/progenitor niche by controlling self-
renewal and differentiation along the crypt-villus axis. Both pathways are frequently 
abnormally activated in CRC and despite the fact that there is no evidence supporting 
interactions of the Brm with Wnt pathways, Brm has been shown to be involved in 
interactions with the ICD22 and CBF-1 elements of the Notch signalling pathway indicating 
that Brm may contribute to colorectal tumorigenesis. Furthermore, together with the other 
ATPase subunit of SWI/SNF complex Brg1, Brm has been implicated in the transcriptional 
activation and repression of many genes and therefore in alteration of gene expression. One 
of those genes, CD44, is a major downstream target of β-catenin and it has been reported that 
its expression increases with a progression of the CRC (Wielenga et al. 1993, Zeilstra et al. 
2008). Brm has been shown to associate with CD44 promoter (Strobeck et al. 2001, Reisman 
et al. 2002, Banine et al. 2005, Batsché et al. 2006) suggesting it may directly influence the 
levels of CD44 expression however no effect of Brm  deficiency on CD44 expression was 
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observed (as described in Chapter 3.2.7). Moreover Brm has been reported to be necessary 
for Rb-mediated growth inhibition as Brm-deficient cancer cell lines are resistant to Rb-
mediated cell cycle arrest (Strober et al. 1996, Reisman et al. 2003) and Brm can cooperate 
with Rb to repress cyclin A which is crucial in regulating the progression through the cell 
cycle (Dahiya et al. 2001). 
  
Initiation of tumorigenesis by activating mutations in the Wnt cascade and subsequent 
neoplastic transformation makes targeting of components of the Wnt pathway downstream of 
β-catenin an interesting potential avenue for therapy. For the same reason, alterations in 
elements of SWI/SNF complex that are believed to function as bona fide specialized tumour 
suppressors such as Brm ATPase may result in modulation of phenotypes observed during 
CRC tumorigenesis.  
 
This chapter will aim to characterise the effects of Brm deficiency on Wnt-driven 
tumorigenesis in the small intestinal and colonic epithelium as well as the potential of Brm to 
act as a modulator of CRC. 
 
4.2 Results 
4.2.1 Placing Brm in a context of aberrant Wnt signalling 
In order to investigate the effects of Brm deficiency in the context of aberrant Wnt signalling 
specific to the intestinal epithelium, I exploited the Cre recombinase conditional knock-out 
system to inactivate Apc. Targeted Apc alleles contain loxP sites placed within introns on 
both sides of exon 14 and recombination between those loxP sites mediated by Cre 
recombinase results in a frame-shift mutation and the expression of a truncated version of 
Apc characterised by the loss of function (Shibata et al., 1997). 
Animals carrying Brm null alleles were intercrossed with mice carrying Tg(Cyp1a1-
cre/ESR1)1Dwi transgene (abbreviated here as AhCreER) (Kemp et al., 2004). AhCreER 
recombinase is expressed under the control of Aryl hydrocarbon (Ah) promoter element 
derived from the rat cytochrome P4501A1 gene but additionally contains a modified 
hormone-binding domain of the estogen receptor (ER). Therefore the induction of AhCreER 
requires the administration of tamoxifen together with beta-naphthoflavone and 
recombination occurs in a range of tissues including the intestinal epithelium, liver and 
pancreas (Ireland et al., 2004). In the intestinal epithelium, expression of the AhCreER 
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transgene is restricted to the bottom of the crypt of Lieberkühn with stem cells and early 
progenitor cells being the only cell populations in which AhCreER is expressed. Cre 
mediated recombination driven by the AhCreER results in a lower recombination frequency 
in the intestinal epithelium in comparison to that delivered by AhCre recombinase. Due to the 
differences in the nature of constitutive (Brm null) and conditional (Apc floxed) alleles, loss 
of Brm and Apc alleles does not occur simultaneously.  
The effects of the constitutive inactivation of Brm alleles in the intestinal epithelium have 
been previously described in Chapter 3. 
4.2.2 Brm loss does not improve survival of Apc-deficient animals 
A number of carcinogenesis studies reported that Brm is silenced in 10-25% of solid tumours 
whereas transgenic knock-out of Brm potentiates tumour development in vivo. Therefore, I 
aimed to examine whether Brm deficiency in the intestinal epithelium would alter Wnt-driven 
tumorigenesis accomplished by homozygous inactivation of Apc.   
In order to investigate the long-term effects of Brm loss in the context of Wnt signalling 
activation and intestinal neoplasia, 70 day cohorts of AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null animals were induced with five bi-daily intraperitoneal injections 
of 80mg/kg β-naphthoflavone with Tamoxifen at 12 hour intervals. AhCreER- control mice 
were induced alongside the above cohorts (n≥12 for all cohorts except AhCreER+Apcfl/flBrm 
null n=7). Mice were then aged for a maximum of 100 days or until they developed signs of 
ill health and had to be sacrificed and appropriate tissues harvested. Whilst none of the 
animals from the control cohort became ill within the timeframe of the experiment, 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals started showing signs of ill 
health as early as 8 and 9 days post induction respectively. Survival analysis of 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null cohorts showed that all animals 
became ill and had to be sacrificed within less than 3 weeks of induction (Figure 4.1a, median 
survival of 9 and 12 days, respectively). Close observation of the induced experimental 
animals from the first day that they displayed early signs of ill health revealed that symptoms 
in the AhCreER
+
Apc
fl/fl
Brm null mice developed more rapidly and these mice had to be 
sacrificed within 24 hours, whereas in AhCreER
+
Apc
fl/fl
Brm
+/+
 mice the progression of the 
symptoms was less rapid, allowing mice to be maintained for a further 2-3 days. The analysis 
of the overall survival probability revealed no statistically significant difference between the 
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AhCreER
-
 Control 
AhCreER
+
Apc
fl/fl
Brm
+/+
  
AhCreER
+
Apc
fl/fl
Brm null 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null cohorts (Figure 4.1b, Log-Rank test 
p=0.144).  
Histological analysis of H&E sections of small intestinal epithelium of 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null cohorts identified numerous mono-
crypt adenomas and formation of early stage small adenomas with no perceptible differences 
in the tumour progression between those two cohorts of Apc-deficient animals (Figure 4.1c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
AhCreER
+
Apc
fl/fl
Brm
+/+
  
AhCreER
+
Apc
fl/fl
Brm null 
143 
 
 
 
 
 
 
Figure 4.1 Brm deficiency does not alter the survival of animals with a homozygous inactivation of Apc. 
Cohorts of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null were induced using an appropriate protocol 
along with AhCreER
-
 control mice (n≥7). Animals were aged for 100 days post induction or until they have 
developed signs of ill health. (A) Survival data was presented as a Kaplan-Meier plot and revealed a significant 
difference in the survival probability of both experimental cohorts in comparison to control animals (Log-Rank 
test p<0.0001, n≥7 for either cohort). (B) Analysis of survival probability between AhCreER+Apcfl/flBrm+/+ and 
AhCreER
+
Apc
fl/fl
Brm null revealed no significant difference (Log-Rank test p=0.144, n≥7). (C) H&E sections 
microscopic analysis identified numerous mono-crypt adenomas in the epithelium of both 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals with no perceptible differences between the 
dysplastic tissues. 
  
AhCreER+Apcfl/flBrm+/+ AhCreER+Apcfl/flBrm null 
C 
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4.2.3 Brm loss is compatible with nuclear β-catenin  
In many studies focusing on Apc deficiency, β-catenin is used as a surrogate marker of Apc 
loss, as a specific change in the localization of β-catenin into the nucleus is a well-recognized 
immediate effect of dysregulated Wnt signalling
 
(Sansom et al. 2004). Previous studies in our 
laboratory on the Brm paralogue Brg1 revealed that Brg1 loss is incompatible with Wnt-
driven adenoma formation as in the small intestinal epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 
mice at 30 and 100 days post induction all mono-crypt adenomas characterised by nuclear β-
catenin were also found to express Brg1. Immunohistochemical analysis of β-catenin 
expression in the small intestine of AhCreER
+
Apc
fl/fl
Brm null revealed numerous dysplastic 
aberrant crypt foci (ACF) and small lesions with nuclear localisation of β-catenin (Figure 
4.2). This pattern of expression was similar to that observed in AhCreER
+
Apc
fl/fl
Brm
+/+
 
indicating that Wnt signalling activation does occur in AhCreER
+
Apc
fl/fl
Brm null mice. Due 
to the very short survival of both AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null 
mice, only multiple intestinal lesions and small tumours were observed in Apc experimental 
cohorts. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Brm deficiency is compatible with Wnt pathway activation in the stem cells and progenitors cells of 
small intestinal epithelium. Immunohistochemical analysis of β-catenin expression in AhCreER+Apcfl/flBrm+/+ 
and AhCreER
+
Apc
fl/fl
Brm null cohorts at days 10-12 post-induction showed multiple intestinal lesions with 
nuclear β-catenin. The constitutive nature of Brm loss ensured that the observed pattern of β-catenin localisation 
was consistent across the small intestinal epithelium. Scale bar represents 100μm. 
AhCreER+Apcfl/flBrm+/+ AhCreER+Apcfl/flBrm null 
Anti-β-catenin 
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4.2.4 Brm deficiency is permissive of Apc loss and accentuates some of the 
manifestations associated with Wnt signalling activation 
No previous direct links between the Brm chromatin remodelling factor and the Wnt 
signalling pathway have been reported, however due to the more rapid and severe progression 
of symptoms of ill health in AhCreER
+
Apc
fl/fl
Brm null mice in comparison to the 
AhCreER
+
Apc
fl/fl
Brm
+/+ 
mice and a non-tumour morbidity, I investigated whether Brm loss 
may amplify the effects of aberrant Wnt activation in the small intestinal epithelium. Due to 
the lower efficiency of the AhCreER-driven recombination in comparison to that observed by 
other recombinases (such as AhCre), tissue sections showing similar ratios of unfloxed to 
floxed tissues were selected for further histological analysis. Initially, the morphology of 
tissue sections was assessed revealing some of previously published histological features of 
Wnt activated intestinal epithelium, such as elongated crypts (Sansom et al., 2004). The 
analysis of histological and functional parameters (crypt length, villus length, levels of 
apoptosis and proliferation) of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null 
revealed differences between those cohorts. The results of quantitative analysis of those 
histological parameters are summarized in Table 4.1 and Figure 4.3. 
 
Initial morphological analysis of small intestinal H&E sections of control AhCreER
-
, 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals revealed altered crypt-villus 
architecture in both Apc-deficient cohorts characterized by an elongated crypt extending 
towards the crypt-villus axis and an absence of distinct crypt compartment compared to the 
epithelium of control animals. Furthermore, both crypt and villus lengths were assessed on 
H&E stained tissue sections as the average number of cells (± standard deviation) from the 
bottom of the crypt of Lieberkühn till the crypt-villus junction and from the crypt-villus 
junction to the top of the villus. Small intestinal epithelium crypts of the 
AhCreER
+
Apc
fl/fl
Brm
+/+
 mice and DKO mice were found to be significantly increased in 
comparison to the control animals (42.090±0.082 and 43.545±0.940 compared to 
21.617±0.92, p values for either comparison p<0.001, n≥4) and furthermore crypts of DKO 
animals are more elongated than those found in Apc deficient epithelium (p=0.022, n=4, 
Figure 4.3a). The quantification of villus length revealed a significant difference between 
control animals and both AhCreER
+
Apc
fl/fl
Brm
+/+
 and DKO animals with a marked decrease 
in length of the villus in both Apc deficient cohorts (73.402±1.478, 48.003±1.871 and 
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51.59±3.108, p values for either comparison p<0.001, n≥4). No difference in the villus length 
between AhCreER
+
Apc
fl/fl
Brm
+/+
 and DKO was detected (p value=0.095, n=4, Figure 4.3b).  
Both apoptosis and mitosis have been detected and scored on the basis of 
immunohistochemical staining using specific markers: Cleaved Caspase-3 for sequential 
caspase activation cascade in cell apoptosis and Ki67 protein expressed in all active phases of 
the cell cycle except G0. Scoring of apoptosis revealed a significant increase in apoptosis 
levels in both AhCreER
+
Apc
fl/fl
Brm
+/+
 and DKO mice in comparison to control animals 
(0.866±0.06, 3.505±0.142 and 4.905±0.347, p values for either comparison p<0.001, n≥4). 
Notably, a significant increase in the number of Cleaved Caspase-3-posistive cells scored was 
revealed in the epithelium of DKO animals compared to AhCreER
+
Apc
fl/fl
Brm
+/+
 (p=0.015, 
n=4, Figure 4.3c). Similarly to Caspase 3 staining, the quantification of the cells scored as 
positive for Ki67 proliferation marker revealed a marked increase in the levels of 
proliferation between control and AhCreER
+
Apc
fl/fl
Brm
+/+
 and DKO animals (13.51±0.70, 
56.53±6.242 and 64.83±5.720, p values for either comparison p<0.001, n≥4). No difference 
in the number of Ki67-positive cells in the small intestinal epithelium was detected between 
DKO and AhCreER
+
Apc
fl/fl
Brm
+/+
 (p=0.098, n=4, Figure 4.3d).   
Therefore in the context of conditional deletion of Apc, Brm loss has further amplified some 
of the effects of aberrant Wnt signalling activation such as an increase in crypt length and 
apoptosis levels however only an non-significant trend of an increase in the size of the 
proliferative compartment was detected in the small intestinal epithelium of 
AhCreER
+
Apc
fl/fl
Brm null animals in comparison to the AhCreER
+
Apc
fl/fl
Brm
+/+
 cohort.  
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Parameter  Cohort  Mean  SD    
Control vs 
Apc KO 
p-values 
Control vs 
DKO 
 
Apc KO 
vs DKO 
Crypt 
length  
Control 
Apc KO 
DKO  
21.617 
42.09 
43.545  
0.92 
0.082 
0.940 
0.000 0.000 0.022 
Villus 
length  
Control 
Apc KO 
DKO 
73.402 
48.003 
51.59 
1.478 
1.871 
3.108  
0.000 0.000 0.095 
Caspase 
positive 
cells  
Control 
Apc KO 
DKO 
0.866 
3.505 
4.904  
0.060 
0.142 
0.347 
0.000 0.000 0.015 
Ki67 
positive 
cells  
Control 
Apc KO 
DKO 
13.395 
56.53  
64.83 
0.762 
6.242 
5.720  
0.000 0.000 0.098 
 
Table 4.3 Quantitative analysis of the effects of Brm loss on the histology of Wnt-activated small intestinal 
epithelium. Epithelium from small intestine from Cre
-
 Brm
+/+
 (marked as Control), AhCreER
+
Apc
fl/fl
Brm
+/+
 
(marked as Apc KO) and  AhCreER
+
Apc
fl/fl
Brm null (marked DKO) was harvested from animals at days 10-12 
post induction. Histological parameters including crypt and villus length, apoptosis and proliferation were 
quantified and comparison between those two cohorts was conducted using statistical software. 
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Figure 4.3 Histological analysis of the effects of Brm loss in the Wnt-activated small intestinal epithelium. 
Control AhCreER
-
 and experimental AhCreER
+
Apc
fl/fl
Brm
+/+
 (marked as Apc KO) and AhCreER
+
Apc
fl/fl
Brm 
null (marked DKO) was harvested from animals at days 10-12 post induction. A-D histological parameters such 
as (A) crypt length (B) villus length were counted on H&E sections. The average number of (C) Caspase 3 (D) 
Ki67-positive cells was scored on the corresponding immunostained sections. Error bars represent standard 
deviation and asterisk symbol indicates those histological parameters that showed a statistically significant 
difference (p value <0.05) between cohorts of mice. Exact values, standard deviations, p values are provided in 
Table 4.1. 
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4.2.5 Brm loss leads to a change in distribution pattern of proliferating cells in 
the Wnt-activated epithelium of small intestine 
  
The position of the Ki67 positive cells was analysed to assess the changes in the distribution 
of proliferating cells and furthermore the distribution of the proliferative compartment within 
the epithelium of the small intestine. Analysis of cumulative frequency of Ki67 positive cells 
revealed a significant increase in the number of Ki67-labelled cells along the length of the 
intestinal crypt-villus axis in Apc deficient cohorts in comparison to controls (p values for 
either comparison p<0.001, n≥4). Furthermore, a change in the distribution of proliferating 
cells marked by Ki67-positivity was observed in DKO animals in comparison to 
AhCreER
+
Apc
fl/fl
Brm
+/+
 animals suggesting Brm deficiency permitted for a differential 
pattern of proliferating cells distribution along the crypt-villus axis of the small intestinal 
epithelium (Kolmogorov-Smirnov Z test, p<0.001, n≥4, Figure 4.4).  
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Figure 4.4 Analysis of proliferative compartment by Ki67 staining of control and experimental Apc-deficient 
animals at day 10-12 post induction. (A) Cumulative frequency analysis of Ki67-positive cells revealed a 
significant enlargement of the proliferative compartment in AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm 
null animals in comparison to control mice (Kolmogorov- Smirnov Z test p<0.0001, n≥4).  Comparison of the 
distribution of proliferating cells between AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals 
revealed a significantly more expanded proliferative compartment in AhCreER
+
Apc
fl/fl
Brm null mice 
(Kolmogorov-Smirnov Z test, p<0.001, n≥4). (B) Immunohistochemical analysis of Ki67 staining confirmed the 
enlargement of proliferative compartment in the small intestinal epithelium of AhCreER
+
Apc
fl/fl
Brm null. Scale 
bar represents 100 μm. 
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4.2.6 Brm loss affects the differentiation of the certain intestinal epithelial cell 
types 
The interactions between Wnt and Notch signalling pathways play a crucial role in 
maintaining the homeostasis of the intestinal epithelium as well as being responsible for cell 
fate decisions of immature progenitor cells undergoing differentiation towards distinct 
populations of mature cells belonging to either the absorptive or secretory lineages. Previous 
studies of conditional deletion of Apc indicated that Wnt activation promotes proliferation 
and simultaneously leads to perturbation of the differentiation process. As evidenced before, 
in the context of Apc loss and subsequent aberrant Wnt signalling, Brm loss has shown to 
amplify some of the effects of Wnt activation on the crypt length and proliferative 
compartment in the epithelium of small intestine. Accordingly, the quantitative analysis of 
four main mature epithelial cell types found in the small intestine was conducted in 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals at day 10-12 post induction 
in order to characterise the effects of Brm loss on the cell differentiation in context of 
activated Wnt signalling. 
To assess the abundance and the distribution of enterocytes belonging to the absorptive 
lineage in the small intestinal epithelium, alkaline phosphatase staining was carried out 
marking the brush border of the enterocytes. A marked decrease in the intensity and the 
thickness of the staining was observed within the epithelium of Apc-deficient mice in 
comparison to the normal epithelium of control animals (Figure 4.5). A pronounced reduction 
in the brush border staining was detected in DKO animals compared to 
AhCreER
+
Apc
fl/fl
Brm
+/+
. 
Alcian Blue staining was performed to assess the frequency of goblet cells in the small 
intestine in experimental and control animals. Scoring of the positively stained cells showed a 
significant reduction in the number of goblet cells in both AhCreER
+
Apc
fl/fl
Brm
+/+
 and DKO 
animals per half crypt-villus compared to controls (6.37±0.185, 3.59±0.120 and 4.42±0.224, 
p values for all comparisons p<0.001, n≥4). Consistent with previous observations in small 
intestine in  context of homeostasis, a significant increase in the number of Alcian Blue-
stained cells was detected in Brm deficient animals in the context of Apc loss in comparison 
to AhCreER
+
Apc
fl/fl
Brm
+/+
 mice (p<0.001, n≥4, Figure 4.6) with the frequency of goblet cells 
being intermediary between normal and Wnt activated epithelium.  
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Paneth cells numbers and positions were scored by carrying out lysozyme 
immunohistochemical staining. The quantification of Paneth cells showed a significant 
increase in the number of cells present in the half-crypt between control and both cohorts of 
experimental animals (4.48±0.262 and 4.4±0.205 compared to 1.73±0.153, p values for all 
comparisons p<0.001, n≥4). Scoring of lysozyme-positive cells in the small intestinal 
epithelium of DKO revealed no difference from AhCreER
+
Apc
fl/fl
Brm
+/+
 mice (p=0.678, n≥4, 
Figure 4.7a). As normal levels of Wnt signalling are responsible for the positioning of Paneth 
cells within the crypt, the distribution of Paneth cells along the half crypt axis was scored in 
control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals. The analysis of 
cumulative frequency of lysozyme-positive cells revealed a significant expansion of Paneth 
cells in both Apc-deficient cohorts in comparison to controls (for either comparison, p<0.001, 
n≥4) as in the intestinal epithelium of control mice, Paneth cells were restricted to the base of 
the crypt whereas animals from both Apc-deficient cohorts showed a wider distribution of 
lysozyme-positive cells throughout the crypt compartment. The analysis of Paneth cell 
distribution revealed no differences between AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null small intestinal epithelium (p=0.283, n≥4, Figure 4.7b).  
Grimelius staining was used to identify another mature cell type belonging to the secretory 
lineage, namely enteroendocrine cells. The quantification of positively stained cells revealed 
a significant reduction in the number of cells with Grimelius staining in both Apc deficient 
and the DKO cohort in comparison to controls (0.37±0.033, 0.39±0.027 and 2.14±0.05 
respectively, p values for all comparisons p<0.0001, n≥4). The number of enteroendocrine 
cells in the small epithelium of DKO did not differ significantly from 
AhCreER
+
Apc
fl/fl
Brm
+/+
 epithelium (p=0.274, n≥4, Figure 4.8).   
The expression of Hes1 and Math1 the Notch effector genes is a key factor in the regulation 
of cell fate between absorptive and secretory lineages therefore expression levels of Hes1, 
Math1 and Muc2 were assessed by qRT-PCR allowing an assessment at the transcriptional 
level. mRNA was extracted from small intestinal samples of controls, 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm
 
null and control animals at the day 10-12 
post induction. qRT-PCR analysis of Hes1 revealed no changes between control and Apc-
deficient mice (p=0.487, n=6, Figure 4.9) with a marked decrease observed in DKO animals 
(p=0.022 and p=0.028 respectively, n=6). A significant increase in mRNA of Math1 in both 
Apc experimental cohorts was observed in comparison to controls (Figure 4.9, p=0.034 and 
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p=0.042, n=6). In contrast Muc2 expression remained unaltered in all but Apc-deficient 
cohort (Figure 4.9, p=0.039, n=6). 
 
Overall, the quantification of mature cell types in Wnt activated small intestinal epithelium 
revealed that Brm deficiency affects the differentiation of both absorptive and secretory 
lineage by leading to a marked reduction in the brush border enterocytes and a significant 
increase in the number of goblet cells.  
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Figure 4.5 Alkaline phosphatase staining detected a decreased brush border enterocytes in the epithelium of Apc 
deficient animals. The small intestinal sections of control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm 
null animals harvested at days 10-12 post induction were stained for alkaline phosphatase. Staining with 
chromogen revealed a marked decrease in the alkaline phosphatase expression in the small intestinal epithelium 
of both experimental cohorts compared to control mice. Visual inspection of the epithelium of 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals revealed a difference between those two cohorts 
with further reduction in brush border staining in Brm deficient animals. The scale bar represents 100μm.  
 
 
 
 
 
 
 
 
 
 
 
AhCreER+Apcfl/flBrm+/+ AhCreER+Apcfl/flBrm null 
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Figure 4.6 Alcian Blue staining was used to identify goblet cells within small intestinal epithelium. The small 
intestinal sections of control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals dissected at days 
10-12 post induction were stained to detect mucin secreting cells. Alcian Blue staining revealed a significant 
reduction in the number of stained cells in the small intestinal epithelium of both Apc-deficient cohorts (for 
either comparison p<0.001, n≥4). The quantification of Alcian Blue-positive cells detected a significant increase 
in goblet cells in DKO epithelium in comparison to AhCreER
+
Apc
fl/fl
Brm
+/+
 epithelium (p<0.001, n≥4). The 
scale bar represents 100μm.  
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Figure 4.7 Immunohistochemistry against lysozyme was carried out to visualize Paneth cells within small 
intestinal epithelium. The small intestinal sections of control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm 
null animals dissected at days 10-12 post induction were stained to reveal the number and localisation of Paneth 
cells. (A) Lysozyme staining detected a significant increase in number of Paneth cells in both experimental 
cohorts in comparison to controls (for either comparison p<0.001, n≥4). No changes in the numbers of Paneth 
cells were observed between DKO and Apc-deficient animals (p=0.678, n≥4). (B) Subsequent Cumulative 
frequency analysis of Paneth cell distribution revealed a significant expansion of Paneth cells throughout the 
crypt in AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null small intestine compared to control animals (for 
either comparison Kolmogorov-Smirnov Z test p<0.001, n≥4) with no difference observed between DKO and 
Apc-deficient cohorts (Kolmogorov-Smirnov Z test p=0.283, n=4).. The scale bar represents 100μm. 
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Figure 4.8 Grimelius staining of small intestinal sections was carried out to label enteroendocrine cells. The 
small intestinal sections of control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals dissected at 
days 10-12 post induction were stained to identify enteroendocrine cells. This cell-specific staining revealed a 
significant decrease in the number of enteroendocrine cells in Apc-deficient animals in comparison with 
controls (for either comparison, p<0.001, n≥4). The quantification of positively stained cells detected no 
difference in the enteroendocrine cell numbers between DKO and AhCreER
+
Apc
fl/fl
Brm
+/+
 animals. The scale 
bar represents 100μm. 
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Figure 4.9 The transcriptional levels of Hes1, Math1 and Muc2 were assessed by quantitative real-time-PCR 
(qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised with β-actin (n=6). Analysis of 
levels of Hes1 mRNA showed a significant downregulation of expression in the epithelium of DKO animals  in 
comparison to both control and Apc-deficient animals (p=0.022 and p=0.028 respectively, n=6). The levels of 
Math1 mRNA were significantly upregulated from those observed in controls (p=0.034 and p=0.042, n=6) 
whereas no changes in the Muc2 expression was observed between Apc-deficient epithelium with or without 
functional Brm (p=0.039, p=6)  
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4.2.7 Brm loss does not modulate β-catenin levels and localisation following loss 
of Apc  
Histological analysis of proliferation, apoptosis and cell differentiation in 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null epithelium suggested that Brm 
deficiency does modulate some of the phenotypes observed following Wnt activation in Apc-
deficient animals.  
In order to investigate whether the apparent accentuation of the Wnt-driven phenotype by 
Brm deficiency is caused by modulation of Wnt signalling I initially assessed the levels of 
stabilised β-catenin in the small intestinal epithelium. One of the immediate effects of loss of 
Apc is the disruption of β-catenin destruction complex in the cytoplasm subsequently 
allowing the accumulation of non-phosphorylated and therefore stabilized β-catenin. The 
accumulation of β-catenin in the nucleus results in the activation of Wnt-driven transcription 
of genes (Waterman et al. 2002) hence it is one of the hallmarks of activated Wnt signalling 
upon Apc loss. Therefore I aimed to examine the levels of stabilised β-catenin in the small 
intestinal epithelium of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals at 
day 10-12 post induction. 
As previously described in section 2.2.3, immunohistochemical analysis of β-catenin 
expression at day 10-12 post induction in AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm 
null animals identified nuclear localisation of β-catenin in the floxed areas of epithelium in 
both experimental cohorts. However no discernible difference in the expression levels of 
stabilized β-catenin was detected between Apc-deficient and DKO mice.  
The levels of β-catenin stabilization were quantified by Western blotting in 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals at the day 10-12 post 
induction (n=4). The analysis of the levels of protein detected significantly higher levels of 
activated β-catenin in both Apc-deficient cohorts in comparison to controls (Figure 4.10a) 
however the analysis of the levels of nuclear β-catenin between AhCreER+Apcfl/flBrm+/+ and 
AhCreER
+
Apc
fl/fl
Brm null animals revealed no difference in the expression of this protein in 
the intestinal epithelium samples (Figure 4.10b).  
Therefore the effects of Brm loss on the phenotype of Apc-deficient small intestinal 
epithelium are not directly mediated at the level of major downstream effector of Wnt 
signalling β-catenin further suggesting that modulations of Wnt-driven tumorigenesis in 
AhCreER
+
Apc
fl/fl
Brm null epithelium may occur somewhere downstream of β-catenin.  
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Figure 4.10 Brm loss does not affect the levels of stabilized β-catenin in the small intestinal epithelium of Apc-
deficient animals. (A) Western blotting analysis of samples from AhCreER
-
, AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null animals harvested at day 10-12 post induction showed a marked increase in the levels 
of activated β-catenin in Apc-deficient animals in comparison to controls. β-actin represents a loading control 
for the blot. (B) The analysis of β-catenin levels by densitometry revealed no differences in protein levels 
between DKO and Apc-deficient animals (p=0.318, n≥4, Mann Whitney U Test).  
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4.2.8 Brm deficiency modulates the expression of genes crucial to the 
development and progression of CRC 
No direct interactions between Brm chromatin remodelling factor and the Wnt pathway have 
been reported to date however Brm has been reported to associate with one of the major 
downstream targets of β-catenin, namely CD44 (Reisman et al. 2002, Banine et al. 2005, 
Batsché et al. 2006) as well as with the transmembrane glycoprotein E-cadherin whose 
expression is associated with size, differentiation and invasive potential of CRCs. These 
observations may suggest that whereas there is no association between Brm and the major 
effector of Wnt signalling (β-catenin), Brm may indirectly influence the levels of Wnt target 
genes such as CD44 and c Myc and other genes crucial in CRC tumorigenesis such as E-
cadherin. Therefore I aimed to investigate whether Brm loss modulated the transcriptional 
program activated via mutation of Apc gene by performing a qRT-PCR analysis of expression 
levels of a subset of Wnt target genes and genes involved in the development and progression 
of CRC. mRNA was extracted from small intestinal tissue samples of control, 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals dissected at day 10-12 post 
induction.  
The assessment of mRNA levels of CD44, c-Myc and Cyclin D1 and E-cadherin revealed a 
significantly higher expression of these genes in the epithelium of AhCreER
+
Apc
fl/fl
Brm
+/+
 
animals compared to controls (for all comparisons p<0.05, n≥4, Figure 4.11). Remarkably, 
the up-regulation of those genes in the epithelium of AhCreER
+
Apc
fl/fl
Brm null animals was 
less pronounced with levels of c-Myc and Cyclin D1 not different from those observed in the 
control small intestinal epithelium. Strikingly, E-cadherin was the only gene within the 
studied subset of genes whose mRNA levels displayed a trend of increase in DKO mice in 
comparison to Apc-deficient cohort however this trend was not proved to be significant 
(p=0.073, n≥4). However, in the absence of an independent measure which would account for 
differences in the level of APC/β-catenin in the epithelium and therefore levels of Wnt 
activation, the above results could not be fully interpreted.   
Furthermore, I assessed the influence of Brm deficiency on the expression of the CD44 Wnt 
target gene by immunohistochemical staining of AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null tissue sections of small intestine with an antibody against CD44 
(Figure 4.12). Due to the AhCreER recombinase driving recombination of the targeted Apc 
allele at below 100% efficiency (Kemp 2004), the areas of unfloxed epithelium neighbouring 
with neoplastic tissue could be identified within the intestinal epithelium allowing inter- and 
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intra-comparison of CD44 expression. To further facilitate the analysis, I performed 
immunohistochemical staining against β-catenin which is well-known as a surrogate marker 
of Apc loss. Comparison of the non-neoplastic epithelium labelled by membranous β-catenin 
and Wnt-activated epithelium with nuclear β-catenin in both experimental cohorts revealed a 
marked increase in CD44 expression in the neoplastic areas of tissue. Moreover, analysis of 
the pattern of CD44 expression in the neoplastic epithelium between AhCreER
+
Apc
fl/fl
Brm
+/+
 
and AhCreER
+
Apc
fl/fl
Brm null cohort detected a noticeable decrease in the expression of 
CD44 in the DKO mice consistent with qRT-PCR results.  
Taken together, these observations suggest that Brm loss is capable of suppressing β-catenin-
mediated transcriptional activation of Wnt target genes and other crucial players in CRC 
tumorigenesis however this effect seems to be specific to a particular subset of genes.  
 
 
 
Figure 4.11 Brm loss suppresses the expression of the Wnt target genes and genes involved in development and 
progression of CRC. The transcriptional levels of Wnt targets CD44 and c-Myc as well as Cyclin D1 and E-
cadherin genes was quantified by quantitative real-time-PCR (qRT-PCR) as shown in bar graph form. The data 
from qRT-PCR are normalised with β-actin and the asterisks indicate comparisons that were found to be 
significantly different (p<0.05, n≥4). Analysis of levels of CD44, c-Myc and Cyclin D1 mRNA displayed a 
significant decline in expression of those genes in the epithelium of AhCreER
+
Apc
fl/fl
Brm null in comparison to 
AhCreER
+
Apc
fl/fl
Brm
+/+
 animals.  
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Figure 4.12 Brm deficiency results in the diminished expression of CD44 in context of aberrant Wnt signalling. 
Immunohistochemical staining against β-catenin and CD44 was performed on the serial sections of small 
intestinal epithelium of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals. The analysis of β-
catenin staining allowed for identification of Apc-deficient regions of epithelium (green box) and unfloxed areas 
(red box). The analysis of CD44 expression revealed a marked decrease in the CD44 expression in DKO cohort 
in comparison to Apc-deficient animals confirming the change in CD44 levels observed by qRT-PCR. The scale 
bar represents 100 μm. 
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4.2.9 Brm deficiency leads to the reduction of the Wnt-mediated expansion of 
stem cell population 
Previous studies focusing on early stages of intestinal neoplasia found that many CRCs 
express high levels of intestinal stem cell-specific genes suggesting an expansion of intestinal 
stem cell population as a consequence of aberrant Wnt signalling (Sansom et al. 2004, Jubb 
et al. 2006, Merlos-Suarez et al. 2011). Taking into the account the significantly attenuated 
expression of Wnt target genes in Brm-deficient animals but similar phenotype and survival 
between both Apc-deficient experimental cohorts, I investigated whether the lack of 
improved phenotype might be due to Brm loss exacerbating the expansion of intestinal stem 
cell population in the Wnt activated epithelium of small intestine. To this end, mRNA was 
extracted from the tissue samples of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null 
animals at day 10-12 post induction was used for qRT-PCR.  
The expression levels of intestinal stem cell markers Ascl2, Lgr5 and Olfm4 revealed a trend 
of a decrease in both Ascl2 and Lgr5 expression in DKO animals in comparison with Apc-
deficient animals however this result did not reach significance (p=0.288 and p=0.425 
respectively, n=6, Figure 4.13a). Notably, a significant decrease in the expression levels of 
Olfm4 in the epithelium of AhCreER
+
Apc
fl/fl
Brm null animals was detected (p=0.048, n=6).  
The diminished levels of these intestinal stem cell markers in the DKO cohort may simply 
reflect perturbation of Wnt signalling rather than changes in the actual stem cell 
compartment. Notably, Olfm4 is a Wnt independent stem cell marker and may therefore be 
used as a more direct assessment of changes in the stem cell compartment. Therefore to 
extend the qRT-PCR data above, in situ hybridisation against Olfm4 was conducted on the 
small intestinal tissue from control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null 
animals harvested at day 10-12 post induction (Figure 4.13b). Analysis of Olfm4 expression 
in the epithelium of control mice detected positive staining at the base of the intestinal crypt 
whereas in the epithelium of Apc-deficient animals Olfm4 staining was present throughout 
the length of the Wnt activated crypt extending towards the crypt-villus axis. Conversely, 
DKO animals Olfm4 expression in the area where Olfm4 probe has bound was limited to the 
base of the crypt similarly to the pattern observed in control animals. To conclude, these 
results suggest that in the context of aberrant Wnt signalling Brm loss attenuates the 
expression of the Wnt independent stem cell marker Olfm4.  
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Figure 4.13 Analysis of intestinal stem cell niche in Brm null animals. (A) The transcriptional level of Ascl2, 
Lgr5 and Olfm4 was assessed by quantitative real-time-PCR (qRT-PCR) as shown in bar graph form. The data 
from qRT-PCR are normalised with β-actin. Analysis of levels of Ascl2 and Lgr5 mRNA revealed a trend of 
decrease in DKO experimental animals in comparison to AhCreER
+
Apc
fl/fl
Brm
+/+
 animals which was not 
significant (p=0.288, p=0.425 respectively, n=6). A significant 7-fold decrease in the expression levels of Olfm4 
was observed in DKO cohort (p=0.048, n=6) (B) In situ hybridization against Olfm4 detected a significant 
decrease in the amount of probe bound in the Wnt-activated small intestinal epithelium of DKO in comparison 
to AhCreER
+
Apc
fl/fl
Brm
+/+
 animals. While a marked expansion of stem cell zone was observed in Apc-deficient 
animals compared to controls, the Olfm4 riboprobe-stained area was substantially lower in DKO cohort than in 
AhCreER
+
Apc
fl/fl
Brm
+/+
 mice. Scale bar represents 100 μm.  
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4.2.10 Brm loss has mild effects on the homeostasis of large intestinal epithelium 
 
As observed previously, in the Wnt-activated epithelium of small intestine Brm deficiency 
leads to the morphological abnormalities such as elongated crypt compartment and increase 
in apoptosis as well as some changes in the differentiation of mature epithelial cell types 
resulting in a marked decline in the brush border enterocytes and an increase in goblet cell 
population when compared to Apc-deficient animals. Due to the differences in the effects of 
Brm loss on the epithelium of small and large intestine (described in the chapter 3) together 
with the fact that colonic epithelium is also expressing AhCreER recombinase, I aimed to 
examine the effects of Brm deficiency on the colonic epithelium in AhCreER
+
Apc
fl/fl
Brm
+/+
 
and AhCreER
+
Apc
fl/fl
Brm null animals dissected at day 10-12 post induction. A quantitative 
analysis performed on this tissue sections is summarized in Table 4.2. 
Similarly to the observations of Wnt-activated epithelium of small intestine, macroscopic 
analysis of colonic epithelium during tissue harvesting revealed no gross tissue abnormalities 
or perceptible tumours that could be assessed macroscopically.    
Crypt length has been assessed on H&E stained sections as the average number of cells (± 
standard deviation) from the base of the crypt of Lieberkühn all the way to the flat surface of 
the colonic epithelium. Crypt size was found to be increased in colonic epithelium of both 
Apc-deficient and DKO animals compared to controls (30.66±1.33, 28.56±1.49 and 
24.31±0.32, p=0.012 and p=0.002 respectively, n≥4, Figure 4.14a). There was no difference 
in the crypt length between AhCreER
+
Apc
fl/fl
Brm null and AhCreER
+
Apc
fl/fl
Brm
+/+
 animals 
(p=0.096, n≥4).  
Apoptosis within the epithelium was detected and scored by Cleaved Caspase-3 
immunohistochemical staining. Similarly to the effects of Wnt activation of small intestinal 
epithelium, the quantitative analysis of Cleaved Caspase-3-positive cells revealed a 
significant increase in levels of apoptosis in Apc-deficient versus control mice (0.65±0.02 
and 0.060±0.016, p=0.0001 n≥4, Figure 4.14b). A marked increase in the number of Caspase-
3-positive cells was also detected in the epithelium of AhCreER
+
Apc
fl/fl
Brm null animals in 
comparison to control animals (1.17±0.14 and 0.060±0.016, p=0.0001 n≥4) and moreover the 
observed increase in the apoptosis in the colonic epithelium of DKO animals was significant 
compared to Apc-deficient cohort (p=0.001, n≥3, Figure 4.14b). The assessment of the size of 
proliferative compartment was performed using staining against Ki67 proliferation marker. 
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Quantification of Ki67-positive cells within the colonic epithelium showed that the average 
number of proliferating cells per crypt in Apc-deficient animals remains unaltered in 
comparison to control animals (7.57±0.67 and 6.61±1.04, p=0.196, n≥4, Figure 4.14c). In 
contrast, I detected a significant increase in the proliferation levels in DKO animals compared 
to control animals (11.35±1.59 and 6.61±1.04, p=0.001, n≥4). Furthermore, an increase in the 
number of Ki67-positive cells was observed in the epithelium of AhCreER
+
Apc
fl/fl
Brm null 
versus AhCreER
+
Apc
fl/fl
Brm
+/+
 animals (p=0.004, n≥4, Figure 4.14b).  
Therefore in the context of colonic epithelium and Wnt activation via mutation in Apc gene, 
the quantitative analysis of Brm-deficient tissue did not reveal any alteration in the length of 
crypt in contrast to marked increase in both apoptosis and proliferation levels when compared 
to Apc-deficient epithelium. Whereas the general morphology of Wnt-activated large 
intestine appears to not be affected by constitutive loss of Brm, the crucial cellular processes 
of apoptosis and proliferation are indeed altered.    
Parameter  Cohort  Mean  SD    
Control vs 
Apc KO 
p-values 
Control vs 
DKO 
 
Apc KO 
vs DKO 
Crypt 
length  
Control 
Apc KO 
DKO  
24.31 
30.66 
28.56  
0.319 
1.331 
1.492 
0.012 0.002 0.096 
Caspase 
positive 
cells  
Control 
Apc KO 
DKO 
0.060 
0.650 
1.172  
0.016 
0.025 
0.148 
0.000 0.000 0.001 
Ki67 
positive 
cells  
Control 
Apc KO 
DKO 
6.609 
7.574 
11.35 
1.039 
0.671 
1.595  
0.196 0.001 0.004 
 
Table 4.2 Quantitative analysis of the effects of Brm loss on the histology of Wnt-activated colonic epithelium. 
Epithelium from large intestine from Cre
-
 Brm
+/+
 (marked as Control), AhCreER
+
Apc
fl/fl
Brm
+/+
 (marked as Apc 
KO) and AhCreER
+
Apc
fl/fl
Brm null (marked DKO) was harvested from animals at days 10-12 post induction. 
Histological parameters including crypt length, apoptosis and proliferation were quantified and comparison 
between those two cohorts was conducted using statistical software.  
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Figure 4.14 Histological analysis of the effects of Brm loss in the Wnt-activated colonic epithelium. Control 
AhCreER
-
 and experimental AhCreER
+
Apc
fl/fl
Brm
+/+
 (marked as Apc KO) and AhCreER
+
Apc
fl/fl
Brm null 
(marked DKO) was harvested from animals at days 10-12 post induction. A-C histological parameters such as 
(A) crypt length were counted on H&E tissue sections. The average number of (B) Cleaved Caspase3 and (C) 
Ki67-positive cells was scored on the corresponding immunostained sections. Scale bar represents 100 μm. 
Error bars represent standard deviation and asterisk symbol indicates those histological parameters that showed 
a statistically significant difference (p value <0.05) between cohorts of mice. Exact values, standard deviations, 
p values are provided in Table 4.2 
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4.2.11 Brm loss results in a change in the distribution of proliferating cells  in 
the Apc-deficient colonic epithelium 
 
Immunohistochemical staining with Ki67 proliferation marker was also used to assess the 
shape of the proliferative compartment within the colonic epithelium of control, 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals. 
The analysis of the cumulative frequency of Ki67-positive cells showed a significant 
expansion of the proliferative compartment in both AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null cohorts in comparison to controls (Kolmogorov-Smirnov Z test 
p=0.001, n≥4, Figure 4.15). Furthermore, the distribution of proliferating cells in the Apc-
deficient experimental cohorts revealed a redistribution of Ki67-positive cells in the 
epithelium of Brm-proficient animals (Kolmogorov-Smirnov Z test p=0.001, n≥4) therefore 
suggesting that Brm loss alters the shape of the proliferative compartment in Wnt-activated 
epithelium.  
 
Figure 4.15 Analysis of proliferative compartment by Ki67 staining of AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brm null epithelium animals at day 10-12 post induction. Cumulative frequency analysis of 
Ki67-positive cells revealed a significant enlargement of the proliferative compartment in 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals in comparison to control mice (Kolmogorov- 
Smirnov Z test p<0.001, n≥4).  Proliferative compartment is significantly shorter in AhCreER+Apcfl/flBrm null 
in comparison to Apc-deficient colonic epithelium (Kolmogorov-Smirnov Z test, p<0.001, n≥4).  
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4.2.12 Brm deficiency does not alter differentiation status in Wnt-activated 
colonic epithelium 
 
Consistent with the results from the previous section showing the alterations in both 
apoptosis and proliferation of Wnt-activated colonic epithelium, I aimed to examine whether 
the differentiation potential of progenitor cells within this epithelium was also affected by 
Brm deficiency. The analysis of populations of mature epithelial cells of secretory lineage 
was carried out on the tissue sections of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm 
null animals harvested at day 10-12 post induction.  
Alcian Blue staining was performed to assess the population of goblet cells in the colonic 
epithelium of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals (Figure 4.14). 
The quantification of positively stained cells revealed a significant decrease in the number of 
goblet cells per half crypt between control and Apc-deficient animals as well as between 
controls and DKO animals (6.50±0.07 versus 4.98±0.19 and 6.50±0.07 versus 5.00±0.34, 
p=0.0001 for either comparison, n≥4). However no difference in the number of Alcian Blue-
stained cells was detected in the crypts of DKO mice compared to Apc-deficient cohort 
(p=0.905, n≥4, Figure 4.16). 
The numbers of enteroendocrine cells present in the colonic crypts were determined using 
Grimelius staining. Identification and scoring of these cells per half crypt showed a marked 
decline in the numbers of Grimelius-stained cells in the Apc-deficient and DKO animals in 
comparison to control animals (0.47±0.06 versus 1.61±0.05 and 0.5±0.02 respectively, 
p=0.0001 for either comparison, n≥4, Figure 4.17). The number of enteroendocrine cells in 
the colonic epithelium of AhCreER
+
Apc
fl/fl
Brm null mice was unaltered from that of 
AhCreER
+
Apc
fl/fl
Brm
+/+
 cohort (p=0.52, n≥4).  
The quantification of the mature cell types that are predominant in the epithelium of large 
intestine revealed in the context of aberrant Wnt signalling, Brm-deficient animals display the 
general trend of diminished differentiation of epithelial cell types in comparison to the 
control cohort, however these changes are no different to those observed in the Apc-deficient, 
Brm proficient animals. 
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Figure 4.16 Alcian Blue staining was used in order to mark goblet cells within colonic epithelium. The colon 
sections of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals were dissected at day 10-12 post 
induction and stained using cell specific stain detecting mucin secreting cells. Black arrows indicate individual 
goblet cells within the epithelium. Staining revealed no changes in the number of Alcian Blue-positive cells in 
DKO animals in comparison with Apc-deficient cohort. The scale bar represents 100μm.  
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Figure 4.17 Grimelius staining of colonic sections was carried out to visualize the number of enteroendocrine 
cells on colonic epithelium sections of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals dissected 
at day 10-12 post induction. Black arrow indicates individual enteroendocrine cell within the epithelium. The 
scoring of numbers of cells detected no difference in numbers of enteroendocrine cells between DKO and Apc-
deficient epithelium. The scale bar represents 100μm. 
 
 
  
AhCreER+Apcfl/flBrm+/+ AhCreER+Apcfl/flBrm null 
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4.2.13 Brm deficiency leads to the attenuation of the β-catenin-activated 
transcription of Wnt target genes 
Previous observations indicating that Brm deficiency is capable suppression of the expression 
of Wnt target genes CD44 and c-Myc in the Wnt activated small intestinal epithelium 
(section 2.2.8). In order to compare the effects of Brm loss in the Wnt-driven tumorigenesis 
between small intestinal and colonic epithelium as well as to investigate whether Brm loss 
might also attenuate the Wnt-driven transcriptional program, I performed a qRT-PCR 
analysis of expression levels of some Wnt target genes and genes involved in the 
development and progression of CRC. mRNA was extracted from colon tissue samples of 
control, AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals dissected at day 10-
12 post induction.  
The expression analysis of mRNA levels of CD44, c-Myc and Cyclin D1 revealed a 
significantly higher expression of these genes in the epithelium of Apc-deficient animals 
compared to controls (for all comparisons p<0.05, n≥4, Figure 4.18). Similarly to the results 
obtained from small intestine, the up-regulation of both Wnt target genes in the epithelium of 
AhCreER
+
Apc
fl/fl
Brm null animals was less pronounced than in AhCreER
+
Apc
fl/fl
Brm
+/+
 
cohort. Expression levels of CD44 in DKO animals were indifferent from those observed in 
the control small epithelium whereas c-Myc mRNA remained significantly higher. The levels 
of expression of cyclin D1 were significantly higher in the AhCreER
+
Apc
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/flBrm null epithelium compared to controls (p<0.05, n≥4) with no difference 
between both Apc-deficient cohorts (p=0.265, n≥4).  
As shown in the small intestinal epithelium, the presence of lesions with nuclear β-catenin in 
the colonic epithelium of AhCreER
+
Apc
fl/fl
Brm null animals indicated that Brm is 
dispensable for Wnt-driven CRC.  Immunohistochemical analysis was used to further assess 
the effect of Brm deficiency on the tumorigenesis driven by the Apc loss. In particular, I 
aimed to examine whether the expression of the CD44 Wnt target gene was altered in the 
colonic lesions as CD44 upregulation is one of the well-described phenotype manifestations 
of aberrant Wnt signalling in colorectal tumorigensis. The staining of colonic 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null sections with antibody against CD44 
was performed on tissue from animals dissected at day 10-12 post induction (Figure 4.19). 
Analysis of patterns of CD44 expression in the neoplastic epithelium labelled with nuclear β-
catenin in both Apc-deficient cohorts revealed a marked decrease in CD44 expression in the 
174 
 
AhCreER
+
Apc
fl/fl
Brm null sections in comparison with AhCreER
+
Apc
fl/fl
Brm
+/+
 sections 
which is consistent with the qRT-PCR results.  
Taken together, these observations suggest that Brm loss is compatible with Wnt-driven 
tumorigenesis in the colonic epithelium. In the context of an activated Wnt pathway, Brm 
deficiency reduces transcriptional activation of Wnt target genes in particular CD44, 
however, deficiency failed to attenuate the expression of cyclin D1 and E-cadherin, other key 
genes in CRC tumorigenesis. These results differ from those obtained from small intestinal 
epithelium suggesting that some modifications of Wnt-driven turmorigenesis by Brm appear 
be tissue- or cell type-specific.  
 
 
 
 
 
Figure 4.18 Brm loss suppresses the expression of the Wnt target genes. The transcriptional levels of Wnt 
targets CD44 and c-Myc as well as Cyclin D1 and E-cadherin genes was quantified by quantitative real-time-
PCR (qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised with β-actin and the 
asterisks indicate comparisons that were found to be significantly different (p<0.05, n≥4). Analysis of levels of 
CD44, c-Myc revealed a significant decrease in the expression of those genes in the epithelium of 
AhCreER
+
Apc
fl/fl
Brm null in comparison to AhCreER
+
Apc
fl/fl
Brm
+/+
 animals. The expression levels of two other 
key genes participating in the development and progression of CRC, cyclin D1and E-cadherin were found 
unaltered between those two Apc-deficient experimental cohorts.   
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Figure 4.19 Brm deficiency leads to decrease in the expression of CD44 in context of activated Wnt pathway in 
the colonic epithelium. Immunohistochemical staining against β-catenin and CD44 was performed on the serial 
sections of colonic epithelium of AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals. The analysis 
of β-catenin staining allowed for identification of Apc-deficient regions of epithelium (green box) characterized 
by the presence of nuclear β-catenin. The comparative analysis of CD44 expression between the epithelia of 
AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals showed a perceptible decrease in the CD44 
expression in DKO cohort in comparison to Apc-deficient animals. The scale bar represents 100 μm. 
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4.3 Discussion 
In the previous chapter, I examined the impact of Brm deficiency in the homeostasis of 
epithelium of small and large intestine. In spite of numerous studies initially indicating 
SWI/SNF chromatin remodelling complex components as bona fide tumour suppressor 
genes, homozygous constitutive loss of Brm was not capable of inducing tumorigenesis in 
any of previously studied tissue type, nor in the small intestinal or colonic epithelium. In 
comparison to other transgenic murine models of SWI/SNF subunit deficiencies, both 
constitutive and conditional, loss of Brm ATPase did not lead to lethal phenotype. Brm 
deficiency resulted in the expansion of elongated crypts, unaffected proliferative 
compartment and significant upregulation of differentiation towards secretory lineages of 
mature epithelial cell type, however, stem cell function and intestinal homeostasis in general 
remained unaffected. To summarize, the results obtained indicated that deficiency in Brm 
chromatin remodelling factor is not capable of inducing tumorigenesis on its own which 
occurs in case of deficiency in SNF5 subunit of SWI/SNF chromatin remodelling complex. 
Histological analyses of human tumours suggested that alterations in SWI/SNF, in catalytic 
subunits such as Brm and Brg1 in particular, are frequently found in the gastric, leukemia, 
lung, prostate and skin cancers (reviewed in Weissman et al. 2009). The role of Brm as a 
component of the remodelling complex that is indispensable for Rb-mediated growth 
inhibition (Strober et al. 1996, Reisman et al. 2003) as well as being one of the key regulators 
of the expression of the Wnt target gene CD44 in cancer cell lines (Strobeck et al. 2001, 
Banine et al. 2005, Batsché et al. 2006) both implicated Brm as a potential factor contributing 
towards CRC tumorigenesis. Wnt signalling plays a critical role in the intestinal homeostasis 
and is dysregulated in almost all cases of intestinal neoplasia in both mice and humans. 
Therefore investigating whether Brm is capable of indirect interaction with the Wnt pathway 
and subsequently the effects of Brm deficiency in the context of aberrant Wnt signalling in 
vivo, is of a great importance for validation of Brm as a potential tumour suppressor gene in 
CRC tumorigenesis.   
In this chapter, I investigated whether loss of Brm chromatin remodelling factor is capable of 
escalating Wnt-driven intestinal tumorigenesis caused by homozygous loss of Apc. The other 
aim of this study was to examine the modification of the activated Wnt pathway phenotype 
by Brm deficiency. In order to achieve this, I exploited a conditional Cre-loxP recombination 
system specific to intestinal epithelium to inactivate both alleles of Apc gene subsequently 
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leading to aberrantly activated Wnt pathway. Targeted Apc loss was put in the context of 
Brm loss by introduction of this allele to mice already bearing constitutive Brm null alleles. 
The results presented in this chapter show that Brm deficiency does not accelerate or suppress 
Wnt-driven tumorigenesis as both survival of animals and phenotype of Apc-deficient lesions 
are indifferent from those found in Apc KO animals. While Brm loss in the context of 
activated Wnt signalling leads to even further enlarged crypts, an increase in apoptosis, and 
an expansion of proliferative compartment at the cost of decline in differentiation, it also 
suppressed the expression of Wnt target genes and expansion of the stem cell population 
leading eventually to restoration of optimal level of Wnt activation in tumour cells similar to 
that seen in Apc-deficient intestinal epithelium. 
4.3.1 Brm deficiency affects the survival of Apc-deficient animals  
As shown in the previous chapter, constitutive loss of both alleles of Brm does not induce 
tumorigenesis in the small or large intestinal epithelium, therefore I aimed to investigate 
whether Brm deficiency would enhance the development of intestinal neoplasia in the context 
of targeted loss of Apc gene. By exploiting a mouse model of germline mutation in Apc
580S
 
under the expression of intestinal-specific Cre recombinase (AhCreER) I have generated two 
cohorts of animals with homozygous Apc loss with and without Brm null alleles. 
Experimental AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null animals as well as 
AhCreER
- 
controls were aged and the intestinal epithelium was harvested once mice became 
ill. All AhCreER
+
Apc
fl/fl
Brm
+/+
 and AhCreER
+
Apc
fl/fl
Brm null had to sacrificed within the 
first 3 weeks following induction by Tamoxifen and β-napthoflavone. In contrast to other 
pan-intestinal recombinases, AhCreER expression is restricted to a relatively small 
population of intestinal stem cells and early intestinal progenitor cells. Exploiting this limited 
expression of AhCreER would possibly allow long-term activation of Wnt pathway as in 
order for cells carrying an induced loss of Apc to become detectable within the epithelium, 
numerous rounds of cell division must occur.  
Despite the use of a tissue-specific Cre recombinase and a dually-controlled expression 
system, no long-term macroscopical tumour burden analysis was possible due to the overall 
short lifespan of experimental animals. Microscopic analysis of intestinal epithelium revealed 
numerous single crypt lesions and some larger lesions with highly dysplastic cells all 
featuring expression of stabilized β-catenin. In contrast in the colonic epithelium, the number 
of lesions expressing nuclear β-catenin as well as their size was lower than in small intestine 
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suggesting that the activation of Wnt-driven tumorigenesis lead to graduated neoplastic 
response within the intestinal epithelium. Furthermore, the analysis of survival probability 
detected no difference between Apc-deficient mice with or without Brm. Whereas the lack of 
effect on early stage dysplasia in Brm null animals has been previously well described (Reyes 
et al. 1998, Muchardt and Yaniv 1999), the observation that Brm deficiency is unable to 
accelerate the formation of tumours is in contrast with previous reports from lung and skin 
cancers suggesting that Brm contributes towards carcinogenesis. This disparity in results may 
indicate that Brm chromatin remodelling factor acts as a tumour suppressor in a tissue-
specific manner or even more specifically, in a cell-type dependent manner. This tissue-
specific requirement for SWI/SNF chromatin remodelling has been previously demonstrated 
by Holik et al. (PhD thesis 2011) showing that Brg1 loss is not compatible with Wnt 
activation and expression of nuclear β-catenin in the small intestinal epithelium subsequently 
implicating that only Brg1 proficient intestinal lesions have the capacity to develop towards 
more advanced forms of neoplasia.  
Previous studies on murine models showed that the exposure of Brm-deficient animals to 
ethyl carbamate results in the increased development of lung adenomas (Glaros et al. 2007). 
Similarly the study of skin carcinogenesis showed that Brm null animals had an increased 
incidence of skin and ocular tumours once exposed to ultraviolet radiation compared to wild-
type animals (Halliday 2012). Furthermore analysis of Brm expression in human cancers 
revealed that reduction of Brm expression in human gastric and prostate cancers correlates 
with poor prognosis whereas loss of heterozygosity at the Brm locus in the head and neck 
cancer is associated with poor prognosis in humans. However in this study I did not observe 
an acceleration of Wnt-driven tumorigenesis in the epithelium of small or large intestine 
suggesting that Brm might not function as bona fide tumour suppressor gene in the intestinal 
neoplasia. Notably, a transgenic model of skin cancer exploiting p53 deficiency combined 
with a loss of Brm failed to detect higher tumour number than that of p53
+/-
 however the 
growth rate of the tumours was significantly higher in Brm
-/-
 p53
+/-
 compared to p53
+/-
 
(Halliday et al. 2012). Loss of p53 is known as one of the earliest events in UV-induced skin 
carcinogenesis, similar to the mutations in Apc in colorectal cancers, indicating that whereas 
Brm does not influence overall tumour burden, there might be a requirement for Brm 
expression for tumour suppression in a cell type-specific manner. 
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Taken together, the results obtained from normal intestinal epithelium as well as Wnt-
activated epithelium suggest that in a short term study, Brm does not attenuate or accelerate 
tumour development.   
4.3.2 Brm deficiency has a dual role in small intestinal epithelium by enhancing 
some histological effects of activated Wnt signalling with concomitant 
suppression of Wnt target genes  
As suggested in previous reports, due to the role of Brm ATPase subunit in transcriptional 
activation and repression rather than acting as a direct tumour suppressor of signalling 
pathways in human cancers, I investigated the effects of Brm deficiency in the context of 
aberrant Wnt signalling in the small intestinal epithelium. The activation of Wnt pathway was 
achieved by conditional deletion of both alleles of Apc gene in the context of constitutive loss 
of Brm (Brm null) under the expression of intestinal-specific Cre recombinase AhCreER.  
Initial analysis of Apc-deficient epithelium with and without Brm loss revealed characteristic 
phenotype associated with initiation and early development of intestinal lesions, mimicking 
features of conditional Apc loss under control of the AhCre promoter observed by Sansom et 
al. (2004). Further analysis of the histological parameters such as crypt length, proliferation, 
apoptosis and differentiation revealed the exacerbation of cellular responses mediated by 
stabilized β-catenin in the Brm-deficient epithelium. In contrast, the gene expression analysis 
showed a significantly reduced Wnt target gene expression in DKO animals in comparison to 
levels observed in Brm-proficient Apc-deficient animals. Overall, these observations from the 
small intestinal epithelium suggest that Brm plays a dual role in enhancing the effects of Wnt 
activation on processes such as proliferation and apoptosis as well as in parallel mediating 
suppression of expression of Wnt target genes.    
Microscopic analysis of small intestinal epithelium of DKO animals identified numerous 
high-grade dysplastic cells characterized by the presence of nuclear β-catenin staining within 
the crypt-villus structures. The general architecture of the epithelium was altered with a 
distinct crypt compartment no longer identifiable whereas in some areas of tissue with a 
much higher than other regions number of Apc-deficient cells, the architecture along the 
crypt-villus axis was dysmorphic and significantly altered.  Enlarged abnormal crypts, 
increase in apoptosis levels and a significant expansion of proliferative compartment 
measured by Ki67 distribution analysis – all features of acute activation of Wnt signalling 
(Sansom et al. 2004) were shown to be even more pronounced in the small intestine of Brm 
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deficient mice. Notably, the same morphological parameters were altered in the small 
intestinal epithelium of Brm null animals (section 3.2.4) and consistent with studies reporting 
a marked increase in Ki67 proliferation index in epithelial compartment of murine prostate 
cancers (Shen et al. 2008) furthermore indicating that functional Brm might be required for 
the maintenance of the required levels of proliferating cells in the normal as well as Wnt-
activated small intestinal epithelium. Expanding number of tumour cells featuring progenitor-
like phenotype and upregulation of intestinal stem cell-specific genes Ascl2, Lrg5 and Olfm4 
are presumably additionally causing perturbations in proliferation and further development of 
intestinal lesions (Merlos-Suarez et al. 2011). Surprisingly in the epithelium of Brm deficient 
animals, elevated levels of proliferation concurred with a marked depletion of the Wnt-
independent stem cell marker gene Olfm4. Both gene expression analysis by qRT-PCR and in 
situ hybridization of Olfm4-specific riboprobe showed a significant decrease when compared 
to Apc-deficient epithelium. In the normal intestinal homeostasis, the stem cell niche is 
located at the base of the crypt and actively supported by neighbouring Paneth cells however 
in the case of aberrant Wnt signalling in Brm deficient epithelium Paneth cells are localised 
at higher positions along the crypt-villus axis whereas remarkably, Olfm4 expression is 
restricted to the base of the crypt. A significant decline in Olfm4 expression and its 
restoration to the normal stem cell niche compartment suggest the attenuation of an 
expansion of the stem cell-like populations in the small intestinal epithelium of DKO 
animals.  
Although cellular migration in the epithelium of Apc-deficient animals was not quantified in 
the course of this study, previous reports by Sansom et al. (2004) showed that inactivation of 
Apc under the expression of AhCre recombinase completely abrogated migration of BrdU-
labelled cells along the crypt-villus axis. The absence of functional Brm did not have any 
effect on cell migration in the epithelium of Brm null animals in comparison to controls 
therefore taken together these results suggest that observed changes in the populations of 
proliferating cells are not caused by abrogation of migration and failure of removal of 
dysplastic cells. 
As described in the previous chapter, Brm was shown to play an important role in the 
differentiation of mature epithelial cell types by modulation of Notch pathway effectors. 
Furthermore Brm deficiency was also found to affect the cell differentiation in response to 
activated Wnt signalling. The most pronounced changes were the reduction in the brush 
border enterocytes accompanied by an increase in the population of goblet cells. Wnt and 
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Notch pathways are the key regulators of the maintenance of stem cells and progenitor cells 
whereas Notch effector Hes1 and its antagonist Math1 direct the differentiation of those 
progenitor cells towards either absorptive or secretory cell lineage (Jensen et al. 2000). Wnt-
activated small intestinal epithelium has been previously shown to display significantly 
reduced alkaline phosphatase and Villin expression indicating the diminished numbers of 
brush border enterocytes (Sansom et al. 2004). A concomitant decline in the secretory cell 
populations was observed in the Apc-deficient epithelium with an exception of Paneth cells 
whose very low numbers and confinement to the crypt base were lifted under acute Wnt 
signalling (Battle et al. 2002, Sansom et al. 2004). Loss of functional Brm expression in the 
small intestinal epithelium resulted in a further decline in the population of brush border 
enterocytes in the DKO animals. However a homogenous decline in all secretory cell lineage 
populations as described by Sansom et al. (2004) in a model of Apc loss was not observed in 
this study. In contrast, along with decrease in enterocytes a simultaneous increase in goblet 
cell numbers was detected in the epithelium of DKO animals. The increase in Alcian Blue-
positive goblet cells was significant in comparison to Apc-deficient epithelium as well as in 
comparison to controls expressing functional Brm indicating that loss of Brm has led to an 
intermediate effect on goblet cell differentiation between the normal numbers of goblet cells 
in the normal intestinal epithelium and Wnt-activated Apc-deficient epithelium. Scoring of 
enteroendocrine cell numbers and Paneth cell numbers as expected have identified a 
significantly underrepresented population of enteroendocrine cells and a marked increase in 
Paneth cells and their mislocalisation from crypt base along the crypt-villus axis in the Apc-
deficient epithelium of both Brm-proficient and Brm-deficient animals. However the 
differentiation patterns of those two cell types was not altered by the absence of functional 
Brm in DKO animals. In parallel to quantification of differentiation traits on the histological 
sections, the analysis of gene expression of Notch effectors detected a significant fluctuation 
of expression of Hes1 and Math1 in the intestinal epithelium of Apc-deficient cohorts. 
Downregulation of Hes1 expression in the epithelium of DKO animals further confirmed 
transcriptional repression of this gene in the absence of functional Brm. Strikingly, a 
significant up-regulation of Math1 levels was detected in both Apc-deficient cohorts 
suggesting that the intermediate numbers of Goblet cells in the small intestinal epithelium of 
DKO animals may be a result of concomitant down-regulation of Hes1 and up-regulation of 
Math1 which overdrives Hes1-driven suppression of differentiation towards secretory lineage 
differentiation. To summarize, consistent with previous reports showing that Brm-containing 
remodelling complexes are preferentially recruited to Hes1 and Hes5 promoters these results 
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suggest that Brm is involved in transcriptional activation of particular subsets of genes 
regulating proliferation and apoptosis as well as concomitant activation and repression of 
separate genes governing cell differentiation. Therefore the lack of homogenous response to 
activation of Wnt signalling by Brm accounts for the enhancement of some and attenuation of 
other histological parameters of small intestinal epithelium. While some differences in the 
overall experimental design between our study and that of Sansom et al. (2004) should be 
noted such as use of dually-regulated Cre recombinase with a lower recombination efficiency 
and slightly different criteria of histological scoring and therefore could account for the 
magnitude of the effects observe, the phenotype in animals that lost both copies of Apc gene 
appears to be quite consistent in both studies.  
Taken together, in the context of aberrant Wnt signalling, Brm deficiency enhanced some of 
the cellular responses mediated by activated Wnt pathway such as proliferation, apoptosis 
and impaired enterocyte differentiation. Further attenuation of differentiation of absorptive 
lineage cells was parallel with lifted impairment of goblet cell differentiation and its 
restoration to levels intermediate between normal and Apc-deficient epithelium. No observed 
effect of Brm on the enteroendocrine and Paneth cell populations suggested that the 
expansion of goblet cell population by Brm deficiency is a direct effect of this ATPase 
subunit of Notch signalling effectors which is independent of acute activation of Wnt 
pathway.  
The aggravation of some of the histological parameters in a response to Wnt activation in the 
small intestinal epithelium of DKO animals suggests a possible link between the Brm 
chromatin remodelling factor and the Wnt pathway. However the precise mechanism of how 
this enhancement of phenotype occurs remained unclear. Previous reports showed that 
components of Wnt pathway including β-catenin have failed to interact with SWI/SNF 
complexes in ChIP experiments indicating the absence of direct interaction and suggesting 
that Wnt pathway may require different types of complexes in order to mediate its 
downstream effects (Kadam and Emerson 2003). Therefore whereas Brm is not capable of 
regulation of β-catenin expression, it could possibly be involved in the transcriptional 
activation of Wnt receptors or promote active translocation of β-catenin into the nucleus. 
Immunohistochemical analysis of Wnt activated epithelium of Brm proficient and Brm-
deficient animals revealed that many cells expressed nuclear β-catenin staining however the 
comparison between both cohorts of the level of Wnt activation was not possible using this 
method. To explore this possibility of indirect regulation of Wnt pathway by Brm, I have 
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quantified the levels of active β-catenin in the small intestinal epithelium of DKO mice. 
Western blotting analysis detected no differences in the levels of stabilized β-catenin between 
those two cohorts of Apc-deficient animals further confirming that Brm does not play role in 
the stabilization and accumulation of β-catenin. These results demonstrate that exacerbation 
of the effects of Apc loss on proliferation, apoptosis and differentiation potential of 
progenitor cells in the small intestinal epithelium of DKO animals do not occur as a 
consequence of elevated levels of main Wnt pathway effector β-catenin. 
The other possible mechanism of Wnt-driven phenotype modulation by Brm was the trans-
activation of downstream of β-catenin Wnt target genes. The expression levels of genes 
involved in the transcriptional program activated in response to aberrant Wnt signalling such 
as CD44, c-Myc, cyclin D1 and E-cadherin. Surprisingly, CD44, c-Myc and cyclin D1 were 
downregulated in the small intestinal epithelium of DKO animals in comparison to Apc-
deficient mice. Similar transcription levels of Wnt target genes were reported by Holik et al. 
(2014) suggesting that deficiency in either ATPase of chromatin remodelling complex results 
in the attenuation of the Wnt transcriptional program. Whereas CD44 and c-Myc immediate 
Wnt targets are overexpressed in all colorectal tumours, cyclin D1 expression become up-
regulated upon the progression of small neoplastic lesions into adenomas (Sansom et al. 
2005). These observations suggest that although many parameters of Wnt-activated Brm-
deficient epithelium are enhanced suggesting acceleration in tumorigenesis, the absence of 
functional Brm might result in the repression of transcriptional program activated by β-
catenin stabilization and translocation to the nucleus. However the expression levels of E-
cadherin remained significantly up-regulated in the small intestinal epithelium of both Apc-
deficient cohorts. Previous reports have indicated that the CD44 promoter becomes 
hypermethylated and silenced in the Brm null model as well as numerous Brm-deficient 
cancer cell lines (Banine et al. 2005, Batsché et al. 2006), moreover ChIP assays showed the 
association of Brm chromatin remodelling factor with this region of CD44 suggesting that 
Brm is required for transcriptional activation of CD44 with Brm deficiency directly 
influencing the transcription of CD44 gene. Brm-induced changes in the methylation status of 
CD44 promoter region could occur directly by Brm promoting the activities of genes that are 
capable of alteration of DNA methylation or indirectly by promoting the transcription of 
those genes through via two possible routes: blocking of abilities of methyltransferases to 
methylate CD44 promoter or recruitment of demethylases to these promoter sequences. The 
exact mechanism by which Brm is affecting the transcriptional activation of CD44 has not yet 
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been confirmed. ChIP-seq experiments by Damiano et al. (2013) showed that c-Myc was 
found to bind the core promoter region of Brm and MEK-ERK signalling pathway is capable 
of activating c-Myc to reduce the transcription of Brm SWI/SNF subunit. However c-Myc 
was also indicated as a direct target for Brm-mediated transcriptional repression (Coisy-
Quivy et al. 2006) suggesting that the mechanism underlying the transcriptional repression of 
c-Myc in the DKO small intestinal epithelium appears to be driven by more complex and 
two-way interactions between c-Myc and Brm.  
 
Taken together, the data presented in this chapter suggest that the modulation of Wnt-driven 
tumorigenesis in the small intestinal epithelium of Brm-deficient animals occurs at different 
levels. First of all, enhanced crypt length, proliferation and apoptosis suggest an enhanced 
phenotype, which is however not consistent with the survival probability analysis. 
Furthermore, Brm loss results in the impaired expression of Wnt target genes as well as 
reduced expression of the stem cell marker Olfm4. The net result of these changes is the 
development of only small lesions and low-grade adenomas in the small intestinal epithelium 
of DKO. Ablation of transcriptional program activated by aberrant Wnt signalling can 
consequently lead to less severe than expected responses in proliferation, apoptosis and 
differentiation to Wnt activation. 
4.3.3 Brm deficiency has mild effects on the Wnt-activated colonic epithelium   
The data obtained in the chapter 3 suggested that the effects of Brm loss differ between the 
small intestinal and colonic epithelium indicating some tissue-specificity of functional Brm. 
Therefore I aimed to investigate whether those differences in the response to Brm deficiency 
are also present in the context of aberrant Wnt signalling in the colonic epithelium. As 
previously described in section 2.1.1 the activation of Wnt pathway was achieved by 
conditional deletion of loxP-flanked Apc allele under the expression of AhCreER 
recombinase together with constitutive loss of functional Brm.  
Morphological analysis of Apc-deficient epithelium with and without Brm deficiency 
revealed the presence of multiple lesions expressing stabilized β-catenin in the colonic 
epithelium however those morphological changes in the architecture were far less 
pronounced and occur less frequently than those observed in the small intestinal epithelium. 
Notably, these observations would be consistent with the hypothesis that a variation in the 
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physiological levels of Wnt activity across the length of intestines influences the distribution 
of lesions and tumours (Leedham et al. 2012). Equally some of these changes might reflect 
differences in Cre mediated recombination levels between those animals.  
The phenotypic responses in the Wnt-activated colonic epithelium should closely resemble 
those reported in the small intestine by Samson 2004 including elongated crypts, increase in 
proliferation and apoptosis, expansion of proliferative compartment and up-regulation of 
transcriptional program mediated by β-catenin stabilization. Histological analysis of colonic 
epithelium of DKO animals detected significantly increased proliferation and apoptosis levels 
with no alterations of crypt length in comparison to Apc-deficient animals. These results are 
in contrast to previous data from large intestine (section 3.2) showing the opposite phenotype 
in context of Brm loss – enlarged crypts coincide with no changes in either proliferation or 
apoptosis. Independently of the population size of Ki67-positive cells, Brm-deficiency 
appears to induce the shift and extension of proliferative compartment in the colonic 
epithelium of both Brm null and DKO animals. The shift in the alterations of cellular 
responses in the Wnt-activated Brm-deficient epithelium suggest that some modulations of 
phenotype by Brm loss may be highly dependent on the level of activity of Wnt pathway for 
regulation of cellular processes along the crypt-villus axis of colonic epithelium. 
Subsequently, qRT-PCR gene expression analysis showed a significant down-regulation of 
Wnt target gene expression in DKO animals in comparison to levels observed in Brm-
proficient Apc-deficient animals whereas no changes in the expression levels of genes such 
as cyclin D1 and E-cadherin were detected. In overall, these observations from small 
intestinal epithelium suggest that Brm plays a dual role in enhancing the effects of Wnt 
activation on processes such as proliferation and apoptosis as well as in parallel mediating 
suppression of expression of Wnt target genes.    
As described in the previous chapter, Brm was shown to play an important role in the 
differentiation of mature epithelial cells of secretory lineage by modulation of Notch pathway 
effectors. Similarly, the size of the populations of differentiated cell types, in particular goblet 
cells, is affected by the loss of functional Brm in the Wnt-activated small intestine. Notably, a 
marked decrease in the populations of goblet and enteroendocrine cells was observed in Apc-
deficient epithelium when compared to controls however no alterations in the secretory cell 
populations were shown between DKO and Apc-deficient mice. The absence of response to 
Brm deficiency in the context of aberrant Wnt pathway in colonic epithelium might further 
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indicate that the extent of Apc phenotype modulation is highly dependent upon the local 
levels of Wnt activation.  
To summarize, Brm deficiency has very mild effects on the Wnt-activated colonic epithelium 
resulting in an enhancement of both proliferation and apoptosis. However the absence of 
severe effects in the colonic morphology due to those alterations suggests that other 
mechanisms may counteract the response. The repression of β-catenin-mediated 
transcriptional program of immediate Wnt targets CD44 and c-Myc which concurs with 
increased proliferation and apoptosis may in longer term halt the exacerbation of Wnt-driven 
tumorigenesis. Furthermore, Brm was shown to be capable of compensating for loss of Brg1 
ATPase subunit in the colonic but not small intestinal epithelium suggesting that some of the 
modifications of phenotype driven by Apc loss in context of Brm deficiency might indeed be 
a response to fluctuations in the expression of its paralogue, Brg1.  
 
 
4.3.4 Conclusions 
Taken together, the observations described in this chapter indicate that small intestinal and 
colonic epithelium substantially differ in their response to activation of Wnt signalling in the 
context of Brm deficiency. In both cases, the maintenance of “progenitor-like” phenotype of 
Apc-mutant cells is accompanied by distinct pattern of cellular changes characteristic for Wnt 
activation via loss of Apc however the direction and the magnitude of those alterations is 
very specific to either small intestinal or colonic epithelium. In normal epithelium, 
homeostasis is maintained by a very discreet interplay between pathways and numerous 
components of Wnt, Notch, Hedgehog and TGF-β/BMP signalling, similarly in Wnt-
activated epithelium, the optimal but not excessive level of β-catenin activation is required 
for tumorigenesis and its development (Albuquerque et al. 2002). The discrepancy between 
small intestinal and colonic epithelium could be a result of two separate mechanisms. Firstly, 
the phenotype coinciding Brm deficiency may be context-dependent and result in different 
array of responses in different type of epithelium. This would be consistent with the 
assumption that the basal gradient of Wnt activity and therefore the extent of the activation of 
Wnt pathway via Apc loss differs between proximal small intestine and the colon. Therefore 
different level of Wnt activation in different type of intestinal epithelium would influence the 
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severity of changes due to Brm deficiency.  Secondly, the perturbations of histological 
parameters associated with Apc loss may also reflect β-catenin-independent effects, notably 
the up-regulation of Brm paralogue Brg1in order to compensate for Brm function. Both 
ATPases of SWI/SNF complex have been previously shown to be partially redundant in their 
functions however this mechanism appears to be tissue-specific and often cell type-specific.  
In all, the effects of Brm deficiency on the small intestinal and colonic epithelium in the 
contexts of both – normal homeostasis and Wnt-driven tumorigenesis should be additionally 
considered in the context of Brg1 expression in those tissues in regard to reveal the function 
of Brm chromatin remodelling subunit in the intestinal tract.
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Chapter 5  
Investigating the effects of Brg1 loss in the 
epithelium of small and large intestine in the 
context of Brm deficiency 
 
5.1 Introduction 
The data presented in the previous two chapters revealed that Brm deficiency results in a 
wide range of cellular responses whose effects on phenotype differ between small intestine 
and colonic epithelium as well as between normal homeostatic and Wnt-activated tissue. 
Previous studies on Wnt pathway effects on intestinal tissue indicate that such discrepancies 
between the phenotypes could occur due to differential levels of basal Wnt signalling activity 
(Leedham et al. 2012). As suggested before, the role of Brm may also be partially 
compensated by its paralogue Brg1.  
Catalytic subunits of SWI/SNF chromatin remodelling complex Brm and Brg1 have been 
implicated in regulating transcriptional activation and repression of numerous genes 
regulating a variety of cellular processes. Both ATPases share 75% sequence homology and 
share a core consisting of functional domains: QLQ, proline-rich, HSA, ATPase, Rb-binding 
and Bromo domain (Kadam and Emerson 2003). The evidence from cell line studies 
speculated that ATPase subunits might be redundant for homeostasis of the tissue and share 
many common cellular functions. However further reports conducted on both cell lines and 
murine models of disease revealed that Brm and Brg1 catalytic subunits are recruited in 
response to specific signalling pathways by unique interactions with different protein 
domains (Kadam and Emerson 2003) indicating that some form of compensation mechanism 
may exist between those ATPases however it would be partial and result in a particular 
tissue-specific response.  
Although no evidence exists supporting the possibility of interaction between Brm and the 
Wnt pathway, there is evidence of involvement of the Brm paralogue Brg1 in a direct 
interaction with the Wnt pathway through its capacity of regulating Wnt target genes such as 
Cyclin D1 and CD44 (Baker et al. 2001, Kadam and Emerson 2002, 2003).  
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Both considered as putative tumour suppressor genes, Brm and Brg1 have been shown to be 
frequently lost concomitantly in lung, pancreas, skin, ovary and breast cancers (Numata et al. 
2013, Liu et al. 2011, Reisman et al. 2009, Glaros et al. 2007, Reisman et al. 2005, 
Yamamichi et al. 2005, Fukuoka et al. 2004, Reisman et al. 2002, reviewed in Weissman and 
Knudsen 2009). Moreover in contrast to deficiency in either of the subunits individually, 
concomitant loss of activity of both ATPases has been correlated to poor prognosis in lung 
and prostate cancer. Previous data obtained by Holik et al. (2013, 2014) indicated that Brg1 is 
required for maintenance of intestinal stem cells and in the absence of functional Brg1 
attenuates Wnt-driven tumorigenesis in the small intestinal epithelium suggesting that Brm 
and Brg1 play important but distinct roles in modulation of cancer phenotype.    
In order to explore the effects of concomitant loss of both ATPase subunits on the small 
intestinal and colonic epithelium I have explored the consequences of loxP targeted deletion 
of Brg1 allele (using AhCreER recombinase) in the context of constitutive loss of Brm as 
described in section 2.1.1.  The evaluation of the effects of deficiency in both Brm and Brg1 
appears appropriate to distinguish between those histological changes described in the 
previous two chapters due to Brm deficiency and possible Brg1 compensation. Additionally I 
aimed to investigate the respective levels of Brm and Brg1 in Brg1- and Brm-deficient 
lesions in the context of Wnt activation induced by Apc loss in the small intestinal and 
colonic epithelium. This chapter will aim to characterise the effects of Brm and Brg1 
deficiency on the small and large intestinal epithelium.  
 
5.2 Results 
 
5.2.1 Concomitant loss of Brm and Brg1 results in animals that are viable and 
not prone to tumorigenesis 
Mating of animals carrying the Brg1 targeted allele under the expression of AhCreER 
recombinase (AhCreER
+
Brg1
fl/fl
) with Brm null (Brm
-/-
) resulted in the absence of neonatal 
lethality, litters of normal size and fertility of resulting progeny. No differences were 
observed in viability between DKO, Brm null and wild-type (control) littermates.   
Similarly as with the Brm null animals, Brm null Brg1 KO mice were monitored for signs of 
illness or tumour formation, twice a week for a period of a year but no abnormalities were 
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observed. Morphological analysis of H&E sections revealed no dysplasia of the epithelium of 
small or large intestinal tissue. 
 
5.2.2 AhCreER recombinase drives mosaic loss of Brg1 and subsequent 
repopulation in the small intestinal epithelium of AhCre
+
Brg1
fl/fl
Brm null 
mice  
As previously reported by Holik (PhD Thesis, 2011), a mosaic pattern of Brg1 loss was 
observed in Brg1-deficient small intestinal epithelium under the control of AhCreER 
recombinase. Histological analysis of further time-points post induction showed that the 
number of crypts retaining Brg1-deficient cells decreased at regular intervals and by day 35 
post induction no crypts containing Brg1-deficient cells were detected indicating that the 
small intestinal epithelium was repopulated with wild-type cells. Due to limited expression of 
AhCreER recombinase in the intestinal epithelium, being restricted to stem cell and 
progenitor cells and being activated at the frequency lower than 100%, Brg1-deficient cells 
were identified predominantly in the crypt compartment or along the crypt-villus axis and 
were present in small clusters of cells neighbouring with Brg1-proficient cells. Although 
AhCreER recombinase enforces some limitations to the histological analysis of tissue, the 
mechanism of activation evades the presumed off-target lethality observed in the animals 
expressing AhCre recombinase.  
Cohorts of AhCreER
-
 (control), AhCreER
+
Brg
fl/fl
Brm
+/+
 and AhCreER
+
Brg1
fl/fl
Brm null 
animals at 70 days of age were induced with five bi-daily daily intraperitoneal injections of 
80mg/kg β-naphthoflavone with Tamoxifen at 12 hour intervals. All mice were then aged for 
a maximum of 50 days and were sacrificed at appropriate time-points (day 3, day 5, day 7, 
day 10, day 15, day 30, day 50, n≥4) when intestinal tissues were harvested. No animals from 
induced cohorts became ill within the timeframe of the experiment. Identification of Brg1-
deficient cells in the AhCreER
+
Brg
fl/fl
Brm
+/+
 and AhCreER
+
Brg1
fl/fl
Brm null small intestinal 
epithelium was performed using immunohistochemical staining against Brg1. Consistent with 
the previous study (Holik et al. 2013), a pattern of mosaic loss of Brg1 was observed in both 
AhCreER
+
Brg
fl/fl
Brm
+/+
 and AhCreER
+
Brg1
fl/fl
Brm null animals as early as 3 days post 
induction. Quantification of the number of crypts containing Brg1-deficient cell clusters at all 
time-points showed a decrease in the frequency of deficient crypts in the small intestinal 
epithelium of both Brg1KO and DKO animals. By day 15, less than 5% of all small intestinal 
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crypts contained Brg1-deficient cell clusters in both DKO and Brg1KO animals. The vast 
majority of crypts consisted of Brg1-proficient cells only, indicating that Brg1-deficient cells 
are slowly eliminated from the epithelium and replaced by wild-type cells (Figure 5.1). 
Interestingly, on day 3 post induction the proportion of Brg1-deficient versus Brg1-proficient 
crypts was significantly lower in the context of Brm null epithelium. In contrast, at day 30 
post induction qualitative assessment of Brg1 expression failed to detect any crypts with 
Brg1-deficient cell clusters in Brg1KO animals whereas such crypts were retained for longer 
in the epithelium of DKO mice. However by day 50 post induction, microscopic analysis 
failed to identify any Brg1-deficient cells in either experimental cohort suggesting that 
eventually all epithelium is Brg1-profiecient.  
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Figure 5.1 Brg1 loss under the expression of AhCreER recombinase is characterized by mosaic pattern of Brg1-
deficient and Brg1-proficient crypts. AhCreER
+
Brg1
fl/fl
 and AhCreER
+
Brg1
fl/fl
Brm null animals were induced 
according to an appropriate protocol and tissues were harvested at day 3, 5, 7, 10, 15, 30 and 50 post induction. 
Immunohistochemical staining against Brg1 was conducted to assess Brg1 expression where crypts containing 
more than 6 Brg1-deficient cells were counted across small intestinal epithelium. The quantification of Brg1 
expression revealed a trend of decrease in the frequency of Brg1-deficient crypts in both cohorts with a 
significantly lower number of crypts at day 3 post induction in DKO mice. Scale bar represents 100 μm.   
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5.2.3 Brg1  loss in the context of a Brm null allele has mild effects on small 
intestinal homeostasis 
Due to the short-term retention of Brg1-deficient cells in the small intestinal epithelium 
repopulation under the expression of AhCreER recombinase, an appropriate time-point along 
the gut repopulation timeline had to be selected in order to allow further histological analysis 
of concomitant loss of both ATPases in the small intestinal epithelium. In regards to the 
numbers of crypts displaying Brg1-deficient cell clusters as well as the uniform pattern of 
Brg1 loss in AhCreER
+
Brg1
fl/fl
Brm null mice, day 5 post induction was selected for this 
purpose. Consistency between the time-points at which animals were sacrificed allowed for 
the analysis between DKO, Brm null and control cohorts. Serial sections of small intestinal 
epithelium tissue were stained against Brg1 and antibodies against Cleaved Caspase-3 and 
Ki67 for subsequent histological analysis conducted only in Brg1-deficient intestinal crypts.   
Microscopic analysis of H&E sections of AhCreER
+
Brg1
fl/fl
Brm null animals revealed no 
obvious morphological abnormalities or tumorigenesis. The quantitative analysis of 
functional parameters of the epithelium detected some fine differences between DKO, Brm 
null and control animals. The results of quantitative analysis of those histological parameters 
are summarized in Table 5.1. 
Crypt and villus lengths were assessed on H&E stained sections as the average number of 
cells (± standard deviation) from the bottom of the crypt upwards to the crypt-villus junction 
and from the crypt-villus junction upwards to the top of the villus where the cell shedding 
occurs. Assessment of crypt size showed that crypt length remained unaltered in the DKO 
epithelium in comparison to both control and Brm null (22.27±0.265 versus 21.617±0.920 
and 22.564±0.156, p=0.097 and p=0.109 respectively, n≥4, Figure 5.2a). Similarly, the 
quantification of the villus length detected no change in the villus size (72.997±1.358 versus 
73.402±1.478 and 71.668±1.475, p=0.954 and p=0.162, n≥4, Figure 5.2b).  
The scoring of apoptosis levels detected a significant decrease in the number of cleaved 
Caspase-3- positive cells in DKO epithelium in comparison to control animals (0.025±0.01 
versus 0.866±0.06, p<0.001, n≥4). The decline in the apoptosis levels was equally abrupt 
when compared to Brm null mice (0.025±0.01 versus 0.744±0.338, p<0.001, n≥4, Figure 
5.2c).  Strikingly, the quantification of proliferating cells showed a significant depletion of 
Ki67-positive cells in the epithelium of DKO animals in comparison to both controls and 
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Brm null (6.116±0.257 versus 13.395±0.762 and 13.513±0.702 respectively, p<0.0001 for 
either comparison, n≥4, Figure 5.2d). 
Therefore in the context of Brm loss, Brg1 deficiency in the small intestinal crypts results in a 
decrease in the numbers of both apoptotic and proliferating cells when compared to either 
control or Brm null tissue. Quantitative analysis of other morphological factors such as crypt 
and villus size detected no alterations in DKO animals.  
 
Parameter  Cohort  Mean  SD              p-values 
Control vs 
DKO 
 
Brm null vs 
DKO 
Crypt 
length  
Control 
Brm null 
DKO  
21.617 
22.564 
22.27 
0.920 
0.156 
0.265 
0.097 0.109 
Villus 
length  
Control 
Brm null 
DKO 
73.402 
71.668 
72.997 
1.478 
1.475 
1.358  
0.954 0.162 
Caspase 
positive 
cells  
Control 
Brm null 
DKO 
0.866 
0.744 
0.025  
0.060 
0.338 
0.010 
0.001 0.001 
Ki67 
positive 
cells  
Control 
Brm null 
DKO 
13.395 
13.513  
6.116 
0.762 
0.702 
0.257  
0.000 0.000 
 
Table 5.1 Quantitative analysis of the effects of Brg1 deficiency on the small intestinal histology in the context 
of constitutive Brm loss. Epithelium from small intestine from AhCreER
-
 Brm
+/+
 (marked as Control) and 
AhCreER
+
 Brm null (marked as Brm null) was harvested at day 70 of age and AhCreER
+
Brg1
fl/fl
Brm null 
(marked as DKO) was harvested from animals at 5 days post induction. Histological parameters including crypt 
and villus length, apoptosis and proliferation were assessed and the comparison between those three 
experimental cohorts was conducted using statistical software. 
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D C 
 
 
 
Figure 5.2 Histological analysis of the effects of mosaic Brg1loss in the small intestinal epithelium of Brm null 
animals. Control, Brm null and DKO experimental animals were harvested at day 5 post induction. A-D bar 
graphs represent histological parameters such as (A) crypt length (B) villus length that were counted on H&E 
sections for all animals. The average number of (C) Cleaved Caspase 3 (D) Ki67-positive cells was quantified 
on the corresponding immunostained sections. Error bars represent standard deviation and asterisk symbol 
indicates those histological parameters that showed a statistically significant difference (p value<0.05) between 
cohorts of mice. Exact values, standard deviations, p values and numbers of animals included in the experiments 
are provided in Table 5.1. Scale bar represents 100 µm. 
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5.2.4 Mosaic loss of Brg1 changes the pattern of distribution of proliferating 
cells in the Brm null epithelium of small intestine 
Further to the analysis of the size of the proliferating compartment of the small intestinal 
epithelium, the distribution of Ki67-positive cells was assessed in order to investigate 
whether the reduction in the numbers of proliferating cells led to changes in the shape of the 
proliferative compartment. The analysis of cumulative frequency of Ki67-positive cells 
revealed a significant expansion of the zone occupied by proliferating cells along the length 
of the intestinal crypt in the epithelium of DKO animals in comparison to control and Brm 
null (Kolmogorov-Smirnov Z test, p=0.015 and p=0.001 respectively, n≥4, Figure 5.3). This 
observation suggested that the distribution of Ki67-positive cells is altered and more irregular 
along the crypt-villus axis in the Brg1- and Brm-deficient small intestinal epithelium however 
it did not result in the reduction of proliferative compartment.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 A change in shape of proliferative zone in the small intestinal epithelium of AhCreER
+
Brg1
fl/fl
Brm 
null animals. Tissues of control, Brm and DKO mice were harvested and immunohistochemical analysis of Ki67 
staining was performed. Cumulative frequency analysis of Ki67-positive cells revealed significant change in the 
shape of proliferative compartment in the DKO epithelium in comparison to both control and Brm null 
(Kolmogorov-Smirnov Z test p=0.015 and p=0.001 respectively, n≥4) with an expansion at the base of the 
intestinal crypt.  
 
* 
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5.2.5 Brg1-deficiency affects the differentiation of goblet cells in the small 
intestinal epithelium of AhCreER
+
Brg1
fl/fl
Brm null animals 
As evidenced in the previous sections, Brg1 loss in the context of Brm null allele results in 
the depletion of the Ki67 proliferative compartment. In order to assess whether these changes 
in the proliferation affect the differentiation processes in the epithelium, the quantitative 
analysis of mature epithelial cell types found in the small intestinal epithelium was conducted 
in AhCreER
+
Brg1
fl/fl
Brm null mice at day 5 post induction and compared to the data from 
control and Brm null mice at day 70 of age (section 3.2.6) in order to further characterise the 
effects of Brm loss on the maintenance of small intestinal homeostasis. Brg1-deficient crypts 
have been identified by the presence of minimum 5 adjacent Brg1-deficient cells on the basis 
of Brg1 immunohistochemical staining conducted on the serial section of the epithelial tissue.  
The only differentiated cells belonging to an absorptive lineage, enterocytes were assessed 
using alkaline phosphatase staining. The abundance in enterocytes is marked by brush border 
thickness and revealed a marked decrease in the intensity and thickness of the staining in the 
DKO animals compared to control and Brm null animals (Figure 5.4) 
Secretory lineage goblet cells were identified using Alcian Blue staining. The performed 
staining allowed for quantification of the numbers of goblet cells in the small intestine of 
AhCreER
+
Brg1
fl/fl
Brm null animals (Figure 5.5). Scoring of the Alcian Blue-positive cells 
detected a significant decline in the number of goblet cells in the DKO animals per half crypt-
villus in comparison to controls (4.830±0.158 versus 6.375±0.185, p<0.0001, n≥4). Parallel 
pattern of decrease in the frequency of goblet cells in DKO epithelium was found when 
compared to Brm null epithelium (4.830±0.158 versus 7.402±0.304, p<0.0001, n≥4 Figure 
5.5a). The presence of enteroendocrine cells within small intestinal epithelium was assessed 
using Grimelius staining. The scoring of the enteroendocrine cells detected no difference in 
the number of Grimelius-positive cells in Brm null Brg1 KO animals in comparison to 
controls (2.052±0.172 versus 2.142±0.050 and 2.24±0.078, p=0.375 and p=0.114 
respectively, n≥4, Figure 5.5b).    
The quantification of Paneth cells numbers as well as distribution was performed using 
lysozyme immunohistochemistry carried out on the appropriate sections of small intestinal 
epithelium (Figure 5.6). The quantification of the Paneth cells showed no difference in the 
number of cells present in the half-crypt between DKO and controls (1.767±0.103 versus 
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1.725±0.153, p=0.585, n≥4) or DKO and Brm null animals (1.767±0.103 versus 
1.837±0.264, p=506, n≥4, Figure 5.6). 
The quantification of differentiated cell types in the small intestinal epithelium of Brg1 and 
Brm deficient mice revealed that Brg1 loss in context of Brm null allele leads to severe 
depletion in brush border enterocytes and goblet cells. Together with depletion in the 
numbers of Ki-67-positive cells in the proliferative compartment, this shift in the 
differentiation suggests that concomitant loss of both catalytic subunits attenuated 
differentiation of specific mature cell types belonging to both absorptive and secretory 
lineage.  
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Figure 5.4 Alkaline phosphatase staining detected the normal brush border pattern corresponding to the 
membrane of differentiated enterocytes. The small intestinal sections of control, Brm null and DKO mice were 
stained for alkaline phosphatase. Brush border staining revealed a decline in the alkaline phosphatase expression 
in the epithelium of Brm null Brg1KO animals when compared to sections of control and Brm experimental 
animals. However in case of DKO animals, alkaline phosphatase staining appears to be present in the epithelial 
cells as well as on their surface. The scale bar represents 100μm.  
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Figure 5.5 Cell-specific stains were performed for identification of cells of secretory lineage. Alcian Blue 
staining was used in order to detect goblet cells whereas Grimelius staining was carried out to visualize 
enteroendocrine cells within small intestinal epithelium. The small intestinal sections of control, Brm null and 
DKO mice were stained and the populations of mature cells were quantified. (A) Analysis of small intestinal 
tissue for Alcian Blue-stained cells revealed a significant decline in the goblet cells in the epithelium of DKO 
animals in comparison to control and Brm animals. (B) In contrast, the assessment of enteroendocrine cells 
revealed no change in the number of stained cells between the epithelium of DKO and control or Brm null 
animals.  
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Figure 5.6 Immunohistochemistry against lysozyme was performed to mark Paneth cells within small intestinal 
epithelium. The small intestinal sections of control, Brm null and DKO mice were stained to reveal the number 
and localisation of Paneth cells. The red semi-circle marks Brg1-deficient crypts with more than 5 adjacent Brg1 
deficient cells whereas green semi-circle marks a Brg1-proficient crypt. The analysis of both number and 
position of lysozyme-positive cells in the small intestinal epithelium showed no differences in DKO mice when 
compared to control and Brm animals. The scale bar represents 100μm. 
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5.2.6 Mosaic loss of Brg1 in Brm-deficient colonic epithelium of 
AhCreER
+
Brg1
fl/fl
Brm null animals is characterized by a long-term 
retention of Brg1–negative clusters of epithelial cells 
As previously described for small intestine, furthermore I aimed to analyse the consequences 
of Brg1-deficiency in the context of Brm null allele on the colonic epithelium. Parallel to the 
experiment conducted in the small intestinal tissue, mosaic pattern of Brg1 loss was observed 
in Brm- and Brg1-deficient colonic epithelium under control of AhCreER recombinase.  
Cohorts of AhCreER
-
 (control), AhCreER
+
Brg
fl/fl
Brm
+/+
 and AhCreER
+
Brg1
fl/fl
Brm null 
animals at 70 days of age were induced with five bi-daily daily intraperitoneal injections of 
80mg/kg β-naphthoflavone with Tamoxifen at 12 hour intervals (n≥28 for all cohorts). 
Colonic tissues were harvested from induced animals that have been aged until particular 
experimental time-points (n≥4) with no lethality observed during the timeframe of the 
experiment.  
Identification and subsequent quantification of Brg1-deficient colonic crypts in the 
AhCreER
+
Brg
fl/fl
Brm
+/+
 and AhCreER
+
Brg1
fl/fl
Brm null epithelium was carried out using 
immunohistochemical staining against Brg1. Similar to small intestinal pattern of mosaic loss 
of Brg1 across the colonic tissue was observed however in contrast to small intestine 
characterized by small clusters of Brg1-deficient cells, colonic crypts frequently were 
completely devoid of Brg1 expression.    
Further quantification of the colonic crypts consisting of Brg1-deficient cell at all time-points 
showed a steady decline in the frequency of such a crypts in the epithelium of DKO in the 
first 7 days post induction followed by a two-fold decrease observed at day 10 and the 
maintenance of the proportion of Brg1-deficient to Brg1-proficient crypts till the end of 
experimental timescale. However in the context of functional Brm, the initial proportion of 
Brg1-deficient crypts in the colonic epithelium was significantly lower in Brg1 KO than in 
DKO animals. The elimination of Brg1-deficient colonic crypts occurred at much slower rate 
in Brg1 KO epithelium with less fluctuation in the frequency of Brg1-deficient crypt and 
from day 10 post induction between 10-15% of all colonic crypts retained Brg1-deficient 
clusters of cells (Figure 5.7).  
Although the frequency of Brg1-deficient cell clusters in the colonic epithelium of both DKO 
and Brg1 KO animals display a trend of decrease, in contrast to small intestine those cells are 
retained within the epithelium for a long-term (Figure 5.7). Interestingly, whereas in small 
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intestine of DKO animals the proportion of Brg1-deficient crypts on day 3 post induction is 
significantly lower than in Brg1 KO, in the colonic epithelium this situation is inversed.                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Mosaic loss of Brg1 under the expression of AhCreER recombinase is maintained within the colonic 
epithelium. AhCreER
+
Brg1
fl/fl
 and AhCreER
+
Brg1
fl/fl
Brm null animals were induced according to an appropriate 
protocol and tissues were harvested at day 3, 5, 7, 10, 15, 30 and 50 post induction in a same manner as in small 
intestine. Immunohistochemical analysis of Brg1 expression conducted on the colonic epithelium in both 
experimental cohorts of animals was used to score the number of crypts containing more than 6 Brg1-deficient 
cells relative to the total number of colonic crypts. The quantification of Brg1 expression revealed a trend of 
decrease in the frequency of Brg1-deficient crypts in both cohorts concomitant with the long-term retention of 
Brg1-deficient crypts in both epithelia. 
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5.2.7 Brg1 loss in the context of Brm null allele leads to severe decrease in 
apoptosis levels and an expansion of proliferative zone in colonic 
epithelium 
As described in the previous chapter (section 3.2.11) homeostasis of colonic epithelium in the 
context of Brm loss appears to be well-maintained with no perceptible differences from 
normal Brm-proficient epithelium. I aimed to investigate the effects of combined loss of Brm 
and Brg1 on the morphology of colonic epithelium. The deficiency in the functional catalytic 
subunits of SWI/SNF chromatin remodelling complex failed to results in macroscopic 
abnormalities or tumorigenesis in the cohort of DKO animals. Quantitative analysis of 
histological parameters revealed significant changes in the level of apoptosis and when 
compared to control and Brm null mice. The effects of mosaic loss of Brg1 in the context of 
constitutive Brm deficiency on the large intestinal epithelium were investigated in 
AhCreER
+
Brg1
fl/fl
Brm null (DKO), AhCreER
+
Brm null (Brm null) and AhCreER
-
 (control) 
animals at day 5 post induction. A quantitative analysis carried out is summarized in Table 
5.2. 
The length of colonic crypt was assessed on H&E stained sections as the average number of 
cells (± standard deviation) from the bottom of the crypt upwards till the flat surface of the 
epithelium. No change in the crypt size of DKO mice was observed when compared to 
control and Brm null colonic epithelium (24.64±0.311 versus 24.309±0.319 and 
24.497±0.431, p>0.05 for either comparison, n≥4, Figure 5.8a).  
The levels of apoptosis within the colonic epithelium were quantified using Cleaved Caspase-
3 immunohistochemical staining. The assessment of stained cells showed a significant 
decrease in the number of apoptotic cells in the epithelium of AhCreER
+
Brg1
fl/fl
Brm null in 
comparison to both control and Brm null mice (0.005±0.01 versus 0.060±0.016 and 
0.064±0.022, p=0.002 for either comparison, n≥4, Figure 5.8b). However, the analysis of 
proliferating cells on colonic epithelium by Ki67 immunohistochemistry detected no 
difference between the average number of proliferating cells per crypt in DKO and control 
and Brm-deficient cohort (5.48±1.077 versus 6.609±1.039 and 7.921±2.547, p=0.182 and 
p=0.104 respectively, n≥4, Figure 5.8c) similarly to the quantification of apoptosis by 
Cleaved Caspase-3.  In contrast to the quantification of proliferating cell population in the 
colonic epithelium which revealed no alterations, the analysis of the cumulative frequency of 
Ki67-positive cells detected a significant shift in the shape of proliferating zone in DKO 
animals. Proliferative compartment marked by Ki67 distribution revealed a great expansion 
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in AhCreER
+
Brg1
fl/fl
Brm null epithelium in comparison to both control and Brm null tissue 
(Kolmogorov-Smirnov Z test p=0.0001 for either comparison, n≥4, Figure 5.8d). This result 
is parallel to the small intestinal analysis indicating that the distribution of proliferating cells 
and therefore the shape of proliferative compartment in the DKO mice is affected by Brm 
loss.  
Taken together, Brg1 loss in the context of Brm deficiency within the colonic epithelium 
affects several histological parameters leading to a severe depletion in the number of 
apoptotic cells concurring with an expansion in shape of proliferative compartment. 
Strikingly, no increase in the total number of Ki67-labelled proliferating cells was noted in 
parallel to the change in the shape of proliferative compartment. No gross morphological 
abnormalities or tumorigenesis were observed in the colonic tissue of AhCreER
+
Brg1
fl/fl
Brm 
null suggesting that in a short-term the homeostasis in the large intestinal epithelium is 
maintained even in the absence of both ATPase subunits of SWI/SNF chromatin remodelling 
complex.    
Parameter  Cohort  Mean  SD              p-values 
Control vs 
DKO 
 
Brm null vs 
DKO 
Crypt 
length  
Control 
Brm null 
DKO  
24.309 
24.497 
24.670 
0.319 
0.431 
0.311 
0.428 0.581 
Caspase 
positive 
cells  
Control 
Brm null 
DKO 
0.060 
0.064 
0.005  
0.016 
0.021 
0.010 
0.001 0.001 
Ki67 
positive 
cells  
Control 
Brm null 
DKO 
6.609 
7.921  
5.480 
1.039 
2.547 
1.077 
0.182 0.104 
 
Table 5.2 Quantitative analysis of the effects of Brg1 deficiency on the histology of Brm null colonic 
epithelium. Epithelium from large intestine from AhCreER
-
Brm
+/+
 (marked as control), AhCreER
+
Brm null 
(marked as Brm null) and AhCreER
+
Brg1
fl/fl
Brm null (marked as DKO) was harvested from animals and 
histological parameters including crypt length, apoptosis and proliferation were quantified and the comparison 
between those experimental cohorts was conducted using statistical software. 
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Figure 5.8 Histological analysis of the effects of induced mosaic Brg1 loss in the Brm null colonic epithelium. 
AhCreER
+
Brg1
fl/fl
Brm null animals were harvested at day 5 post induction whereas Brm null and control 
animals were dissected at day 70 of age. A-D histological parameters of (A) crypt length were counted on H&E 
sections for control and Brm deficient animals. The average number of (B) Cleaved Caspase3 and (C) Ki67-
positive cells was scored on the appropriately stained sections. (D) Cumulative frequency analysis detected a 
significant expansion of the proliferative compartment in DKO animals in comparison to Brm null and control 
animals. The green half-circle indicates colonic crypts Brg1 proficient crypts whereas red half-circle indicates 
Brg1-deficient crypts with 5 or more adjacent Brg1-deficient epithelial cells. The black arrow indicates cell 
positive for Cleaved Caspase 3 staining. Error bars represent standard deviation and asterisk symbol indicates 
those histological parameters that showed a statistically significant difference (p value <0.05) between cohorts 
of mice. Exact values, standard deviations, p values and numbers of animals included in the experiments are 
provided in Table 5.2 
 
  
* 
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5.2.8 Brg1 deficiency in the context of concomitant Brm loss results in a 
decrease in the differentiation of epithelial cells along the secretory 
lineage  
Although homeostasis in the colonic epithelium in the context of Brm and Brg1 loss appears 
to be maintained in a short-term, the fluctuations in the numbers of apoptotic and actively 
proliferating cells might affect the differentiation potential within the epithelium. Therefore I 
aimed to quantify the size of mature epithelial cell populations in the colonic epithelium of 
AhCreER
+
Brg1
fl/fl
Brm null at day 5 post induction and compared it to both Brm null and 
control cohorts.  
Alcian Blue staining was carried out to identify the most abundant cell type of colonic 
epithelium goblet cells. The scoring of the numbers of those secretory lineage cells revealed a 
severe depletion in DKO animals in comparison to Brm null and control animals 
(5.495±0.041 versus 7.630±0.405 and 6.50±0.071, p<0.0001 for either comparison, n≥4, 
Figure 5.9a). 
The presence of enteroendocrine cells in the epithelium was confirmed using grimelius 
staining. The quantification of enteroendocrine cells per half colonic crypt detected a marked 
decrease in the population of those cells in the epithelium of DKO mice compared to control  
and Brm-deficient cohorts (0.865±0.055 versus 1.61±0.052 and 1.47±0.066, p<0.0001, n≥4, 
Figure 5.9b).    
To summarize, the quantification of the predominant differentiated cell types of the colonic 
epithelium revealed a marked depletion in both goblet and enteroendocrine cells of secretory 
lineage suggesting a shift in the differentiation pattern in the Brm- and Brg1-deficient large 
intestine.  
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Figure 5.9 Brg1 loss in the context of Brm null epithelium leads to significant reduction in the goblet and 
enteroendocrine cells of large intestine. The colonic sections of control, Brm null and DKO mice were stained 
and the populations of mature cells were quantified. (A) Analysis of goblet cells stained with Alcian Blue 
showed a significant decline in the goblet cells in the epithelium of DKO animals in comparison to control and 
Brm animals. (B) Similarly, the quantification of the frequency of enteroendocrine cells detected a significant 
change in the number of grimelius-stained cells between the epithelium of DKO and control or Brm null 
animals.  
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5.2.9 Concomitant deficiency in Brm and Brg1 under the expression of 
AhCreER in the context of Apc loss results in the abrogation of intestinal 
architecture 
As described in the previous sections of this chapter, the effects of mosaic Brg1 loss in the 
context of both small intestinal and colonic epithelium were investigated in order to assess 
whether the magnitude of the effects observed in the intestinal epithelia of Brm null allele is 
due to the modification of phenotype by Brm itself or other parallel mechanisms such as 
upregulation of Brg1 expression. Concomitant loss of both ATPase subunits of SWI/SNF 
chromatin remodelling complex is a frequent event in many types of human cancer and 
furthermore both cell line and murine studies indicated that the compensatory mechanism 
between Brm and Brg1 is tissue-specific and limited to only some particular transcriptional 
regulatory functions. Therefore I aimed to explore the effects of induced loss of Brg1 and 
constitutive loss of Brm in the context of Wnt activation. This was achieved by exploiting 
Cre loxP-mediated conditional knock-out of Brg1 and Apc alleles in the intestinal epithelium. 
In order to investigate the long-term effects of concomitant loss of Brm and Brg1 in the 
context of Wnt signalling activation and tumorigenesis, the cohorts of 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+
 (named as ApcBrg1KO) and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm 
null (named as TripleKO) animals at 70 days of age were induced with five bi-daily 
intraperitoneal injections of 80mg/kg β-naphthoflavone with Tamoxifen at 12 hour intervals 
along with AhCreER
-
 controls (n≥7). All animals were aged for maximum 100 days or until 
they have developed signs of ill health and had to be sacrificed and appropriate tissues were 
harvested. As observed previously in chapter 4, none of control animals became ill within the 
time course of the experiment. In contrast, some of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals began displaying signs of ill health as early as 3 
days post induction respectively. Whereas none of Triple KO animals survived past day 12 
post induction, many AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+ 
mice survived longer with few until 100 
days post induction and were sacrificed at the experimental end-point. The analysis of the 
overall survival probability revealed no significant difference between the 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null, AhCreER
+
Apc
fl/fl
Brm null and AhCreER
+
Apc
fl/fl
 cohorts 
(median survival for TripleKO=9 days, Figure 5.10, Log-Rank test p=0.127). In contrast a 
significantly longer survival observed in AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+
 in comparison to 
AhCreER
+
Apc
fl/fl 
(Figure 5.10, Log-Rank test p=0.001) and trends of increase in survival 
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when compared to AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals (Figure 5.10, Log-Rank test 
p=0.064) and AhCreER
+
Apc
fl/fl
Brm null (Figure 5.10, Log-Rank test p=0.072).   
 
The morphological examination of TKO intestinal tissue as day 8-10 post induction revealed 
no macroscopic tumours in either small intestinal or colonic epithelium. Further histological 
analysis of small intestine showed a high degree of intestinal dysplasia (Figure 5.11). Wnt-
activation-driven changes in the architecture of small intestinal epithelium were severe and 
distinguishing between crypt and villus region was not possible for the vast majority of the 
tissue. These observations resulted in the subsequent failure to conduct detailed analysis of 
histological parameters and cell populations. In parallel, the analysis of the frequency of 
Brg1-deficient crypts in Wnt-activated epithelium was impossible.    
In contrast to small intestine, the morphology of colonic tissue was less dysplastic enabling 
the quantification of Brg1-deficient crypts in the colonic epithelium of 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+ 
and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null mice at days 8-10 post 
induction. The comparison between two cohorts revealed a significant decline in the number 
of Brg1-deficient colonic crypts in the epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
animals compared to AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+
 (24.346±10.204 versus 41.605±4.845, 
p=0.018, n≥4, Figure 5.12). This result suggested that in the context of Wnt activation 
mediated by β-catenin, much lower levels of Brg1-deficiency are tolerated in the Brm null in 
contrast to Brm-proficient epithelium. 
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Figure 5.10 Deficiency in both Brm and Brg1 does not alter the survival of animals with a homozygous 
inactivation of Apc. Cohorts of AhCreER
+
Apc
fl/fl
Brm
+/+
, AhCreER
+
Apc
fl/fl
Brm null, AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 
Brm
+/+ 
and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null were induced using an appropriate protocol along with AhCreER
-
 
control mice (n≥7). Animals were aged for 100 days post induction or until they have developed signs of ill 
health. (A) Survival was presented as a Kaplan-Meier plot revealed no significant difference in the survival 
probability of TripleKO experimental mice in comparison to other Apc-deficient animals (Log-Rank test p 
values indicated in the table, n≥7 for either cohort).  
Genotype  ApcKO ApcBrm KO ApcBrg1KO  TripleKO 
APC KO  -  0.144  0.001  0.127  
APC BRM  0.144  -  0.072  0.341  
APC BRG1  0.001  0.072  -  0.064  
TRIPLE  0.127  0.341  0.064  -  
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Figure 5.11 Microscopical analysis of H&E sections of small intestinal and colonic epithelium of 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals reveals severe intestinal dysplasia across the tissue. The intestinal 
epithelium from all animals within TKO cohort underwent a morphological analysis revealing enlarged crypts 
characteristic for Wnt-activated epithelium furthermore showing no tumours in either type of epithelium. The 
scale bar represents 100 µm.  
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Figure 5.12 Deficiency in Brm and Brg1 ATPases is tolerated at much lower levels in the colonic epithelium of 
animals carrying a homozygous inactivation of Apc. Cohorts of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+
 and 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null were induced using an appropriate protocol and tissues of intestinal tissue was 
harvested.  The immunohistochemical analysis of Brg1 expression in the colonic epithelium revealed a 
significant difference in the number of Brg1-deficient crypts between TripleKO and ApcBrg1KO experimental 
mice (24.346±10.204 versus 41.605±4.845, n≥4, p=0.018).  
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5.2.10 Brg1 deficiency potentiates the effects of Brm loss on the transcriptional 
program of Wnt target genes in the context of Wnt activation 
Previous reports suggested that Brg1 can act as a trans-activator of transcription of Wnt target 
genes in colorectal cancer (Baker 2001) indicating that mutations or inactivation of Brg1 
would result in the alteration of the expression of Wnt genes. Therefore I aimed to explore 
whether  the absence of both functional ATPase subunits leads to the failure of SWI/SNF 
complexes to remodel chromatin which subsequently alters the transcriptional program of 
epithelial cells of small and large intestine in the AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
epithelium. 
The cohorts of control, AhCreER
+
Apc
fl/fl
Brm null and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
animals were induced according to an appropriate protocol at 70 days of age and their 
intestinal tissues were harvested. mRNA was extracted and qRT-PCR analysis of the 
expression levels of β-catenin, c-Myc, CD44 and Cyclin D1 was conducted for small intestine 
and colon. A significant down-regulation of CD44 and Cyclin D1 in the small intestine of 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null mice was detected in comparison to epithelium of both 
AhCreER
+
Apc
fl/fl
 and AhCreER
+
Apc
fl/fl
Brm null (for both comparisons p<0.05, n≥4, Figure 
5.13a) however no difference in the levels of c-Myc were detected between TripleKO and 
ApcBrmKO animals. Strikingly, in the colonic epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm 
null a marked up-regulation of all Wnt target genes was detected (for all comparisons p<0.05, 
n≥4, Figure 5.13b) when compared with the gene expression levels in AhCreER+Apcfl/fl and 
AhCreER
+
Apc
fl/fl
Brm null colonic epithelium. 
These results indicate that small intestinal and colonic epithelium deficient in both Brm and 
Brg1 response in an inverse manner to Wnt activation. More specifically it revealed that the 
effects of concomitant loss of both ATPases on the gene expression are not consistent with 
severe morphological changes observed in the epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm 
null animals therefore indicating that the high level of dysplasia reported in the small 
intestinal epithelium is not due to transcriptional activation of Wnt target genes mediated by 
β-catenin.  
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Figure 5.13 Brg1 deficiency suppresses the expression of the Wnt target genes in the small intestine with 
concurring upregulation of the same genes in the colonic epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
animals. The transcriptional levels of Wnt targets CD44, c-Myc and Cyclin D1 genes were quantified by 
quantitative real-time-PCR (qRT-PCR) as shown in bar graph form. The data from qRT-PCR are normalised 
with β-actin and the asterisks indicate comparisons that were found to be significantly different (p<0.05, n≥4). 
(A) Analysis of levels of CD44, c-Myc and Cyclin D1 mRNA revealed a significant decline in expression of 
CD44 and Cyclin D1 genes in the small intestinal epithelium when compared to AhCreER
+
Apc
fl/fl
 and 
AhCreER
+
Apc
fl/fl
Brm null animals. (B) In contrast, colonic epithelium was characterized by a marked 
upregulation of CD44, c-Myc and Cyclin D1 in AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null mice in comparison to ApcKO 
and ApcBrmKO cohorts.  
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5.2.11 The upregulation of Brm in the Brg1-deficient neoplastic lesions of 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 colonic epithelium 
In order to investigate whether Brm is capable of compensating for loss of Brg1 in the 
context of Apc deficiency, I aimed to explore the expression of Brm in the intestinal 
neoplasia Wnt-activated small intestinal and colonic epithelium. Intestinal tissue harvested at 
days 8-10 from AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+ 
and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
animals induced at 70 days of age with five bi-daily intraperitoneal injections of 80mg/kg β-
naphthoflavone with Tamoxifen at 12 hour intervals was used to perform 
immunofluorescence for Brm and Brg1. Both small intestinal and colonic epithelium was 
examined for the presence of the neoplastic lesions characterized by neighbouring Brg1-
deficient and Brg1-proficient crypts and the levels of Brm expression within those lesions 
were qualitatively analysed. 
In the small intestine of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm
+/+ 
animals, the analysis of the 
dysplastic areas of epithelium containing both Brg1-deficient and Brg1-proficient lesions 
revealed no perceptible changes in Brm expression. This observation suggested that Brm is 
not playing a compensatory role for Brg1 loss in the small intestinal epithelium (Figure 5.14).  
In contrast to this data, the neoplastic areas of colonic epithelium revealed that Brg1-deficient 
lesions show higher levels of Brm expression in comparison to neighbouring Brg1-proficient 
lesions indicating that in the context of large intestinal mosaic loss of Brg1, Brm becomes 
upregulated and may possibly compensate for some of the functions of Brg1 specific for 
colonic tissue (Figure 5.14). The examination of TripleKO epithelium further confirmed that 
in the absence of Brm expression in AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null epithelium this 
mechanism fails to compensate for Brg1 loss further modulating colonic phenotype of Apc-
deficient animals.    
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Figure 5.14 The upregulation of the expression of Brm in the colonic epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 
animals. Double immunofluorescence for Brm and Brg1 was conducted on the small intestinal and colonic 
tissue sections of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 induced using an appropriate protocol. The immunohistochemical 
analysis of Brm expression in the neighbouring Brg1-proficient (yellow arrow) and Brg1-deficient (blue arrow) 
lesions in both types of the epithelium revealed higher expression levels of Brm in the Brg1-deficient lesions of 
colon. The comparison conducted in the small intestinal epithelium detected no changes in the Brm expression 
independent upon the Brg1 status. The scale bar represents 100 μm.  
  
Small intestinal epithelium 
Colonic intestinal epithelium 
Anti-Brg1      Anti-Brm       Merged 
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5.2.12 The expression levels of Brm and Brg1 in the small intestinal and colonic 
epithelium are context- and tissue-dependent    
Taking into the account numerous reports indicating structural and biochemical similarities, 
redundancy in the function in murine models of human cancers and fluctuations in the 
expression in the human tumour tissue between Brm and Brg1, there have been several 
questions remaining through the course of experiments conducted within this thesis. 
Upregulated levels of Brm were found frequently in many Brg1-deficienct human cancer cell 
lines (Reyes et al. 1998, Bultman et al. 2000, Muchardt and Yaniv 2001, Strobeck et al. 
2002) suggesting that Brm could compensate for the loss of its paralogue ATPase however in 
the absence of data from murine models of cancer or human neoplastic tissue, fluctuations in 
expression between Brm and Brg1 could not be appropriately assessed. Therefore I aimed to 
quantify the gene expression levels of both Brm and Brg1 in all experimental cohorts used in 
this thesis to explore the possibility of existence of compensatory mechanism between Brm 
and Brg1 in the intestinal epithelium as well as to further assess the impact of a deficiency in 
a single catalytic subunit on the SWI/SNF mediated chromatin remodelling. mRNA was 
extracted from small intestinal and colonic epithelium of AhCreER
-
Brm
+/+ 
(control),  
AhCreER
+
Brm null (Brm null), AhCreER
+
Brg1
fl/fl
 (Brg1KO), AhCreER
+
Brg1
fl/fl
Brm null 
(BrmBrg1KO), AhCreER
+
Apc
fl/fl
 (ApcKO), AhCreER
+
Apc
fl/fl
Brm null (ApcBrmKO), 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 (ApcBrg1KO) and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null (TripleKO) 
and qRT-PCR analysis using TaqMan probes for Brg1 and Brm was conducted.  
The analysis of Brm and Brg1 expression in the colonic epithelium in the context of 
maintained homeostasis revealed 1.5 fold upregulation of Brg1 in the Brm null tissue, 10 fold 
increase in Brm in the mosaic Brg1KO and remarkably over a 50 fold increase in the gene 
expression levels of Brg1 in the AhCreER
+
Brg1
fl/fl
Brm null epithelium (Figure 5.15a). 
Surprisingly, in the small intestinal tissue no upregulation but diminished levels of Brg1 were 
detected in the Brm null epithelium. However consistent with observations in the colon, qRT-
PCR analysis showed a marked increase in Brm levels in the epithelium of AhCreER
+
Brg1
fl/fl 
animals as well as 4 fold upregulation in Brg1 in the BrmBrg1KO cohort (Figure 5.15a).  
Moreover the parallel gene expression analysis was conducted for both types of intestinal 
epithelium in the context of Wnt activation via deletion of Apc. Similar pattern of fluctuation 
in the expression of Brm and Brg1 were detected with a significant downregulation of Brg1 
in the ApcBrmKO small intestinal and colonic epithelium. A marked 8 fold increase in Brm 
mRNA levels was found in the small intestine of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 however in the 
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context of colon it was only equal to 2 fold increase (Figure 5.15b). Importantly in contrast to 
homeostatic tissues, a sharp decline in the levels of Brg1 was observed in both types of 
epithelium in the AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null samples. Taken together these results 
suggest that the pattern of fluctuation between Brm and Brg1 levels is different in the context 
of normal or neoplastic epithelium with some perceptible changes in the magnitude of 
changes between small intestinal and colonic epithelium. 
In summary, the analysis of Brm and Brg1 gene expression in the context of both normal 
intestinal homeostasis and Wnt-driven tumorigenesis showed significant fluctuations of 
mRNA levels of either ATPase depending upon the status of its respective paralogue. These 
changes were observed in both small intestinal and colonic epithelium however the fold 
changes of a greater magnitude were observed in the homeostatic in contrast to Wnt-activated 
epithelium.  
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Figure 5.15 The fluctuations in the gene expression of Brm and Brg1 in the small intestinal and colonic 
epithelium in the context of normal homeostasis and Wnt-driven tumorigenesis. The transcriptional levels of 
Brm and Brg1 were quantified by quantitative real-time-PCR (qRT-PCR) as shown in bar graph form. The data 
from qRT-PCR are normalised with β-actin and the asterisks indicate comparisons that were found to be 
significantly different (p<0.05, n≥4). Analysis of levels of Brg1 ATPase revealed a significant decline in 
expression in the small intestinal epithelium of Brm-deficient animals with a mild increase observed in the 
colon. In contrast, Brm was shown to be upregulated 10 fold in the intestinal epithelium of Brg1KO mice. In the 
context of Wnt-activation, Brg1 is characterized by significant downregulation in all Brm-deficient tissues 
whereas Brm transcription levels are maintained at very high levels in the Brg1-deficient epithelium. 
0
10
20
30
40
50
60
R
e
la
ti
ve
 m
R
N
A
 le
ve
ls
Brg1
Brm 
0
1
2
3
4
5
6
7
8
9
R
e
la
ti
ve
 m
R
N
A
 le
ve
ls
Brg1
Brm
* 
* 
* 
* 
* * 
* 
* * * 
222 
 
5.3 Discussion 
 
5.3.1 Loss of Brg1 under the expression of  AhCreER recombinase leads to 
repopulation by wildtype Brg1-proficient cells in the context of Brm null 
epithelium of small intestine with concomitant retention of Brg1-deficient 
crypts in the colon 
Previous reports by Holik (PhD Thesis, 2011) showed that Brg1 was characterized by a 
mosaic pattern of loss under control of AhCreER recombinase in the small intestinal and 
colonic epithelium. Further histological analysis of experimental time-points post induction 
showed that the number of crypts retaining Brg1-deficient cells gradually decreased resulting 
in the absence of crypts containing Brg1-deficient cells by day 35 post induction indicating 
that in the context of small intestine, the epithelium became repopulated with wildtype cells 
expressing Brg1. In contrast, the colonic epithelium could be distinguished by the long term 
retention of Brg1-deficient crypts as long as 490 days post induction.  
I aimed to investigate further this pattern of Brg1 loss, repopulation of epithelial cells and the 
fate of Brg1-deficient crypts in the context of Brm null allele. Similar time-points to those 
set-out by Holik (2011) were analysed for the frequency of Brg1-deficient intestinal crypts 
detecting a parallel mechanism of elimination of Brg1-deficient cells and slow repopulation 
of epithelium by Brg1-proficient cells. By day 15 post induction less than 5% of all crypts in 
Brg1KO and DKO animals were Brg1-deficient. As quantitative analysis of 
AhCreER
+
Brg1
fl/fl
Brm null epithelium showed low levels of apoptosis in Brg1-deficient 
small intestinal crypts, the decrease in the frequency of Brg1-deficient crypts is unlikely to 
occur due to programmed cell death of Brg1-deficient cells. Although the rates of 
repopulation of small intestinal epithelium seem indistinguishable between Brg1KO and 
DKO animals, the initial frequency of Brg1-deficient crypts indicate that in the context of 
Brm allele, Brg1 is lost as significantly lower rate in Brm null rather than Brm-proficient 
animals and those crypts require a longer time to regain their Brg1-proficient status.  
These results suggest that in the small intestinal epithelium there is a strong selection against 
the presence Brg1-deficient cells which further magnifies in the context of constitutive Brm 
loss. Considering the expression pattern of AhCreER recombinase, the mosaic loss of 
functional Brg1 specifically in stem cell and early progenitor cell populations could possibly 
be a driver of crypt repopulation as non-recombined stem and progenitor cells could rescue 
the small intestinal epithelium from the long-term consequences of Brg1 deficiency. 
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Concomitant deficiency in both ATPases within those crypts may however result in the 
extension of time required for turnover of epithelial cells and therefore complete elimination 
of Brg1-deficient crypts in the AhCreER
+
Brg1
fl/fl
Brm null epithelium.  
In parallel, the analysis of the Brg1 expression in the colonic epithelium of 
AhCreER
+
Brg1
fl/fl
Brm null animals was conducted revealing a contrasting effects of a long-
term retention of Brg1-deficient colonic crypts in both AhCreER
+
Brg1
fl/fl
Brm null and 
AhCreER
+
Brg1
fl/fl
Brm
+/+
 animals. The frequency of Brg1-deficient colonic crypts remains at 
a steady rate of approximately 15% throughout all experimental time-points in both Brm-
deficient and Brm-proficient epithelium.   
In summary, Brm and Brg1 might both be dispensable for proliferation of the large intestinal 
epithelium and a long-term retention of crypts however in the context of small intestine, a 
reduction in the frequency of Brg1-deficient cells suggests that expression of functional Brg1 
is important for the maintenance of intestinal architecture independently of its Brm status.  
5.3.2 The repopulation of small intestinal epithelium is halted by reduced 
proliferation levels in AhCreER
+
Brg1
fl/fl
Brm null concomitant with the 
dysregulation of differentiation along the secretory lineage  
In the absence of induced pan-epithelial loss of Brg1 similar to the constitutive loss of Brm in 
the intestinal epithelium, I aimed to conduct a quantitative characterization of small intestinal 
and colonic epithelium at day 5 post induction ensuring that over 30% of the crypts within 
epithelium are Brg1-deficient.  
The morphological analysis of small and large intestine revealed no architectural 
abnormalities with crypts retaining their normal appearance in comparison to neighbouring 
Brg1-proficient counterparts. The intestinal crypt in both small intestine and colon represents 
a proliferative compartment of the epithelium which is regulated predominantly by Wnt 
signalling (reviewed in Pinto and Cleavers 2005). In the small intestine, the concomitant 
deficiency in Brm and Brg1 resulted in the significant decrease in the number of proliferating 
cells marked by Ki67 immunohistochemistry. Analysis of the distribution of Ki67-positive 
cells further revealed that this severely reduced pool of proliferating cells is localized 
predominantly towards the base of the crypt. In contrast, in the colonic epithelium the 
proliferation levels in DKO crypts are indifferent from those observed in Brm null and 
controls. Taken together, it can be extrapolated that the longer retention of Brg1-deficient 
crypts in the small intestinal epithelium is partially due to the significantly reduced levels of 
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proliferation in the DKO epithelium allowing for slower rate of repopulation by Brg1-
proficient cells. The notion of diminished population of proliferating Ki67-positive cells in 
the homeostatic intestinal epithelium of AhCreER
+
Brg1
fl/fl
Brm null mice is not supported by 
experiments in human cancer cell lines and prostate cancer reporting that the deficiency in 
both Brm and Brg1 results in the abrogation of the ability of Rb to arrest cellular proliferation 
(Strobeck et al. 2002, Marshall et al. 2003, Shen et al. 2008). In this case the disparity 
between our observations and mentioned reports might be due to the context – homeostasis 
versus tumorigenesis - in which the tissue was found rather than tissue-specific alterations. 
Previous reports indicated Notch and Wnt as the key signalling pathways regulating the 
differentiation of epithelial cells along the absorptive and secretory lineage. Brg1 has 
previously been proposed as a factor required for the trans-activation of Wnt target genes 
regulating a wide array of cellular processes such as apoptosis and proliferation (Baker 2001). 
In contrast, Brm has been shown to be preferentially recruited to the promoters of Hes1 and 
Hes5 Notch genes (Kadam and Emerson 2003) as well as to interact with ICD22 and CBF-1 
Notch proteins (Kadam and Emerson 2003). The decline in the number of goblet cells 
accompanied by the decrease in brush border enterocytes in the DKO crypts of small intestine 
is contradictory to the increase in the size of goblet cells population in Brm null. However, a 
trend of decrease in the number of goblet cells was reported in the context of small intestinal 
Brg1 loss under the expression of VillinCre recombinase (Holik A, PhD thesis 2011). In 
parallel, colonic crypts of DKO are characterized by the depletion in the numbers of goblet 
and enteroendocrine cells which is again in contrast to observations by Holik (PhD thesis, 
2011). In the light of those contrasting data and the results presented in chapter 3, Brm status 
is crucial for the differentiation of the epithelial cells along the secretory lineage in intestinal 
epithelium whereas the dynamics of the changes occurring in the AhCreER
+
Brg1
fl/fl
Brm null 
animals indicates that the concomitant deletion of Brm and Brg1 may possibly establish a 
unique phenotype different of those observed in the cases of loss of either particular ATPase.   
5.3.3 Concomitant loss of both Brm and Brg1 does not exacerbate the 
phenotype of Wnt activation in the colonic epithelium 
Whereas the effects of pan-epithelial deletion of Brg1 in the intestinal epithelium were 
previously reported by Holik et al. (2013, 2014) along with the consequences of constitutive 
loss of Brm described in the chapter 3, I aimed to characterize the effects of concomitant loss 
in Brm and Brg1 in the intestinal epithelium in the context of Wnt activation in order to 
further characterize the roles of both ATPase subunits in colorectal cancer.  
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Concomitant loss of both ATPases of SWI/SNF chromatin remodelling complex was 
reported to occur at a higher frequency than a deficiency in only one subunit in lung cancers 
whereas the situation is vice versa in gastric cancer (Reisman et al. 2003, Fukuoka et al. 
2004, Yamamichi et al. 2007). Furthermore, the same non-small cell lung cancer study 
showed that deficiency in Brm and Brg1 is associated with a poor prognosis for the patients 
(Reisman et al. 2002) whereas another study in prostate cancer correlated reduction in the 
expression of Brm in particular as a marker for worse survival (Sun et al.  2007).  
In order to investigate the effects of concomitant loss of Brm and Brg1 in the context of 
epithelium of intestine I initially conducted a morphological analysis of the intestinal 
epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals revealed a severe dysplasia in the 
small intestine whereas colonic tissue was less severely affected. The survival probability 
analysis revealed no significant differences in the lifespan between AhCreER
+
Apc
fl/fl
, 
AhCreER
+
Brm null and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null mice however a trend of decrease 
in survival was observed comparing AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null and 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 indicating that supplemental deficiency in Brm factor leads to 
reduced lifespan of animals. These data suggest that small intestinal epithelium is dependent 
upon the normal functioning of either of ATPases in a much higher degree than large 
intestine. The reduction in lifespan of animals carrying a deletion of Apc and Brg1 indicated 
that whereas Brm does not affect the Wnt-driven tumorigenesis mediated by Apc loss it 
might act in a tumour suppressor manner in the context of Wnt-activated intestinal epithelium 
deficient in its paralogue Brg1.     
One of the hallmarks of colorectal tumorigenesis is the activation of β-catenin-mediated 
transcriptional program that occurs in the context of Wnt activation. Therefore I aimed to 
investigate whether a reduction in liferspan of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null mice in 
comparison to AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 animals is due to the modulation of Wnt signalling. 
The assessment of the expression levels of several Wnt target genes such as c-Myc, CD44 and 
Cyclin D1 was conducted using qRT-PCR revealing significant downregulation of CD44 and 
Cyclin D1 in the small intestine of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animal. Interestingly the 
expression of c-Myc was not altered between AhCreER
+
Apc
fl/fl
Brm null, 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl 
and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals. In parallel, the 
expression analysis in the colonic epithelium showed similar but less severe reduction in the 
expression in Wnt target genes. The discrepancy between the Wnt signalling levels in small 
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and colonic epithelium might explain the differences in the degree of intestinal dysplasia 
observed in the either type of epithelium.     
Taken together, in the context of Wnt activation it appears Brm is playing an auxiliary role to 
Brg1 in the modulation of lifespan and histological phenotype.   
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Chapter 6  
General discussion 
 
Colorectal cancer remains one of the most frequently diagnosed malignancies in the 
developed countries accounting for over13% of all new cancer cases annually. Although the 
survival rates have increased over the last two decades, colorectal cancer is still characterized 
by a high mortality rate, being the 2
nd
 most common cause of cancer death. Dysregulation of 
Wnt signalling via Apc loss or stabilizing mutations in β-catenin is at the core of over 80% of 
all CRC cases. The current treatments of CRC involve surgical removal of the tumour mass 
combined with neoadjuvant and adjuvant care using chemotherapy or radiotherapy or both in 
some cases of rectal cancer. The concept of stratified medicine in cancer treatment 
culminated in the large-scale genetic profiling of colorectal tumours combined with extensive 
analyses of molecular events occurring during cancer initiation and progression. Importantly, 
numerous potential markers and therapeutic candidates have been identified throughout this 
process implicating both genetic and epigenetic changes that may play an important role in 
the modulation of many cancers including CRC. 
The potential role of the SWI/SNF chromatin remodelling complex and more specifically its 
catalytic ATPases Brm and Brg1 as bona fide tumour suppressor genes in contributing 
towards tumorigenesis in a tissue-specific manner was suggested as a promising avenue for 
development of novel therapeutic strategies. Importantly, in contrast to many other tumour 
suppressor genes which are frequently mutated, Brm is rather silenced in the context of 
human solid tumours. The notion that the expression and therefore the function of Brm could 
possibly be restored provides some serious implications for clinical targeted therapy of 
tissues dependent on Brm functioning. Moreover numerous cell line studies have indicated 
that histone deacetylase acid (HDAC) inhibitors are capable of re-induction of Brm 
expression in Brm-deficient cell lines and this re-expression is sufficient for restoration of 
Rb-mediated growth inhibition and expression of Wnt target CD44 (Strobeck et al. 2002, 
Glaros et al. 2007, Kahali et al. 2013). As targeting of developmental pathways involved in 
tumorigenesis such as Hedgehog, Wnt and Notch pathways could be achieved at multiple 
levels within the signalling cascade like ligand expression or interactions between ligand and 
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receptor, modulation of the expression of downstream Wnt target genes like CD44 and β-
catenin would be an interesting alternative to explore.  
Furthermore in light of the fact that both Wnt and Notch signalling are implicated in 
intestinal homeostasis involving stem cell maintenance as well as in colorectal tumorigenesis, 
the interaction of the Brg1 catalytic subunit with β-catenin (Baker et al. 2001), together with 
exclusive interactions of Brm with CBF-1 and ICD-22 Notch pathway effectors (Kadam and 
Emerson 2003) all suggest that the ATPase subunits of the SWI/SNF chromatin remodelling 
complex might act as good potential therapeutic targets in CRC. One of the potential 
obstacles to this is the notion in regards to the high degree of homology (~75% amino acid 
sequence identity), between Brm and Brg1,which suggests they may be capable of 
compensating for each other in case of loss of either ATPase. This is not a common 
consensus as other sources in dicate tissue-specificity and gene-selectivity of interactions of 
Brm-containing and Brg1-containing complexes suggesting distinct roles for each catalytic 
subunit of SWI/SNF in regulating gene expression (Kadam and Emerson 2003, Marshall et 
al.  2003). 
In the absence of data regarding a role of Brm in the intestinal tissue, the potential of 
ATPases of SWI/SNF chromatin remodelling complex to act as tumour suppressor genes, as 
well as potential clinical targets remained undetermined. Therefore, I aimed to investigate the 
effects of Brm deficiency in the normal intestinal epithelium in the context of homeostasis 
and further in the context of Wnt pathway activation via loss of Apc. Whereas the small 
intestine is recognized as a tissue that accurately recapitulates many aspects of human CRC 
tumorigenesis, due to some differences in the morphology of the epithelium and the fact that 
a primary site of human tumours is in the colonic epithelium, both small intestine and colon 
were investigated.  
As described in this thesis, these notions have been explored leading to the following 
findings:  
1) Brm is redundant for the maintenance of intestinal homeostasis in the context of 
functional Brg1 paralogue 
2) In the context of Wnt activation, loss of Brm modulates Wnt-driven intestinal 
neoplasia by suppression of Wnt target genes and attenuation of the expansion of stem 
cells which concurs with expansion of the proliferative compartment  
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3) Differences in the mRNA levels of Brm and Brg1 were found between the intestinal 
and colonic epithelium and the severity of phenotypes observed appears to be 
dependent upon the status of both ATPases of SWI/SNF  
Taken together, in this chapter I will discuss all of the above notions summarized in the Table 
6.1. 
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      SMALL INTESTINE        COLONIC EPITHELIUM 
 Brm null BrmBrg1 KO BrmApc KO Brm null BrmBrg1 
KO 
BrmApc KO 
Histology:       
Crypt length        
Villus length        N/A     N/A       N/A 
Cell death:       
Proliferation:       
Cell numbers       
Cell distribution changes changes    changes    changes  
Cell differentiation:       
Enterocytes       N/A     N/A       N/A 
Goblet cells       
Enteroendocrine cells       
Paneth cells       N/A     N/A       N/A 
Wnt pathway:       N/A     N/A     N/A  
At protein level IHC βcat   βcat  IHC βcat      
At mRNA level βcat    
CD44 
 CD44          
c-myc  
cyclinD1 
  βcat     
CD44         
c-myc 
Notch pathway:       N/A     N/A       N/A       N/A 
At protein level Math1 
HES5 loss 
 
 
    
At mRNA level Math1  HES1    
Stem cell niche:        N/A       N/A       N/A 
Olfm4 in situ        
At mRNA level No changes  Olfm4     
Brg1 expression:       
       
Other notes:  Repopulation 
by Brg1 
wildtype cells 
  Retention of 
Brg1 
deficient cell 
 
In the context of homeostasis:  
•  Brm is redundant for the maintenance of SC zone 
•  Brm imposes restriction to the proliferative compartment expansion 
•  Brm together with Brg1 maintains the expression of CD44 Wnt target gene 
•  Brg1 might partially compensate for Brm function, in particular in colonic epithelium   
In the context of Wnt signalling activation:  
•  Brm is redundant for the Wnt activation via Apc loss 
•  Brm regulates the expression of Wnt target genes via β-catenin-independent mechanism 
•  Brm regulates the expression of Olfm4 Wnt-independent SC marker  
•  Brg1 has antagonistic effects on the Wnt target gene expression  in Wnt-activated small intestine and 
colon in the context of Brm loss 
 
Table 6.1 The summary of histological analyses of all phenotypes involving Brm null allele in both small 
intestinal and colonic epithelium. Red arrow indicates statistically significant increase/upregulation, green arrow 
– statistically significant reduction/downregulation and purple arrow – the parameters that no difference/change. 
N/A refers to the parameters which have not been investigated or are small intestinal/colonic-specific. The 
impact of Brm on the homeostasis of small intestinal and colonic epithelium and tumour suppressing function of 
Brm and its requirement in the Wnt-activated epithelium is dependent upon the status of Brg1 paralogue in the 
respective tumours. The disparity in the results between small intestinal and colonic epithelium are associated 
with differential Wnt gradient and limiting capacities of Brg1 to compensate for Brm function.  
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6.1 The effects of Brm loss on the intestinal epithelium are 
dependent on the physiological levels of Wnt activity  
The role of SWI/SNF chromatin remodelling complexes in facilitating the accessibility of 
DNA sequence is a fundamental requirement for transcription to occur and coincident with 
this notion, complexes associated with either of catalytic subunits Brm or Brg1 have been 
implicated in regulation of a plethora of cellular processes and signalling pathways involved 
in cell self-renewal, proliferation, differentiation and cell death (reviewed in Narlikar et al. 
2002). While numerous in vivo studies on human cancer cell lines suggested that ATPases of 
the SWI/SNF complex share some common functions (Chiba 1994, Strober et al. 1996, 
Bourachot et al. 2003), the differential distribution in the preimplantation stages of mouse 
development between Brm and Brg1 (LeGouy 1998) together with experiments conducted in 
a model of osteoblast differentiation revealed that Brm and Brg1 might indeed function in an 
antagonistic manner and be associated with either repression or activation of particular 
promoters in the tissue-specific context (Flowers 2009). Furthermore the same reports 
suggest that Brm is frequently functionally redundant and therefore plays an auxiliary role in 
the regulation of gene expression, a notion consistent with the Brg1 null phenotype which is 
embryonic lethal (Bultman et al. 2000), and the Brm null phenotype which is characterized 
by animals that are viable and overtly no different to their wildtype littermates (Reyes et al. 
1998). Although the role of Brm have been described in several reports investigating the 
effects of Brg1 loss, limited data exists on the role of Brm on the homeostasis or 
tumorigenesis of differentiated tissue types. The results presented in this thesis represent an 
extensive analysis of the effects of Brm deficiency in the context of homeostasis and Wnt-
driven tumorigenesis in the murine small intestinal and colonic epithelium.   
A comparison of the consequences of Brm and Brg1 loss in the small intestinal epithelium 
(Brg1 data presented by Holik A in the PhD thesis 2011) revealed a degree of specialization 
of Brm-containing complexes in performing particular function in tissue-dependent context. 
Analysis of the proliferation levels using Ki67 and BrdU markers showed no differences in 
the size of the population of proliferating cells measured by the number of positive cells 
across the crypt-villus axis, however the distribution of those cells revealed an expansion of 
the proliferating compartment in the epithelium of Brm null mice. This is in contrast to the 
data by Reyes (1998) indicating a 4 fold increase in the number of BrdU-positive cells in the 
livers of Brm null animals. However, this observed disparity in the results might be due to the 
morphological differences between those tissues where similar effects – pro-proliferative 
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capacities in Brm deficient context - are differentially expressed in the spatial setting of a 
particular tissue type – increase the number of proliferating cells in the liver in comparison to 
an expansion of the proliferating compartment in the small intestine. In the context of 
concomitant loss of both Brm and Brg1 driven by the expression of the AhCreER 
recombinase transgene, a marked decline in the number of proliferating cells was detected 
coinciding with changes in the distribution of Ki67-positive cells indicating that whereas Brm 
does not appear to display pro-proliferative effects in a form of alterations to cell numbers 
such as those observed in case of pan-epithelial loss of Brg1 (Holik PhD thesis 2011), the 
expansion of proliferative compartment is a Brm-dependent process. Perturbations in the 
proliferation of Brm-deficient cells has been previously reported in numerous cell lines 
characterized by Rb-insensitivity as a result of Brm loss, however the analysis of the cell 
cycle regulators p21 and p17 did not provide any further insight into the possible mechanism 
by which Brm mediates its anti-proliferative functions (Kadam and Emerson 2003). 
One tissue-specific effect observed in the small intestinal epithelium of Brm null animals was 
CD44 expression. Interestingly, no changes at the transcriptional level of CD44 were detected 
in the Brm null experimental animals while the pattern of CD44 loss was reported in vivo in 
Brm-deficient human cancer cell lines (Reisman et al. 2002, 2003) as well as in multiple 
tissues including gut epithelium of Brm null mice (Reisman et al. 2002). Whereas there is a 
possibility of transient repression of CD44 expression in all investigated systems however 
taking into the account the timeframe of experiments and the extensive differences in the data 
obtained, this seems unlikely. One other possibility is that there is a difference in the 
requirement for CD44 function between those cells, which subsequently would imply 
reliance of small intestinal epithelium on CD44 for the maintenance of homeostasis as the 
presence of CD44 on the cell surface is recognised as a marker for intestinal progenitors 
(Fevr 2007). Lastly, considering that Brg1 expression is retained in the epithelium of Brm 
null animals, the levels of Brg1 ATPase may be sufficient for the activation of the CD44 
promoter ensuring that the appropriate levels of CD44 expression are maintained within this 
tissue. It could therefore be extrapolated that no specific compensatory mechanism would be 
needed but rather a shift between Brm-containing and Brg1-containing complexes at the level 
of CD44 promoter. 
These observations suggest that Brm might play a similar or parallel role to Brg1 in intestinal 
homeostasis, however the extent of the effects would be more limited and less severe than 
those one observed in the Brg1-deficient tissue. 
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In regards to the anti-proliferative capacities of Brm, in the context of Wnt-driven 
tumorigenesis Brm loss was found to lead to an expansion of Ki67-positive cell distribution, 
therefore again the spatial distribution of proliferating cells can be influenced by Brm status.  
In the context of active Wnt signalling, qRT-PCR analysis detected an extensively 
downregulated CD44 expression in both small intestine and colon which was further 
confirmed by immunohistochemical analysis of Apc-deficient epithelium in the context of 
Brm proficiency and Brm loss. The expression of CD44 expression is a well-known hallmark 
of colorectal tumorigenesis (Shibata 1997, Huh 2009) implicating that Brm may be directly 
interacting with Wnt pathway downstream of β-catenin through the regulation of target genes 
expression. The lack of any effect of Brm null allele on the expression of CD44 in the normal 
small intestinal homeostasis might be unexpected when compared to the diminished 
expression of CD44in the context of aberrant Wnt signalling. However taking into the 
account the gradient of active Wnt signalling and stem cells ranging from very high in the 
proximal small intestine and relatively low in the colon in CRC (Leedham et al. 2012) in 
regards to what appears to be low levels of Wnt which are required for normal intestinal 
homeostasis, the response to Brm deficiency as evidenced by the changes in CD44 expression 
would indicate an extensive reliance of Brm effects on underlying Wnt activity within the 
intestinal epithelium. A “just right hypothesis” suggesting that the impairment of Apc-
containing β-catenin destruction complex must result in the β-catenin accumulation and Wnt 
activation sufficiently high to generate tumours (Albuquerque et al. 2002) is consistent with 
the above data and provides further evidence for the differential responses to Brm deficiency 
in the context of Wnt-driven tumorigenesis between the small intestinal and colonic 
epithelium. 
The absence of a lethal phenotype for Brm null animals as well as increased Brm expression 
during cellular differentiation (LeGouy 1998, Reyes et al. 1998) both indicate that Brm is 
redundant for the maintenance of stem cells. Following Wnt activation there is a Wnt-driven 
expansion of the stem cell population (Jubb 2006) however, in the context of Brm deficiency, 
Wnt-activated epithelium of small intestine revealed a significant decrease in the intestinal 
stem cell marker Olfm4. Both in situ hybridization using anOlfm4 riboprobe and analysis of 
gene expression detected diminished levels of Olfm4 in the small intestinal epithelium of 
AhCreER
+
Apc
fl/fl
Brm null mice. No alterations were observed in the gene expression of other 
intestinal stem cell markers(Lgr5 and Ascl2) which are direct Wnt target genes, suggesting a 
lack of interaction between the Wnt pathway elements and Brm function as suggested by 
234 
 
Kadam and Emerson (2003). The speculation that Brm is capable of regulating the stem cell 
compartment of intestinal epithelium and that this interaction is limited to the Wnt-
independent stem cell marker Olfm4 would implicate that signalling pathways regulating 
self-renewal and maintenance of stem cells and progenitors other than Wnt must be 
mediating these effects. The control of self-renewal and the fate of intestinal progenitors have 
been attributed to interaction between Wnt and Notch pathway (Fre 2005, 2009, van Es 2005, 
reviewed in Noah 2013), suggesting that signalling through the Notch cascade could provide 
Brm with an alternative option for by-passing Wnt pathway. The mediation of Brm 
consequences through Notch without further activation of Wnt signalling via the β-catenin 
pathway effector would be consistent with other reports indicating that in the context of 
aberrant Wnt signalling, Notch is present downstream of β-catenin (Rodilla et al. 2009, 
Peignon et al. 2011).  
6.2 Bona fide role of Brm as a tumour suppressor gene in Wnt-
driven colorectal tumorigenesis is dependent upon the Brg1 
status indicating a synthetic lethality relationship between 
ATPases of SWI/SNF chromatin remodelling complex   
Alteration in the catalytic subunits of the SWI/SNF chromatin remodelling complex have 
been implicated in human diseases as factors contributing towards tumorigenesis in a tissue-
specific manner (reviewed in Wilson and Roberts 2011). Loss of Brm expression in the 
context of UV-induced skin cancer mouse model (Halliday et al. 2012) was associated with 
higher growth rate of skin tumours consistent with the role of Brm in the cell cycle control 
(Reyes et al. 1998). Analysis of human skin lesions was indicative of a tumour suppressive 
role for both Brm and Brg1 in the progression of skin cancer towards more invasive tumours 
(Bock et al. 2011, Moloney et al. 2009) suggesting that whereas Brm appears to not be 
necessary for tumour initiation, loss of expression occurs as a late event in the skin 
tumorigenesis. The role of Brm in Rb-mediated cell cycle arrest and its pro-proliferative 
capacities provide skin tumours with a growth advantage consistent with a tumour suppressor 
loss phenotype. Consistent with the above, a downregulation in Brm expression has been 
observed in non-small cell lung cancer where it was frequently lost along with Brg1 
expression indicating poor prognosis (Reisman et al. 2002, 2003). Similarly, the loss of Brm 
expression in prostate tumours has been reported to correlate to a higher proliferative index 
and overall poor survival probability in comparison to Brm-proficient counterparts (Sun et al. 
2007,Shen et al. 2008). The prognostic potential of Brm for classification of gastric cancer 
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was explored by Yamimichi et al. (2007), who showed a positive correlation between 
deficiency in Brm expression and poorly differentiated tumour phenotype. In parallel, the 
same study indicated that Brm expression is present in all colorectal cancer cell lines whereas 
staining of colonic mucosa against Brm revealed no decrease in Brm expression suggesting 
that Brm is a marker for gastric but not colorectal tumorigenesis.  
In the chapter 4 of this PhD thesis I explored the possibility that Brm plays a tumour 
suppressor role in the epithelium of the small intestine and colon. Due to previous notions 
suggesting that the loss of both alleles of Brm was required in a murine model of UV-induced 
photocarcinogenesis (Halliday et al. 2012), I assessed the effects of Brm null status on the 
Wnt-driven tumorigenesis of intestinal epithelium.   
Whereas loss of Brm expression in human lung and prostate tumours was associated with a 
poor prognosis and decrease in survival, parallel studies using murine models reported 
increased growth potential of Brm-deficient lung and skin tumours with no indications in 
regards to survival probability of experimental animals (Glaros et al. 2007, Halliday et al. 
2012). The analysis of Brm loss in the context of aberrant Wnt signalling mediated through 
Apc loss failed to reveal an alteration of survival probability dependent upon Brm expression 
status.While conditional loss of Apc under the expression of AhCreER recombinase results in 
the perturbation of normal intestinal homeostasis and initiation of tumorigenesis, the 
activation of Wnt signalling leads to very short lifespan of experimental animals making the 
analysis of frequency or size of tumours very limited. In addition, Brm status does not appear 
to alter the survival probability of Apc-deficient animals as seen by a median survival, 
however Brm null mice are characterized by an earlier onset of symptoms suggesting that 
tumour initiation and early neoplastic change occurs at the faster rate in Brm-deficient 
epithelium. Consistent with that, the ethyl carbamate model of lung carcinogenesis indicated 
loss of Brm as factor potentiating the initiation and development of lung tumours (Glaros et 
al.  2007).These results suggest that Brm plays a tumour suppressing role in the epithelium of 
lung and intestine, however the acceleration tumorigenesis occurs through the changes in the 
proliferation rates and gene expression rather that do not translate into dramatic differences in 
survival probability.  
The significance of Brm in the context of Wnt-driven colorectal tumorigenesis in a short-term 
study was further explored by comparing Brm-deficient, Brg1-deficient as well as Brm and 
Brg1-deficient intestinal epithelium to elaborate the impact of loss of a particular ATPase to 
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determine whether the reported effects on colorectal tumorigenesis are caused directly by the 
loss of catalytic subunit or by alteration in the remaining SWI/SNF chromatin remodelling 
complexes through a shift in their subunit reliance. Analysis of the survival probability 
between AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null and AhCreER
+
Apc
fl/fl
Brm null showed no 
significant differences in the survival suggesting that in the context of Brm null allele Brg1 
proficiency or deficiency does not alter tumorigenesis. Moreover, in response to Wnt 
activation, the expression levels of Wnt target genes in the small intestine were suppressed in 
a similar manner between those two cohorts of animals suggesting similar mechanism of 
tumorigenesis. Whilst conditional loss of Brg1 in the intestinal epithelium is incompatible 
with β-catenin accumulation and Wnt activation leading to improved survival of Apc-
deficient mice and (Holik 2014), either loss of its paralogue Brm or concomitant loss of both 
Brm and Brg1 does not display a similar effect on the survival probability. The upregulation 
of Brm at the transcription level in the Brg1-deficienct Wnt-activated small intestinal 
epithelium together with survival data suggest that Brm might be capable of partial 
compensation for Brg1 function extending the survival of Apc-deficient animals. In the 
context of concomitant loss of both Brm and Brg1 the same compensation mechanism would 
be absent leading to the survival probability being indistinguishable from that of 
AhCreER
+
Apc
fl/fl
 mice. Analysis of mRNA levels of Brg1 in the small intestinal epithelium 
of Apc-deficient animals carrying the Brm null allele indicate that low levels of Brg1 
expression cannot compensate for the loss of Brm subunit. Moreover, consistent with the 
notion that only Brg1-proficient lesions of the epithelium become Wnt-activated, cells with 
high levels of Brg1 expression would express the stabilized form of β-catenin and 
subsequently higher Wnt activity potentially accelerating tumorigenesis in 
theAhCreER
+
Apc
fl/fl
Brm null cohort and eventually resulting in the poor prognosis of those 
animals and similar survival to both AhCreER
+
Apc
fl/fl
 and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null 
mice. A similar notion exploiting the existence of a compensatory mechanism between Brm 
and Brg1 in vivo was explored by Oike et al. (2013), suggesting that silencing of Brm would 
provide a therapeutic window for Brg1-deficient cancers however this synthetic lethality 
relationship between two catalytic subunits of SWI/SNF complex relies on the strong tumour 
suppressor role of Brg1 in the context of lung epithelium. Moreover, whereas Brm was 
previously found to functionally compensate for Brg1 in Brg1-deficient human cancer cell 
lines leading to the restoration of Rb signalling and cell cycle arrest as well as re-expression 
of CD44 (Bultman et al. 2000, Reisman et al. 2002, 2003, Glaros et al. 2007). However the 
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extent of the compensation or the mechanism by which it occurs has not been explored within 
this PhD thesis. 
6.3 Future directions  
The data presented in chapter 4 and 5 together demonstrate that the loss of Brm is capable of 
modulation of Wnt-driven tumorigenesis in the intestinal epithelium and furthermore that 
additional deficiency of Brm in the context of Brg1 loss in Wnt-activated tissue exacerbates 
the effects of Brg1 loss. Taken together these results implicate that the presence of Brm 
provides a survival advantage in Brg1-deficient intestinal epithelium and subsequently might 
be a marker for a better prognosis in the colorectal tumorigenesis. In order to explore the anti-
cancer potential of Brm, a long-term study investigating the effects of Brm loss on the 
intestinal tumorigenesis in animals carrying a heterozygous loss of Apc driven by the 
expression of AhCre or AhCreER recombinase transgene would be necessary.    
Several findings in this study suggest the potential for Brm as a novel therapeutic in 
colorectal tumorigenesis. There are a number of possible routes forward to explore this 
further. Firstly, chromatin immunoprecipitation analysis of the small intestinal and colonic 
epithelium would be required in order to establish whether Brm is associated with promoters 
of the Wnt and Notch target genes reported as modulated in this thesis.  Genome-wide 
expression analysis in the context of Brm loss, Brg1 loss and concomitant Brm and Brg1 loss 
in the Wnt-activated epithelium would provide a greater insight into the role of SWI/SNF 
chromatin remodelling in CRC.  
In regards to the animal model used in the experiments, the construction of a conditional Brm 
knock-down allele that could be expressed under the pan-intestinal VillinCre or other 
intestinal-specific recombinase would eliminate Brm effects on other tissues and more 
specifically on the intestinal microenvironment. Stem-cell-specific loss of Brm using 
Lgr5CreER could be used to exclude the possibility of Brm modulating stem cell population 
however due to extremely low levels of recombination a high risk of false negatives exists in 
using this system. In contrast, Apc
Min
 mouse model could replace conditional deletion of both 
Apc alleles driven by AhCreER recombinase. The use of this model of CRC would allow for 
the development of multiple intestinal tumours in the murine epithelium around 6 months of 
age facilitating the observations of the effects of SWI/SNF complex loss in long-term by 
traditional knock-down using Cre-loxP system or using Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPR) to silence Brm in the pre-existing tumours. 
238 
 
5.3.4 Concomitant loss of both Brm and Brg1 does not exacerbate the 
phenotype of Wnt-driven tumorigenesis in the colonic epithelium 
Previous in vivo studies detected an increase in the expression of Brm in the Brg1-deficient 
human cancer cell lines which concurred in some cases with the compensation of Brg1 
function by Brm in mediating the Rb-mediated signalling and restoration of CD44 expression 
(Muchardt and Yaniv 2001, Strobeck et al. 2003). These observations indicate that whereas 
the functional compensation could lessen the impact of deficiency in one catalytic subunit, 
other experiments suggested that Brm and Brg1 display partially redundant functions and 
therefore a disparity may exist in their interactions with target genes regulating tumorigenesis 
(Strobeck et al. 2000, Reisman et al. 2002).  
Therefore I aimed to establish the transcriptional levels of Brm and Brg1 in the small 
intestinal and colonic epithelium across all experimental cohorts used in the preparation of 
this thesis. mRNA from small intestinal and colonic tissue of AhCreER
-
Brm
+/+
 (control), 
AhCreER
+
Brm null (Brm null), AhCreER
+
Brg1
fl/fl
 (Brg1KO), AhCreER
+
Brg1
fl/fl
Brm null 
(DKO), AhCreER
+
Apc
fl/fl
 (ApcKO), AhCreER
+
Apc
fl/fl
Brm null (ApcBrmKO), 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 (ApcBrg1KO) and AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null (TripleKO) 
was extracted and qRT-PCR analysis of mRNA levels of Brm in Brm-proficient animals and 
Brg1 in both Brg1-proficient and Brg1-deficient cohorts. The analysis of the intestinal 
epithelium in the context of the homeostasis revealed that Brg1 is 1.5 fold upregulated in the 
Brm null colonic tissue while in the small intestine a decline rather than an increase in the 
Brg1 is reported. In contrast, in the Brg1KO epithelium of both small and large intestine we 
noted a 10 fold increase in the Brm expression. Nonetheless, combined loss in Brm and Brg1 
detected over 50 fold change in Brg1 in the colon in comparison to 4 fold increase in the 
small intestine. Taken together these results suggest that in the context of small intestinal 
epithelium the fluctuations in the gene expression of Brm and Brg1 are substantially high 
suggesting that intestinal epithelium is not SWI/SNF-independent and requires the function 
of chromatin remodelling complexes containing either Brm or Brg1 at a very discreet levels.   
In the context of Apc deletion and thus Wnt-driven tumorigenesis in the intestinal epithelium, 
the fluctuations in Brm and Brg1 expression were detected by qRT-PCR analysis. A 
significant downregulation of Brg1 in the small intestine and colon of Wnt-activated Brm-
deficient epithelium similar to the effect observed in the Brm null homeostatic tissue 
indicates that in the context of small intestinal epithelium Brg1 is not capable of replacing 
Brm in SWI/SNF chromatin remodelling complexes lacking Brm catalytic subunit. 
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Importantly in contrast to homeostatic tissues, levels of Brg1 were downregulated 
significantly in the intestinal epithelium in the AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null suggesting 
that in the context of Wnt activation, compensation mechanism may be damaged and 
therefore the shift to the large numbers of Brg1-containing complexes is not viable. 
Interestingly, in both types of Brg1-deficient epithelium we have detected 10 fold increases in 
Brm expression however previous reports investigating pan-epithelial loss of Brg1 under the 
expression of VillinCre indicated that deficiency in Brg1 results in the abrogation of stem cell 
maintenance and rapid disruption of crypt-villus architecture therefore suggesting that Brm is 
not capable of compensating for Brg1 function in the maintenance of homeostasis. The 
discrepancies in those observations would be consistent with notion that post-transcriptional 
mechanism such as translation of existing mRNA or protein stability could be responsible for 
the expression levels and therefore possibly compensation between Brm and Brg1. Moreover 
4 fold upregulation in small intestine and 56 fold in colon in the epithelium of 
AhCreER
+
Brg1
fl/fl
Brm null in contrast to a decrease in the Brg1 expression levels in 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null animals might potentially be responsible for very mild 
phenotype of concomitant loss of Brm and Brg1 in normal epithelium in comparison to the 
high level of dysplasia and destruction of crypt-villus architecture in the 
AhCreER
+
Apc
fl/fl
Brg1
fl/fl
Brm null epithelium. 
Furthermore, in order to investigate whether Brm is upregulated at the protein level in the 
epithelium and therefore capable of compensating for Brg1 loss in the context of Wnt 
activation, double immunofluorescence against Brg1 and Brm was conducted on the small 
intestinal and colonic epithelium of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 animals. Importantly, the 
comparison between neighbouring Brg1-proficient and Brg1-deficient lesions revealed that 
Brm expression is upregulated in the colonic but not small intestinal epithelium in contrast to 
fold changes detected by qRT-PCR. Several considerations should be taken into account 
while analyzing the changes observed. Notably, Leedham et al. (2012) assessed the 
physiological levels of Wnt activity and the size of stem cell population across the length of 
intestines in the murine model of stabilizing β-catenin mutation showing that a differential 
Wnt activity and therefore differential response to aberrant Wnt signalling. The same study 
also reported that neoplastic transformation of the epithelium is more severe in the proximal 
small intestine in contrast to very mild effects on the colonic epithelium (Leedham 2012). 
Whereas the authors did not establish the levels of Wnt signalling in the normal intestinal 
epithelium, it is plausible that parallel gradient should be observed in the homeostatic tissue.  
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Taken together these results could provide some insight into the existence of a great 
discrepancy between small intestinal and colonic epithelium and the fluctuations in Brm and 
Brg1 gene expression between those two types of epithelium. This notion however does not 
explain the changes in the gene expression quantified by qRT-PCR and the observations 
conducted using double immunofluorescence in the context of Wnt activation by Apc loss. 
Although mRNA levels of Brm in the small intestine of AhCreER
+
Apc
fl/fl
Brg1
fl/fl
 mice are 4 
fold higher than in the respective colonic epithelium, the disparity of these results with 
reported protein levels of Brm in the same tissue could further indicate that despite of the 
high levels of mRNA further changes occur at the translational or protein level that could 
lead to degradation of existing mRNA template and lower Brm expression. Moreover, we 
previously showed that deficiency in both Brm and Brg1 is well-tolerated in a large intestine 
of AhCreER
+
Brg1
fl/fl
Brm null mice in contrast to small intestinal epithelium. The magnitude 
of changes in Brm and Brg1 expression could be tissue-specific where particular mRNA level 
is “enough” for functional compensation in colon yet “not sufficient” in the context of small 
intestine. This notion would be consistent with more prominent transcriptional upregulation 
of Brm in the small intestine rather than in the colon which however concurs with increased 
expression of Brm and milder phenotype in the large intestinal tissue. The differential 
expression between Brm and Brg1 as described in the mouse embryo showing ubiquitous 
expression of Brg1 throughout the development and higher levels of Brm specifically during 
the differentiation (LeGouy 1998) could account for some of the extent of fold changes 
between Brm-deficient and Brg1-deficient experimental cohorts. Another possible 
explanation for the differences ATPase gene expression levels between homeostatic and Wnt-
activated epithelium could be the impairment of the compensation mechanism in cancer cells. 
The damage in the compensation between Brm and Brg1 is consistent with the increased 
severity of the phenotype in cells carrying Apc deletion than the consequences of deficiency 
in either catalytic subunit in the normal intestinal epithelium.     
Therefore data presented in this chapter suggested that there is a requirement for functional 
Brm or Brg1 ATPase for the maintenance of homeostasis of the epithelium as well as for 
Wnt-driven tumorigenesis. The disparity in the compensation level between Brm and Brg1 
are dependent upon the context of small intestinal or colonic epithelium. While the 
maintenance of homeostasis in Brg1-deficient colonic epithelium requires higher levels of 
Brm upregulation, this prerequisite is less rigorous in the context of Wnt activation as 
transformation and neoplastic response to aberrant Wnt signalling is diminished to a great 
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degree due to gradient in physiological Wnt activity. It can be extrapolated that in the small 
intestinal epithelium the dependency upon respective levels of Brm and Brg1 is inversed due 
to higher gradient of underlying Wnt signalling. Taken together, the results from this and 
previous chapters reveal that Brm and Brg1 ATPases of SWI/SNF chromatin remodelling 
complex show an exceptional tissue-specificity for their functions. Tissue-specificity, Wnt 
gradient and functional redundancy between Brm and Brg1 would therefore account for a 
wide array of the phenotypes and transcriptional responses reported in the intestines of 
various cohorts of experimental animals. SWI/SNF chromatin remodelling complexes 
containing either Brm or Brg1 are subjected to the delicate equilibrium with some limited 
potential of replacement and compensation and with the alterations in the proportions of 
Brm-associated and Brg1-associated complexes generating alternative phenotypes 
characterized by various severities.
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